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Abstract 
Calmodulin (CaM) is a small, acidic cytosolic calcium binding protein that responds to increases in 
intracellular Ca
2+
 concentrations. It is proposed to be involved in binding to and regulating over 300 
functionally and structurally diverse proteins. It is comprised of an N- and C- terminal lobe separated 
by a highly flexible central linker region. Each of these lobes contains two EF hand motifs that are 
each capable of binding to one Ca
2+
-ion. CaM is found to exist primarily in two states: the Ca
2+
-
replete form, holoCaM, or the Ca
2+
-deplete form, apoCaM. Both forms of CaM are able to bind to 
target proteins. CaM also undergoes post translational modifications that play a role in its regulation 
of target proteins.  
 An important target of CaM are the nitric oxide synthase (NOS) enzymes. NOS catalyzes the 
conversion of L-arginine to L-citrulline and nitric oxide (·NO). Three isoforms of NOS are found in 
mammalian cells: endothelial (eNOS); neuronal (nNOS); and inducible (iNOS). All three isoforms of 
NOS are homodimeric and comprised of an N-terminal heme domain, containing the active site, and a 
C-terminal flavin-binding domain containing FAD-, FMN-, and NADPH- binding sites, linked 
together by a CaM-binding region. The nNOS and eNOS isoforms are constitutively expressed and 
are Ca
2+
-CaM-dependent. In contrast, iNOS is regulated at the transcriptional level and is Ca
2+
-
independent. NOS is also found to be regulated through the phosphorylation and de-phosphorylation 
of key residues, specifically Thr 495, which is found in the CaM-binding domain. The exact 
mechanism of how CaM activates NOS is not fully understood. Studies have shown CaM to act like a 
switch that causes a conformational change in NOS to allow for the electron transfer between the 
reductase and oxygenase domains through a process that is thought to be highly dynamic. This thesis 
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is focused on the structure and dynamics of CaM and CaM mutant constructs bound to the target 
peptides of the NOS CaM-binding domain at saturating and physiological concentrations of Ca
2+
.  
 To investigate the structural and functional effects that the phosphorylation of Thr495 of 
eNOS may have on eNOS activation by CaM, the solution structure of CaM bound to the peptide 
comprising the eNOS CaM-binding domain phosphorylated at Thr495 was determined. To investigate 
the Ca
2+
-dependency of CaM binding NOS, nuclear magnetic resonance (NMR) studies were 
performed at various free Ca
2+
 concentrations to determine the structure and dynamics of NOS and 
CaM interactions at physiological Ca
2+
 concentrations. The results illustrate that structures of CaM-
NOS complexes determined at saturating Ca
2+
 concentrations cannot provide a complete picture 
because the differences in intramolecular dynamics become visible only at physiological Ca
2+
 levels.  
Numerous studies use CaM mutants incapable of binding Ca
2+
 in either the N- or C-lobe to 
mimic apoCaM, with some of these studies reporting functional differences when comparing the 
mutant and apo forms of CaM. We investigated the structural consequences of these mutations by 
determining the residue-specific chemical shift perturbations induced by these mutations. This was 
accomplished by determining the full backbone chemical shift assignments of three Ca
2+
-deficient 
CaM mutants in the absence and presence of Ca
2+
, and investigating their interaction with the iNOS 
enzyme through determination of the solution structure of a Ca
2+
-deficient CaM mutant with iNOS. 
The use of NMR spectroscopy allowed for the determination of high resolution structures of these 
complexes. 
15
N relaxation and H/D exchange experiments also allowed for the analysis of the 
structural dynamics occurring in these complexes. NMR spectroscopy is an efficient method for 
studying the dynamics and structures of protein-protein and protein-peptide complexes. 
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Chapter 1 
Literature Review 
1.1 Calmodulin 
1.1.1 Calcium Signaling. 
Calcium (Ca
2+
) ions are important intracellular secondary messengers that relay information within 
cells to regulate their activity. Intracellular Ca
2+
 concentrations regulate multiple cellular processes 
such as cell-cell interactions, cell proliferation, fertilization, muscle contraction, neuron transmission, 
and cell death (Berridge et al., 1998; Evenäs et al., 1998). The intracellular Ca
2+
 concentration ranges 
from a resting state of 50-100 nM up to 1-10 μM in an activated cell (Carafoli, 1987; Evenäs et al., 
1998; Islam, 2012). Intracellular Ca
2+
 can be derived from internal sources by being released from 
Ca
2+
 stores in the endoplasmic or sarcoplasmic reticulum, or from external sources outside by passing 
through various channels spanning the plasma membrane (Berridge et al., 1998; Evenäs et al., 1998; 
Islam, 2012). The functional response to increased calcium levels is regulated by a group of Ca
2+
-
binding proteins that respond to these increases in intracellular Ca
2+
 concentration. Many of these 
Ca
2+
-binding proteins contain a Ca
2+
-binding motif, called an EF hand (Figure 1.1).  
The EF hand motif consists of a helix-loop-helix structure with Ca
2+
 binding occurring in the 
loop region. It is normally paired with another EF hand, with the loop region of each interacting 
through an antiparallel β sheet (Babu et al., 1988; Strynadka and James, 1989). An important Ca2+-
binding protein that contains an EF hand motif is calmodulin (CaM), which contains two pairs. Each 
EF hand motif of CaM consists of 12 amino acids, rich in aspartate and glutamate residues (Figure 
1.1B), which adopt a coil structure between positions 1-6, a short β strand between 7-9, and an α-
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helix between 10-12.  Ca
2+
 is coordinated through 7 oxygen ligands from six residues in the 1-3-5-7-
9-12 positions (Figure 1.1). This results in a pentagonal bipyramidal co-ordination of Ca
2+
 (Babu et 
al., 1988). The destabilizing repulsion caused by the close proximity of the negatively-charged 
carboxylate sidechains involved in coordinating the Ca
2+
 ion is offset by the hydrogen-bonding 
network in the loop. In the absence of Ca
2+
 the EF hands pack with their central core consisting of 
hydrophobic residues and their solvent-exposed faces consisting of charged, hydrophilic residues, in a 
“closed” conformation (Strynadka and James, 1989). Once a Ca2+ ion binds, the helices rearrange, 
into a more “open” conformation, causing the exposure of the hydrophobic residues that are then able 
to bind to target proteins (Strynadka and James, 1989). 
 
Figure 1.1: Ca
2+
-binding EF hand motif showing Ca
2+
 co-ordination. 
(A) Stick representation of Ca
2+
 co-ordination by the EF hand III of CaM. The pentagonal 
bipyramidal co-ordination of the Ca
2+
 ion and oxygen atoms used to stabilize the ligand co-ordination 
of Ca
2+
 are represented by dashed lines. The oxygen atoms, Ca
2+
 ion, and coordinating water are 
shown in red, green and yellow, respectively. Figure derived from PDB 3CLN (Babu et al., 1988). 
(B) Consensus Ca
2+
-binding loop for CaM’s 4 EF hand motifs. This shows the 1-3-5-7-9-12 position 
pattern of the coordinating amino acids, X, Y, Z, -X, -Y and -Z, in the pentagonal bipyramidal co-
ordination binding of Ca
2+
 (Gifford et al., 2007). Secondary structure elements are colored gray for 
coil, blue for β strand and red for α-helix. 
1.1.2 Overview of Calmodulin. 
CaM is a ubiquitous, multifunctional protein, consisting of 148 amino acids and having a molecular 
weight of 16.7 kDa. It is a highly conserved protein that functions as a cytosolic Ca
2+
 receptor in 
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response to varied intracellular signals in almost all eukaryotic cells (Ikura and Ames, 2006). CaM is 
found to have 100% sequence homology in vertebrates, although it is coded for by three genes, CaM 
I, CaM II, and CaM III (Chien and Dawid, 1984; Ikura and Ames, 2006). CaM is transcribed into 
eight mRNAs that are targeted to different cellular domains, where local protein synthesis occurs. 
This indicates that mRNA translocation, and not the CaM protein, is responsible for local CaM pools 
in the different intracellular compartments (Palfi et al., 2002; Kortvely and Gulya, 2004). CaM is also 
found to be highly conserved in other organisms such as plants, fungi and protozoa (Friedberg, 1990). 
1.1.3 Structure of CaM. 
CaM is a small, highly acidic protein (pI approximately 3.9 to 4.3), consisting of N- and C-terminal 
globular domains connected by a flexible central linker (Liu, Y. P.Cheung, 1976; Crouch and Klee, 
1980). Each domain contains an EF hand motif pair, giving CaM the ability to bind a total of four 
Ca
2+
 ions (Crouch and Klee, 1980; Perret et al., 1988). The EF hands of the C-terminal domain 
(Kd~10
-6
M) have a 10-fold higher affinity for Ca
2+
 than the EF hands of the N-terminal domain 
(Kd~10
-5
M), with cooperative binding within each domain (Crouch and Klee, 1980; Martin et al., 
1985). It has been shown that Ca
2+
-binds to CaM in the order of EF hand III, EF hand IV, EF hand I, 
then EF hand II, with Ca
2+
 ion dissociating in the reverse order (Kilhoffer et al., 1992). Even though 
CaM could potentially exist in various Ca
2+
 bound states, it is primarily found in two states: fully 
Ca
2+
-deplete, apoCaM; and fully Ca
2+
-bound, holoCaM (Figure 1.2).  
The N-terminal domain of CaM is comprised of residues 1-75 and the C-terminal domain is 
comprised of residues 82-148, with residues 76-81 corresponding to the flexible central linker. The 
secondary structure of CaM is essentially the same in the apo and holo-forms; however, there are 
differences in helix packing. The structure of apoCaM is more compact than holoCaM, with each 
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domain consisting of four tightly packed antiparallel α-helices. Although these helices are packed 
tighter in the apo form compared to the holo form of CaM, they have been found to be much more 
mobile, with Ca
2+
 binding dramatically reducing their flexibility (Zhang et al., 1995a).  Also 
apoCaM’s C-terminal domain is much more dynamic than its N-terminal domain as observed in the 
solution structures determined by Kuboniwa et al. (1995)(Figure 1.2A).  
 
Figure 1.2: Structure comparison of apo and holo CaM. 
(A) ApoCaM from PDB 1CFC (Kuboniwa et al., 1995), showing highly mobile C-terminal domain, 
(B) holoCaM from PDB 3CLN (Babu et al., 1988), and (C) holoCaM from PDB 1PRW in a compact 
conformation (Fallon and Quiocho, 2003). Residues 1−40 of CaM (EF hand I) are colored red, 
residues 41−79 (EF hand II) purple, residues 80−114 (EF hand III) green, and residues 115−148 (EF 
hand IV) blue. Ca
2+
 ions are shown in green.  
 Upon Ca2+ binding, the EF hands undergo a structural rearrangement, consisting of the 
antiparallel packing of the α-helices shifting to a perpendicular packing. This allows the negatively 
charged side chains to coordinate the Ca
2+
 ion, resulting in a hydrophobic pocket being present on the 
surface of each domain that is not present in the apo-CaM conformation (Kuboniwa et al., 1995; 
Zhang et al., 1995a). This causes the two globular domains of CaM to rotate outwards, increasing the 
distance between them, and changing the more compact shape of apoCaM to the more extended 
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dumbbell shape of holoCaM (Yamniuk and Vogel, 2004). The structures of holoCaM can be in an 
extended state or a compact form (Figure 1.2B and C), illustrating the wide range of conformations 
CaM can adopt because of  its highly flexible linker region (Babu et al., 1988; Chattopadhyaya et al., 
1992; Fallon and Quiocho, 2003).  
 The large hydrophobic patches exposed in holoCaM are rich in methionine residues, with 
four in each domain and one in the central linker, contributing 46% of the total hydrophobic surface 
area (Zhang et al., 1995a). These 9 methionine residues comprise 6% of the total amino acid content 
of CaM, which is much greater than the 1% methionine content average in known proteomes (Ikura 
and Ames, 2006). This high abundance of methionine residues is thought to play an important role in 
CaM’s target recognition due to the high polarizability of the methionine sulfur atom and the ability 
of the long flexible side chains to allow them to be highly conformationally adaptable (Gellman, 
1991). The central linker region of holoCaM,  was originally thought to be a long rigid α-helix from 
the crystal structures, however, it is found to be highly flexible, with the ability to be bent. This 
allows for the orientation of the N- and C-terminal domains to change independently of each other to 
accommodate the binding of different target proteins (Persechini and Kretsinger, 1988).  
1.1.4 CaM binding to Target Proteins. 
Through the use of protein databases recognizing CaM binding motifs, it has been proposed that CaM 
is able to bind to over 300 target proteins (Yap et al., 2000; Shen et al., 2005; Ikura and Ames, 2006). 
This analysis involves the evaluation of a sequence on the basis of its electronic and hydrophobic 
properties and secondary-structure tendency to identify putative basic amphiphilic α-helical motifs 
(Yap et al., 2000; Shen et al., 2005). Currently over 80 unique CaM complexes have been deposited 
in the PDB, along with the characterization of the binding affinity of many more CaM-binding 
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proteins (Shen et al., 2005; Tidow and Nissen, 2013; Mruk et al., 2014). As mentioned earlier CaM 
could potentially exist in various Ca
2+
-bound states, specifically the Ca
2+
-replete, or holo state, and 
the Ca
2+
-deplete, or apo state. Each of these Ca
2+
-saturated states of CaM has been found to bind to 
target proteins. When CaM interacts and binds in the apo form it is referred to as Ca
2+
-independent 
activation, and in the holo form as Ca
2+
-dependent (Rhoads and Friedberg, 1997; Vetter and Leclerc, 
2003).  
 A defined consensus sequence doesn’t exist for CaM-binding sites, however, target proteins 
that bind to CaM generally have a small binding domain of approximately 20 amino acids. These 
domains contain a hydrophobic face in contact with CaM and a basic face in contact with solvent and 
the negatively charged amino acids of CaM’s linker region (O’Neil and DeGrado, 1990). This basic 
face also has important electrostatic interactions that may form salt bridges with aspartate and 
glutamate residues in CaM’s central linker and C-terminal domain (Crivici and Ikura, 1995). The 
binding domains have a tendency to form basic, amphiphilic α-helices, containing bulky hydrophobic 
amino acids (O’Neil and DeGrado, 1990). These conserved bulky hydrophobic amino acids are 
typically arranged in a 1-5-8-14 (which also contains the 1-8-14 motif), 1-5-10 or IQ motif. The 1-5-
8-14 motif is composed of (FILVW)XXX(FAILVW)XX(FAILVW)XXXXX(FILVW) and the 1-5-10 
motif is composed of (FILVW)XXX(FILV)XXXX(FILVW). The underlined amino acids occupy 
sites 1-5-8-14 or 1-5-10 and represent anchoring residues, whereas X can be any amino acid (Rhoads 
and Friedberg, 1997). They are termed anchoring residues because they interact with the hydrophobic 
patches in the terminal domains of CaM, allowing the basic residues between them to interact with 
the linker region (Afshar et al., 1994). Some target proteins are also able to bind to CaM in a Ca
2+
-
independent manner. These target proteins include those that are only bound to apoCaM, and those 
that are tightly bound to CaM in the presence and absence of Ca
2+ 
(Rhoads and Friedberg, 1997). 
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These proteins contain the consensus IQ motif that has the general sequence IQXXXRGXXXR, 
where X can be any amino acid (Rhoads and Friedberg, 1997). However, this consensus sequence is 
also found in some Ca
2+
-dependent proteins (Jurado et al., 1999).  Some examples of well 
characterized CaM binding proteins and their binding modes are summarized in Table 1.1.  
Table 1.1: Overview of some CaM-target proteins. 
Group Target enzyme or protein  Number of Ca
2+
 
CaM binding with canonical binding mode 
Protein kinases CaM-dependent protein kinase I (CAMKI) 4 
 CaM-dependent protein kinase II (CAMKII) 4 
 Myosin light chain kinase (MLCK) 
Death-associated protein kinase  (DAPK) 
4 
4 
Phosphatases Calcineurin 4 
Second messenger Nitric Oxide Synthase (NOS)  4 
 Inducible NOS  0 
 Plasma-membrane Ca
2+
-ATPases (PMCA) 4 
 Voltage-dependent Ca
2+
 channels (CaV1.1) 
CaV2.1 
4 
4 
 Ryanodine receptor RYR1 4 
 Type I adenylate cyclase 4 
Cytoskeletal and 
membrane proteins 
Neuromodulin 0 
 PEP-19 0 
CaM binding in elongated binding mode 
 Bacillus anthracis edema factor (EF) 2 
Ion Channels Small-conductance Ca
2+
-activated K
+
 channels (SK2) 2 
 Voltage-gated sodium channels (Nav1.5) 4 
 Nav1.5 0 
2 CaM bind 1 target protein 
 Myosin-5A 0 
1 CaM binds 2 target proteins 
Enzyme Glutamate decarboxylase 4 
Table made with information from Jurado et al. (1999); Tidow and Nissen (2013); Mruk et al. (2014). 
 Through the structure determination of CaM bound to target peptides or proteins by X-ray 
crystallography and NMR spectroscopy it has been shown that CaM is able to bind in a variety of 
conformations (Table 1.1 and Figure 1.3). The most common binding conformation for canonical 
CaM-recognition motifs consists of the unwinding of the central linker and the N- and C-terminal 
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domains of CaM wrapping around the target protein. This binding can be in a parallel or anti-parallel 
conformation: parallel indicates that the N-terminal lobe of CaM binds towards the N-terminal lobe of 
the target protein and the C-terminal lobe of CaM binds towards the C-terminal lobe of the target 
protein; antiparallel indicates that the terminal lobes of CaM bind to the opposite terminal lobes of the 
target protein (Yamniuk and Vogel, 2004). The electrostatic interactions described above play a big 
role in the orientation of the target protein with respect to the lobes of CaM (Afshar et al., 1994). 
Other unique conformations of CaM binding to target proteins can involve a conformation where: 
CaM itself is wrapped by the target protein and one lobe of CaM is Ca
2+
-saturated (Drum et al., 
2002); more than one CaM subunit is required for target binding (Houdusse et al., 2006); one CaM 
subunit can bind multiple targets (Yap et al., 2003); and only one lobe of CaM is involved in binding 
(Elshorst et al., 1999). 
 
 9 
 
 
Figure 1.3: Structures of CaM bound to various target proteins in various conformations. 
(A) CaM bound to CaM-dependent kinase kinase (CaMKK) in a parallel conformation from PDB 
1IQ5 (Kurokawa et al., 2001). (B) CaM bound to myosin light chain kinase (MLCK) in an anti-
parallel conformation from PDB 2BBN (Ikura et al., 1992). (C) CaM in complex with the edema 
factor of adenylyl cyclase of B. anthracis from PDB 1K93 (Drum et al., 2002). (D) Two apoCaMs 
bound to an unconventional myosin V IQ domain from PDB 2IX7 (Houdusse et al., 2006). CaM has 
the same color scheme as Figure 1.2.The target peptide or enzyme is rendered in light blue. 
1.1.5 Post-Translational Modifications of CaM. 
CaM is found to undergo post-translational modifications that have been suggested to play a role in 
regulating its activity with target proteins. The modifications CaM is found to undergo in vivo include 
acetylation, trimethylation, carboxylmethylation, proteolytic cleavage, and phosphorylation (Benaim 
and Villalobo, 2002). The effect of these CaM modifications on the binding and activation of 
different target proteins still remains unclear (Ikura and Ames, 2006).  
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CaM has 18 putative sites that could be phosphorylated, including 4 serine, 12 threonine and 
2 tyrosine, with 8 sites (Figure 1.4) being shown to be phosphorylated in vitro (Benaim and Villalobo, 
2002). Furthermore, three of these sites, Thr79, Ser81, and Ser101, have been found to be 
phosphorylated in vivo in rat liver, by protein-serine/threonine kinases, (i.e. casein kinase II and 
myosin light-chain kinase) and protein-tyrosine kinases, (i.e. the insulin receptor and the epidermal 
growth factor receptor) (Quadroni et al., 1994; Benaim and Villalobo, 2002).  
 
Figure 1.4: Structural representation of known phosphorylation sites in CaM. 
The 8 amino acid sites in CaM know to be phosphorylated are labeled in red and purple. Residues 
labeled in purple have been found to be phosphorylated in vivo.  
The effect of phosphorylated CaM on target proteins has been investigated. A study by 
Quadroni et al. (1998) found that CaM phosphorylated in vitro by casein kinase II (CKII) increased 
the Vmax of neuronal nitric oxide synthase (nNOS) 2.6-fold and its activity 2-fold. This group 
previously showed CKII is able to phosphorylate CaM at residues Thr79, Ser81and Ser101, but did 
not determine which one was important for the increase in nNOS activity (Quadroni et al., 1994, 
1998). Another study involving the in vitro phosphorylation of CaM at Tyr99 by tyrosine protein 
kinase III (TPK-III) determined that Tyr99-phosphorylated CaM increased the Vmax of nNOS 3.45-
fold and its activity 2.16-fold (Corti et al., 1999). Mishra et al. (2010) hypothesized that hypoxia-
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induced CaM phosphorylated at Tyr99 by TPK-III has a higher affinity for nNOS than non-
phosphorylated CaM, leading to increased activation of nNOS and increased production of nitric 
oxide (·NO). The increased tyrosine phosphorylation of CaM at Tyr99 in the cerebral cortex of 
newborn piglets resulting from hypoxia is mediated by the ·NO derived from nNOS (Mishra et al., 
2010).  
1.2 Nitric Oxide Synthase (NOS) 
One of the many target enzymes that CaM has been found to bind and regulate is nitric oxide 
synthase (NOS). NOS catalyzes the conversion of L-arginine to L-citrulline and nitric oxide (·NO) 
through two monooxygenase reactions. This reaction (Figure 1.5) uses reduced nicotinamide adenine 
dinucleotide phosphate (NADPH) as the electron donor in the presence of oxygen. ·NO is a short-
lived, highly reactive diatomic free radical that can be induced in a variety of cell types and is 
essential in many biological functions (Nahrevanian and Amini, 2009). ·NO has been found to be 
associated with neurotransmission, cellular signaling, vasodilation and the immune response 
(Alderton et al., 2001; Nahrevanian and Amini, 2009).  
 
Figure 1.5: Reaction scheme of NOS-catalyzed conversion of L-arginine to L-citrulline and 
·NO. 
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1.2.1 Isoforms of mammalian NOS. 
Three isoforms of NOS exist in mammals, all of which have different localization and cellular 
function. The three isoforms are neuronal NOS (nNOS, NOS I), inducible NOS (iNOS, NOS II), and 
endothelial NOS (eNOS, NOS III). These isoforms have 51-57% sequence homology in humans and 
differ in size from one another, with nNOS, eNOS and iNOS having a molecular weight of 165, 133 
and 130 kDa, respectively (Alderton et al., 2001; Zhang et al., 2001). The eNOS and nNOS enzymes 
have been found to be constitutively expressed and are thus referred to as the constitutive NOS 
(cNOS) isoforms. They are found to be activated by increased cellular Ca
2+
 through binding to 
holoCaM and are thus Ca
2+
-dependent (Roman et al., 2002). In contrast, iNOS is regulated at the 
transcriptional level in vivo by cytokines in macrophages and tightly binds CaM at basal levels of 
Ca
2+
. Since iNOS binds to CaM regardless of Ca
2+ 
concentration it is classified as Ca
2+
-independent 
(Cho et al., 1992; Roman et al., 2002). 
 The NOS enzymes are homo-dimeric proteins, with each monomer containing an N-terminal 
oxygenase domain and a multi-subdomain C-terminal reductase domain (Figure 1.6). The oxygenase 
domain contains binding sites for iron protoporphyrin IX (heme), (6R)-5,6,7,8-tetrahydrobiopterin 
(H4B), and the substrates L-arginine and molecular oxygen (Alderton et al., 2001). The reductase 
domain contains binding sites for flavin mononucleotide (FMN), flavin adenine dinucleotide (FAD), 
NADPH and in the cNOS isoforms an autoinhibitory region (Alderton et al., 2001). The reductase 
and oxygenase domains are connected by a linker containing a CaM binding domain.  
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Figure 1.6: Domain structure of NOS isozymes. 
The oxygenase and reductase domains are shown in red and pink, respectively. A CaM-binding 
domain separates the oxygenase and reductase domains. Numbers represent the amino acid residue at 
the start and end of the oxygenase, FMN, and FAD/NADPH domains (Alderton et al., 2001).   
 Currently there are no structures of any of the full isoforms available, due to their large size 
and dynamic nature which makes X-ray crystallography and NMR spectroscopy not feasible. 
However, crystal structures of the individual domains have been determined, along with an electron 
microscopy study modelling the eNOS, nNOS and iNOS holoenzymes in the absence (only nNOS 
and eNOS) and presence of holoCaM (Figures 1.7 and 1.8). These include: the oxygenase domain of 
all three isoforms (Fischmann et al., 1999; Li et al., 2001, 2014; Matter et al., 2005, PDBs 4NOS, 
1FOP, 1ZVL, 4D1N and 4D1O); the reductase domain of nNOS (Zhang et al., 2001; Garcin et al., 
2004, PDBs 1TLL and 1F20; CaM bound to the CaM-binding region of eNOS (Aoyagi et al., 2003, 
PDB 1NIW) and nNOS (Valentine et al., 2006, PDB 2O60); CaM bound to the CaM-binding region 
of iNOS (Ng et al., 2009, PDB 3GOF) and CaM bound to the FMN domain with the CaM-binding 
region of iNOS (Xia et al., 2009, PDB 3HR4).  
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Figure 1.7: Crystal structures of NOS oxygenase domains and NOS CaM-binding regions in 
complex with holo-CaM. 
The crystal structure of (A) bovine eNOS oxygenase domain dimer (from PDB 1FOP Li et al., 2001), 
(B) human eNOS oxygenase domain dimer (from PDB 4D1O Li et al., 2014), (C) CaM bound to 
CaM-binding region peptide of eNOS (from PDB 1NIW Aoyagi et al., 2003) (D) rat nNOS 
oxygenase domain dimer (from PDB 1ZVL Matter et al., 2005), (E) human nNOS oxygenase domain 
dimer (from PDB 4D1N Li et al., 2014), (F) CaM bound to CaM-binding region peptide of nNOS 
(from PDB 2O60 Valentine et al., 2006), (G)human iNOS oxygenase domain dimer (from PDB 
4NOS Fischmann et al., 1999), (H) CaM bound to CaM-binding region peptide with FMN domain 
(from PDB 3HR4 Xia et al., 2009), (I) CaM bound to CaM-binding region peptide of iNOS (from 
PDB 3GOF Ng et al., to be published), (J) rat nNOS reductase domain dimer (from PDB 1TLL 
Garcin et al., 2004) and (K) rat nNOS reductase (from PDB 1F20 Zhang et al., 2001).  
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Figure 1.8: Model Structure of iNOS and eNOS architecture based on EM data 
A. The iNOS homology model was generated based on fitting the nNOS reductase crystal structure 
(PDB 1TLL), iNOS FMN/CaM binding domain structure (PDB 3HR4) and the iNOS oxygenase 
dimer (PDB 4NOS). They were fit into a reconstruction of the EM map from the input, the 
intermediate, and the output states of iNOS. Reprinted from Proc. Natl. Acad. Sci. U. S. A, 111 (35), 
Campbell, M. G.; Smith, B. C.; Potter, C. S.; Carragher, B.; Marletta, M., Molecular Architecture of 
Mammalian Nitric Oxide Synthases, E3614–E3623, 2014 with permission from PNAS. B. The eNOS 
homology model was generated based on fitting the nNOS reductase crystal structure (PDN 1TLL), 
iNOS FMN/CaM binding domain structure (PDB 3HR4) and the eNOS oxygenase dimer (PDB 
1FOP). The final model fit of the eNOS homodimer into the reconstruction of eNOS cryo-EM maps 
in the absence of CaM on the left and presence of CaM on the right. One monomer is shown in red, 
the other in blue. Reprinted from Journal of Structural Biology, 188 (1),  Volkmann, N.; Martasek, P.; 
Roman, L. J.; Xu, X. P.; Page, C.; Swift, M.; Hanein, D.; Masters, B. S., Holoenzyme structures of 
endothelial nitric oxide synthase - An allosteric role for calmodulin in pivoting the FMN domain for 
electron transfer, 46-54, 2014, with permission from Elsevier. Data in B was acquired in the absence 
of NADP
+
, suggesting a “closed” state, whereas an “open” state would occur when both CaM and 
NADP
+
 are bound, as observed in the input state in A with data from Campbell et al. The structures in 
A would more accurately describe NOS. 
 17 
 
The crystal structures of the oxygenase domains show that all three isoforms have a similar 
fold and that the dimer interface contains the heme and a structural zinc ion coordinated by four 
conserved cysteine residues, two from each monomer, which are involved in dimer stability (Roman 
et al., 2002). These structures have also shown the reductase domains of eNOS and nNOS form 
dimers, stabilized by salt bridges and hydrogen bonding in the interface, which has been disputed 
(Roman et al., 2002; Campbell et al., 2014). The iNOS reductase domain has not been observed to 
form a dimer (Roman et al., 2002; Garcin et al., 2004).  
 
Figure 1.9: Electron transfer within NOS dimer. 
The two NOS monomers are shown in blue and red. Electrons are transferred from (A) NADPH to 
FAD (B) to the FMN subdomain of the reductase domain of one monomer. Then (C) to the heme in 
the oxygenase domain of the opposite monomer (Alderton et al., 2001; Campbell et al., 2014). 
1.2.2 NOS mechanism. 
The mechanism of the electron transfer in NOS is still not fully understood, but possible mechanisms 
have been proposed. However, CaM binding to the CaM-recognition linker of the NOS enzymes is 
required to initiate the electron transfer reaction. This mechanism begins with the transfer of electrons 
from NADPH to FAD (Figure 1.9A), then from FAD to FMN in the reductase domain, which is 
known as the input state (Figure 1.9B). This is followed by transition to the output state (Figure 
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1.9C), that involves the electron transfer from the FMN subdomain to the heme of the oxygenase 
domain of the opposite monomer (Alderton et al., 2001; Campbell et al., 2014). This electron transfer 
from FMN to the heme of the opposite oxygenase domain cannot proceed without a subunit 
realignment and occurrence of conformational changes because the distance between them is 70 Å 
(Garcin et al., 2004). It was previously thought that CaM binding to the CaM-binding domain of NOS 
causes a dynamic process where the FMN subdomain is allowed to swing back and forth between the 
FAD and heme, shown in Figure 1.10 (Garcin et al., 2004; Daff, 2010). 
 
Figure 1.10: Structures of the domains of NOS aligned by amino acid sequence. 
Shown is the reductase domain of nNOS (PDB 1TLL), CaM-binding region of eNOS bound with 
CaM (PDB 1NIW) and the dimeric oxygenase domain of nNOS (PDB 1ZVL). The FMN domain 
proposed to “swing” between the FAD and heme is circled in black. Reprinted from Nitric Oxide, 23 
(10), Daff, S., NO Synthase: Structures and Mechanisms, 1-11, 2010, with permission from Elsevier. 
More recent studies using cryo-electron microscopy, and biophysical techniques, such as 
pulsed-electron paramagnetic resonance, have given better insight into the CaM activated NOS 
mechanism (Campbell et al., 2014; Leferink et al., 2014; Volkmann et al., 2014). Although crystal 
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structures of individual domains of NOS have been reported, no NOS holoenzyme structure had been 
determined. Electron-microscopy studies were used to obtained a higher order domain architecture of 
inducible, endothelial, and neuronal NOS with and without CaM bound. The structures are similar, 
consisting of a dimerized oxidase domain, which acts as the anchoring dimeric structure for the entire 
enzyme molecule. It is flanked by two separated reductase domains, which exist in an equilibrium of 
conformations that alternate between FAD-FMN electron transfer and FMN–heme electron transfer 
with CaM binding inducing a shift in the conformational equilibrium to allow efficient electron 
transfer in NOS enzymes (Campbell et al., 2014; Volkmann et al., 2014). The conformations in 
Figure 1.8 represent snapshots of the continuous electron transfer pathway from the reductase domain 
in one monomer to the oxidase domain in the opposite monomer, which reveal that only a single 
reductase domain participates in electron transfer at a time. CaM activates NOS through the 
stabilization of structural intermediates and precise positioning of the pivot for the FMN domain 
tethered shuttling motion to accommodate efficient and rapid electron transfer in NOS (Campbell et 
al., 2014; Leferink et al., 2014; Sobolewska-Stawiarz et al., 2014; Volkmann et al., 2014).  
All this information leads to a refined mechanism of NOS activity that suggests NOS exists in 
an equilibrium of conformations (Figure 1.11). In the resting state, both reductase domains adopt 
mostly open or ‘extended’ conformations, which shift towards a more ‘closed’ conformation upon 
binding of NADPH (Sobolewska-Stawiarz et al., 2014). Upon CaM binding, NOS adopts a variety of 
conformations compatible with both inter-flavin electron transfer, “input” state, and FMN to heme 
electron transfer, “output” state (Campbell et al., 2014; Volkmann et al., 2014).  
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Figure 1.11: Current proposed mechanism for electron transfer: 
In the open state (resting state), both reductase domains adopt mostly open or ‘extended’ 
conformations, which are very flexible. This shift towards a more ‘closed’ conformations upon 
binding of NADPH. Upon CaM binding, NOS adopts a variety of conformations compatible with 
both inter-flavin electron transfer, “input” state, and FMN to heme electron transfer, “output” state, 
indicated by the yellow arrow. Only one FMN domain participates in electron transfer at a time 
(Campbell et al., 2014; Leferink et al., 2014). 
1.2.3 CaM binding to NOS enzymes. 
CaM binds to NOS with a 1-5-8-14 CaM-binding motif, as shown in Figure 1.12, with the binding 
region consisting of residues 491-512 of eNOS, 731-752 of nNOS and 510-531 of iNOS (Aoyagi et 
al., 2003). 
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                                                  1           5          8            14 
             eNOS  TRKKT FKEVA NAVKI SASLM GT   (491-512) 
             nNOS   RRAI G FKKLA EAVKF SAKLM GQ  (731-752) 
               iNOS    RRE I P LKVLV KAVLF ACMLM RK   (510-531) 
Figure 1.12: Sequence of CaM-binding domains of NOS. 
Residues corresponding to the 1-5-8-14 CaM-binding motif are shown. The sequences are for human 
iNOS, rat nNOS and bovine eNOS. Acidic and basic residues are shown in red and blue, respectively. 
A previous crystal structure and a solution structure from our lab show that the CaM binding 
region of iNOS forms an α-helix that CaM wraps around, as shown in Figure 1.7 H and I (Xia et al., 
2009; Piazza et al., 2012). Although iNOS displays Ca
2+
-independent binding, it contains a 1-5-8-14 
consensus binding motif of Ca
2+
-dependent proteins, similar to cNOS, instead of containing the 
consensus IQ binding motif characteristic of Ca
2+
-independent proteins, as described in section 1.1.3. 
However, its sequence differs from nNOS and eNOS by 42% and 30%, respectively, and has a much 
larger patch of hydrophobic residues in its α-helical conformation that binds with higher affinity to 
CaM (Aoyagi et al., 2003). Spratt et al. (2007) had previously shown that an iNOS peptide containing 
the CaM binding region binds to CaM in an antiparallel orientation, which was confirmed by the 
determined structures of the CaM-iNOS complex.  
The rate constants for the binding of CaM to the NOS target peptides have been determined 
using several methods and show that CaM binds to the iNOS peptide with a higher affinity than the 
cNOS peptides (Table 1.2). The methods used include: fluorescence measurements with dansylated 
CaM (Vorherr et al., 1993; Anagli et al., 1995; Matsubara et al., 1997); surface plasmon resonance 
(SPR, Zoche et al., 1996); competition assays (Zhang and Vogel, 1994; Venema et al., 1996; Yuan et 
al., 1998); and FRET and stopped-flow spectroscopy (Wu et al., 2011). 
These results showed that the cNOS peptides reversibly bind to CaM with nanomolar 
affinities and no binding was observed in the absence of Ca
2+
, suggesting that the regulation of 
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cellular Ca
2+
 concentrations modulates this dynamic interaction. CaM binding to the iNOS peptide 
was found to be irreversible, Ca
2+
-independent and to occur with a higher affinity. Ca
2+
 removal did 
not remove CaM from the iNOS peptide. However, Wu et al. found that the Ca
2+
-depleted N- and C- 
lobes of CaM slowly separated from each other likely due to the conformational rearrangement of apo 
CaM. 
Table 1.2: Binding kinetics of CaM binding to NOS peptides. 
 ka (M
-1
s
-1
) kd (s
-1
) Kd (nM) 
eNOS 2.9 x 10
8i
  4.5
i 
1.6
i
, 2.9
g
, 4.0
f
 
nNOS 1.58 x 10
5e
, 6.6 x 10
8i
  7.87 x 10
-4e
, 3.7
i 
1.0
c
, 1.8
a
, 2.2
b
, 5.0
e
, 5.6
i 
iNOS 3 x 10
4e
, 6.1 x 10
8i 
<10
-5e
, 0.063
i 
<0.1
d,e
, 0.1
f
, 0.3
h
, 1.5
f
, 3.3
i
 
 
a 
(Vorherr et al., 1993) 
b 
(Zhang and Vogel, 1994) 
c
 (Sheta et al., 1994) 
d
 (Anagli et al., 1995) 
e
 (Zoche et al., 1996) 
f
 (Venema et al., 1996) 
g
 (Matsubara et al., 1997) 
h
 (Yuan et al., 1998) 
i
 (Wu et al., 2011) 
A study by Weissman et al. (2002) showed four steps are required for CaM binding and 
activation of nNOS. First Ca
2+
 binds to the C-lobe of CaM, followed by this now Ca
2+
-replete lobe 
binding to nNOS. When the intracellular Ca
2+
 concentration is increased the N-lobe binds Ca
2+
, then 
this Ca
2+
-replete lobe binds to nNOS. This model also suggests the reverse order of these steps occurs 
for deactivation of nNOS when the intracellular Ca
2+
 concentration decreases (Weissman et al., 
2002).  
1.2.4 Regulation of NOS. 
The cNOS isoforms contain an autoinhibitory (AI) loop and all NOS isoforms contain extended C-
terminal tails that act in conjunction with CaM as elements to regulate NOS’s activity. The AI loop 
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found in the cNOS enzymes is positioned adjacent to the CaM-binding region and is thought to lock 
the FMN domain in its electron accepting position when Ca
2+
 concentrations are low. Upon the 
increase of the Ca
2+
 concentration the AI  loop is only displaced upon Ca
2+
-replete CaM binding 
(Salerno et al., 1997; Garcin et al., 2004). Another study showed that when this AI loop was removed 
from the cNOS isoforms, Ca
2+
-dependent CaM activation was reduced and enzymatic activity 
increased by a factor of two compared to wild-type, and when it was inserted in the iNOS reductase 
domain, activity decreased by one third of wild-type (Montgomery et al., 2000; Knudsen et al., 2003). 
This implicates the AI loop in playing a role in the Ca
2+
 dependency of the cNOS isoforms perhaps by 
the direct interaction with CaM or the CaM binding site (Jones et al., 2004). 
 The C-terminal domain is thought to play a role in the electron transfer between the flavins, 
as well as protecting the NOS enzymes from becoming fully oxidized (Roman et al., 2002). All three 
isoforms have a C-terminal tail, ranging from 21 to 42 amino acids, with nNOS being the longest and 
iNOS the shortest. Removal of this tail from the NOS isoforms resulted in a large increase in electron 
flow between the flavins; however, these truncated NOS enzymes became fully oxidized without 
exhibiting the one-electron semiquinone form of the wild-type enzyme (Roman et al., 2002). 
 These regulatory elements are responsible for the control of the Ca
2+
 dependency of the NOS 
isoforms, and the control of electron flow, as well as providing a protective function for NOS. The 
binding of CaM to cNOS displaces these regulatory elements; however, the absence of this AI loop 
and the shorter C-terminal tail in iNOS along with the Ca
2+
-independence of iNOS require further 
study. 
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1.2.5 Post-Translational Modifications of NOS. 
The binding of CaM and the transfer of electrons from the reductase to the oxygenase domain of the 
cNOS enzymes, particularly eNOS, is dependent on protein phosphorylation and dephosphorylation 
(Fleming and Busse, 2003). Phosphorylation of eNOS can occur on serine, tyrosine and threonine 
residues and eNOS contains many potential phosphorylation sites that can play a role in regulating its 
activity (Fleming et al., 1998; Harris et al., 2001; Michell et al., 2001; Kou et al., 2002). 
Phosphorylation of Ser 1177, which is located in the C-terminal tail extension, in the reductase 
domain has been found to result in the activation of eNOS, whereas the phosphorylation of Thr 495 
within the CaM-binding domain has been found to reduce eNOS activity (Fleming et al., 2001; 
Matsubara, 2003; Tran et al., 2008). Phosphorylation of Ser 633, found in the AI loop, has also been 
shown to increase eNOS activity (Michell et al., 2002) Perturbations of eNOS phosphorylation have 
been reported in a number of diseases (Kolluru et al., 2010). Phosphorylation of Thr495 acts as a 
negative regulatory site and has been reported to interfere with the binding of CaM to the CaM-
binding domain affecting activation of the enzyme (Fleming et al., 2001; Fleming and Busse, 2003). 
1.3 NMR Spectroscopy 
One of the main methods to determine the 3D structure of a protein is through the use of NMR 
spectroscopy. NMR can be used to determine high resolution 3D structures, comparable to X-ray 
crystallography, and to monitor protein-ligand interactions and internal dynamics of a protein 
(Wüthrich, 1986). NMR is also used to determine structures of proteins and molecules that cannot be 
crystallized due to their high flexibility and mobility. The determination of large protein structures 
becomes a limitation of NMR because of chemical shift overlap and lower sensitivity. Also, proteins 
require the incorporation of isotopes such as 
15
N and 
13
C, which are costly (Wüthrich, 1986; 
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Cavanagh et al., 2007). For NMR studies of complexes, both partner proteins must be available in 
stable isotopically (
13
C, 
15
N) labeled forms. The most common technique for isotopically labeling 
proteins is to clone and over express them in bacteria, most frequently using E. coli. 
The NMR experiment consists of placing a solution of the protein of interest inside a static 
magnetic field and detecting the unique resonance frequencies of the NMR active nuclei when they 
are exposed to radiofrequency (RF) radiation (Wüthrich, 1986; Ernst, Richard et al., 1987). The first 
step in this structure determination is to completely assign the 
1
H spectrum of the protein, then assign 
as many nuclear Overhauser enhancement (NOE) interactions as possible (James and Oppenheimer, 
1994; Neuhaus and Williamson, 2000).The principal information necessary for determining the 3D 
structure of a protein is derived from NOE measurements, which provide a set of internuclear proton 
distance constraints (James and Oppenheimer, 1994). NOEs are due to the dipolar coupling, through-
space, between nuclei, in which the local field at one nucleus is influenced by the presence of the 
other (Neuhaus and Williamson, 2000). The larger the number of NOE restraints, the higher the 
accuracy of the structure.  
The problem with the assignment of larger proteins is overlapping of resonances and 
increased line widths, due to the increasing rotational correlation time. The solutions to these 
problems are the isotopic labelling of the sample and the use of 2D and 3D heteronuclear NMR 
(Ernst, Richard et al., 1987; Evans, 1995). 2D experiments are used to measure the correlation of two 
nuclei resonance frequencies through-bond or through-space (Wüthrich, 1986). The use of 3D and 4D 
experiments have aided in overcoming the problem of overlapping peaks by expanding the 2D 
spectrum into additional dimensions, allowing these overlapping areas to be separated into layers. 
One of the key spectra used in structure determination is the 
1
H-
15
N-heteronuclear single 
quantum correlation (HSQC) experiment (Bodenhausen and Ruben, 1980). This experiment 
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correlates each proton attached to a nitrogen atom in the protein, which include the backbone amides 
except proline, and the side chain amides. This spectrum provides the “finger print” of the protein, 
typically giving rise to one peak for each amino acid in the protein. Assignment of these peaks to 
specific residues in the protein cannot be done using the 
1
H-
15
N-HSQC alone, and other 3D 
experiments must be performed. These experiments were used to assign the 
1
H, 
13
C, and 
15
N chemical 
shifts for the protein and are shown in Figure 1.13. Once all of the 
1
H, 
13
C, 
15
N resonance assignments 
have been determined, the through-space nuclear Overhauser effect spectroscopy (NOESY) 
experiment can be used to determine distance constraints. The NOESY shows NOE cross-peaks of 
nuclei that are close (within ~5Å) in the folded protein but may be far away in the primary sequence 
(Wüthrich, 1986). 
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Figure 1.13: Heteronuclear multidimensional NMR experiments used for resonance 
assignments of proteins. 
NMR experiments used to make resonance assignments for 
1
H, 
13
C and 
15
N nuclei in a protein 
(Cavanagh et al., 2007). This is done by the transfer of magnetization through bonds, shown by blue 
lines, to different nuclei, shown by blue circles. (A) HNCA-3D experiment which correlates the 
15
N 
and NH chemical shifts with the intraresidue and preceding residue Cα shift (Kay et al., 1990). (B) 
CBCA(CO)NH-3D experiment which correlates the 
15
N and NH chemical shifts with the preceding 
residue Cα and Cβ shift (Grzesiek and Bax, 1992b). (C) HNCO-3D experiment which correlates the 
15
N and NH chemical shifts with the preceding residue carbonyl shift (Kay et al., 1990). (D) 
HN(CO)CA-3D experiment which correlates the 
15
N and NH chemical shifts with the preceding 
residue Cα shift (Bax and Ikura, 1991). (E) HCACO which correlate the carbonyl shift the 
intraresidue Cα and Hα shifts (Kay et al., 1990). (F) 3D-TOCSY (TOtal Correlation SpectroscopY) 
HSQC-3D experiment which correlates the 
15
N and NH chemical shifts with the side chain 
1
H shifts 
(Bax et al., 1990). 
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1.3.1 Strategy for NMR spectra assignment. 
The NMR spectra were visualized and assignments made using the Computer Aided Resonance 
Assignment (CARA) version 1.8.4 (Keller, 2005). The assignment of the protein starts with the 
1
H-
15
N-HSQC spectrum. After arbitrarily assigning system numbers to each peak in the 
1
H-
15
N-HSQC 
spectrum, HNCA, HN(CO)CA and CBCA(CO)NH spectra are used to correlate the HN of amino acid 
“i” on the 15N-HSQC to a Cα of amino acid “i” and “i-1”, and Cβ of “i-1”.  
After all possible peaks are assigned to HN, Cαi, Cαi-1 and Cβi-1, the HNCA is used to start 
the backbone assignment. The residues are connected by finding the best matches of the Cαi chemical 
shift from one system with the Cαi-1 chemical shift of a different system. This is done by viewing the 
HNCA spectrum as a strip for each amide peak system and aligning all best possible carbon chemical 
shifts for the preceding and subsequent amide system. Residues chosen as starting points for the 
backbone assignment are those that have unique carbon chemical shifts, such as threonine, alanine 
and glycine. The backbone is connected by confirming that the chemical shifts of the adjacent amino 
acids are in the correct range for the required amino acid in the sequence. 
After a tentative backbone assignment is made using the HNCA spectrum, the 
15
N-NOESY-
HSQC spectrum is used to aid in confirming the assignment. In the HNOE plane of each NH in the 
15
N-
NOESY, cross peaks of the NHi-1 and NHi+1 should be present, which, if the backbone assignment is 
correct, will correspond to the NH of the adjacent amino acids in the sequence. Next, the intraresidue 
side chain carbon and proton peaks are assigned using various TOCSY experiments obtained. The 
side chain carbon assignments are made using the hCCH-TOCSYali experiment, whereas, the side 
chain proton assignments are made using the HCcH-TOCSYali, 
15
N-TOCSY-HSQC and HcccoNH 
experiments. After all possible spins are assigned to each amino acid, NOE cross peaks can be 
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assigned by analyzing the various NOESY experiments obtained. The 
15
N-NOESY HSQC and 
13
Cali-
NOESY HSQC spectra are viewed and all cross peaks not assigned to intraresidue protons are 
assigned to interresidue protons.  
1.3.2 NMR methods for studying protein dynamics. 
In addition to 3D structures, NMR spectroscopy can also provide quantitative information on 
molecular dynamics of protein systems at a residue specific level. These studies provide direct 
evidence of structural changes and intramolecular dynamics associated with functions that are central 
to understanding the role of dynamics in protein function (Kay, 1998, 2005; Ishima and Torchia, 
2000; Wand, 2001; Kempf and Loria, 2003; Kwan et al., 2011). By tracking chemical shift changes, 
NMR spectroscopy is able to characterize very weak interactions between proteins and ligands at 
atomic (or residue) levels (Pochapsky et al., 2010; Sikic et al., 2010). NMR spectroscopy can also 
provide information about conformational dynamics and exchange processes of biomolecules at 
timescales ranging from picoseconds to seconds, and is very efficient in determining ligand binding 
and mapping interaction surfaces of protein/ligand complexes as shown in Figure 1.14 (Kay, 1998; 
Ishima and Torchia, 2000). 
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Figure 1.14: Time scales of various dynamic processes found in proteins and NMR method used 
to determine them (Kay, 1998, 2005; Ishima and Torchia, 2000). 
1.3.2.1 Amide exchange experiments. 
Detailed information about fluctuations in protein structures and site-specific information on the 
stability of secondary structural elements can also be obtained from the measurement of amide proton 
(NH) hydrogen/deuterium exchange (H/D) rates using NMR spectroscopy (Andrec et al., 1995; 
Polshakov et al., 2006; Ma and Nussinov, 2011). These fluctuations expose some of the NH to the 
D2O solvent, thus facilitating the NH/ND exchange process while other amide protons remain 
protected from exchange. The exchange rate of NHs in proteins is determined by a combination of 
their intrinsic exchange rate in the absence of secondary structure and the presence of secondary 
structure and solvent inaccessibility that protect from exchange (Englander and Kallenbach, 1983; 
Englander and Mayne, 1992). H/D exchange experiments are also useful for accessing the stability of 
specific structure elements within a protein or protein complex (Williams et al., 2003, 2004).  
1.3.2.2 15N relaxation experiments. 
Information about residue specific internal dynamics on the fast, picosecond to nanosecond, timescale 
is determined primarily from model-free analyses (Lipari and Szabo, 1982a; Kay, 1998). This is 
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accomplished through the analysis of longitudinal (T1) and transverse (T2) relaxation, as well as 
heteronuclear NOEs (Kay et al., 1989). This allows internal motions such as bond vibrations and 
librations to be interpreted through the determination of order parameters (S
2
) and internal effective 
correlation times (τe) by the “model free” approach (Lipari and Szabo, 1982a). These parameters 
quantitatively describe the magnitude and time scale of local, intramolecular motions and thus allow 
one to correlate molecular dynamics with biological function. The model-free approach characterizes 
backbone mobility using an order parameter S
2
, which may be interpreted as the amplitude of the 
motion, and a correlation time, τi, which is the characteristic time constant of this motion (Kay, 2005, 
2015; Kay and Frydman, 2014).  
1.4 Research Objectives 
The purpose of this thesis was to further characterize the structural and dynamic interaction of CaM 
with the NOS enzymes. This was to be accomplished by:  
1. Determining the solution structure of CaM bound to the peptide of the eNOS CaM-binding 
domain phosphorylated at Thr495. 
2. Elucidating the chemical shift perturbations induced by residue specific mutations of CaM 
interacting with NOS peptides and determining the structure of a Ca
2+
-deficient CaM mutant 
with eNOS. 
3. Determine the structure and dynamics of NOS and CaM interactions at physiological Ca2+ 
concentrations.  
4. Investigate the structural changes induced by Ca2+-binding disabling mutations to CaM. 
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Chapter 2 
Solution structure of calmodulin bound to the target peptide of 
endothelial nitric oxide synthase phosphorylated at Thr495* 
2.1 Introduction 
CaM is a ubiquitous cytosolic Ca
2+
-binding protein that consists of two globular domains joined by a 
flexible central linker region. CaM binds and activates the Ca
2+
- dependent cNOS enzymes at 
elevated intracellular cellular Ca
2+
 concentrations, whereas, CaM binds and activates iNOS in a Ca
2+
-
independent manner. A large conformational change that CaM induces in the reductase domain of the 
NOS enzymes allows for the FMN domain to interact with the FAD to accept electrons and pass the 
electrons on to the heme during catalysis (Welland and Daff, 2010). Clearly, these conformational 
changes caused by CaM are important in stimulating efficient electron transfer within the NOS 
enzymes. 
                                                     
*
 The results presented in this chapter have been published: 
Piazza, M., Taiakina, V., Guillemette, S. R., Guillemette, J. G., Dieckmann, T., (2014) Solution 
Structure of Calmodulin bound to the target peptide of Endothelial Nitric Oxide Synthase 
phosphorylated at Thr495, Biochemistry, 53 1241-1249. 
Unless otherwise stated, all of the work reported in this chapter was performed and analyzed by the 
candidate. The experiment depicted in Figure 2.5 was performed by S. R. Guillemette. The experiment 
depicted in Figure 2.13 was performed by V. Taiakina. 
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The activity of eNOS is regulated by multiple mechanisms, including posttranslational 
modifications such as protein phosphorylation (Fleming and Busse, 2003; Piazza et al., 2012). The 
binding of CaM and the transfer of electrons from the reductase to the oxygenase domain of eNOS is 
dependent on protein phosphorylation and dephosphorylation (Fleming and Busse, 2003). The eNOS 
enzyme can be phosphorylated on serine, tyrosine and threonine residues and contains many potential 
phosphorylation sites that can play a role in regulating its activity (Fleming et al., 1998; Harris et al., 
2001; Michell et al., 2001; Kou et al., 2002). Phosphorylation of Ser1177 in the reductase domain has 
been found to result in the activation of eNOS, whereas the phosphorylation of Thr495 within the 
CaM-binding domain has been found to reduce eNOS activity (Fleming et al., 2001; Matsubara, 
2003; Tran et al., 2008). Perturbations of eNOS phosphorylation have been reported in a number of 
diseases (Kolluru et al., 2010). Phosphorylation of Thr495 acts as a negative regulatory site and has 
been reported to interfere with the binding of CaM to the CaM-binding domain affecting activation of 
the enzyme (Fleming et al., 2001; Fleming and Busse, 2003). 
 There is considerable interest in understanding the structural and functional effects that the 
phosphorylation of Thr495 in eNOS has on the calcium dependent CaM binding and activation of the 
enzyme. In the present study the structural and functional effects that the phosphorylation of eNOS 
has on binding to CaM were investigated. Steady-state fluorescence and isothermal titration 
calorimetry (ITC) were used to monitor the binding of CaM to the wild type eNOS CaM-binding 
domain peptide and the eNOS CaM-binding domain peptide phosphorylated at Thr495 at various free 
Ca
2+
 concentrations. The structural effects of Thr495 phosphorylation on CaM binding to eNOS were 
investigated by the determination of the solution structure of CaM bound to the eNOS CaM-binding 
domain peptide phosphorylated at Thr495. This investigation provides a better understanding of the 
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interaction of CaM with the phosphorylated or nonphosphorylated CaM-binding domain of eNOS at 
Thr495. 
2.2 Methods and experiments 
2.2.1 CaM protein expression. 
The vector pET9d (NOVAGEN) used to express the rat calmodulin was made by Newman (2003) by 
cloning in the CaM sequence using restriction enzyme sites, NcoI and BaMHI. An overnight culture 
of transformed E. coli BL21 (DE3) with pET9dCaM was used to inoculate 1 L of LB media in 4 L 
flasks supplemented with 30 μg/ml of kanamycin. Protein expression was induced after an OD600nm of 
0.6 - 0.8 was reached with 500 μM isopropyl-β-D-thiogalactopyranoside (IPTG) and the cells were 
harvested after 4 h by centrifugation at 6000 x g at 4°C for 5 minutes. 
2.2.2 CaM purification. 
Cells were resuspended in 4 volumes of 50 mM MOPS, 100 mM KCl, 1 mM EDTA, 1 mM DTT, pH 
7.5 and lysed by homogenization using an Avestin EmulsiFlex-C5 homogenizer (Ottawa, ON). The 
lysate was then clarified by centrifugation at 48,000 x g for 30 minutes at 4°C. To the clarified 
supernatant, CaCl2 was added to a concentration of 5 mM in order to saturate CaM with Ca
2+
 and 
induce the exposure of hydrophobic patches in the N- and C-domains of CaM to allow CaM to 
interact with the resin. This Ca
2+
-saturated supernatant was then loaded onto phenyl sepharose 6 fast 
flow highly-substituted resin (GE Healthcare Bio-Sciences, Baie d’Urfe, PQ) in a 1 cm x 10 cm 
column connected to the Äkta design system (GE Healthcare Bio-Sciences, Baie d’Urfe, PQ) 
equilibrated with 50 mM Tris-HCl, 1 mM CaCl2, pH 7.5 @ 4°C. After the Ca
2+
-saturated solution 
was loaded; the resin was washed with 5 column volumes of the above buffer. The resin was 
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subsequently washed with 3 column volumes of 50 mM Tris-HCl, 500 mM NaCl, 1 mM CaCl2, pH 
7.5 @ 4°C to remove any non-specific proteins that were interacting with the resin. The resin was 
finally washed with 3 column volumes of 50 mM Tris-HCl, 1 mM CaCl2, pH 7.5 to remove NaCl 
from the resin. CaM was then eluted from the phenyl sepharose resin with 10 mM Tris-HCl, 10 mM 
EDTA, pH 7.5 @ 4°C and 2 mL fractions were collected. Fractions were then scanned from 325 to 
250 nm on a Varian Cary UV–visible Spectrophotometer (Varian, Mississauga, ON). Fractions 
displaying the characteristic absorbance peaks of CaM at 277 nm (for tyrosine residues) and 269, 265, 
259, and 253 nm (for phenylalanine residues) were pooled and concentrated to 2 mL sample sizes. 
The samples were then run through a HiLoad 16/600 Superdex 75 column (GE Healthcare Bio-
Sciences, Baie d’Urfe, PQ) connected to the Äkta design system using buffer consisting of 50 mM 
Tris-HCl, 0.5 mM EDTA, pH 7.5. Fractions eluted at the characteristic time point for proteins of 
CaM’s size were collected. Isolation and purity of the CaM proteins (148 residues) were confirmed 
by ESI-MS and SDS-PAGE. 
2.2.3 NOS CaM-binding domain peptides. 
The human eNOS (TRKKTFKEVANAVKISASLMGT, 22 residues corresponding to residues 491-
512 from the full length eNOS protein) peptide was custom synthesized by Sigma-Aldrich Inc. The 
Thr495 phosphorylated human eNOS (TRKKpTFKEVANAVKISASLM, 20 residues corresponding 
to residues 491-510 from the full length eNOS protein) peptide was custom synthesized by GenScript. 
The phosphorylation was confirmed by ESI-MS.  
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2.2.4 NMR experiments. 
2.2.4.1 Sample preparation for NMR investigation. 
An overnight culture of transformed E. coli BL21 (DE3) with pET9dCaM was used to inoculate 1 L 
of M9 media (11.03 g/L Na2HPO4·7H2O, 3.0 g/L KH2PO4, 0.5 g/L NaCl, 2 mM MgSO4, 0.1 mM 
CaCl2, 3 μM (NH4)6(MO7)24, 400 μM H3BO3, 30 μM CoCl2, 10 μM CuSO4, 80 μM MnCl2·4H2O, 10 
μM ZnCl2, 10 mM FeSO4, 100 μg/mL kanamycin) containing 2 g/L 
13
C-glucose and 1 g/L 
15
NH4Cl. 
13
C-
15
N CaM was purified as described in section 2.2.2. The samples were prepared for NMR 
experiments via a buffer exchange into NMR solution (100 mM KCl, 10 mM CaCl2, 0.2 mM NaN3, 
90% H2O/10% 
2
H2O) at pH 6.0 using a YM10 centrifugal filter device (Millipore Corp., Billerica, 
USA). All NMR samples contained at least 1 mM CaM in a total volume of 500 μL. The samples 
were transferred into 5 mm NMR sample tubes and stored at 4
o
C until required for NMR 
experiments.  
The expression and purification of the various isotopically labeled CaM constructs produced 
peptide-free holoCaM. To obtain the complex, CaM samples were titrated with eNOSpT495 peptide 
to saturation in a 1:1 CaM:peptide ratio.. The synthetic eNOSpT495 peptide was prepared by 
dissolving the powdered peptide in water to produce a concentration of 1 mM, aliquot into 200 μL 
and 100 μL fractions in 0.5 mL Eppendorf tubes and then lyophilized. Complex formation was 
monitored after each addition by acquisition of a 
1
H-
15
N heteronuclear single-quantum coherence 
(HSQC) spectrum.  
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2.2.4.2 NMR spectroscopy and data analysis. 
NMR spectra were recorded at 25
o
C on a Bruker 600 MHz DRX spectrometer equipped with XYZ-
gradients triple-resonance HCN probe (Bruker, Billerica, MA, USA).  Spectra were analyzed using 
the program CARA (Keller, 2005). 
Specific assignments of the CaM backbone resonances were achieved using a combination of 
3D triple resonance experiments including HNCA, HN(CO)CA, CBCA(CO)NH, and HNCO 
(Grzesiek and Bax, 1992b; Muhandiram and Kay, 1994). Side-chain resonances were assigned using 
the TOCSY type experiments HC(C)H-TOCSY, (H)CCH-TOCSY and H(CCO)NH (Bax et al., 
1990). Specific assignments of the eNOSpThr495 peptide were obtained from 
15
N-double-filtered 
NOESY experiments (Ikura and Bax, 1992). 
2.2.4.3 Structure calculation. 
The 
1
H, 
13
C and 
15
N resonance assignments were utilized to identify constraints for the structure 
calculations. Distance constraints for the solution structure of CaM-eNOSpThr495 were obtained 
from 
15
N-NOESY-HSQC, 
13
C- NOESY-HSQC and 
15
N-double-filtered NOESY spectra acquired on 
samples containing labeled CaM and unlabeled peptide (Fesik and Zuiderweg, 1990; Clore and 
Gronenborn, 1991; Ikura and Bax, 1992). In addition, dihedral angle restraints were derived from 
chemical shift analysis with TALOS+ (Shen et al., 2009). CNSsolve version 1.2 (Brunger et al., 
1998) was used to perform the structure calculations. The calculation was initiated with an extended 
conformation file and run through several iterations of a standard simulated annealing protocol to 
minimize the energies. The final 20 lowest energy structures were selected. 
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2.2.4.4 Accession Numbers. 
The coordinates and NMR parameters for the ‘Solution Structure of Calmodulin bound to the target 
peptide of Endothelial Nitrogen Oxide Synthase phosphorylated at Thr495' have been deposited in the 
PDB and BMRB and have been assigned RCSB ID code rcsb103588, Protein Data Bank (PDB) ID 
code 2mg5 and BMRB accession number 19586.  
2.2.5 Delphi calculation of the CaM structures. 
Delphi electrostatic potentials of the structure was calculated using the DelPhiController interface of 
UCSF Chimera 1.5.3, build 33475 (Pettersen et al., 2004). The parseRes atomic radii file and atomic 
charge file were used as the input files in the calculation. The electrostatic potential surface was 
visualized in Chimera.  
2.2.6 Dansylation of CaM. 
Dansyl-CaM was prepared as previously described (Kincaid et al., 1982). CaM (1 mg/ml) was buffer 
exchanged into 10 mM NaHCO3, 1 mM EDTA, pH 10.0, at 4°C. 30 μl of 6 mM dansyl-chloride (5-
dimethylaminonapthalene-1-sulfonyl chloride) in DMSO (1.5 mol/mol of CaM) was added to 2 ml of 
CaM, with stirring. After incubation for 12 hr at 4°C, the mixture was first exhaustively dialyzed 
against 500 volumes of 150 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl, pH 7.5, at 4°C, and then 
exhaustively dialyzed against 500 volumes of water. Labeling yields were determined from 
absorbance spectra using the ε320 of 3,400 M
-1
cm
-1
 and were compared to actual protein 
concentrations determined using the Bradford method with wild-type CaM used as the protein 
standard (Chen, 1968). ESI-MS was used to confirm successful dansyl-labeling of each CaM protein. 
The concentration of dansyl-CaM in all experiments was 2 μM.  
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Figure 2.1: Mechanism of dansyl chloride labelling of wild-type CaM. 
2.2.7 Steady state fluorescence.  
Fluorescence emission spectra were obtained using a PTI QuantaMaster spectrofluorimeter 
(London,ON). Fluorescence measurements were made on 50 μL samples consisting of dansyl-CaM (2 
μM) alone or with eNOS or eNOSpThr495 peptide in 30 mM MOPS, 100 mM KCl, 10 mM EGTA, 
pH 7.2 with an increasing concentration of free Ca
2+
. Free Ca
2+
 concentration was controlled using 
the suggested protocol from the calcium calibration buffer kit from Invitrogen. The excitation 
wavelength for all of the dansyl-CaMs was set at 340 nm and emission was monitored between 400 
and 600 nm. Slit widths were set at 2 nm for excitation and 1 nm for emission. Relative fluorescence 
was calculated by the following equation: relative fluorescence = (F - F0)/(Fmax - F0), where F is the 
measured intensity, Fmax is the maximum intensity, and F0 is the intensity without added Ca
2+
. 
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Figure 2.2: Fluorescence emission spectrum of D-CaM (solid line, excitation at 340 nm) and 
excitation spectrum (dotted line, emission max at 500 nm). 
2.2.8 Isothermal titration calorimetry. 
All ITC recordings were performed on a Microcal ITC200 from Microcal (Northampton, MA) at 
25°C, 1000 rpm stir speed, and reference power set to 5 µcal/s. In the experiments at saturating Ca
2+
 
concentrations the buffer used was 30 mM MOPS, 100 mM KCl, pH 7.2 and 1 mM CaCl2 and was 
identical between cell and syringe. In the experiments at 225 nM free Ca
2+
 the calcium calibration 
buffer kit from Invitrogen was used and the buffer consisted of 30 mM MOPS, 100 mM KCl, pH 7.2 
10 mM EGTA and 6.0 mM CaEGTA and was identical between cell and syringe. Buffer into buffer, 
peptide into buffer and buffer into CaM controls showed no significant baseline decay or drift and 
relatively low, consistent heats of injection, indicating sufficiently matched cell and syringe buffer 
conditions. 39 µL of each peptide was titrated into 200 µL of CaM at varying concentrations (optimal 
starting conditions were determined empirically), typically from 100 µM peptide into 10 µM CaM to 
500 µM peptide into 50 µM CaM, over the course of 20–30 injections at 2–3 min intervals. Data 
analysis was performed using Origin ITC200 Origin70 module with pre-loaded fitting equations for 
one- and two-sites models. The one-set-of-sites model was found to be applicable to all experiments. 
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2.2.9 Circular dichroism (spectropolarimetry). 
CD was performed using a Jasco J-715 CD spectropolarimeter and analyzed using J-715 software 
(Jasco Inc., Easton, MD, USA) as previously described (Fernando et al., 2002) with some 
modifications. Samples were measured in a 1 mm quartz cuvette (Hellma, Concord, ON) and kept at 
25°C using a Peltier type constant-temperature cell holder (model PFD 3505, Jasco, Easton, MD). 
Samples consisted of 10 μM of synthetic eNOS or eNOSpThr495 CaM-binding domain peptides.  
Samples were in 10 mM Tris-HCl buffer (pH 7.5), 150 mM NaCl, and 200 μM CaCl2. Spectra were 
recorded over a 190-250 nm range with a 1.0 nm band width, 0.2 nm resolution, 100 mdeg sensitivity 
at a 0.125 s response and a rate of 100 nm/min with a total of 25 accumulations. Data is expressed as 
the mean residue ellipticity (θ) in degree cm2dmol-1. 
2.3 Results and discussion 
2.3.1 NMR spectroscopy and CD. 
NMR spectroscopy was used to assess changes to the CaM-eNOS complex due to the 
phosphorylation of Thr495. However, as mentioned above in section 2.2.4.1, the eNOSpThr495 
peptide had to be titrated into the 
13
C-
15
N CaM solution to achieve the 1:1 binding of CaM to the 
eNOSpT495 peptide. This was done by acquiring a 
15
N-HSQC spectrum after each titration of 
eNOSpT495 and monitoring the shift changes of the CaM amide peaks (shown in Figure 2.3). The 
titration of CaM with eNOSpT495 exhibited a slow exchange, where, as the titration proceeded, one 
could see that the intensity of the amide peak of the unbound CaM decreased as the intensity of the 
amide peak of the eNOSpT495 bound CaM increased. The sample was considered to be fully bound 
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to the eNOSpT495 peptide when the peak of free CaM disappeared and only the peak of bound CaM 
was visible. This saturated sample was used for all other NMR experiments.  
 
Figure 2.3: Overlay of 
1
H-
15
N HSQC spectra of CaM being titrated with eNOSpThr495 peptide. 
The initial 
15
N-HSQC spectrum of CaM (red) was overlaid with the spectra of different ratios of 
eNOSpT495 peptide to Ca
2+
-CaM. The ratios are 1:3 ratio (blue), 2:3 ratio (purple) and 1:1 ratio 
(green). The HSQC spectra show amino acid residue assignments determined for the peptide-bound 
CaM. 
The 
15
N-HSQC spectrum of CaM-eNOSpThr495 was compared to that of CaM with the wild 
type eNOS peptide. Figure 2.4 shows the overlay of the 
15
N-HSQC spectra of CaM-eNOS with that of 
CaM-eNOSpThr495. Cross peaks for the majority of amides in the CaM-eNOSpThr495 complex 
overlap with those of CaM-eNOS complex. However, amides in the C-domain, specifically the 
amides of residues in EF hand IV, do not overlap with those of CaM-eNOS due to differences in 
chemical shifts. Also not seen in Figure 2.4 is the chemical shift difference of E7, which is located in 
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the heavily overlapped central portion of the spectra. This data suggests that the structures of the 
CaM-eNOS complex and the CaM-eNOSpThr495 complex are quite similar. This provides further 
evidence that this phosphorylation affects residues E7 and E127, which are in close proximity to the 
phosphorylated Thr495 in the structure. This has been previously postulated by Aoyagi et al. when 
they suggested that the addition of a negatively charged phosphate group would cause electrostatic 
repulsion between E7 and E127 (Aoyagi et al., 2003). 
 
Figure 2.4: Overlay of 
1
H-
15N HSQC spectra of the CaM−eNOS peptide complex (green) and 
the CaM−eNOSpThr495 peptide complex (red). 
The effect of phosphorylation on the secondary structure of the peptide was investigated 
using trifluoroethanol (TFE) monitored by circular dichroism spectroscopy. The TFE is used to 
mimic hydrophobic environments and is known to induce α-helical conformation in peptides that 
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have a propensity to form this secondary structure. Both eNOS peptides showed no apparent structure 
in the buffer solution with 0% TFE. A comparison of the tendency of each peptide to form an α-helix 
was then performed by recording spectra after the addition of increasing concentrations of TFE. The 
formation of an α-helix is generally accompanied by the appearance of negative ellipticity at 208 and 
222 nm. Both peptides showed increased amounts of secondary structure as more TFE was added. In 
both cases, there was an increase in apparent α-helical structure with increasing TFE concentration. 
With increasing concentrations of TFE, the negative ellipticity at 222 nm of both peptides plateau at 
TFE concentrations above 30% (see Figure 2.5). While this result indicates that the increase in helical 
structure does not appreciably change above 30% TFE, the phosphorylated peptide did not show as 
large an α-helical content as the nonphosphorylated peptide (Figure 2.5).  The structural effects of the 
phosphorylation leading to the diminished helical structure of the peptide can be due to the charged 
and bulky nature of the phosphate, destabilization of electrostatics that can result in nonproductive 
interaction with neighboring residues or the high desolvation penalty of the side chain (Broncel et al., 
2010). Specifically, it has been previously proposed that phosphorylation at Thr495 OG1 would 
disrupt its hydrogen bond with the Glu498 backbone amide, possibly affecting the α-helical 
secondary structure of the peptide (Aoyagi et al., 2003). In addition, the Thr495 is next to one of the 
anchoring residues in the classical ‘1-5-8-14’ CaM binding sequence motif.  A negatively charged 
phosphorylated Thr495 next to the first residue of the motif will likely disrupt the helical structure of 
the region.  
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Figure 2.5: Comparison of UV−CD spectra between wild-type eNOS and eNOSpThr495 CaM-
binding peptides in buffers with varying TFE concentrations. 
The ellipticiy at 222 nm is shown as a function of TFE concentration. 
While the propensity of the phosphorylated eNOS CaM binding domain to form an -helix 
appears to be diminished, the final structure of the peptide bound to CaM is very similar to that of the 
nonphosphorylated form of the peptide. The diminished -helical propensity could account for the 
reduced activity of the enzymes associated with the phosphorylated form.   
2.3.2 Structure of CaM-eNOSpThr495 CaM binding domain peptide complex. 
The NMR analysis of CaM with the eNOSpThr495 peptide (Figure 2.6A) followed routine 
procedures with the backbone resonance assignment based primarily on 3D triple resonance 
techniques, using the previously assigned chemical shifts of CaM with wild type eNOS peptide as a 
starting point. The HNCA experiment (Figure 2.6B) was supported by CBCA(CO)NH and 
HN(CO)CA experiments. This combination of techniques resulted in complete backbone assignments 
for CaM, with the exception of the prolines and the first two N-terminal amino acids (Appendix B).  
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Figure 2.6: Composite figure of NMR structural data. 
(A)
 1
H-
15
N HSQC spectrum of the eNOSpThr495 CaM-binding domain peptide. (B) 3D HNCA strips 
of sequential amino acids Gly96 to Ile100 of CaM. The connection between the alpha carbon of the 
previous and successor residue are shown.  
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Subsequently, sidechain resonances for CaM were assigned using HC(C)H-TOCSY, 
(H)CCH-TOCSY and H(CCO)NH experiments and for the eNOSpThr495 peptide using the 
15
N-
13
C-
double-filtered NOESY experiment (Figure 2.7).  
 
Figure 2.7: 
15
N-
13
C-double filtered NOESY spectrum of eNOSpThr495 of the CaM-
eNOSpThr495 complex.
 
Some of the NH, NH/HA and NOE cross peaks are labeled in the spectrum. The peaks are numbered 
as per the residue number from the full length eNOS enzyme. 
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NOEs for structure determination of the eNOSpThr495 peptide bound to CaM were extracted 
from 
15
N-
13
C-edited NOESY, 
13
Cali-NOESY and 
15
N-double-filtered NOESY experiments. The three 
dimensional solution structure of CaM bound to the human eNOS CaM binding domain peptide 
phosphorylated at Thr495 (CaM-eNOSpThr495) was calculated using the CNSsolve software 
program. The structure of the complex is based on a large number of experimental constraints and is 
well defined. Structure and input data statistics are summarized in Table 2.1.  
Table 2.1: Statistics for the CaM-eNOSpThr495 peptide structural ensemble 
 CaM-eNOSphos Complex 
NMR-derived distance and dihedral angle restraints 
 Calmodulin eNOSphos peptide CaM-eNOSphos complex 
NOE constraints 1513 119 62 
Dihedral angles from 
TALOS+ 
288 N/A N/A 
Total number of restraints 1982 
Structure statistics for the 20 lowest energy structures 
Mean deviation from 
ideal covalent geometry 
 
Bond lengths (Ǻ)  0.010 
Bond angles (deg.) 1.3 
Average pairwise RMSD 
(Ǻ) for all heavy atoms of 
the 20 lowest energy 
structures 
All Residues Ordered Residues
a 
Selected Residues
b 
Backbone Atoms  1.3 0.9 0.9 
Heavy Atoms 1.7 1.4 1.4 
Ramachandran statistics 
(%) 
 
Residues in most 
favored region  
86.0 
Residues in additional 
allowed regions  
13.5 
Residues in generously 
allowed region  
0.4 
Residues in disallowed 
region 
0.0 
a 
Ordered residue ranges: 6A-8A,10A-36A,39A-77A,79A-148A,495B-508B 
b 
Selected residue ranges: 6A-8A,10A-36A,39A-77A,79A-148A,495B-508B 
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The family of 20 final structures is shown in Figure 2.8A. The average structure showing the 
location of the phosphorylation of Thr495 of the eNOS peptide, which is found near the N-terminal 
end of the peptide is shown in Figure 2.8B. Residues 1-4 (corresponding to 491-494 of eNOS) at the 
N-terminus of the eNOSpThr495 CaM binding region peptide were not included in the structure 
calculation because they could not be unambiguously assigned. This could be due to the addition of 
the phosphate group which has been theorized to destabilize the helical propensity of the peptide 
(Aoyagi et al., 2003). Based on the comparison of the 
15
N-double filtered NOESY experiments for 
CaM with eNOS peptide and CaM with eNOSpThr495 peptide there was little change in the chemical 
shifts observed for pThr495 and Thr495. 
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Figure 2.8: Solution structure of CaM bound to eNOSpThr495 CaM binding domain peptide. 
(A) Superposition of the ensemble of the 20 lowest energy structures of CaM bound to the 
eNOSpThr495 peptide. Backbone atom traces of CaM are shown in dark blue and the 
eNOSpThr495eNOS peptide are shown in light blue. (B) Cartoon ribbon view of the average solution 
structure of CaM-eNOSpThr495 complex. (C) Cartoon ribbon view showing residues in close 
proximity to the phosphorylated Thr495 of the eNOS peptide. Ca
2+
 ions are shown as green dots and 
are modeled in their known locations. Residues 1-40 of CaM (EF Hand I) are colored red, 41-79 (EF 
Hand II) are purple, 80-114 (EF Hand III) are green, and 115-148 (EF Hand IV) are blue. The peptide 
is colored in a lighter blue and the N and C terminus are labeled N’ and C’, respectively. The 
phosphorylated Threonine is shown as stick model. 
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2.3.3 Comparison of the CaM-eNOS vs CaM-eNOSpThr495 complexes. 
When the solution structure of CaM-eNOS is superimposed onto that of the CaM-eNOSpThr495 
structure, the two structures are shown to be quite similar, however, a few local differences are seen 
(Figure 2.9). When aligned with respect to the backbone atoms of the peptide, a difference is shown 
in the orientation of helix A of CaM between the two structures, with helix A of CaM-eNOSpThr495 
pushed away from the N-terminus of the peptide (where the phosphorylated Thr495 is located). EF 
hand IV (colored blue) is also shifted farther away from the peptide in the CaM-eNOSpThr495 
structure. The rest of the CaM-eNOSpThr495 structure superimposes quite well on the CaM-eNOS 
structure. This, along with the 
1
H-
15
N-HSQC spectra overlay, confirms that the phosphorylation of 
Thr495 doesn’t have an effect on the structure of CaM away from the site of the phosphorylation. 
 
Figure 2.9: Superpositions of the CaM-eNOS peptide solution structure and the CaM-
eNOSpThr495 peptide solution structure. 
Comparison of solution structures of CaM-eNOSpThr495 peptide (dark colors) with CaM-eNOS 
peptide (light colors) by superimposing the two structures and viewing it along the bound peptide 
from its N-terminus (N’) to its C-terminus (C’) on the left (front view), and rotated 90° around the 
horizontal axis with the N-terminus of the bound peptide on the top on the right (bottom view). The 
two structures are aligned by superimposing backbone atoms of the bound peptides. The color scheme 
is the same as figure 2.8. 
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2.3.4 Electrostatic effects of the phosphorylation of Thr495. 
The addition of the phosphate group to Thr495 of the eNOS peptide shows structural effects on EF 
hands I and IV. This is first illustrated by the 
1
H-
15
N-HSQC spectra overlay of the CaM-eNOS and 
CaM-eNOSpThr495 complexes (Figure 2.4) and is clearly shown by the structure overlay of the two 
structures (Figure 2.9). The analysis of the CaM-eNOSpThr495 structure with DelPhi illustrates that 
this modification to the peptide creates a more negative potential on the N-terminal region of the 
peptide, which is located in a negatively charged region of CaM (Figure 2.10C, D). This negative 
charge is not present in the CaM-eNOS complex (figure 2.10B) and thus would not cause any 
electrostatic repulsion. This phosphate group is in close proximity to E7, which is found in helix A of 
EF hand I, and E127, found in helix G of EF hand IV. The electrostatic repulsion between the 
phosphate group and helix A of EF hand I gives an explanation as to why helix A is pushed further 
from the peptide in the CaM-eNOSpThr495 complex, as shown in Figure 2.9. This also explains why 
helix G and EF hand IV are shifted further away from the eNOSpThr495 peptide. This electrostatic 
repulsion could be affecting CaM’s ability to coordinate Ca2+ by interfering with the EF hands I and 
IV, which would help explain why CaM has diminished ability to bind eNOS phosphorylated at 
Thr495 at physiological Ca
2+
 levels. 
 53 
 
 
Figure 2.10: Delphi-calculated electrostatic potential maps. 
The Delphi-calculated electrostatic potential maps are projected on the surface of the CaM-eNOS 
peptide complex (A, B) and the CaM-eNOSpThr495 peptide complex (C, D). Thr495 and pThr495 
are displayed on the peptide by an * and . The Delphi-calculated electrostatic potential maps are 
colored with a chimera color key ranging from (-15) red to (0) blue. 
2.3.5 Fluorescence spectroscopy suggests increased Ca2+ sensitivity of CaM with the 
eNOS peptide. 
Binding of the eNOS and eNOSpThr495 peptides with CaM was further studied using dansylated 
CaM (dansyl-CaM). Dansyl-CaM is a useful tool to detect conformational changes in CaM as a result 
of interactions with Ca
2+
, peptides or other proteins because the intensity of the fluorescence spectrum 
is enhanced and shifted when the dansyl moiety becomes embedded in a hydrophobic environment 
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(Kincaid et al., 1982; Johnson and Wittenauer, 1983). Without Ca
2+
 present there was no blue shift or 
enhancement of dansyl fluorescence spectrum observed when eNOS peptide or eNOSpThr495 
peptide were added. In the presence of Ca
2+
, this shift and enhancement of the fluorescence spectrum 
was observed. To analyze the Ca
2+
 dependency of the two complexes we performed Ca
2+
 titration 
fluorescence experiments in triplicate (Figure 2.11).  
 
Figure 2.11: Fluorescence emission spectra of dansyl-CaM in the presence of eNOS and 
eNOSpThr495 peptides. 
Fluorescence measurements were made on 50 μL samples consisting of dansyl-CaM (2 μM) alone or 
with eNOS or eNOSpThr495 peptide in 30 mM MOPS, 100 mM KCl, 10 mM EGTA, 10 mM 
CaEGTA, pH 7.2 with an increasing concentration of free Ca
2+
. The excitation wavelength for all of 
the dansyl-CaMs was set at 340 nm and emission was monitored between 400 and 600 nm. Slit 
widths were set at 2 nm for excitation and 1 nm for emission. 
The relative fluorescence was calculated for CaM and for CaM with either eNOS or 
eNOSpThr495 peptide (Figure 2.12). Without peptides, dansyl-CaM exhibited fluorescence changes 
in a Ca
2+
 concentration range of 0.35-2.8 µM. The fluorescence changes of the dansyl-CaM-eNOS 
complex occurred in a much lower Ca
2+
 concentration range, which may correspond to a 
physiological Ca
2+
 concentration. The dansyl-CaM-eNOSpThr495 complex showed no difference in 
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Ca
2+
 dependency when compared to CaM alone. These Ca
2+
 titration experiments provide information 
about the conformational transitions of CaM with the peptides and Ca
2+
.  
 
Figure 2.12: Ca
2+
 dependency of dansyl-CaM fluorescence with or without eNOS and 
eNOSpThr495 peptides. 
Normalized fluorescence is shown for CaM, CaM-eNOS complex, and CaM-eNOSpThr495 under 
assay conditions described in section 2.2.7. 
The result of the CaM-eNOS complex binding with Ca
2+
 at lower Ca
2+
 concentrations than 
CaM alone indicate that the Ca
2+
 affinity of CaM is enhanced with peptide binding to CaM. This is 
not seen in interaction of CaM with eNOSpThr495 peptide. This increased Ca
2+
 sensitivity of CaM 
have also been seen with other peptides interacting with CaM (Mori et al., 2000). This suggests that 
binding of eNOS peptide to CaM increases the Ca
2+
 sensitivity of CaM in the physiological Ca
2+
 
range, whereas eNOSpThr495 does not. 
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2.3.6 Isothermal titration calorimetry.  
Isothermal titration calorimetry (ITC) was used to examine the thermodynamic profiles associated 
with the binding CaM to the two target peptides. Since the values obtained for binding constants 
show slight variations when performed using different methods and conditions (Vorherr et al., 1993; 
Censarek et al., 2002), all of our experiments were performed by ITC using exactly the same 
conditions. Representative titrations for each are shown in figure 2.13.  
 
Figure 2.13: Isothermal titration calorimetry (ITC) data for CaM with eNOS and eNOS 
pThr495 at saturated and 225 nM free Ca
2+
. 
ITC analysis indicates binding of the eNOS peptide and no binding of eNOSpThr495 peptide to CaM 
at physiological Ca
2+
 levels. Representative raw sample data for several CaM-peptide titrations. 
 
Table 2.2: Thermodynamics of CaM-peptide interactions measured by ITC. 
 N (sites) Kd (μM) ΔH (kcal/mol) ΔS (cal/mol/K) 
CaM-eNOS with 225 nM free 
Ca
2+ 1.00 ± 0.01 0.2 ± 0.03 9.39 ± 0.13 62.0 
CaM-eNOS with 1mM free Ca
2+
 1.02 ± 0.02 0.7 ± 0.2 -4.48 ± 0.16 13.3 
CaM-eNOSpThr495 with 225 
nM free Ca
2+
 
0.0096 ± 0.86
* 
>50
 
41.07 ± 369.9
* 
140
* 
CaM-eNOSpThr495 with 1 mM 
free Ca
2+
 
1.11 ± 0.01 0.3 ± 0.08 1.74 ± 0.03 35.5 
*These results cannot be fit reliably by the ITC software and are indicative of poor or no binding 
between CaM and the eNOSpThr495 peptide. 
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In the presence of excess calcium (1mM) wild type eNOS peptide binds to CaM by an 
exothermic interaction. As previously reported for the binding of the nNOS peptide, (Yamniuk and 
Vogel, 2005) eNOS binding proceeds with a negative enthalpy (ΔH), a positive entropy (ΔS) and 
modest affinity (Kd = 0.7µM) (Table 2.2). This indicates that the interaction is driven by favorable 
enthalpy and entropy. In contrast, the binding of the eNOSpThr495 peptide under the same conditions 
is weakly endothermic, with a comparable affinity to that of wild type (Kd = 0.3µM). A similar 
endothermic interaction has been reported for apoCaM titrated with mutant peptides corresponding to 
the CaM binding domain of  iNOS, an isoform that is known to bind to CaM in the absence of Ca
2+
 
(Censarek et al., 2004). The eNOSpThr495 binding interaction proceeds with positive ΔH and ΔS. 
The interaction is therefore driven by the increase in entropy. Both peptides showed a 1:1 
stoichiometry with CaM as expected.  
Because our fluorescence studies showed an apparent difference in binding at low calcium 
concentrations, we attempted to thermodynamically characterize the interactions under these 
conditions. Intriguingly, at low [Ca
2+
]free, the binding of wild type eNOS peptide to CaM becomes 
highly endothermic, the entropy gain increases over fourfold, and its affinity for CaM increases 
slightly (Kd = 0.2µM). A similar result showing a switch from an exothermic to an endothermic 
interaction has been reported for the binding of the nNOS CaM target domain to CaM by simply 
changing the experimental conditions going from a higher to a lower temperature (Yamniuk and 
Vogel, 2005). The ΔH under low 225nM calcium conditions is now positive and unfavorable for 
binding. The change in enthalpy is compensated by a positive ΔS much larger than that observed for 
the wild type peptide binding in excess calcium. In contrast, the binding of eNOSpThr495 to CaM in 
these low [Ca
2+
]free conditions becomes negligible (Figure 2.13). This is consistent with our 
fluorescent experiments showing no apparent binding under these conditions. In essence, these results 
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indicate that non-phosphorylated eNOS is more sensitive to ambient cellular Ca
2+
, and 
phosphorylation serves as an attenuator of Ca
2+
-CaM regulation of eNOS. 
2.4 Conclusions 
We set out to understand how phosphorylation of a single residue in the CaM target domain results in 
diminished NOS enzyme activity. Previous studies had shown that an eNOS enzyme carrying a 
phosphomimetic T495D mutation binds very weakly to CaM. In contrast, the control mutant T495A 
showed strong binding to CaM (Fleming et al., 2001). Enzyme studies also showed that only 
phosphorylation of T495 or the mutation T495D resulted in the loss of eNOS enzyme activity. It had 
been postulated that phosphorylation of T495 reduces output by hindering the association of CaM 
with its binding site (Aoyagi et al., 2003). Until the present study, there had not been a structural 
study using a phosphorylated T495 residue. Our solution structure shows that in the presence of 
excess calcium, phosphorylation does not prevent the binding of CaM to the phosphorylated peptide. 
While the exact mechanism of how phosphorylation of Thr495 in eNOS adversely affects the 
activation of the enzyme is still unknown, a careful look at the complex does provide some idea of the 
reported cause for the reduced enzyme activity. A comparison of the two structures in figures 2.4 and 
2.8 show that the most significant changes in the pThr495 solution structure involved two CaM amino 
acids E7 and E127. In addition both E11 and M124 are found to be in close proximity to the pThr495 
phosphate group. The previously reported crystal structure of CaM bound to the human eNOS peptide 
shows that the side chains of these amino acids are in contact with a number of amino acids in the 
eNOS peptide (Aoyagi et al., 2003). Both E7 and E11 are part of helix A of the EF hand 1 in CaM. 
The E7 side chain is in contact with eNOS residues K497 and E498 and has ionic interactions with 
R492. The E11 side chain is in contact with eNOS residues E498, A502 and I505 and has a hydrogen 
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bond with N501. Our results shown in Figure 2.9 indicate that helix A is pushed away from the 
peptide likely due to electrostatic repulsion.  
The M124 and E127 residues are both in helix G of EF hand 4 in CaM.  The side chain of 
M124 is in contact with eNOS residues T495, F496 and V499. Residue E127 of CaM has contact 
with T495 and K497. In addition E127 has ionic interactions with K493 and the backbone of T496. 
Electrostatic repulsion could again account for the displacement of helix G of EF hand 4 away from 
the peptide (Figure 2.9). Looking closely at the Delphi image with the phosphate present, the 
phosphorylation of Thr495 adds a negative charge that is close to helix G (Figure 2.10).  The 
displacement of helix A and G may not be significant under conditions with 1 mM calcium, but under 
physiological low calcium concentration conditions, a more significant displacement of these helices 
may have a detrimental effect on enzyme binding and activation. This comes from our dansyl-CaM 
experiments showing that the pThr495 peptide required significantly higher concentrations of calcium 
to bind to CaM. Our calorimetric study also showed a lack of binding of CaM to the phosphorylated 
peptide in the presence of 225nM free calcium. We used TFE to induce α-helical formation and used 
spectropolarimetry to monitor the changes in the secondary structure of the two eNOS peptides. The 
secondary structure of both peptides plateaus in 30% TFE but phosphorylation appears to result in a 
reduction in the degree of α-helical structure in the peptide. In the presence of high concentrations of 
Ca
2+
, the solution structure shows that both peptides form an α-helical structure when bound to CaM. 
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Figure 2.14: 
1
H-
15
N HSQC spectra of CaM, CaM-eNOS and CaM-eNOSpThr495 peptide 
complexes. 
(A) Overlay of 
1
H-
15
N HSQC spectra of CaM (red) and CaM-eNOS peptide complex (green) at 
225nM free Ca
2+
. (B) Overlay of 
1
H-
15
N HSQC spectra of CaM (red) and CaM-eNOSpThr495 
peptide complex (green) at 225nM free Ca
2+
. This indicates binding of the eNOS peptide to CaM, as 
seen by the difference of the two HSQC spectra but no binding of the eNOSpThr495 peptide at 
225nM free Ca
2+
. 
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In summary, the interactions of CaM with the peptides based on the eNOS CaM binding 
domain or the eNOS CAM binding domain phosphorylated at Thr495 are very similar at saturating 
Ca
2+
 concentrations. This is confirmed by our NMR spectroscopy, fluorescence and ITC results. At 
the lower Ca
2+
 concentration of 225nM, near physiological Ca
2+
 levels, no significant binding of CaM 
to eNOSpThr495 is observed by either method (Figure 2.14), whereas CaM is binding to 
nonphosphoryated eNOS. When Thr495 is phosphorylated, our results indicate there is a diminished 
propensity for the formation of an α-helix by the peptide in combination with electrostatic repulsion 
that may account for the diminished CaM-dependent activation of the eNOS enzyme under low 
physiological calcium concentrations. 
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Chapter 3 
Chemical shift perturbations induced by residue specific mutations 
of CaM interacting with NOS peptides* 
3.1 Introduction 
CaM consists of two globular domains joined by a flexible central linker region. Each one of these 
domains contains two EF hand pairs capable of binding to Ca
2+
. Each EF hand consists of a helix-
loop-helix structural element, with the 12 residue long loop being rich in aspartates and glutamates. 
Upon Ca
2+
 binding to CaM’s EF hands, CaM undergoes a conformational change that exposes 
hydrophobic patches on each domain thereby allowing CaM to associate with its intracellular target 
proteins. The central linker’s flexibility allows it to adapt its conformation to optimally associate with 
its intracellular targets (Persechini and Kretsinger, 1988). CaM is able to bind to target proteins in the 
                                                     
*
 The results presented in this chapter have been published as part of: 
Piazza, M., Guillemette, J. G., Dieckmann, T., (2015) Chemical Shift perturbations induced by 
residue specific mutations of CaM interacting with NOS peptides, Biomolecular NMR Assignments, 
9, 299-302. 
Piazza, M., Guillemette, J. G., Dieckmann, T., (2016) Chemical Shift Assignments of Calmodulin 
constructs with EF hand mutations, Biomolecular NMR Assignments, 10, 193-198. 
Unless otherwise stated, all of the work reported in this chapter was performed and analyzed by the 
candidate. 
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Ca
2+
-replete and Ca
2+
-deplete forms. There is considerable interest in obtaining a better understanding 
of the structural basis for CaM’s ability to bind and recognize its numerous target proteins. 
NOS enzymes are one of the target proteins bound and regulated by CaM. At elevated Ca
2+
 
concentrations, CaM binds to and activates eNOS making it a Ca
2+
-dependent NOS enzyme. In 
contrast, iNOS is transcriptionally regulated in vivo by cytokines and binds to CaM at basal levels of 
Ca
2+
. The Ca
2+
-deficient mutant CaM proteins can be used to allow for a specific structural 
investigation of Ca
2+
-dependent/independent activation and binding of CaM to iNOS. To study the 
Ca
2+
-dependent/independent properties of binding and activation of target proteins by CaM, 
numerous studies use a series of CaM mutants that involves conversion of Asp to Ala at position 1 of 
each EF hand (Geiser et al., 1991; Xia et al., 1998; Xiong et al., 2010). Changing the aspartate residue 
at position 1 of the EF hand loop of CaM inactivates the EF hand toward Ca
2+
 binding. These CaM 
proteins are defective in Ca
2+
 binding in either the N-terminal lobe EF hands (CaM12; CaM D20A and 
D56A mutations), the C-terminal lobe EF hands (CaM34; CaM D93A and D129A), or all four of its 
Ca
2+
-binding EF hands (CaM1234; mutations at D20A, D56A, D93A and D129A inclusive). A recent 
study by Xiong et al. (2010) has shown that although conversion of D93 and D129 to Ala effectively 
inhibits Ca
2+
 binding to EF hands III and IV, the mutations may cause some structural perturbations 
in the C-domain. This suggests that the Ca
2+
-deficient CaM mutants may adapt a different structure 
compared to that of the apo N- and C-domains of CaM. 
The interaction of CaM with NOS is also regulated by a number of post-translation 
modifications including phosphorylation at Tyrosine 99 (Corti et al., 1999; Jang et al., 2007; Mishra 
et al., 2010). Studies of central nervous tissue hypoxia in newborn piglets indicated that 
phosphorylation of Y99 of CaM affect the activity of NOS in vivo (Mishra et al., 2009, 2010). The 
helix 2-helix 6 region (latch domain) of CaM is also an important interaction site between CaM and 
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NOS and plays a critical role in NOS activation (Su et al., 1995). Amino acid mutations in this site 
have been shown to impair activation of the NOS enzymes also (Su et al., 1995). To allow the 
structural studies to be performed, a phosphomimetic form of CaM, CaM Y99E, and CaM Y99E 
containing a N111D latch domain mutation were used in the investigation. 
Here we present the NMR resonance assignments of C-lobe Ca
2+
-replete and deplete CaM12, 
N-lobe Ca
2+
-replete and deplete CaM34, CaM1234 in the absence of Ca
2+
, N-lobe Ca
2+
-replete CaM34 
with the iNOS peptide, CaM Y99E with the eNOS peptide and CaM Y99E N111D with the iNOS 
peptide. Prior to this study the solution structures of apoCaM, holoCaM and holoCaM with the iNOS 
and eNOS CaM-binding domain peptide have been determined (Kuboniwa et al., 1995; Piazza et al., 
2012). By comparing to the wild type complexes we clearly show that the phosphomimetic CaM and 
mutation of a latch domain residue cause slight perturbations of resonance frequencies for residues 
near the mutation sites and involved in the C-terminal Ca
2+
 binding sites, whereas the N-terminal and 
linker region residues appear unaffected. These assignments can also be used to solve the solution 
structures of these Ca
2+
-deficient CaM mutants and compare them to known structures of apoCaM. 
Furthermore, this method allows for quick structural characterization of other CaM or CaM mutants 
interacting with various NOS peptides and provides the basis for a detailed study of CaM-NOS 
interaction dynamics using 
15
N relaxation methods. 
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3.2 Methods and experiments 
3.2.1 Expression of CaM mutant proteins: CaM Y99E; CaM Y99E N111D; CaM1234; 
CaM12; and CaM34. 
The QuikChange site-directed mutagenesis procedure was used to produce vectors coding for CaM 
Y99E and CaM Y99E N111D. These plasmids were subcloned into the kanamycin resistant 
pET9dCaM plasmid. Plasmids coding for CaM12, CaM34 and CaM1234 were a generous gift from Dr. 
John Adelman (Oregon Health & Sciences University, Portland, OR, USA) (Lee et al., 2003). These 
plasmids were subcloned into the kanamycin resistant vector pET9dCaM. CaM Y99E, CaM Y99E 
N111D, CaM12, CaM34 and CaM1234 were expressed in E. coli BL21DE3 competent cells and grown 
in M9 media 1 L of M9 media (11.03 g/L Na2HPO4·7H2O, 3.0 g/L KH2PO4, 0.5 g/L NaCl, 2 mM 
MgSO4, 0.1 mM CaCl2, 3 μM (NH4)6(MO7)24, 400 μM H3BO3, 30 μM CoCl2, 10 μM CuSO4, 80 μM 
MnCl2·4H2O, 10 μM ZnCl2, 10 mM FeSO4, 100 μg/mL kanamycin) containing 2 g/L glucose and 1 
g/L 
15
NH4Cl at 37°C. Protein expression was induced at an OD600nm of 0.6 with 500 μM isopropyl-β-
D-thiogalactopyranoside (IPTG) and harvested after 4 h by centrifugation at 6000 x g at 4°C for 5 
minutes. 
3.2.2 Purification of CaM mutant proteins. 
Cells were resuspended in 4 volumes of 50 mM MOPS, 100 mM KCl, 1 mM EDTA, 1 mM DTT, pH 
7.5 and lysed by homogenization using an Avestin EmulsiFlex-C5 homogenizer (Ottawa, ON). The 
lysate was then clarified by centrifugation at 48,000 x g for 30 minutes at 4°C. To the clarified 
supernatant, CaCl2 was added to a concentration of 5 mM in order to saturate CaM with Ca
2+
 and 
induce the exposure of hydrophobic patches in the N- and C-lobes of CaM to allow CaM to interact 
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with the resin. This Ca
2+
-saturated supernatant was then loaded onto 20 mL of phenyl sepharose 6 fast 
flow highly-substituted resin (GE Healthcare Bio-Sciences, Baie d’Urfe, PQ) in a 1 cm x 30 cm 
Econo-column (Bio-Rad Laboratories, Mississauga, ON) equilibrated with 50 mM Tris-HCl, 1 mM 
CaCl2, pH 7.5 @ 4°C. After the Ca
2+
-saturated solution was loaded; the resin was washed with 100 
mL of the above. The resin was subsequently washed with 80 mL of 50 mM Tris-HCl, 500 mM 
NaCl, 1 mM CaCl2, pH 7.5 @ 4°C to remove any non-specific proteins that were interacting with the 
resin. The resin was finally washed with 50 mL of 50 mM Tris-HCl, 1 mM CaCl2, pH 7.5 to remove 
NaCl from the resin. CaM was then eluted from the phenyl sepharose resin with approximately 30 mL 
of 10 mM Tris-HCl, 10 mM EDTA, pH 7.5 @ 4°C and 2 mL fractions were collected. Fractions were 
then scanned from 325 to 250 nm on a Varian Cary UV–visible Spectrophotometer (Varian, 
Mississauga, ON). Fractions displaying the characteristic absorbance peaks of CaM at 277 nm (for 
tyrosine residues) and 269, 265, 259, and 253 nm (for phenylalanine residues) were pooled and 
concentrated to 2 mL sample sizes. The samples were then run through a HiLoad 16/600 Superdex 75 
column (GE Healthcare Bio-Sciences, Baie d’Urfe, PQ) connected to the Äkta design system (GE 
Healthcare Bio-Sciences, Baie d’Urfe, PQ) using buffer consisting of 50 mM Tris-HCl, 0.5 mM 
EDTA, pH 7.5. Fractions eluted at the characteristic time point for proteins of CaM’s size were 
collected.  Isolation and purity of the CaM proteins (148 residues) were confirmed by ESI-MS and 
SDS-PAGE. 
3.2.3 NOS CaM-binding domain peptides. 
The human iNOS (RREIPLKVLVKAVLFACMLMRK, 22 residues corresponding to residues 510-
531 from the full length iNOS protein) and eNOS (TRKKTFKEVANAVKISASLMGT, 22 residues 
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corresponding to residues 491-512 from the full length eNOS protein) peptides were synthesized and 
purchased from Sigma.  
3.2.4 NMR spectroscopy. 
3.2.4.1 Sample preparation for NMR investigation. 
The CaM Y99E or CaM Y99E N111D samples were prepared for NMR experiments via a buffer 
exchange into 100 mM KCl, 10 mM CaCl2, 0.2 mM NaN3, 90% H2O/10% 
2
H2O at pH 6.0 using a 
YM10 centrifugal filter device (Millipore Corp., Billerica, USA). The Ca
2+
 saturated CaM12 and 
CaM34 samples were prepared for NMR experiments via a buffer exchange into 100 mM KCl, 10 mM 
CaCl2, 0.2 mM NaN3, 90% H2O/10% 
2
H2O at pH 6.0 using a YM10 centrifugal filter device 
(Millipore Corp., Billerica, USA). The Ca
2+
 free CaM12 and CaM34 samples were prepared for NMR 
experiments via a buffer exchange into 100 mM KCl, 0.5 mM EDTA, 0.2 mM NaN3, 90% H2O/10% 
2
H2O at pH 6.0 using a YM10 centrifugal filter device. All NMR samples contained at least 1 mM 
CaM Y99E, CaM Y99E N111D, CaM12, CaM34 or CaM1234 in a total volume of 500 μL. The samples 
were transferred into 5 mm NMR sample tubes and stored at 4
o
C until required for NMR 
experiments. NMR experiments on the complexes were conducted on samples titrated with either 
iNOS or eNOS peptide to saturation in a 1:1 CaM:peptide ratio. Complex formation was monitored 
after each addition by acquisition of a 
1
H-
15
N heteronuclear single-quantum coherence (HSQC) 
spectrum.  
3.2.4.2 NMR spectroscopy and data analysis.  
NMR spectra were recorded at 298K on Bruker 600 MHz DRX spectrometers equipped with XYZ-
gradients triple-resonance HCN probe (Bruker, Billerica, MA, USA).  Specific NMR resonance 
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assignments were achieved using 
1
H-
15
N HSQC, HNCA, CBCA(CO)NH, (H)CCH-TOCSY, 
HC(C)H-TOCSY, 15N-TOCSY-HSQC, 
13
C-NOESY-HSQC and 
15
N-NOESY-HSQC experiments, 
while using the NMR resonance assignments of the previous wild type CaM or CaM-complexes as a 
starting point. Spectra were analyzed using the program CARA (Keller, 2005). 
3.3 Results 
3.3.1 Assignments and data deposition for CaM Y99E with eNOS peptide. 
Figure 3.1 shows the superposition of the 
1
H-
15
N HSQC spectra of the CaM Y99E bound to the eNOS 
CaM binding domain peptide versus wild type CaM bound to the eNOS CaM binding domain 
peptide. Chemical shift changes (Figure 3.2) induced by the phosphomimetic mutant appear for the 
amides in the C-lobe, specifically the amides of residues 96-101 and 130-138. Almost all of these 
residues participate in coordinating the Ca
2+
 ion in EF hands III and IV. The rest of the amide 
resonances overlay quite well with each other suggesting a similar structure of the N-domain for both 
complexes.  
Almost complete amide resonance assignment for CaM Y99E bound to the eNOS CaM 
binding domain peptide was achieved (Appendix C). Overall 97.9% of all 
1
H
N
, 
15
N resonances were 
assigned with the exception of the first A1 residue, D129, E140 and the two Proline residues. The 
chemical shift assignment of CaM Y99E with eNOS was deposited in the BMRB database under 
accession number 25257.  
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Figure 3.1: Superposition of 
1
H-
15
N HSQC spectra of CaM Y99E-eNOS peptide (black) and 
wild type CaM-eNOS peptide (grey). 
Each backbone amide resonance is labeled with the amino acid type and position in the sequence. 
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Figure 3.2:  Chemical shift differences between wtCaM-eNOS and CaM Y99E-eNOS. 
The contribution of 
1
HN and 
15
N chemical shift changes for each residue was calculated as Δδ = 
√[(Δδ1HN)2 + (Δδ15N/5)2], where Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical 
shifts between the indicated protein. 
3.3.2 Assignments and data deposition for CaM Y99E N111D with iNOS peptide. 
Figure 3.3 shows the superposition of the 
1
H-
15
N HSQC spectra recorded at 298 K on the CaM Y99E 
N111D bound to the iNOS CaM binding domain peptide versus wild type CaM bound to the iNOS 
CaM binding domain peptide. Chemical shift changes (Figure 3.4) induced by the phosphomimetic 
and latch domain mutant appear for the amides in the C-lobe, specifically the amides of residues 96-
103, 110-115 and 130-138. These residues participate in coordinating the Ca
2+
 ion in EF hands III and 
IV and are part of helix 6 of the latch domain. Surprisingly the rest of the amide resonances overlay 
quite well with each other suggesting a similar structure of the N-lobe for both complexes, including 
the residues of helix 2 which are part of the helix 2-helix 6 latch domain.  
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Almost complete amide resonance assignment for CaM Y99E N111D bound to the iNOS 
CaM binding domain peptide was achieved (Appendix D). Overall 98.6% of all 
1
H
N
, 
15
N resonances 
were assigned with the exception of the first A1 residue, E120 and the two Proline residues.  The 
chemical shift assignment of CaM Y99E N111D with iNOS was deposited in the BMRB database 
under accession number 25253.  
 
Figure 3.3: Superposition of 
1
H-
15
N HSQC spectra of CaM Y99E N111D-iNOS peptide (black) 
and wild type CaM-iNOS peptide (grey). 
Each backbone amide resonance is labeled with the amino acid type and position in the sequence. 
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Figure 3.4: Chemical shift differences between wtCaM-iNOS and CaM Y99E N111D-iNOS. 
The contribution of 
1
HN and 
15
N chemical shift changes for each residue was calculated as Δδ = 
√[(Δδ1HN)2 + (Δδ15N/5)2], where Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical 
shifts between the indicated protein. 
3.3.3 Assignments and data deposition for Ca2+ deplete and Ca2+ replete CaM12 and 
CaM34. 
Table 3.1 shows the list of Ca
2+
-deficient CaM mutants used in this study, the completion of their 
chemical shift assignments and their BMRB accession identification codes. For apoCaM12 almost all 
non-proline backbone resonances were assigned (97.9%) with the exception of A1, D2 and F92 
(Appendix F). The chemical shift assignment of apoCaM12 was deposited in the BMRB database 
under accession number 26682. ApoCaM34 had most non-proline backbone resonances assigned 
(94.5%) with the exception of residues A1, D2, R90, V91, F92, I100, V136 and E140 (Appendix G). 
The chemical shift assignment of apoCaM34 was deposited in the BMRB database under accession 
number 26683. For the Ca
2+
-CaM12 construct 97.9% of non-proline backbone resonances were 
assigned excluding A1, D2 and A57. The chemical shift assignment of Ca
2+
-CaM12 was deposited in 
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the BMRB database under accession number 26685. Ca
2+
-CaM34 all non-proline backbone resonances 
were assigned (91.8%) with the exception of A1, D2, E67, M72, R86, R90, V91, F92, A93, I100, 
V136 and E140. The chemical shift assignment of Ca
2+
-CaM34 was deposited in the BMRB database 
under accession number 26686. 
Table 3.1: Ca
2+
-deficient CaM mutants used in this study and completion of chemical shift 
assignments. 
CaM mutant Nuclei assigned % Backbone 
assigned 
% Sidechain 
assigned 
Residues missing
a
 BMRB 
# 
ApoCaM12 H, NH 97.9 N/A
b 
A1, D2, F92 26682 
ApoCaM34 H, NH 94.5 N/A
b 
A1, D2, R90, V91, 
F92, I100, V136, 
E140 
26683 
Ca
2+
-CaM12 H, NH 97.9 N/A
b 
A1, D2, A57 26685 
Ca
2+
-CaM34 H, NH 91.8 N/A
b 
A1, D2, E67, M72, 
R86, R90, V91, F92, 
A93, I100, V136, 
E140 
26686 
ApoCaM1234 H, NH, Cα, Cβ, 
Hα, Hβ, Hγ,  
Hδ 
97.2 96.6 Cα, 90.5 Cβ, 
84.0 sidechain H, 
96.6 Hα, 91.9 Hβ  
A1, D2, R90, I100 26681 
Ca
2+
-CaM34-
iNOS 
H, NH, Cα, Cβ, 
Cγ ,Cδ ,  Hα, 
Hβ, Hγ,  Hδ 
98.6 97.3 Cα, 96.4 Cβ, 
89.4 sidechain H, 
97.3 Hα, 96.4 Hβ  
A1, I100 26687 
a
Chemical shifts were not assigned for P43 or P66. 
b
Experiments to assign sidechain nuclei were not acquired. 
The chemical shift changes induced by Ca
2+
 binding to apoCaM12 occur for residues only in 
the C-lobe. This lobe contains the EF hands not affected by mutation and thus still able to undergo the 
conformational change associated with binding Ca
2+
. The N-lobe residues show little chemical shift 
differences indicating a similar structure for the N-lobe in both proteins (Figure 3.5A). A similar 
result is found with Ca
2+
 binding to apoCaM34, however, in the opposite lobes (Figure 3.5B). Tiny 
chemical shift differences are seen for the C-lobe and large chemical shift differences are seen for the 
N-lobe. 
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Figure 3.5: Chemical shift differences between (A) Apo and Ca
2+
CaM12, and (B) Apo and 
Ca
2+
CaM34. 
The contribution of 
1
HN and 
15
N chemical shift changes for each residue was calculated as Δδ = 
√[(Δδ1HN)2 + (Δδ15N/5)2], where Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical 
shifts between the indicated protein. The greatest differences are localized to Ca
2+
 binding loops 
where each mutation is present. 
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3.3.4 Assignments and data deposition for CaM1234. 
Figure 3.6 shows the 
1
H-
15
N HSQC spectrum of the CaM1234. Almost complete amide resonance 
assignment for apoCaM1234 was achieved (Appendix E). Overall 97.2% of all 
1
H
N
, 
15
N resonances 
were assigned with the exception of the first residue A1, and D2, R90, I100 and the two Proline 
residues. Among the backbone resonances, 96.6% of Cα, 90.5% of Cβ, and 96.6% of Hα were 
assigned. In total, 84.0% of sidechain 
1H resonances, with 91.9% of Hβ resonances were assigned. 
Overall, the 
1
H-
15
N HSQC spectrum exhibits good resolution and well dispersed signals, indicating a 
uniform and folded protein structure. Chemical shift changes induced by the 4 EF hand mutations 
appear for the amides throughout all 4 of the Ca
2+
-binding EF hands, with the greatest differences 
occurring for the amides in the center of the Ca
2+
-binding loop (Figure 3.7). The amide resonances of 
the loop region between EF hands I and II and the linker region between EF hands II and III show 
little chemical shift differences with each other suggesting a similar structure for both proteins. The 
chemical shift assignment of apoCaM1234 was deposited in the BMRB database under accession 
number 26681. 
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Figure 3.6: 
1
H-
15
N HSQC spectrum of CaM1234. 
Each backbone amide resonance is labeled with the amino acid type and position in the sequence. 
 
Figure 3.7: Chemical shift differences between ApoCaM and CaM1234. 
The contribution of 
1
HN and 
15
N chemical shift changes for each residue was calculated as Δδ = 
√[(Δδ1HN)2 + (Δδ15N/5)2], where Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical 
shifts between the indicated protein. The greatest differences are localized to Ca
2+
 binding loops 
where each mutation is present. 
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3.3.5 Assignments and data deposition for CaM34 with iNOS peptide. 
Figure 3.8 shows the 
1
H-
15
N HSQC spectrum of Ca
2+
-CaM34 bound to the iNOS CaM binding domain 
peptide (Appendix I). Almost complete amide resonance assignment was achieved. Overall 98.6% of 
all 
1
H
N
, 
15
N resonances were assigned with the exception of the first A1 residue, I100 and the two 
Proline residues. Among the backbone resonances, 97.3% of Cα, 96.4% of Cβ, and 97.3% of Hα were 
assigned. In total 89.4% of sidechain 
1H resonances, with 96.4% of Hβ of resonances were assigned. 
Overall, the 
1
H- 
15
N HSQC spectrum exhibits good resolution and well dispersed signals, indicating a 
uniform and folded protein structure. Chemical shift changes induced by the C-lobe EF hand 
mutations appear for the amides in the C-domain, specifically the amides of residues that participate 
in coordinating the Ca
2+
 ion in EF hands III and IV, with the greatest differences occurring for the 
amides in the center of the Ca
2+
-binding loop (Figure 3.9). The amide resonances of the N-lobe show 
little chemical shift differences suggesting a similar structure of the N-lobe bound to iNOS for both 
complexes. The chemical shift assignment of CaM34 with iNOS was deposited in the BMRB database 
under accession number 26687.  
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Figure 3.8: 
1
H-
15
N HSQC spectrum of CaM34-iNOS. 
Each backbone amide resonance is labeled with the amino acid type and position in the sequence. 
 
Figure 3.9: Chemical shift differences between wtCaM-iNOS and CaM34-iNOS. 
The contribution of 
1
HN and 
15
N chemical shift changes for each residue was calculated as Δδ = 
√[(Δδ1HN)2 + (Δδ15N/5)2], where Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical 
shifts between the indicated protein. The greatest differences are localized to Ca
2+
 binding loops 
where each mutation is present.  
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Chapter 4 
Dynamics of nitric oxide synthase calmodulin interactions at 
physiological calcium concentrations* 
4.1 Introduction 
CaM is a small cytosolic Ca
2+
-binding protein that is found in all eukaryotic cells. It is able to bind 
and regulate hundreds of different intracellular proteins (Ikura and Ames, 2006). CaM consists of two 
globular domains connected by a flexible central linker region. Each globular domain contains two 
EF hand pairs that are capable of binding to Ca
2+
. Binding of Ca
2+
 to CaM causes conformational 
changes that expose hydrophobic patches that allow it to bind and activate its intracellular target 
proteins. The flexibility of CaM’s central linker separating the N- and C-domains allows it to adapt its 
conformation to optimally associate with its intracellular targets (Persechini and Kretsinger, 1988).  
NOS enzymes are one of CaM’s target enzymes. The CaM binding domains of NOS contain 
the classical 1-5-8-14 CaM-binding motif. CaM binds and activates the Ca
2+
- dependent eNOS 
enzyme at elevated cellular Ca
2+
 concentrations (Busse and Mulsch, 1990). In contrast, iNOS is 
                                                     
*
 The results presented in this chapter have been published as part of: 
Piazza, M., Guillemette, J. G., Dieckmann, T., (2015) Dynamics of Nitric Oxide Synthase 
Calmodulin - Interactions at Physiological Calcium Concentrations, Biochemistry, 54, 1989–2000. 
Unless otherwise stated, all of the work reported in this chapter was performed and analyzed by the 
candidate. 
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controlled at the transcriptional level in vivo by cytokines and binds to CaM in a Ca
2+
-independent 
manner (Balligand et al., 1994). A large conformational change that CaM induces in the reductase 
domain of the NOS enzymes allows for the FMN domain to interact with both the FAD and the heme 
to accept and pass on the electrons during catalysis (Ghosh and Salerno, 2003; Welland and Daff, 
2010).  
Understanding the structural basis of CaM’s target protein interactions and diverse regulatory 
functions is crucial for rationalizing the regulation pathways and for developing strategies for 
controlling them for medical purposes. It is well established that CaM is able to interact with its target 
enzymes in many different conformations. CaM’s interactions with the various NOS isozymes have 
previously been studied by NMR (Zhang and Vogel, 1994; Zhang et al., 1995b; Matsubara et al., 
1997; Piazza et al., 2012, 2014). In addition to 3D structures, NMR spectroscopy can also provide 
quantitative information on molecular dynamics of protein systems at a residue specific level. These 
studies provide direct evidence of structural changes and intramolecular dynamics associated with 
functions that are central to understanding the role of dynamics in protein function (Kay, 1998; 
Ishima and Torchia, 2000; Wand, 2001; Kempf and Loria, 2003; Kwan et al., 2011). By tracking 
chemical shift changes, NMR spectroscopy is able to characterize very weak interactions between 
proteins and ligands at atomic (or residue) levels (Pochapsky et al., 2010; Sikic et al., 2010).  
Detailed information about fluctuations in protein structures and site-specific information on 
the stability of secondary structural elements can also be obtained from the measurement of amide 
proton (NH) hydrogen/deuterium exchange (H/D) rates using NMR spectroscopy (Andrec et al., 
1995; Polshakov et al., 2006; Ma and Nussinov, 2011). These fluctuations expose some of the NH to 
the D2O solvent, thus facilitating the NH/ND exchange process while other amide protons remain 
protected from exchange. The exchange rate of NHs in proteins is determined by a combination of 
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their intrinsic exchange rate in the absence of secondary structure and the presence of secondary 
structure and solvent inaccessibility that protect from exchange (Englander and Kallenbach, 1983; 
Englander and Mayne, 1992). NH H/D exchange experiments are also useful for accessing the 
stability of specific structure elements within a protein or protein complex (Williams et al., 2003, 
2004).  
Most structural and dynamics studies on CaM-NOS interactions have been performed at non-
physiological conditions using either apo (Ca
2+
 free with EDTA present) or Ca
2+
 saturated (greater 
than 1mM Ca
2+
) conditions. Here we present NMR structural and dynamics data of the CaM-NOS 
complexes at free Ca
2+
 concentrations that are in the resting intracellular Ca
2+
 concentration range of 
less than 100 nM (Carafoli, 1987; Islam, 2012), and at elevated intracellular Ca
2+
 concentrations of 
225 nM as well as under saturation conditions (1mM). Our data highlights remarkable differences in 
the dynamic properties of CaM-NOS complexes at high millimolar Ca
2+
 concentrations when 
compared to nanomolar physiological Ca
2+
 concentrations in a residue specific manner. Although the 
CaM-NOS complexes have similar structures at these Ca
2+
 concentrations, our studies show that the 
complexes behave more dynamic at lower (physiological) concentrations.  
4.2 Methods and experiments 
4.2.1 CaM Protein Expression and Purification.  
Wild-type CaM protein was expressed and purified using phenyl sepharose chromatography, as 
previously described in section 2.2.1 and 2.2.2. Isolation of the CaM protein (148 residues) was 
confirmed by ESI-MS and purity was judged to be > 95% by SDS-PAGE. The human iNOS 
(RREIPLKVLVKAVLFACMLMRK, 22 residues corresponding to residues 510-531 from the full 
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length iNOS protein) and eNOS (TRKKTFKEVANAVKISASLMGT, 22 residues corresponding to 
residues 491-512 from the full length eNOS protein) peptides were synthesized and purchased from 
Sigma.   
4.2.2 Dansylation of CaM.  
Dansyl-CaM was prepared as previously described in section 2.2.6. CaM (1 mg/ml) was buffer 
exchanged into 10 mM NaHCO3, 1 mM EDTA, pH 10.0, at 4°C. 30 μl of 6 mM dansyl-chloride (1.5 
mol/mol of CaM) in DMSO was added to 2 ml of CaM, with stirring. After incubation for 12 hr at 
4°C, the mixture was first exhaustively dialyzed against 500 volumes of 150 mM NaCl, 1 mM 
EDTA, 20 mM Tris-HCl, pH 7.5, at 4°C, and then exhaustively dialyzed against 500 volumes of 
water. Labeling yields were determined from absorbance spectra using the ε320 of 3,400 M
-1
cm
-1
 and 
were compared to actual protein concentrations determined using the Bradford method with wild-type 
CaM used as the protein standard. ESI-MS was used to confirm successful dansyl-labeling of each 
CaM protein. The concentration of dansyl-CaM in all experiments was 2 μM.  
4.2.3 Steady State Fluorescence.  
Fluorescence emission spectra were obtained using a PTI QuantaMaster spectrofluorimeter 
(London,ON). Fluorescence measurements were made on 50 μL samples consisting of dansyl-CaM (2 
μM) alone or with eNOS or iNOS peptide in 30 mM MOPS, 100 mM KCl, 10 mM EGTA, pH 7.2 
with an increasing concentration of free Ca
2+
. Free Ca
2+
 concentration was controlled using the 
suggested protocol from the calcium calibration buffer kit from Invitrogen. The excitation wavelength 
for all of the dansyl-CaMs was set at 340 nm and emission was monitored between 400 and 600nm. 
Slit widths were set at 2 nm for excitation and 1 nm for emission. Relative fluorescence was 
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calculated by the following equation: relative fluorescence = (F - F0)/(Fmax - F0), where F is the 
measured intensity, Fmax is the maximum intensity, and F0 is the intensity without added Ca
2+
. 
4.2.4 Sample Preparation for NMR Investigation.  
CaM for NMR experiments was expressed in E. coli in 1 L of M9 media (11.03 g/L Na2HPO4·7H2O, 
3.0 g/L KH2PO4, 0.5 g/L NaCl, 2 mM MgSO4, 0.1 mM CaCl2, 3 μM (NH4)6(MO7)24, 400 μM H3BO3, 
30 μM CoCl2, 10 μM CuSO4, 80 μM MnCl2·4H2O, 10 μM ZnCl2, 10 mM FeSO4, 100 μg/mL 
kanamycin) containing 2 g/L 
13
C-glucose and 1 g/L 
15
NH4Cl. 
13
C-
15
N-CaM was purified as described 
in section 2.2.2. The Ca
2+
 saturated 
13
C-
15
N-CaM samples were prepared for NMR experiments via a 
buffer exchange into 100 mM KCl, 10 mM CaCl2, 0.2 mM NaN3, 90% H2O/10% 
2
H2O at pH 6.5 
using a YM10 centrifugal filter device (Millipore Corp., Billerica, USA) and had a final concentration 
of 1 mM in a total volume of 500 μL. The 17 nM, 100 nM and 225 nM free [Ca2+] 13C-15N-CaM 
samples were prepared via a buffer exchange into 30 mM MOPS, 100 mM KCl, 90% H2O/10% 
2
H2O, 
pH 7.2, and combinations of 10 mM EGTA and 10mM CaEGTA to obtain 17 nM, 100 nM and 225 
nM concentrations of free Ca
2+
. These samples had a final 
13
C-
15
N-CaM concentration of 200 μM in a 
total volume of 500 μL. The 225 nM free [Ca2+] 13C-15N-CaM samples used for the H/D exchange 
and 
15
N relaxation experiments had a final 
13
C-
15
N-CaM concentration of 1 mM in a total volume of 
500 μL. The samples were transferred into 5 mm NMR sample tubes and stored at 4oC until required 
for NMR experiments. NMR experiments on the complexes were conducted on samples titrated with 
either iNOS or eNOS peptide to saturation in a 1:1 CaM:peptide ratio. Complex formation was 
monitored after each addition by acquisition of a 
1
H-
15
N heteronuclear single-quantum coherence 
(HSQC) spectrum. For the proton-deuterium exchange studies, the CaM-peptide complex samples 
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were lyophilized overnight. The samples were then resuspended in ~100% D2O to the same volume 
and immediately placed into the previously tuned and calibrated NMR spectrometer.  
4.2.5 NMR Spectroscopy and Data Analysis.  
NMR spectra were recorded at 25
o
C on Bruker 600 MHz DRX spectrometers equipped with XYZ-
gradients triple-resonance probes (Bruker, Billerica, MA, USA). Spectra were analyzed using the 
program CARA (Keller, 2005).
 
The amide resonances were assigned by using the previously obtained 
amide chemical shifts of Ca
2+
 saturated CaM with iNOS or eNOS peptide as reference (Piazza et al., 
2012). H/D exchange data was obtained by successive acquisition of 
1
H-
15
N HSQC spectra of each 
sample immediately after they were resuspended in D2O. Each 
1
H-
15
N HSQC experiment was 
acquired with 32 scans and 128 increments for a total acquisition time of 100 minutes. 
15
N T1 
measurements were acquired for eight different durations of the T1 relaxation delay, T= 5, 100, 200, 
300, 400, 500, 600, and 800ms. 
15
N T2 measurements were acquired for eight different durations of 
the T2 relaxation delay, T= 16.6, 33.2, 49.8, 66.4, 99.6, 116.2, 132.8, and 149.4ms. 
1
H-
15
N NOE 
measurements were recorded with two spectra, one with the NOE effect and one without. The 
standard model free approach (Lipari and Szabo, 1982b) was used to determine order parameters (S
2
) 
for each of the CaM-peptide complexes. The order parameters were calculated using the TENSOR 
program version 2.0 (Dosset et al., 2000; Tsan et al., 2000).  
4.2.6 Model of CaM-eNOS Peptide at 225 nM [Ca2+]. 
In order to visualize the dynamics data a model of CaM-eNOS peptide at 225 nM Ca
2+
 was prepared 
using CNSsolve version 1.2 (Brunger et al., 1998). The calculation used the structural constraints for 
the C-terminal residues from the solution structure of CaM with eNOS at saturated Ca
2+
 along with 
 85 
 
the inter-residue constraints of the C-terminal residues to the eNOS peptide. All N-terminal intra and 
inter-residue constraints were deleted and replaced with constraints for the N-terminal residues from 
the apoCaM structure deposited in the PDB (1CFC). The structure calculation was initiated with an 
extended conformation file. The calculation was run through several iterations of a standard simulated 
annealing protocol to minimize the energies. The average of the final 20 lowest energy structures was 
selected for the visualization model. 
4.3 Results  
4.3.1 Fluorescence Spectroscopy of Dansyl-CaM Binding to NOS Peptides.  
The Ca
2+
 dependent binding properties of the CaM binding domains used in our study were first 
investigated using dansyl-labeled CaM proteins (Figure 4.1). Dansyl-CaM is a useful tool to detect 
conformational changes in CaM as a result of interactions with Ca
2+
, peptides or other proteins 
because the intensity of the fluorescence spectrum is enhanced and shifted when the dansyl moiety 
becomes embedded in a hydrophobic environment (Kincaid et al., 1982; Johnson and Wittenauer, 
1983). Without peptides or Ca
2+
 present, dansyl-CaM exhibited a fluorescence maximum at 510nm 
(Figure 4.1A). When Ca
2+
 was titrated into the sample a blue shift (to 490nm) and enhancement of 
dansyl fluorescence spectrum were observed in a Ca
2+
 concentration range of 0.65-2.86 μM (Figure 
4.1B). 
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Figure 4.1: Ca
2+
 dependency of dansyl-CaM fluorescence with or without eNOS and iNOS 
peptides. 
(A) Fluorescence emission spectra of dansyl-CaM in the absence or presence of iNOS and eNOS 
peptides. Fluorescence measurements were made on 50 μL samples consisting of dansyl-CaM (2 μM) 
alone or with iNOS or eNOS peptide in 30 mM MOPS, 100 mM KCl, 10 mM EGTA, 10 mM 
CaEGTA, pH 7.2 with an increasing concentration of free Ca
2+
. The excitation wavelength for all of 
the dansyl-CaMs was set at 340 nm and emission was monitored between 400 and 600 nm. Slit 
widths were set at 2 nm for excitation and 1 nm for emission. (B) Normalized fluorescence is shown 
for CaM, CaM-eNOS complex, and CaM-eNOSpThr495 under assay conditions described in section 
4.2.3. 
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When iNOS peptide was added in the absence of Ca
2+
 the same blue shift and enhancement 
of dansyl fluorescence spectrum observed with addition of Ca
2+
 to CaM alone was seen, but not when 
eNOS peptide was added to the dansyl-CaM (Figure 4.1A). The dansyl-CaM-iNOS complex showed 
no Ca
2+
 dependency when Ca
2+
 was titrated into the sample, as indicated by the lack of fluorescence 
change (Figure 4.1A) and little relative fluorescence difference over the whole range of free Ca
2+
 
concentration additions (Figure 4.1B).  With the addition of Ca
2+
, this blue shift and enhancement of 
the fluorescence spectrum seen with CaM alone was then also observed with the eNOS peptide. 
However, the fluorescence changes of the dansyl-CaM-eNOS complex occurred at a much lower Ca
2+
 
concentration range, beginning at 225 nM. This is consistent with previous studies of eNOS that show 
the enzyme requires 200-300 nM concentrations of free Ca
2+
 to achieve half maximal activity (Sessas 
et al., 1992; Ruan et al., 1996). Hence a concentration of 225 nM free Ca
2+
 was used for the NMR 
studies, corresponding to physiological Ca
2+
 concentrations above basal levels. 
4.3.2 NMR Spectroscopy at Physiological Ca2+ Concentrations.  
NMR experiments were performed at physiological free Ca
2+
 concentrations to provide further 
insights into the structural differences between the two CaM-NOS complexes. 
1
H-
15
N HSQC spectra 
show that the CaM-eNOS complex at a physiological free Ca
2+
 concentration of 225 nM has a C-
terminal lobe that is structurally similar to the Ca
2+
-replete CaM-eNOS complex (Figure 4.2), and an 
N-terminal lobe structurally similar to unbound, Ca
2+
 free apoCaM (Figure 4.3). This can be 
visualized by overlaying the 
15
N-HSQC spectra of CaM-eNOS at 225 nM free [Ca
2+
] with either Ca
2+
-
replete CaM-eNOS or apoCaM.  Cross peaks for amides in the C-domain of CaM-eNOS at 225 nM 
[Ca
2+
] overlap with those of Ca
2+
-replete CaM-eNOS, but amides in the N-domain do not (Figure 
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4.2). And vice versa, cross peaks for amides in the N-domain of CaM-eNOS at 225 nM [Ca
2+
] overlap 
with those of apoCaM, but amides in the C-domain do not (Figure 4.3).  
 
Figure 4.2: Overlay of 
1
H-
15
N HSQC spectra of CaM-eNOS peptide complex at 10 mM CaCl2 
(green) and 225 nM free [Ca
2+
] (red). 
Chemical shift differences between CaM-eNOS peptide complex at 10mM CaCl2 and 225 nM free 
[Ca
2+
]. The contribution of 
1
HN and 
15
N chemical shift changes for each residue was calculated as Δδ 
= √[(Δδ1HN)2 + (Δδ15N/5)2], where Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical 
shifts between the indicated protein. 
 89 
 
 
Figure 4.3: Overlay of 
1
H-
15
N HSQC spectra of apoCaM (green) and CaM-eNOS peptide 
complex at 225 nM free [Ca
2+
] (red). 
Chemical shift differences between apoCaM and CaM-eNOS peptide complex at 225nM free [Ca
2+
]. 
The contribution of 
1
HN and 
15
N chemical shift changes for each residue was calculated as Δδ = 
√[(Δδ1HN)2 + (Δδ15N/5)2], where Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical 
shifts between the indicated protein. 
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More specifically the cross peaks assigned to G25 (EF1), G61 (EF2), I27, I63 (the short 
antiparallel β-sheets between EF1 and EF2), G98 (EF3), G134 (EF4) and I100 and V136 (the short 
antiparallel β-sheets between EF3 and EF4) have specific chemical shifts characteristic of Ca2+ 
binding to each EF hand and the conformation of the EF hand pairs. The cross peaks assigned to G98, 
G134, I100 and V136 for CaM-eNOS at 255 nM Ca
2+
 have very similar chemical shifts to those 
assigned for Ca
2+
-replete CaM-eNOS, indicating that the C-lobe of CaM at 225 nM [Ca
2+
] is Ca
2+
 
replete and bound to the eNOS peptide. On the other hand, the cross peaks assigned to G25, G61, I27 
and I63 have very similar chemical shifts to those assigned for apoCaM, indicating that the N-lobe of 
CaM at 225 nM [Ca
2+
] is Ca
2+
 deplete and not bound to the eNOS peptide. 
This behavior is clearly shown by calculating the chemical shift difference between each set 
of amides. In the overlay of CaM-eNOS at 225 nM free [Ca
2+
] and Ca
2+
-replete CaM-eNOS the 
amide chemical shifts show a difference for all the residues of the N-domain, whereas the amide 
chemical shifts of the C-domain have very small differences (Figure 4.2). In the overlay of CaM-
eNOS at 225 nM [Ca
2+
] and apoCaM the amide chemical shifts show a difference for all the residues 
of the C-domain, whereas the amide chemical shifts of the N-domain have very small differences 
(Figure 4.3). Comparison of the 
1
H-
15
N HSQC spectrum of the eNOS-CaM complex under Ca
2+
 
replete versus that at a Ca
2+
 concentration of 225nM clearly shows that the C-lobe of CaM is the first 
to bind to Ca
2+
 and the eNOS peptide. This is further supported by comparing the 
1
H-
15
N HSQC 
spectra in the presence of 225nM [Ca
2+
] and the apo form of the CaM. These results are consistent 
with the known Ca
2+
 binding properties of the N and C lobes of free CaM in solution (Linse et al., 
1991; Pedigo and Shea, 1995). 
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Figure 4.4: 
1
H-
15
N HSQC spectra of CaM-iNOS peptide complex at (A) 17 nM, (B) 100 nM and 
(C) 225 nM free [Ca
2+
]. 
The spectra at all 3 of these low [Ca
2+
] levels show the same amide chemical shift patterns. (D) 
Overlay of 
1
H-
15
N HSQC spectra of CaM-iNOS peptide complex at 10 mM CaCl2 (green) and 225nM 
free [Ca
2+
] (red). The 
1
H-
15
N HSQC spectra indicate that CaM-iNOS peptide complex maintains 
structural integrity at all Ca
2+
 levels. 
When a similar comparison is made using the CaM-iNOS complex, 
1
H-
15
N HSQC spectra 
indicate that the CaM-iNOS complex maintains structural integrity at all Ca
2+
 levels (Figure 4.4). This 
observation makes sense because CaM interacts with iNOS in a Ca
2+
-independent manner. Figure 4.4 
shows 
1
H-
15
N HSQC spectra of CaM-iNOS at 17 nM, 100 nM and 225 nM free [Ca
2+
]. The spectra at 
all 3 of these low Ca
2+
 levels show the same chemical shift patterns for the amides (Figure 3A-C), 
indicating that the structure of this complex doesn’t change going from free Ca2+ levels representative 
of resting intracellular Ca
2+
 levels (17 and 100 nM Ca
2+
) to elevated Ca
2+
 levels (225 nM Ca
2+
). When 
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these spectra are compared to the 
1
H-
15
N HSQC spectrum of CaM-iNOS complex at saturated [Ca
2+
] 
(10 mM Ca
2+
) we see that the spectra all overlay quite well. The few amide cross peaks that are 
slightly shifted are likely due to the different buffer and pH used for the low Ca
2+
 sample (pH 7.2) and 
saturated Ca
2+
 samples (pH 6.5). A comparison of the specific cross peaks characteristic of Ca
2+
 
binding to each EF hand and the conformation of the EF hand pairs as done with CaM-eNOS for all 
the CaM-iNOS samples illustrates that the structure of CaM bound to the iNOS peptide is very 
similar at low and high free Ca
2+
 concentrations. This suggests that the CaM-iNOS complex binds 
Ca
2+
 at this low basal Ca
2+
 level. NMR data could not be collected for the iNOS peptide interacting 
with apoCaM or CaM1234 (CaM that contains a mutation in each EF hand that disables Ca
2+
 binding) 
due to precipitation of the protein upon addition of the peptide. This behavior has also been seen in 
other studies at higher concentrations of CaM and iNOS peptide (Anagli et al., 1995; Censarek et al., 
2004). This suggests that in the Ca
2+
 deplete form CaM-iNOS adopts a different conformation which 
may expose hydrophobic regions that leads to this aggregation, or that a larger portion of the iNOS 
enzyme is required for binding in apo conditions, as previously suggested (Ruan et al., 1996).  
4.3.3 Amide Exchange and Internal Protein Dynamics for CaM-eNOS Complexes at 
Low and Saturating Ca2+ Concentrations.  
H/D exchange patterns of amides were classified into three categories based on the length of time for 
which the amide peaks were observable in the spectra after D2O exposure: fast exchange (amide 
peaks disappear before first experiment); intermediate exchange (amide peaks disappear between 3 
min and 100 min); and slow exchange (amide peaks remained longer than 200 min). The criteria for 
slow exchange were based on the observation that little change occurs in the spectrum when 
additional 
1
H-
15
N HSQC spectra were obtained after 200 min (data not shown). An intermediate 
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exchange lower limit of 3 min was determined by the amount of time elapsed prior to the acquisition 
of the first NMR spectrum. 
 
Figure 4.5: Selected spectra from the amide H2O/D2O exchange time-course for CaM-eNOS. 
(A) 
1
H-
15
N HSQC spectrum of CaM-eNOS peptide complex at 10 mM CaCl2 obtained in H2O. The 
amide peaks labeled in black indicate amides that have undergone fast exchange with D2O, amide 
peaks labeled grey indicate amides that have undergone intermediate exchange. (B,C) Spectra 
obtained 100 and 200 min after addition of D2O. (D) 
1
H-
15
N HSQC spectrum of CaM-eNOS peptide 
complex at 225nM free [Ca
2+
] obtained in H2O. (E,F) Spectra obtained 100 and 200 min after 
addition of D2O.  
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The amide exchange investigation of the CaM-eNOS complex under Ca
2+
 saturated 
conditions showed very little change over the period investigated (Figure 4.5A-C). Relatively few 
residues have undergone exchange with the D2O as evidenced by the lack of signal disappearance in 
the 
1
H-
15
N HSQC spectra. The few residues that have undergone exchange are found to be at the N 
and C termini, in the loop regions between the two EF hands in each lobe of CaM and in the linker 
region. These are residues that are exposed to the solvent and are not well protected by secondary 
structure elements, such as H-bonding in α-helices, or by binding to the eNOS peptide. Figure 4.7 
shows the H/D exchange data projected onto the previously determined structure of the Ca
2+
 replete 
CaM-eNOS complex (Aoyagi et al., 2003; Piazza et al., 2012). Residues that have undergone fast 
exchange were colored red, while residues that exhibit intermediate exchange have been colored light 
blue and residues exhibiting slow exchange colored blue. 
  When the same set of experiments were performed at 225 nM [Ca
2+
], after 100 min most 
amide protons exchanged with the D2O as shown by the lack of amide cross peaks in the 
1
H-
15
N 
HSQC spectrum. After 200 min only a very few amide resonances remained (Figure 4.5D-F). The 
amides that exhibited fast H/D exchange were mostly found to be from residues in the N-lobe of 
CaM, while those that were protected from exchange, and most of those exhibiting intermediate 
exchange, belonged to residues in the C-lobe of CaM. This amide H/D data was projected onto a 
model representative of the NMR data for the CaM-eNOS complex at 225 nM [Ca
2+
], using the same 
color scheme as above (Figure 4.7). Note that this model has been prepared to better visualize the 
differences between the structure of the CaM-eNOS complex at the 225 nM Ca
2+
 concentration 
compared to the structure at saturating Ca
2+
 concentrations. It does not represent a 3D solution 
structure of the complex under these conditions.  
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As was described above, the 
1
H-
15
N HSQC data suggest that only the C-lobe of CaM is Ca
2+
-
replete and bound to the eNOS peptide, while the N-lobe would be Ca
2+
 free and not bound to the 
peptide. Since the N-lobe is not bound to the peptide it would be more exposed to the solvent, which 
could explain why almost all of the N-lobe residues undergo fast exchange. There are a few residues 
of the N-lobe that exhibit intermediate exchange, such as K30, M36, M51, M72 and M76. These 
residues are all part of α-helices and are found to directly interact with L509, one of the anchoring 
residues of eNOS, in the crystal and solution structures of the complex (Table 4.1) (Aoyagi et al., 
2003; Xia et al., 2009; Piazza et al., 2012). This suggests that even though this lobe is Ca
2+
 free and 
not tightly bound to the peptide it is still maintaining its structural integrity and might also maintain 
some transient interactions with the peptide. The amides of the C-lobe residues that show 
intermediate or slow exchange have been previously shown to interact with the 1-5-8-14 anchoring 
residues of the eNOS peptide (Aoyagi et al., 2003; Piazza et al., 2012). The four slow exchanging 
amides correspond to residues L105, L112, E140 and F141 which interact with the anchoring residues 
F496, A500 and V503 of the eNOS peptide in the structure of the Ca
2+
-replete CaM-eNOS complex. 
The amides that show intermediate exchange are found to either interact with these anchoring 
residues of the eNOS peptide or be a part of α-helices in this lobe.  
The internal dynamics of the CaM complexes at 225 nM [Ca
2+
] and saturating [Ca
2+
] were 
further investigated by measuring the relaxation properties of the backbone 
15
N nuclei in CaM. T1, T2, 
and 
1
H-
15
N NOE values were measured (Figure 4.6). The standard model free approach was used to 
determine order parameters (S
2
) and internal correlation times (τi) for each of the CaM-peptide 
complexes. The comparison of the internal dynamics between the CaM-eNOS complex at 225 nM 
[Ca
2+
] and saturating [Ca
2+
] agrees well with the results found for the H/D exchange experiments. For 
the CaM-eNOS complex at saturating Ca
2+
 concentration low S
2
 and high τi values were found for the 
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residues of the linker region and also in the loop regions between the EF hand pairs. The high degree 
of mobility observed in these regions agrees very nicely with the H/D exchange data, which is shown 
in figure 4.7 by the correlation between worm radius and structure color. S
2
 values for the rest of 
CaM were between 0.8 and 1.0, indicating very little mobility, and agreeing very well with the high 
degree of exchange protection observed in the H/D exchange data. 
Table 4.1: Residues of CaM shown to be within 4 Å of the NOS peptides. 
 Alignment of NOS 
Cam-binding domains 
CaM sidechains in contact with peptides 
Motif 
1-5-8-14 
Human 
eNOS 
Human 
iNOS 
N-terminal Domain C-terminal Domain 
Central 
Linker 
 R492 R511 E6, E7, A10   
 K493 E512  E120, E123, E127  
 K494 I513 E14   
 T495 P514  M124, E127  
1 F496 L515  L105, M124, E127, 
A128, V136, F141, M144 
 
 K497 K516 E7 E127, M144, A147  
 E498 V517 E7, A10, E11, E14   
 V499 L518 E14 M109, E114, M124  
5 A500 V519  F92, F141, M144, M145  
 N501 K520 E11 M145  
 A502 A521 E11, E14, A15, L18   
8 V503 V522  V91, F92, L112  
 K504 L523  S81, E84, I85, A88, 
M145 
 
 I505 F524 E11, E14, A15, M72  M76 
 S506 A525 A15, L18, F19, L39   
 A507 C526 L39 E87  
 S508 M527 M72, K75 E87 M76 
14 L509 L528 F19, M36, M51, M71, 
M72, K75 
  
 M510 M529 L39, Q41, K75 E87  
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Figure 4.6: 
15
N Relaxation data and model free order parameters for the CaM-eNOS complex 
at 225nM Ca
2+
 and saturating Ca2+ conditions. 
Plots as a function of residue number of the measured T1 and T2 values, the 
1
H-
15N NOE, τi, internal 
correlation times, and the order parameter, S
2
, with associated uncertainty are shown. Only residues 
for which the 
15
N-
1
H cross peaks were sufficiently well resolved to permit accurate measurement of 
its intensity are included. 
 
 
 
 
 
 
 98 
 
Table 4.2: Average S
2
 order parameter for each structure element of the CaM-eNOS complex. 
 S
2
 
 A EF1 B Loop C EF2 D Link E EF3 F Loop G EF4 H 
CaM-
eNOS 
225nM 
Ca
2+a 
0.92 
± 
0.11 
0.75 
± 
0.14 
0.91 
± 
0.11 
0.80 
± 
0.14 
0.90 
± 
0.15 
0.72 
± 
0.16 
0.86 
± 
0.10 
0.73 
± 
0.18 
0.88 
± 
0.09 
0.93 
± 
0.04 
0.91 
± 
0.10 
0.80 
± 
0.17 
0.92 
± 
0.05 
0.87 
± 
0.14 
0.90 
± 
0.08 
CaM-
eNOS 
sat 
Ca
2+b
 
0.88 
± 
0.05 
0.92 
± 
0.06 
0.90 
± 
0.08 
0.84 
± 
0.07  
0.89
± 
0.06  
0.89
± 
0.08  
0.93 
± 
0.05 
0.67 
± 
0.15  
0.88 
± 
0.08 
0.96 
± 
0.04 
0.91 
± 
0.08 
0.86 
± 
0.15 
0.88 
± 
0.06 
0.87 
± 
0.10 
0.93 
± 
0.06 
a
Residues comprising each segment: A 6-19; EF1 20-26, 28-29; B 30, 32, 34-39; Loop 40, 41, 44; C 
45-51, 53-55; EF2 56-59, 61-64; D 65, 67-72, 74-75;  Link 76-80; E 82, 84-92; EF3 94-100; F 101-
105, 106-107, 109; Loop 113-117; G 120-123, 125-126; EF4 127-138; H 139-144. 
b
Residues comprising each segment: A 6-19; EF1 20-21, 23-29; B 30-34,36, 38-39; Loop 40-42, 44; 
C 45-47, 49, 51-55; EF2 56, 58-64; D 65, 67-75;  Link 76-77, 79-80; E 82-83, 85-86, 88-92; EF3 93-
96, 98-100; F 101-103, 105-111; Loop 112-118; G 120-126; EF4 127-128, 130-138; H 139-142, 144. 
When the internal dynamics were analyzed for the CaM-eNOS complex at 225 nM [Ca
2+
], a 
significant increase of internal dynamics is found, especially in the N-lobe. The linker region shows 
the same high degree of mobility as observed at saturating [Ca
2+
]. However, an increase of mobility is 
observed for the loop regions between the EF hand pairs, which can be seen by comparing figure 4.7. 
The average order parameter values for each structural element of the C-lobe are very similar at 225 
nM and saturating [Ca
2+
] (Table 4.2), however, the CaM-eNOS complex at 225 nM [Ca
2+
] displays 
greater fluctuation in its S
2
 values, and also contains a greater number of residues that show an 
increased internal correlation time, τi (Figure 4.6). In contrast, the N-lobe of CaM with eNOS at 225 
nM [Ca
2+
] displays an increased internal mobility across the whole domain compared to CaM-eNOS 
at saturated Ca
2+
. More specifically, EF hands 1 and 2 have average order parameter values of 0.75 
and 0.72, respectively, compared to 0.92 and 0.89 for CaM-eNOS at saturating [Ca
2+
] (Table 4.2). 
The N-terminal residues, EF hands and loop region between the EF hand pairs also show an increased 
τi compared to CaM-eNOS at saturating [Ca
2+
], indicating faster internal motions for these regions at 
225 nM [Ca
2+
]. The observed increased mobility, shown by the lower S
2
 and increased τi, for the N-
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lobe of CaM indicates a more dynamic and less rigid structure for this lobe, which correlates well 
with the H/D exchange data.  
 
Figure 4.7: Worm models of CaM-eNOS peptide complexes at 225 nM [Ca
2+
]  and saturated 
[Ca
2+
]  illustrating their internal dynamics and amide H2O/D2O exchange data. 
The worm models were prepared using UCSF Chimera with the render by attribute function. The 
worm radius ranges from 0.25, corresponding to a S
2
 value of 1, to 4, corresponding to a S
2
 value of 
0.4. The color of the residue represents its amide H2O/D2O exchange data. Residues that display fast 
D2O exchange rates are colored red on the ribbon structure. Residues that display intermediate D2O 
exchange rates are colored light blue on the ribbon structure. Residues that display slow D2O 
exchange rates are colored blue on the ribbon structure with their side chain atoms shown. Worm 
models and amide H2O/D2O exchange data for CaM-eNOS complex at 10 mM CaCl2 projected onto 
previously determined solution structure of Ca
2+
-replete
 
CaM-eNOS (PDB 2LL7). Worm models and 
amide H2O/D2O exchange data for CaM-eNOS complex at 225nM free [Ca
2+
] projected onto a model 
representative of the NMR data for the CaM-eNOS complex at 225 nM [Ca
2+
].   
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4.3.4 Amide Exchange and Internal Protein Dynamics for CaM-iNOS Complexes at 
Low and Saturating Ca2+ Concentrations.  
The amide exchange experiments of the CaM-iNOS complex under Ca
2+
 saturated conditions showed 
very little change over the time period investigated (Figure 4.8), with the same location of residues 
undergoing H/D exchange as did in the CaM-eNOS complex. This H/D exchange data was projected 
onto the previously determined solution structure of the Ca
2+
-replete CaM-iNOS complex using the 
same color scheme as described earlier (Figure 4.10). However, in contrast to the CaM-eNOS 
complex at 225nM Ca
2+
 concentration, the C-lobe amides of the CaM-iNOS complex at 225nM Ca
2+
 
concentration had faster exchange rates than the N-terminal residues (Figure 4.8). The amides that 
undergo slow and intermediate exchange correspond to residues that have been found to interact with 
the 1-5-8-14 anchor residues (L515, V519, V522, and L528) of the iNOS peptide (Figure 4.8, 4.10 
and Table 4.1). The iNOS peptide contains hydrophobic residues (V522, L523, Met527, and L528) 
that interact with hydrophobic residues of the N-lobe of CaM (F16, F19, M36, L39, Met71, Met72, 
and Met76) (Xia et al., 2009; Piazza et al., 2012). The slower exchange of these N-lobe CaM residues 
shows they are protected from the D2O solvent, indicating this is a tight hydrophobic interaction with 
the iNOS peptide. In contrast to the iNOS peptide, the eNOS peptide contains hydrophilic residues at 
these locations (with the exception of V503 and L509) that are exposed to the solvent and do not 
protect the CaM from exchange as shown in the H/D exchange data. The amides of the C-lobe 
residues of CaM display mostly fast exchange, indicating that there is less protection due to a weaker 
interaction with the iNOS peptide.  
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Figure 4.8: Selected spectra from the amide H2O/D2O exchange time-course for CaM-iNOS. 
(A) 
1
H-
15
N HSQC spectrum of CaM-iNOS peptide complex at 10 mM CaCl2 obtained in H2O. The 
amide peaks labeled in black indicate amides that have undergone fast exchange with D2O, amide 
peaks labeled grey indicate amides that have undergone intermediate exchange. (B,C) Spectra 
obtained 100 and 200 min after addition of D2O. (D) 
1
H-
15
N HSQC spectrum of CaM-iNOS peptide 
complex at 225nM free [Ca
2+
] obtained in H2O. (E,F) Spectra obtained 100 and 200 min after 
addition of D2O.  
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Analyzing the internal dynamics between the CaM-iNOS complex at 225 nM [Ca
2+
] and 
saturating [Ca
2+
] shows them to agree well with the results found for the H/D exchange experiments. 
For the CaM-iNOS complex at saturating [Ca
2+
] low S
2
 and high τi values were found for the residues 
of the linker region and also in the loop regions between the EF hand pairs, much like was observed 
in the CaM-eNOS complex at saturating [Ca
2+
], which agrees very nicely with the H/D exchange 
data, (Figure 4.10). S
2
 values for the rest of CaM were between 0.8 and 1.0, indicating very little 
mobility, and agreeing well with the high degree of stability observed from the H/D exchange data. 
 
Figure 4.9: 
15
N Relaxation data and model free order parameters for the CaM-iNOS complex at 
225nM Ca
2+
 and saturating Ca
2+
 conditions. 
Plots as a function of residue number of the measured T1 and T2 values, the 
1
H-
15N NOE, τi, internal 
correlation times, and the order parameter, S
2
, with associated uncertainty are shown. Only residues 
for which the 
15
N-
1
H cross peaks were sufficiently well resolved to permit accurate measurement of 
its intensity are included. 
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Table 4.3: Average S
2
 order parameter for each structure element of the CaM-iNOS complex. 
 S
2
 
 A EF1 B Loop C EF2 D Link E EF3 F Loop G EF4 H 
CaM-
iNOS 
225nM 
Ca
2+a 
0.88 
± 
0.08 
0.84 
± 
0.13 
0.89 
± 
0.08 
0.72 
± 
0.20 
0.89 
± 
0.04 
0.80 
± 
0.11 
0.87 
± 
0.06 
0.68 
± 
0.09 
0.89 
± 
0.07 
0.87 
± 
0.10 
0.89 
± 
0.11 
0.77 
± 
0.09 
0.93 
± 
0.05 
0.79 
± 
0.12 
0.81 
± 
0.14 
CaM-
iNOS sat 
Ca
2+b
 
0.83 
± 
0.07 
0.84 
± 
0.08 
0.90 
± 
0.09 
0.75 
± 
0.16 
0.85 
± 
0.07 
0.79 
± 
0.11 
0.87 
± 
0.09 
0.66 
± 
0.20 
0.85 
± 
0.08 
0.87 
± 
0.08 
0.87 
± 
0.10 
0.67 
± 
0.14 
0.84 
± 
0.04 
0.81 
± 
0.14 
0.88 
± 
0.08 
a
Residues comprising each segment: A 6-14, 16-19; EF1 20-29; B 31-37,39; Loop 40-42, 44; C 45-
52, 54-55; EF2 56, 58-64; D 65, 67-72, 75;  Link 77-78, 80; E 82-86, 88-92; EF3 93-100; F 101-106, 
108-109; Loop 112-118; G 119-125; EF4 127-138; H 139-142, 144. 
b
Residues comprising each segment: A 6-13, 15-19; EF1 20-22, 24-29; B 30-39; Loop 40-42, 44; C 
45-55; EF2 56, 58-64; D 65, 67-68, 70-75;  Link 76-80; E 81-84, 86, 88-92; EF3 93-95, 97-100; F 
101-102, 104-106, 108-111; Loop 112-113, 115-118; G 119, 121-126; EF4 127-138; H 139, 141-143. 
When the internal dynamics were analyzed for the CaM-iNOS complex at 225 nM [Ca
2+
], the 
same high degree of mobility observed for the linker region and for the loop regions between the EF 
hands at saturating [Ca
2+
] is shown (Figures 4.10). The average order parameter values for each 
structural element of the complex are quite similar at 225 nM and saturating [Ca
2+
] (Table 4.3), 
however, the CaM-iNOS complex at 225 nM [Ca
2+
]
 
displays greater fluctuation in its S
2
 values, and 
also contains a greater number of residues that show an increased τi. The observed increase in τi for 
the EF hands and loop regions of CaM indicates that the residues in these regions exhibit faster 
internal motions at 225 nM [Ca
2+
] (Figure 4.9). Also Helix H of the CaM-iNOS complex at 225 nM 
[Ca
2+
] is found to have an increased internal mobility (lower S
2
 values) compared to CaM-iNOS at 
saturated [Ca
2+
]. This data indicates that the CaM-iNOS complex has increased internal mobility at 
lower [Ca
2+
], with a more dynamic C-lobe than N-lobe, which correlates well with the H/D exchange 
data.  
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Figure 4.10: Worm models of CaM-iNOS peptide complexes at 225 nM [Ca
2+
]  and saturated 
[Ca
2+
]  illustrating their internal dynamics and amide H2O/D2O exchange data. 
The worm models were prepared using UCSF Chimera with the render by attribute function. The 
worm radius ranges from 0.25, corresponding to a S
2
 value of 1, to 4, corresponding to a S
2
 value of 
0.4. The color of the residue represents its amide H2O/D2O exchange data. Residues that display fast 
D2O exchange rates are colored red on the ribbon structure. Residues that display intermediate D2O 
exchange rates are colored light blue on the ribbon structure. Residues that display slow D2O 
exchange rates are colored blue on the ribbon structure with their side chain atoms shown. Worm 
models and amide H2O/D2O exchange data for CaM-iNOS complex at 10mM CaCl2 projected onto 
previously determined structure of Ca
2+
-replete
 
CaM-iNOS (PDB 2LL6).  Worm models and amide 
H2O/D2O exchange data for CaM-iNOS complex at 225nM free [Ca
2+
] 
 
projected onto previously 
determined structure of Ca
2+
-replete
 
CaM-iNOS (PDB 2LL6).  
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4.4 Discussion 
CaM is able to fine-tune the orientation of its domain and residue contacts to accommodate its 
binding to a variety of target proteins. Mammalian NOS enzymes provide an ideal system for 
investigating the differences in Ca
2+
 dependent activation of target enzymes. The structures of CaM 
interacting with target peptides derived from the three enzymes have all been shown to be very 
similar and to consist of two EF hand pairs lined by a short connector wrapped around a helical 
peptide target. However, the three NOS enzymes show different Ca
2+
 dependent activation by CaM. 
The iNOS enzyme is fully active at basal levels of Ca
2+
 (<100 nM) in a cell, eNOS enzymes require 
200-300 nM concentrations of free Ca
2+
 to achieve half maximal activity (Sessas et al., 1992; Ruan et 
al., 1996). Most investigations have focused on the Ca
2+
 dependent activation of NOS enzymes by 
CaM under non-physiological conditions. Experiments are generally performed in the presence of 
excess Ca
2+
 or excess Ca
2+ 
chelator. In the present study, more physiological relevant free Ca
2+
 
conditions were used to investigate the differential CaM Ca
2+
-dependent binding and activation of 
iNOS end eNOS enzymes. The dynamics of the binding were monitored using NMR H/D exchange 
and 
15
N relaxation experiments under different physiologically relevant free Ca
2+
 concentrations to 
provide a better understanding of the process. In addition, this approach identified the roles played by 
the N and C lobes of CaM in the binding and activation of the NOS enzymes. This is important since 
the binding of Ca
2+
 to CaM is cooperative within each lobe of CaM but not between the lobes, 
meaning that Ca
2+
-binding to N- and C-domains is exclusive from one another (Linse et al., 1991; 
Pedigo and Shea, 1995). On its own, the C-lobe of CaM binds Ca
2+
 with a higher affinity (Kd =10
-6
M) 
than the N-lobe (Kd = 10
-5
M).   
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The Ca
2+
 titration fluorescence experiments provide information about the conformational 
transitions of CaM during the binding of peptides and Ca
2+
. In the absence of peptides CaM 
undergoes a conformational transition from apo to Ca
2+
 bound at Ca
2+
 concentrations above 650 nM. 
When iNOS peptide is added to the dansyl-CaM a fluorescence maximum is seen at 490nm and no 
transition is observed during the Ca
2+
 titration, indicating CaM is bound to the iNOS peptide in both 
the absence and presence of Ca
2+
. In contrast, the eNOS peptide is not bound to CaM in the absence 
of Ca
2+
 but binds to CaM when the Ca
2+
 concentration is at least 225 nM, consistent with the results 
reported for holo eNOS enzymes (Sessas et al., 1992; Ruan et al., 1996).  
4.4.1 At Low Ca2+ Concentrations CaM’s N-Lobe Dissociates From the eNOS Peptide.  
At resting intracellular Ca
2+
 concentrations CaM is unable to bind to the eNOS CaM binding domain 
peptide, whereas it can bind at an elevated free Ca
2+
 concentration of 225 nM. At 225 nM free [Ca
2+
] 
NMR data shows the CaM-eNOS complex displays a structure where the C-lobe is bound to the 
peptide, but the N-lobe is not. In a previous investigation, we used gel mobility shift assays to 
monitor the binding of the eNOS peptide to different truncated half CaM constructs under Ca
2+
 
replete conditions (Spratt et al., 2006). No binding was observed between eNOS and nCaM, and weak 
binding occurred between the peptide and cCaM. These half CaMs also produced little or no activity 
of the eNOS enzyme. Our present results showing a closer association between the C-lobe of CaM 
and the eNOS peptide are consistent with our previous binding studies. 
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4.4.2 CaM-iNOS Complex Has Similar Conformations at Physiological and Saturating 
Ca2+ Levels.  
Most studies analyzing this Ca
2+
-independent nature of CaM and iNOS use apoCaM, however the 
cellular environment is not fully deplete of Ca
2+
, with the basal intracellular Ca
2+
 concentration being 
on the order of 50-100 nM (Carafoli, 1987; Islam, 2012). In order to characterize the complex under 
these physiological conditions 
1
H-
15
N HSQC experiments of the CaM-iNOS complex were performed 
at various free Ca
2+
 concentrations ranging from resting intracellular Ca
2+
 levels to elevated Ca
2+
 
levels and compared to fully saturated Ca
2+
-CaM conditions. The current study suggests that CaM has 
the same structure as observed in Ca
2+
-replete CaM-iNOS when bound to the iNOS peptide at both 
resting and elevated intracellular Ca
2+
 levels.   
Activity of the iNOS enzyme decreased to less than 25% when co-expressed with a mutant 
CaM1234 used to emulate  apoCaM (Spratt et al., 2007a). In a study by Ruan et al (1996), iNOS was 
found to be  maximally active at Ca
2+
 concentrations as low as 0.1 nM in vitro and thus is probably 
maximally active in vivo at basal intracellular Ca
2+
 levels. This suggests that at the lowest Ca
2+
 level 
(17 nM) used in this study the CaM-iNOS complex is Ca
2+
 replete, otherwise a decrease in iNOS 
activity at Ca
2+
 concentrations as low as 0.1 nM would have been seen. 
4.4.3 CaM-eNOS and CaM-iNOS Complexes Show Different Dynamic Interactions at 
Low and Saturating Ca2+ Concentrations.  
The dynamic properties of these complexes were further investigated by performing amide H/D 
exchange time-course experiments and NMR 
15
N relaxation experiments. NH exchange experiments 
provide detailed information on the degree of protection of specific residues within a protein or 
protein complex. This information is useful for determining the stability of secondary structural 
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elements and also identifying residues involved in co-operative binding of a ligand (Williams et al., 
2004; Pervushin et al., 2007). The NMR 
15
N relaxation experiments can be interpreted by the model-
free approach to characterize backbone mobility using an order parameter S
2
, which may be 
interpreted as the amplitude of the motion, and a correlation time, τi, which is the characteristic time 
constant of this motion.  
At the 225 nM free Ca
2+
 concentration CaM alone does not bind Ca
2+
, however, the presence 
of the eNOS peptide enhances the Ca
2+
 affinity of the C-lobe of CaM. The fast exchange of the C-
lobe amides corresponding to the residues involved in coordinating the Ca
2+
 ions indicates that this 
isn’t a very stable or strong interaction at the 225 nM free Ca2+ concentration, when compared to the 
strong association at saturating [Ca
2+
]. The few residues of the N-lobe that exhibit intermediate 
exchange at low [Ca
2+
] suggest that even though this lobe is likely Ca
2+
 deplete and not bound to the 
peptide, based on chemical shift comparison, it still maintains its structural integrity and remains 
folded. This data correlates well with our previous investigation that showed only full length CaM, 
and not the half CaMs, is able to fully activate eNOS (Spratt et al., 2006). The internal dynamics for 
the CaM-eNOS complex at 225 nM [Ca
2+
] and saturating [Ca
2+
] also agrees with our H/D exchange 
data. The lower order parameters observed for the linker region and loop regions between the EF 
hand pairs at low and saturating [Ca
2+
] along with the fast exchange observed from the H/D exchange 
data show these regions have increased internal mobility and less stability. The increased mobility, 
shown by the lower S
2
 and increased τi, for the N-lobe of CaM indicates a more dynamic and less 
rigid structure, which correlates well with the H/D exchange data. The H/D exchange and internal 
mobility results show that the residues of CaM interacting with eNOS’ 1-5-8-14 anchoring residues 
have a strong interaction at low Ca
2+
 concentrations, which keeps the complex bound, while the rest 
of the residues of the CaM protein are able to fluctuate or “breathe”. More specifically, the residues of 
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the C-lobe have a lower degree of internal mobility (higher S
2
) and higher exchange protection, 
indicating stronger interaction with the eNOS peptide to hold the complex together, while the N-lobe 
is more dynamic. At saturating Ca
2+
 concentrations the entire CaM-eNOS complex has become more 
rigid, or structurally stable, than it is at physiological Ca
2+
 levels. 
In contrast, for the CaM-iNOS peptide complex at the 225 nM free Ca
2+
 concentration, the C-
lobe shows faster exchange rates than the N-lobe of CaM. This supports our earlier studies using 
peptides bound to mutant half-CaM proteins indicating that the N-lobe of CaM may not fully 
dissociated from the iNOS peptide even at very low Ca
2+
 concentrations (Spratt et al., 2006). Notably 
when compared to Ca
2+
-replete CaM co-expression, iNOS showed significant 70% activity when co-
expressed with only nCaM and only 12% activity when co-expressed with cCaM. These results show 
that the N-terminal domain of CaM contains important binding and activating elements for iNOS 
(Spratt et al., 2006, 2011). The internal dynamics for the CaM-iNOS complex also agrees with our 
H/D exchange data. As seen with the CaM-eNOS complex, the fast amide exchange and faster 
internal motions observed for the EF hands and loop regions of CaM at the 225 nM [Ca
2+
] indicates 
that the co-ordination of Ca
2+
 by these residues isn’t a very strong interaction when compared to 
saturating [Ca
2+
]. The H/D exchange and internal mobility results show that the residues of CaM 
interacting with iNOS’ 1-5-8-14 anchoring residues have a strong interaction at low [Ca2+], while the 
rest of the residues of CaM display more dynamics and have less exchange protection. More 
specifically residues of CaM’s N-lobe have a lower degree of internal mobility and higher exchange 
protection, indicating stronger interaction with the iNOS peptide, compared to the C-lobe. Taken 
together, this data indicates that the CaM-iNOS complex has increased internal mobility at lower 
[Ca
2+
], with a more dynamic C-lobe than N-lobe.  
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4.4.4 At Low Ca2+ Concentrations CaM Has a Different Interaction With the eNOS and 
iNOS Peptides.  
Our H/D exchange and internal dynamics data show the CaM-iNOS and CaM-eNOS complexes 
exhibit similar dynamic differences between 225 nM and saturated [Ca
2+
], however, the interaction 
with the peptide is different with respect to the individual CaM lobes at low [Ca
2+
]. This is clearly 
shown by the lower degree of internal mobility (higher S
2
 and less residues with τi values) and higher 
exchange protection of the residues of the N-lobe of CaM in the CaM-iNOS complex compared to 
those of the CaM-eNOS complex, while the residues of the C-lobe of CaM in the CaM-eNOS 
complex display lower internal mobility (higher S
2
 and less residues with τi values) and higher 
exchange protection. Our results provide further evidence of stronger interactions of the N-lobe of 
CaM with the iNOS peptide compared to the eNOS peptide, contributing to the stronger binding of 
CaM with iNOS, as seen in previous studies (Venema et al., 1996; Xia et al., 2009; Piazza et al., 
2012).  
4.5 Conclusions 
This is the first study to present NMR structural and dynamics data of the CaM-NOS 
complexes at free Ca
2+
 concentrations that are in the resting and elevated intracellular Ca
2+
 
concentration range. These results demonstrate the importance of performing experiments on CaM-
NOS interactions at Ca
2+
 concentrations that correspond to Ca
2+
 levels relevant to the regulation of 
NOS by CaM in vivo.  We show that when experiments are performed at Ca
2+
 concentrations that are 
typically used in the literature, i.e. saturating [Ca
2+
], the CaM-NOS systems are less dynamic than at 
Ca
2+
 concentrations corresponding to basal and elevated cellular levels. The studies of the CaM-NOS 
complexes that were carried out at saturated Ca
2+
 concentrations miss differences in dynamics that are 
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only detectable at physiological Ca
2+
 levels. Thus, studies involving CaM interactions with NOS at 
saturating Ca
2+
 concentrations don’t allow the investigator to see the contributions of the dynamics 
present in the CaM-NOS complexes. The structures at saturating Ca
2+
 concentrations don’t tell the 
whole story, one needs to look at the dynamics at the same time to obtain a complete picture of the 
molecular basis of NOS regulation by CaM. This illustrates the importance of analyzing these 
complexes at Ca
2+
 concentrations that are within the physiological range in order to fully understand 
how NOS is regulated by CaM interactions in vivo.   
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Chapter 5 
Structure of calmodulin bound to the endothelial nitric oxide 
synthase calmodulin binding domain peptide at physiological 
calcium concentration* 
5.1  Introduction 
CaM consists of two globular domains connected by a flexible central linker region with each 
globular domain containing two EF hand pairs capable of binding to Ca
2+
. Upon binding of Ca
2+
 to 
the EF hands, CaM undergoes a conformational change that exposes hydrophobic patches on each 
domain that allow CaM to associate with its intracellular target proteins. The binding of Ca
2+
 to CaM 
is cooperative within each lobe of CaM but not between the lobes, with the C-lobe of CaM able to 
bind Ca
2+
 with a ten-fold higher affinity than the N-lobe.(Linse et al., 1991; Pedigo and Shea, 1995)  
One of CaM’s target enzymes is the NOS enzymes, which catalyze the production of nitric 
oxide (•NO) (Alderton et al., 2001). There are three NOS isoforms in mammals: neuronal NOS 
(nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS). All are all dimers, with each 
monomer containing an N-terminal oxygenase domain and a C-terminal reductase domain, connected 
by a CaM binding domain. The CaM binding domains of NOS contain the classical 1-5-8-14 CaM-
binding motif. CaM is found to bind to this binding domain in an antiparallel fashion, with the N-lobe 
                                                     
*
 Unless otherwise stated, all of the work reported in this chapter was performed and analyzed by the 
candidate. 
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of CaM binding closer to the C-terminus of this domain, and the C-lobe of CaM binds closer to the N-
terminus (Spratt et al., 2007b). CaM’s interaction with eNOS and nNOS is Ca2+- dependent, requiring 
200-300 nM concentrations of free Ca
2+
 to achieve half maximal activity (Sessas et al., 1992; Ruan et 
al., 1996), whereas CaM binds to iNOS regardless of intracellular Ca
2+
 concentration and is fully 
active at basal levels of Ca
2+
 (<100 nM) in the cell (Carafoli, 1987; Busse and Mulsch, 1990; 
Balligand et al., 1994; Islam, 2012). The oxygenase domain contains binding sites for heme, 
tetrahydrobiopterin (H4B), and the substrate L-arginine. The reductase domain contains binding sites 
for the cofactors FMN, FAD, and NADPH (Alderton et al., 2001; Daff, 2010). Electron flow in the 
NOS enzymes occurs from the NADPH, through the FAD and FMN cofactors, to the heme 
oxygenase domain. Recent studies suggest that the NOS enzymes exist in an equilibrium of 
conformations that alternate between FAD-FMN electron transfer and FMN–heme electron transfer 
and that CaM binding induces a shift in the conformational equilibrium to allow efficient electron 
transfer in NOS enzymes (Leferink et al., 2014; Sobolewska-Stawiarz et al., 2014). When CaM is 
fully bound to NOS, residues of CaM’s N-lobe interact with the FMN subdomain of NOS and form a 
bridge (Tejero et al., 2010). This bridge interaction appears necessary to control the interaction 
between the FMN and heme, which is what enables CaM to activate NOS.  
CaM’s interactions with the various NOS isoforms has previously been studied by NMR 
(Zhang and Vogel, 1994; Zhang et al., 1995b; Matsubara et al., 1997; Piazza et al., 2012, 2014). 
However, most structural and dynamics studies on CaM-NOS interactions have been performed at 
non-physiological conditions using either apo (Ca
2+
 free with excess chelators, such as EDTA, 
present) or Ca
2+
 saturated (greater than 1mM Ca
2+
) conditions which don’t represent the true 
intracellular Ca
2+
 concentration. In the previous chapter, we determined the minimal free Ca
2+
 
concentration needed for CaM to interact with eNOS to be 225 nM (Piazza et al., 2015). Here we 
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determined the NMR structure of the CaM-eNOS complex at a free Ca
2+
 concentration that represents 
this elevated intracellular Ca
2+
 concentration of 225 nM, and compared it to the less physiologically 
relevant high Ca
2+
 concentrations used in previous CaM-eNOS structure calculations. Our study is the 
first study to determine a solution structure of the CaM-eNOS complex at a free Ca
2+
 concentration 
that is in the elevated intracellular Ca
2+
 concentration range. In addition, this study identifies the roles 
played by each individual lobe of CaM in the binding to the eNOS enzyme.  
5.2 Methods and experiments 
5.2.1 Sample preparation for NMR investigation. 
CaM for NMR experiments was expressed in E. coli in 1 L of M9 media (11.03 g/L Na2HPO4·7H2O, 
3.0 g/L KH2PO4, 0.5 g/L NaCl, 2 mM MgSO4, 0.1 mM CaCl2, 3 μM (NH4)6(MO7)24, 400 μM H3BO3, 
30 μM CoCl2, 10 μM CuSO4, 80 μM MnCl2·4H2O, 10 μM ZnCl2, 10 mM FeSO4, 100 μg/mL 
kanamycin) containing 2 g/L 
13
C-glucose and 1 g/L 
15
NH4Cl. 
13
C-
15
N CaM was purified as described 
in section 2.2.2. Isolation of the CaM protein (148 residues) was confirmed by ESI-MS and purity 
was judged to be > 95% by SDS-PAGE. The human eNOS (TRKKTFKEVANAVKISASLMGT, 22 
residues corresponding to residues 491-512 from the full length eNOS protein) peptide was 
synthesized and purchased from Sigma.   
The 225 nM free [Ca
2+
] 
13
C-
15
N-CaM sample was prepared via a buffer exchange into 30 mM 
MOPS, 100 mM KCl, 90% H2O/10% 
2
H2O, pH 7.2, and combination of 10 mM EGTA and 10mM 
CaEGTA to obtain a final 225 nM concentration of free Ca
2+
 using a YM10 centrifugal filter device 
(Millipore Corp., Billerica, USA). The sample had a final 
13
C-
15
N-CaM concentration of 1 mM in a 
total volume of 500 μL. The sample was transferred into 5 mm NMR sample tubes and stored at 4oC 
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until required for NMR experiments. NMR experiments on the complex were conducted on samples 
titrated with eNOS peptide to saturation in a 1:1 CaM:peptide ratio. Complex formation was 
monitored after each addition by acquisition of a 
1
H-
15
N heteronuclear single-quantum coherence 
(HSQC) spectrum.  
5.2.2 NMR spectroscopy and data analysis.  
NMR spectra were recorded at 25
o
C on Bruker 600 MHz DRX spectrometers equipped with 
XYZ-gradients triple-resonance HCN probe (Bruker, Billerica, MA, USA). Spectra were analyzed 
using the program CARA (Keller, 2005).
 
The amide resonances assignments were aided by using the 
previously obtained amide chemical shifts of Ca
2+
 saturated CaM with eNOS peptide as reference 
(Piazza et al., 2012). Specific assignments of the backbone resonances were achieved using a 
combination of three-dimensional triple- resonance experiments, including HNCA, HN(CO)CA, 
CBCA(CO)NH, and HNCO (Grzesiek and Bax, 1992a, 1992b; Muhandiram and Kay, 1994). Side 
chain resonances were assigned using the TOCSY-type HC(C)H-TOCSY and (H)CCH- TOCSY 
experiments (Ikura et al., 1990). Specific assignments of the eNOS peptide were obtained from 
15
N-
double-filtered NOESY experiments (Ikura and Bax, 1992).  
5.2.3 Structure calculation of CaM-eNOS peptide at 225 nM [Ca2+]. 
The 
1
H, 
13
C, and 
15
N resonance assignments were utilized to identify constraints for the structure 
calculations. Distance constraints for the CaM-eNOS complex were obtained from 
15
N NOESY-
HSQC and 
13
C NOESY- HSQC, and 
15
N- double-filtered NOESY spectra acquired on samples 
containing 
13
C-
15
N-CaM and unlabeled peptide (Fesik and Zuiderweg, 1990; Clore and Gronenborn, 
1991; Ikura and Bax, 1992). In addition, dihedral angle restraints were derived from chemical shift 
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analysis with TALOS+. The structure calculation of CaM-eNOS peptide at 225 nM [Ca
2+
] was 
performed using CNSsolve version 1.2 (Brunger et al., 1998). The calculation was initiated with an 
extended conformation file and run through several iterations of a standard simulated annealing 
protocol to minimize the energies. The final 20 lowest energy structures were selected. 
5.2.4 Accession Numbers.  
The coordinates and NMR parameters have been deposited in the Protein Data Bank (PDB) and the 
BioMagResBank (BMRB) and have been assigned PDB entry 2N8J, and BMRB accession number 
25852. 
5.3 Results and discussion 
5.3.1 NMR structure at physiological Ca2+ concentrations.  
NMR experiments were performed at physiological free Ca
2+
 concentrations to provide further 
insights into the structural differences of the CaM-eNOS complex at a more relevant Ca
2+
 
concentration compared to the less physiological relevant high Ca
2+
 concentrations used in all other 
CaM-NOS structure calculations. The three-dimensional solution structure of CaM bound to the 
human eNOS CaM binding domain peptide (CaM−eNOS complex) at 225 nM free Ca2+ was 
determined using multidimensional heteronuclear NMR spectroscopy. The NMR assignment of the 
CaM-eNOS complex followed a similar procedure as that in sections 1.3.1 and 2.3.2. The NMR 
analysis of CaM with the eNOS peptide at 225 nM free Ca
2+
 followed routine procedures with the 
backbone resonance assignment based primarily on 3D triple resonance techniques, using the 
previously assigned chemical shifts of CaM with wild type eNOS peptide at saturated Ca
2+
 as a 
starting point. The HNCA experiment was supported by CBCA(CO)NH and HN(CO)CA 
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experiments. This combination of techniques resulted in complete backbone assignments for CaM, 
with the exception of the prolines and the first two N-terminal amino acids (Appendix H). 
Subsequently, sidechain resonances for CaM were assigned using HC(C)H-TOCSY, (H)CCH-
TOCSY and H(CCO)NH experiments and for the eNOS peptide using the 
15
N-double-filtered 
NOESY experiment. NOEs for structure determination of the eNOS peptide bound to CaM were 
extracted from 
15
N-edited NOESY, 
13
Cali-NOESY and 
15
N-double-filtered NOESY experiments. The 
three dimensional solution structure of CaM bound to the human eNOS CaM binding domain peptide 
(CaM-eNOS) at 225 nM free Ca
2+
 was determined using the CNSsolve software program. The 
structure of the complex is based on a large number of experimental constraints and is well-defined. 
The root-mean-square distance (r.m.s.d.) for ordered residues is 1.9 Å for the backbone atoms and 2.2 
Å for all non-hydrogen atoms (Table 5.1).  
Table 5.1: Statistics for the structural ensemble of CaM-eNOS peptide at 225 nM Ca
2+
. 
 CaM-eNOS Complex 
NMR-derived distance and dihedral angle restraints 
 Calmodulin eNOS peptide CaM-eNOS complex 
NOE constraints  2836 86 37 
Dihedral angles from TALOS+ 280 14 N/A 
Total number of restraints    3253 
Structure statistics for the 20 lowest energy structures 
Mean deviation from ideal covalent geometry  
  Bond lengths (Ǻ)  0.010 
  Bond angles (deg.) 1.2 
Average pairwise RMSD (Ǻ) for all heavy 
atoms of the 20 lowest energy structures 
All 
Residues 
Ordered 
Residues
a 
C-lobe
b 
N-lobe
c 
  Backbone Atoms  2.3 1.9 0.6 0.9 
  Heavy Atoms 2.6 2.2 1.1 1.4 
Ramachandran statistics (%)  
  Residues in most favored region  86.3 
  Residues in additional allowed regions  13.2 
  Residues in generously allowed region  0.4 
  Residues in disallowed region 0.0 
a 
Ordered residue ranges: 4A-78A, 81A-134A, 137A-147A, 154B-161B 
b 
C-lobe residues: 81A-148A 
c 
N-lobe residues: 4A-74A 
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Figure 5.1: Solution structure of CaM-eNOS at 225 nM Ca
2+
. 
Superposition of the ensemble of the 20 lowest-energy calculated NMR solution structures of (A) 
CaM bound to eNOS peptide at 225 nM Ca
2+
 and (D) the previously determined solution structures of 
CaM bound to eNOS peptide at saturated Ca
2+
. The superposition is aligned by the backbone atoms of 
the C-lobe of CaM. Backbone atom traces of CaM are colored dark blue, and the eNOS peptide 
colored light blue. Cartoon ribbon view of the average solution structure of the CaM− eNOS complex 
at (B) 225 nM Ca
2+
 and (E) saturated Ca
2+
. Residues 1−40 of CaM (EF hand I) are colored red, 
residues 41−79 (EF hand II) purple, residues 80−114 (EF hand III) green, and residues 115−148 (EF 
hand IV) blue. The peptide is colored lighter blue. Calcium ions are colored green. Worm models of 
CaM-eNOS peptide complex at (C) 225 nM Ca
2+
 and (F) saturated Ca
2+
 illustrating their internal 
dynamics and amide H/D exchange data. The worm models were prepared using UCSF Chimera with 
the render by attribute function. The worm radius ranges from 0.25 (S
2
 value of 1), to 4 (S
2
 value of 
0.4). Residues that display fast D2O exchange rates are colored red on the ribbon structure. Residues 
that display intermediate D2O exchange rates are colored light blue and residues that display slow 
D2O exchange rates are colored blue. The bound peptide is colored black and shown in wire form. 
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The family of 20 lowest energy structures is shown in Figure 5.1A. When these 20 lowest 
energy structures are aligned by the C-lobe backbone atoms of CaM, the C-lobes of CaM are shown 
to superimpose quite well with each other, whereas the N-lobe has a lot of fluctuation in its relative 
position to the C-lobe, suggesting the N-lobe is less rigid, and more dynamic, than the C-lobe. When 
a similar comparison is made with the superposition of the backbone of the 20 lowest energy 
structures for the previously determined Ca
2+
 saturated CaM-eNOS complex (PDB 2LL7, figure 
5.1D) superposition via both the C- and N-lobes results in well overlaid structures. This more 
dynamic N-lobe of CaM in the CaM-eNOS complex structure at 225 nM free Ca
2+
 can also be shown 
by looking at the r.m.s.d. values for each individual lobe of CaM. The r.m.s.d. for the C-lobe residues 
is 0.6 Å for the backbone atoms and 1.1 Å for all non-hydrogen atoms, whereas it is 0.9 Å for the 
backbone atoms and 1.4 Å for all non-hydrogen atoms of the N-lobe. 
The CaM-eNOS complex at a physiologically relevant free Ca
2+
 concentration of 225 nM has 
a Ca
2+
-replete C-lobe bound to the eNOS peptide and a Ca
2+
 free N-lobe loosely associated to the 
eNOS peptide as shown in figure 5.1B. Residues 1−4 (corresponding to residues 491−494 of eNOS) 
at the N-terminus of the eNOS CaM-binding region peptide show a lack of structure because they 
could not be unambiguously assigned. Comparing to the Ca
2+
 saturated CaM-eNOS complex 
structure (Figure 5.1E) one can see that the N-lobe at 225 nM free Ca
2+
 has a much looser association 
to the eNOS peptide.  
The dynamic properties of these complexes were previously examined in chapter 4 by amide 
H/D exchange time-course and NMR 
15
N relaxation experiments and agree very well with the 
determined solution structure in this study (Piazza et al., 2015). Amide exchange experiments provide 
detailed information on the degree of protection of specific residues within a protein complex and are 
useful for identifying residues involved in co-operative binding of a ligand (Williams et al., 2004; 
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Pervushin et al., 2007). The NMR 
15
N relaxation T1, T2, and 
1
H-
15
N NOE experiments were used to 
characterize backbone mobility by determining an order parameter, S
2
, which may be interpreted to 
describe internal dynamics on a residue specific level (Lipari and Szabo, 1982b; Kay, 1998; Ishima 
and Torchia, 2000; Wand, 2001). There are a few residues of the N-lobe that exhibit intermediate 
exchange, such as M36, M51, M72 and K75. These residues are all found to be part of α-helices and 
have hydrophobic interactions with L509, one of the anchoring residues of eNOS, in the solution 
structure of the complex (Figure 5.1C and 5.3C). The amides of the C-lobe residues that show 
intermediate or slow exchange correspond to CaM residues that also interact with the 1-5-8-14 
anchoring residues of the eNOS peptide in the solution structure (Figure 5.3B). The 
15
N relaxation 
data also correlates very well with the solution structure of the CaM-eNOS complex at 225 nM Ca
2+
. 
The lower overall dynamics of the C-lobe of CaM compared to the N-lobe correspond well with the 
more rigid C-lobe (and lower r.m.s.d. for the C-lobe) observed in the structure. Whereas the N-lobe of 
CaM displays increased backbone mobility, indicating increased dynamics, which correlates well 
with the less rigid N-lobe observed by the increased fluctuations in its overall position relative to the 
C-lobe (Figure 5.1A) and the N-lobe’s higher calculated r.m.s.d. value.  
5.3.2 Structure comparison. 
When the 225 nM free Ca
2+
 CaM-eNOS complex structure is compared to the previously determined 
Ca
2+
 saturated CaM−eNOS complex structure (PDB entry 2LL7), one can see that the C-lobes of 
CaM and peptide orientation are quite similar, however the N-lobe of CaM is structurally different 
(Figure 5.2A,B). When the two structures are aligned with respect to CaM’s C-lobe backbone atoms a 
r.m.s.d. value of 1.023 Å for the backbone atoms of CaM was found. The C-lobes of CaM and the 
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eNOS peptide of each structure superimpose quite well on each other, whereas the N-lobes of CaM 
do not. 
 
Figure 5.2: Comparison of the solution structure of the CaM-eNOS peptide complex at 225 nM 
Ca
2+
 with the solution structures of saturated Ca
2+
 CaM-eNOS peptide complex and apoCaM. 
The solution structures of the CaM−eNOS peptide at 225 nM Ca2+ (dark colors) and at saturated Ca2+ 
(light colors) are aligned by superimposition of the backbone atoms of the C-lobes of CaM (A) 
viewed along the bound peptide from its N-terminus (N′) to its C-terminus (C′) and (B) rotated 
around the horizontal axis with the C-terminus of the bound peptide on the top. The solution 
structures of the CaM−eNOS peptide at 225 nM Ca2+ (dark colors) and apoCaM (light colors) are 
aligned by superimposition of the backbone atoms of the N-lobes of CaM (C) viewed along the bound 
peptide from its N-terminus (N′) to its C-terminus (C′) and (D) rotated around the horizontal axis with 
the C-terminus of the bound peptide on the top. The color scheme is the same as that in Figure 5.1. 
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When the 225 nM free Ca
2+
 CaM-eNOS complex structure is compared to the previously 
determined apoCaM structure (PDB entry 1CFC), there is structural similarity of the N-lobes of CaM, 
whereas the C-lobes of CaM show differences (Figure 5.2C,D). When the two structures are aligned 
with respect to CaM’s N-lobe backbone atoms a r.m.s.d. value of 1.042 Å for the backbone atoms of 
CaM was found. The N-lobes of CaM of each structure superimpose well on each other, whereas the 
C-lobes of CaM do not. 
5.3.3 At low Ca2+ concentrations CaM’s N-lobe is loosely associated to the eNOS 
peptide.  
At resting intracellular Ca
2+
 concentrations CaM is unable to bind to the eNOS CaM binding domain 
peptide, whereas it can bind at an elevated free Ca
2+
 concentration of 225 nM. At the 225 nM free 
Ca
2+
 concentration CaM alone does not bind Ca
2+
 (previously shown by dansyl-CaM fluorescence 
studies in section 4.3.1), however, the presence of the eNOS peptide enhances the Ca
2+
 affinity of the 
C-lobe of CaM. At this free Ca
2+
 concentration the CaM-eNOS complex displays a structure with a 
Ca
2+
-replete C-lobe bound to the peptide, and a Ca
2+
-deplete N-lobe that is loosely associated to the 
peptide via hydrophobic interactions of a few CaM residues to the anchoring residue L509 of eNOS 
(Figure 5.3A,C). The solution structure shows L509 situated in a hydrophobic pocket of CaM 
composed of M36, M51, and M72. This interaction is strong enough to allow CaM to bind to eNOS 
even though this lobe is Ca
2+
-deplete. 
The structure of the CaM-eNOS complex at 225 nM Ca
2+
 shows that the C-lobe of CaM is 
completely bound to the eNOS peptide in a similar fashion as the holoCaM-eNOS complex. Residues 
V91, F92, L105, L112, F141 and M144 of the C-lobe of CaM interact via hydrophobic interactions 
with the anchoring residues F496, A500 and V503 of the eNOS peptide (Figure 5.3A, B). This forms 
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a tight complex between the eNOS peptide and CaM which allows this region of the eNOS peptide to 
adopt an α-helical secondary structure. The C-terminus of the eNOS peptide displays a less α-helical 
secondary structured region due to having a weaker interaction with CaM, which is evidenced by the 
solution structure and the lower amount of NOE contacts observed in the eNOS peptide NOESY 
spectrum. This agrees very well with previous studies that show the NOS peptides have no secondary 
structure when not bound to CaM (Matsubara et al., 1997; Spratt et al., 2007a); and this lack of α-
helical secondary structure further supports a looser association of the N-lobe of CaM to the eNOS 
peptide. 
 124 
 
 
Figure 5.3: Solution structures of CaM bound to the eNOS CaM binding peptide at 225 nM 
Ca
2+
 showing sidechain residues of CaM interacting with side chains of the anchor residues of 
the eNOS peptide. 
(A) Cartoon ribbon view of the average solution structure of the CaM− eNOS complex at 225 nM 
Ca
2+
 showing sidechain residues of CaM interacting with side chains of the anchor residues of the 
eNOS peptide. The side chains are colored by the same color scheme as that in Figure 1. (B) Zoom in 
of the C-lobe of CaM showing sidechain residues of CaM interacting with side chains of the anchor 
residues of the eNOS peptide. (C) Zoom in of the N-lobe of CaM showing sidechain residues of CaM 
interacting with side chains of the anchor residues of the eNOS peptide. 
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5.4 Conclusions 
The solution structure, along with the previous amide exchange and internal mobility results, shows 
that the residues of CaM interacting with eNOS’ 1-5-8-14 anchoring residues have strong interactions 
at 225 nM free Ca
2+
 concentration, which keeps the complex intact, while the rest of the residues of 
the CaM protein are able to fluctuate or “breathe”. Comparing the two lobes of CaM, the residues of 
the C-lobe display a more rigid structure (lower r.m.s.d., lower degree of internal mobility from 
higher S
2
, and higher exchange protection), indicating a stronger interaction with the eNOS peptide to 
hold the complex together, while the N-lobe is more dynamic and loosely associated to the eNOS 
peptide. This is the first study to determine an NMR structure of the CaM-eNOS complex at a free 
Ca
2+
 concentration that is within the physiologically relevant elevated intracellular Ca
2+
 concentration 
range. This structure suggests that the C-lobe of CaM first binds to the N-terminus of eNOS’ CaM-
binding domain and possibly part of the heme domain, while loosely associating to the C-terminus of 
eNOS’ CaM-binding domain when the intracellular Ca2+ concentration is elevated to 225 nM. As the 
intracellular Ca
2+
 concentration increases the N-lobe then binds Ca
2+
 and becomes tightly bound to 
the C-terminus of eNOS’ CaM-binding domain, allowing for the possibility of a bridge to form 
between CaM and the FMN domain, which would induce a shift to the FMN-heme electron transfer 
conformation to allow efficient electron transfer in the NOS enzymes. 
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Chapter 6  
NMR structural studies of Ca2+ binding CaM mutants* 
6.1 Introduction 
CaM consists of two globular domains joined by a flexible central linker region. Each one of these 
domains contains two EF hand pairs capable of binding to Ca
2+
. Each EF hand consists of a helix-
loop-helix structural element, with the 12 residue long loop being rich in aspartates and glutamates 
(Figure 1.1). In the absence of Ca
2+
 the helix-loop-helix motif of the EF hands are in a “closed” 
conformation, with their hydrophobic residues packed into their central core and their charged, 
hydrophilic residues solvent-exposed (Strynadka and James, 1989). Once a Ca
2+
 ion binds, the helices 
rearrange into a more “open” conformation, that exposes hydrophobic patches on each domain 
thereby allowing CaM to associate with its intracellular target proteins (Strynadka and James, 1989). 
The central linker’s flexibility allows it to adapt its conformation to optimally associate with its 
intracellular targets (Persechini and Kretsinger, 1988). CaM is able to bind to target proteins in the 
Ca
2+
-replete and Ca
2+
-deplete forms. There is considerable interest in obtaining a better understanding 
of the structural basis for CaM’s ability to bind and recognize its numerous target proteins. 
NOS enzymes are one of the target proteins bound and regulated by CaM. At elevated Ca
2+
 
concentrations, CaM binds to and activates eNOS making it a Ca
2+
-dependent NOS enzyme. In 
contrast, iNOS is transcriptionally regulated in vivo by cytokines and binds to CaM at basal levels of 
                                                     
*
 Unless otherwise stated, all of the work reported in this chapter was performed and analyzed by the 
candidate. 
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Ca
2+
. The Ca
2+
-deficient mutant CaM proteins can be used to allow for a specific structural 
investigation of Ca
2+
-dependent/independent activation and binding of CaM to iNOS.  
To study the Ca
2+
-dependent/independent properties of binding and activation of target 
proteins by CaM, numerous studies use a series of CaM mutants These include mutations of 
glutamate to glutamine residues at position 12 of each EF hand (Maune et al., 1992; Evenäs et al., 
1999) or mutation of the conserved aspartate to alanine at position 1 of each EF hand (Geiser et al., 
1991; Xia et al., 1998; Xiong et al., 2010). Changing the aspartate residue at position 1 of the EF hand 
loop of CaM inactivates the EF hand toward Ca
2+
 binding. These CaM proteins are defective in Ca
2+
 
binding in either the N-terminal lobe EF hands (CaM12; CaM D20A and D56A mutations), the C-
terminal lobe EF hands (CaM34; CaM D93A and D129A), or all four of its Ca
2+
-binding EF hands 
(CaM1234; mutations at D20A, D56A, D93A and D129A inclusive), depicted in Figure 6.1.  
A recent study by Xiong et al. (2010) has shown that although conversion of D93 and D129 
to Ala effectively inhibits Ca
2+
 binding to EF hands III and IV, the mutations may not only cause 
some structural perturbations in the C-domain but in the N-domain also. This suggests that the Ca
2+
-
deficient CaM mutants may adapt a different structure compared to that of the apo N- and C-domains 
of CaM. To investigate the effect of mutating Asp at position 1 to Ala in each EF hand we performed 
NMR structural studies of CaM12, CaM34, and CaM1234 in the absence and presence of Ca
2+
. A low 
resolution solution structure of CaM1234 was determined and the effects of these mutations were 
compared to the previous solution structure of apoCaM. Previously, Spratt et al. (2007a) performed 
activity studies on iNOS activity using all three of these mutants and found it was active for both 
CaM34 and CaM12 in the presence of Ca
2+
, with rates of 115% and 75%, respectively, whereas with 
CaM1234 less than 25% activity was found. In the presence of EDTA a substantial decrease in iNOS 
activity was found for wild type CaM and CaM34, whereas no substantial decrease in iNOS activity 
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was found for CaM12 or CaM1234. In light of these activity studies we determined a high resolution 
structure of CaM34 bound to the iNOS CaM binding domain peptide and compared that to the 
previously determined holoCaM-iNOS complex to characterize the structural effects this mutation 
may cause.  
 
 
Figure 6.1: Ribbon diagram of apoCaM and Ca
2+
-saturated CaM displaying Asp residues in 
position 1 of each EF hand. 
Residues 1−40 of CaM (EF hand I) are colored red, residues 41−79 (EF hand II) purple, residues 
80−114 (EF hand III) green, and residues 115−148 (EF hand IV) blue. The apoCaM structure was 
modified from PDB 1CFC (Kuboniwa et al., 1995) and holoCaM from PDB 1CLL (Chattopadhyaya 
et al., 1992).  
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6.2 Methods and experiments 
6.2.1 Sample preparation for NMR investigation. 
CaM12, CaM34 and CaM1234 for NMR experiments were expressed in E. coli 1 L of M9 media (11.03 
g/L Na2HPO4·7H2O, 3.0 g/L KH2PO4, 0.5 g/L NaCl, 2 mM MgSO4, 0.1 mM CaCl2, 3 μM 
(NH4)6(MO7)24, 400 μM H3BO3, 30 μM CoCl2, 10 μM CuSO4, 80 μM MnCl2·4H2O, 10 μM ZnCl2, 10 
mM FeSO4, 100 μg/mL kanamycin) containing 2 g/L 
13
C-glucose and 1 g/L 
15
NH4Cl. 
13
C-
15
N CaM 
was purified as described in section 3.2.2.  Isolation of the mutant CaM protein (148 residues) was 
confirmed by ESI-MS and purity was judged to be > 95% by SDS-PAGE. The human iNOS peptide 
(RREIPLKVLVKAVLFACMLMRK, 22 residues corresponding to residues 510-531 from the full 
length iNOS protein) was synthesized and purchased from Sigma.   
The CaM12-iNOS and CaM34-iNOS samples were prepared for NMR experiments via a buffer 
exchange into NMR solution (100 mM KCl, 10 mM CaCl2, 0.2 mM NaN3, 90% H2O/10% 
2
H2O) at 
pH 6.0 using a YM10 centrifugal filter device (Millipore Corp., Billerica, USA). The CaM1234 sample 
was prepared for NMR experiments via a buffer exchange into NMR solution (100 mM KCl, 0.2 mM 
EDTA, 0.2 mM NaN3, 90% H2O/10% 
2
H2O) at pH 6.0 using a YM10 centrifugal filter device 
(Millipore Corp., Billerica, USA). All NMR samples contained at least 1 mM CaM in a total volume 
of 500 μL. The samples were transferred into 5 mm NMR sample tubes and stored at 4oC until 
required for NMR experiments. NMR experiments on the CaM12-iNOS and CaM34-iNOS complex 
were conducted on samples titrated with iNOS peptide to saturation in a 1:1 CaM:peptide ratio. 
Complex formation was monitored after each addition by acquisition of a 
1
H-
15
N heteronuclear 
single-quantum coherence (HSQC) spectrum.  
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6.2.2 NMR spectroscopy and data analysis.  
NMR spectra were recorded at 25
o
C on Bruker 600 MHz DRX spectrometers equipped with 
XYZ-gradients triple-resonance probes (Bruker, Billerica, MA, USA). Spectra were analyzed using 
the program CARA (Keller, 2005).
 
The amide resonances assignments were aided by using the 
previously obtained amide chemical shifts of Ca
2+
 saturated CaM with iNOS peptide as reference 
(Piazza et al., 2012). Specific assignments of the backbone resonances of the CaM12-iNOS and 
CaM34-iNOS complexes and CaM1234 alone were achieved using a combination of three-dimensional 
triple-resonance experiments, including HNCA, HN(CO)CA, CBCA(CO)NH, and HNCO (Grzesiek 
and Bax, 1992a, 1992b; Muhandiram and Kay, 1994). Side chain resonances for the CaM34-iNOS 
complex and CaM1234 alone were assigned using the TOCSY-type HC(C)H-TOCSY and (H)CCH- 
TOCSY experiments (Ikura et al., 1990). Specific assignments of the iNOS peptide in the CaM34-
iNOS complex were obtained from 
15
N-double-filtered NOESY experiments (Ikura and Bax, 1992). 
15
N T2 measurements for the CaM34-iNOS complexes were acquired for eight different durations of 
the T2 relaxation delay, T= 16.6, 33.2, 49.8, 66.4, 99.6, 116.2, 132.8, and 149.4ms. 
6.2.3 Structure calculation of the CaM34-iNOS peptide complex and CaM1234 alone. 
The 
1
H, 
13
C, and 
15
N resonance assignments were utilized to identify constraints for the structure 
calculations. Distance constraints for the CaM1234 were obtained from a 
15
N NOESY-HSQC spectrum. 
Distance constraints for the CaM34-iNOS complex were obtained from 
15
N NOESY-HSQC and 
13
C 
NOESY- HSQC, and 
15
N- double-filtered NOESY spectra acquired on samples containing 
13
C-
15
N-
CaM34 and unlabeled peptide (Fesik and Zuiderweg, 1990; Clore and Gronenborn, 1991; Ikura and 
Bax, 1992). In addition, dihedral angle restraints were derived from chemical shift analysis with 
TALOS+. The structure calculations of CaM34-iNOS peptide complex and of CaM1234 alone were 
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performed using CNSsolve version 1.2 (Brunger et al., 1998). The calculation was initiated with an 
extended conformation file and run through several iterations of a standard simulated annealing 
protocol to minimize the energies. The final 20 lowest energy structures were selected. 
6.3 Results and discussion 
Previously Xiong et al. (2010) showed that the CaM34 mutations caused potential structural changes 
caused by significant changes in amide chemical shifts for apoCaM. They found this mutation also 
affected chemical shifts in the unmodified N-lobe and altered its Ca
2+
 binding properties. They 
postulated that this is possibly due to the loss of stabilizing hydrogen bonds between the side chain of 
Asp93 and backbone amides in apo loop III. We performed NMR studies on the CaM12, CaM34 and 
CaM1234 mutant CaM constructs in the presence and absence of Ca
2+
 to investigate the structural 
perturbations observed by Xiong et al. 
6.3.1 NMR structural study of Ca2+ saturated CaM12 indicates altered N-lobe.  
NMR studies were performed on wild type CaM at various free Ca
2+
 concentrations to determine the 
1
H-
15
N HSQC spectrum of a C-lobe Ca
2+
-replete and N-lobe Ca
2+
-deplete CaM. This spectrum is 
shown in red in figure 6.2, overlaid with the 
1
H-
15
N HSQC spectrum of Ca
2+
-saturated CaM12 in 
green. CaM12 contains mutations in EF hands I and II that make CaM’s N-lobe unable to bind Ca
2+
, 
thus it should have a Ca
2+
-replete C-lobe and Ca
2+
-deplete N-lobe in the presence of Ca
2+
. This should 
result in an 
1
H-
15
N HSQC spectrum that overlays very well with a C-lobe Ca
2+
-replete, N-lobe Ca
2+
-
deplete CaM, however, as evidenced by figures 6.2 and 6.3, chemical shift differences are observed 
throughout the N-lobe, specifically around the loop region of each EF hand. This suggests that the 
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Asp to Ala mutations not only knock out Ca
2+
-binding but also cause structural perturbations 
throughout the whole loop region.  
 
Figure 6.2: Superposition of 
1
H-
15
N HSQC spectra of wild type CaM at 1.3 μM free Ca2+ (red) 
and Ca
2+
 saturated CaM12 (green).  
1
H-
15
N HSQC spectra overlay shows the amide resonances of residues in the N-lobe of CaM12 are 
different from those of wild type CaM at 1.3 μM free Ca2+. The backbone amide resonances of wild 
type CaM at 1.3 μM free Ca2+ are labeled with the amino acid type and position in the sequence. 
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Figure 6.3: Chemical shift differences between CaM at 1.3 μM free Ca2+ and Ca2+ saturated 
CaM12. 
The contribution of 
1
HN and 
15
N chemical shift changes for each residue was calculated as Δδ = 
√[(Δδ1HN)2 + (Δδ15N/5)2], where Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical 
shifts between the indicated protein. The greatest differences are localized to Ca
2+
 binding loops 
where each mutation is present. 
6.3.2 Structural studies of CaM12 and CaM34 indicates possible structural 
perturbations caused by the mutations. 
1
H-
15
N HSQC experiments were then performed to determine if potential structural changes occur 
due to mutations in the CaM12 and CaM34 EF hands in the absence and presence of Ca
2+
. The 
complete backbone assignment of CaM12 and CaM34 in the absence and presence of Ca
2+
 was 
completed and previously discussed in chapter 3. These assignments were used to probe the potential 
structural changes caused by the mutations through an 
1
H-
15
N HSQC comparison with apo and 
holoCaM. Figure 6.4A shows the 
1
H-
15
N HSQC spectra overlay of apoCaM, apoCaM12 and 
apoCaM34 and figures 6.5A and B shows the chemical shift differences calculated from these spectra. 
Cross-peaks for amides in the C-lobe of apoCaM12 overlap with those of apoCaM, however, amides 
in the N-lobe, specifically the residues in the loop regions of the EF hands, do not overlap with those 
of apoCaM. Conversely, cross-peaks for amides in the N-lobe of apoCaM34 overlap with those of 
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apoCaM, however, amides in the C-lobe, specifically the residues in the loop regions of the EF hands, 
do not overlap with those of apoCaM. This data suggests that the Asp to Ala mutations not only 
knock out Ca
2+
 binding to the EF hands but also cause potential structural changes. These structural 
changes appear to only be located to the specific EF hands that contain the mutation and not to the 
opposite domain in each respective CaM mutant. 
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Figure 6.4: Superposition of 
1
H-
15
N HSQC spectra of (A) apo and (B) Ca
2+
-saturated wild type 
CaM (black), CaM12 (green) and CaM34 (red). 
1
H-
15
N HSQC spectra overlay in (A) shows apoCaM (black), apoCaM12 (green) and apoCaM34 (red). 
The backbone amide resonances of apoCaM are labeled. 
1
H-
15
N HSQC spectra overlay in (B) shows 
holoCaM (black), Ca
2+
-CaM12 (green) and Ca
2+
-CaM34 (red). The backbone amide resonances of 
holoCaM are labeled. 
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Figure 6.5: Chemical shift differences between apo and Ca
2+
-replete CaM, CaM12 and CaM34. 
Chemical shift differences for the amide chemical shifts between (A) apoCaM and apoCaM12, (B) 
apoCaM and apoCaM34, (C) holoCaM and Ca
2+
-CaM12, and (D) holoCaM and Ca
2+
-CaM34 are 
shown. The insets in C and D show the chemical shift differences of the C-lobe for holoCaM and 
Ca
2+
-CaM12 and N-lobe for holoCaM and Ca
2+
-CaM34, respectively. The greatest differences are 
localized to Ca
2+
 binding loops where each mutation is present. In the presence of Ca
2+
 some 
chemical shift differences occur for the lobe opposite the mutation sites. The contribution of 
1
HN and 
15
N chemical shift changes for each residue was calculated as Δδ = √[(Δδ1HN)2 + (Δδ15N/5)2], where 
Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical shifts between the indicated protein. 
 137 
 
Figure 6.4B shows the 
1
H-
15
N HSQC spectra overlay of holoCaM, Ca
2+
-CaM12 and Ca
2+
-
CaM34 and figures 6.5C and D shows the chemical shift differences calculated from these spectra. As 
observed for apoCaM12, cross-peaks for the majority of amides in the C-lobe of Ca
2+
-CaM12 overlap 
with those of holoCaM, and amides in the N-lobe, specifically the residues in the loop regions of the 
EF hands, do not overlap. However, unlike apoCaM12 there are a few residues in the C-lobe that are 
calculated to have a chemical shift difference greater than 0.1.  
Also as observed for apoCaM34, cross-peaks for amides in the C-lobe of Ca
2+
-CaM34 overlap 
with those of holoCaM, and amides in the N-lobe, specifically the residues in the loop regions of the 
EF hands, do not. Like Ca
2+
-CaM12, residues in the opposite lobe appear to be affected by the 
mutations also. In the Ca
2+
-CaM34 case there are quite a few C-lobe residues, spread throughout the 
whole domain, that are calculated to have a chemical shift difference greater than 0.1.This data 
suggests that the Asp to Ala mutations not only knock out Ca
2+
 binding to the EF hands where the 
mutations occur, but also cause potential structural changes in the opposite lobe. Some of the residues 
that experience the greatest changes are the hydrophobic residues Phe 12, Phe 16, Leu 18, Phe19 and 
Met36 in EF hand I and the hydrophobic residues, Val55, Ala57, Ile63 and Phe65 in the Ca
2+
-
coordinating loop of EF hand II. This is similar to what Xiong et al. (2010) had observed in their 
study. These structural changes appear to not only be located to the specific EF hands that contain the 
mutation but also to residues of the opposite domain, especially in the case of Ca
2+
-CaM34. 
6.3.3 Solution structure of CaM1234. 
To probe these potential conformational changes further the structure determination of apoCaM1234 
was undertaken. The 
1
H-
15
N HSQC spectrum of CaM1234 exhibits good resolution and well dispersed 
signals, indicating a uniform and folded protein structure (Figure 6.2). Comparing this spectrum to 
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that of apoCaM, chemical shift changes induced by the 4 EF hand mutations appear for the amides 
throughout all 4 of the Ca
2+
-binding EF hands (Figures 6.6 and 6.7). The chemical shift differences 
are a sum of the individual differences observed for the mutated EF hands between apoCaM and 
CaM12, and apoCaM and CaM34. 
 
Figure 6.6: Superposition of 
1
H-
15
N HSQC spectra of CaM1234 (black) and apoCaM (red). 
1
H-
15
N HSQC spectra overlay shows the amide resonances of residues in both lobes of CaM1234 are 
different from those of wild type apoCaM. The backbone amide resonances of CaM1234 are labeled. 
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Figure 6.7: Chemical shift differences between CaM1234 and apoCaM.  
The contribution of 
1
HN and 
15
N chemical shift changes for each residue was calculated as Δδ = 
√[(Δδ1HN)2 + (Δδ15N/5)2], where Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical 
shifts between the indicated protein. The greatest differences are localized to Ca
2+
 binding loops 
where each mutation is present. 
The NMR assignment of CaM1234 followed a similar procedure as described in sections 1.3.1 
and 2.3.2, with the backbone resonance assignment based primarily on 3D triple resonance techniques 
using the previously assigned chemical shifts of apoCaM as a starting point. This combination of 
techniques resulted in complete backbone assignments for CaM1234, with the exception of the two 
prolines and the first two N-terminal amino acids. Subsequently, sidechain resonances were assigned 
using TOCSY experiments and NOEs for the structure calculation were extracted from an 
15
N 
NOESY-HSQC. The use of only an 
15
N NOESY-HSQC spectrum for the gathering of structure 
constraints resulted in a lower resolution structure as shown by the average pairwise r.m.s.d. value of 
the 20 lowest energy structures (Table 6.1). 
The family of 20 lowest energy structures is shown in Figure 6.8A and B. Due to the high 
degree of flexibility of CaM’s central linker it is  not possible to superimpose both the C and N-lobes 
at the same time. Superimposing the ensemble of structures with respect to the N-lobe backbone 
atoms shows a fairly well overlapped N-lobe of CaM1234, with an r.m.s.d. of 2.2 for the backbone 
atoms and 2.7 Å for heavy atoms. While superimposing the ensemble with respect to the C-lobe 
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backbone atoms shows a less well overlapped C-lobe of CaM1234, with an r.m.s.d. of 3.1 for the 
backbone atoms and 4.0 Å for heavy atoms. This indicates the N-lobe has a more stable structure than 
the C-lobe, which has previously been reported to have a well-defined hydrophobic core, compared to 
a C-lobe with a less defined hydrophobic core in the apoCaM structures (Kuboniwa et al., 1995; 
Zhang et al., 1995a).  
Table 6.1: Statistics for the structural ensemble of CaM1234. 
 CaM1234 
NMR-derived distance and dihedral angle restraints 
NOE constraints 782 
Dihedral angles from TALOS+ 240 
Total number of restraints 1022 
Structure statistics for the 20 lowest energy structures 
Mean deviation from ideal covalent 
geometry 
 
Bond lengths (Ǻ)  0.009 
Bond angles (deg.) 0.9 
Average pairwise RMSD (Ǻ) for all heavy 
atoms of the 20 lowest energy structures 
All 
Residues 
Ordered 
Residues
a 
C-lobe
b 
N-lobe
c 
Backbone Atoms  8.8 7.8 3.1 2.2 
Heavy Atoms 9.3 8.3 4.0 2.7 
Ramachandran statistics (%)  
Residues in most favored region  93.2 
Residues in additional allowed regions  6.7 
Residues in generously allowed region  0.0 
Residues in disallowed region 0.0 
a 
Ordered residue ranges: 4A-19A,24A-39A,41A-56A,61A-79A,81A-93A,101A-112A,116A-
130A,137A-146A 
b 
C-lobe residues: 81A-148A 
c 
N-lobe residues: 4A-74A 
Figure 6.8C shows the structure consists of 8 helices, and the characteristic helix-loop-helix 
conformation for each EF hand, as observed in other apo and Ca
2+
-replete structures of CaM 
(Chattopadhyaya et al., 1992; Kuboniwa et al., 1995; Zhang et al., 1995a). When the ensemble of 
structures are superimposed with respect to a specific lobe, the linker region is shown to be very 
flexible, as evidenced by the opposite lobe being distributed in different conformations relative to the 
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superimposed lobe. Also no long range NOEs observed for the linker residues or observed between 
the two lobes suggesting CaM1234 exists as two independent globular domains.   
 
Figure 6.8: Solution structure of CaM1234. 
The superposition of the ensemble of the 20 lowest-energy calculated solution structures of  
CaM1234.(A) The N-terminal domain is superimposed against the energy-minimized average structure. 
(B) The C-terminal domain is superimposed against the energy-minimized average structure. (C) 
Cartoon ribbon view of the energy-minimized average solution structure of the CaM1234. Residues are 
colored following the color-scheme in Figure 6.1. 
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6.3.3.1 Structure comparison apoCaM. 
The CaM1234 structure was compared to the previously determined solution structure of apoCaM 
(PDB entry 1CFC, Kuboniwa et al., 1995), to determine any structural changes incurred by the Asp to 
Ala mutations in position 1 of the four EF hands. Due to the highly flexible linker region described 
above, the two lobes of CaM of the two structures were compared separately (Figure 6.9). When the 
two structures were superimposed with respect to CaM’s N-lobe backbone atoms (residues 4-70) a 
r.m.s.d. value of 2.999 Å was found. Figure 6.9B and C shows the superposition of the N-lobe of 
CaM1234 and apoCaM. In this figure helix C and the loop region between helix B and C overlay quite 
well in both structures, whereas helix B is shifted down from the Ca
2+
-binding loop and helix A is 
tilted away from helix B at the site of the mutation. The biggest structural change observed is in the 
Ca
2+
-binding loop region of EF hand I, which had previously been proposed to have the biggest 
structural change due to the Asp20 to Ala mutation (Xiong et al,. 2010). In the apoCaM structure the 
side chain of Asp 20 points into the loop and is involved in stabilizing hydrogen. The conversion of 
Asp to Ala in the CaM1234 structure causes the loop to have a less compact structure, unravelling the 
α-helix at the C-terminal end of helix A and pushing it away from helix B.  
 The Ca
2+
-binding loop of EF hand II also displays structural changes, however these aren’t as 
large. In the apoCaM structure the side chain of Asp 56 is exposed to the solvent, thus doesn’t have as 
large of a role in stabilizing the loop structure, which could explain the lower degree of structural 
change. In the CaM1234 structure the substituted Ala 56 side chain points into the loop, this disrupts 
the α-helix that Asp 56 adopted, unraveling the loop slightly. This explains the similarity in 
conformation of helix C in both structures. The linker region displays a similar α-helix secondary 
structure for helices D and E, with a hinge region at residue 80 for both structures.  
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Figure 6.9: Comparison of the solution structure of the CaM1234 with the solution structure of 
apoCaM. 
The solution structures of CaM1234 (dark colors) and apoCaM (light colors, Structure 14 from PDB 
1CFC Kuboniwa et al., 1995)) are aligned by superimposition of the backbone atoms of the N-lobes 
of CaM in A. For clarity only the N-lobes of CaM1234 and apoCaM were superimposed in B and C 
and the C-lobes superimposed in D and E. The side chains of Asp in apoCaM and Ala in CaM1234 are 
shown and labeled as D20A, D56A, D93A and D129A. The color scheme is the same as figure 6.1. 
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When the two structures are superimposed with respect to the C-lobe backbone atoms 
(residues 84-148) a r.m.s.d. value of 3.762 Å was found. Figure 6.9D and E shows the superposition 
of the C-lobe of CaM1234 and apoCaM, which displays less drastic conformational changes compared 
to the N-lobe, but more subtle changes. Like EF hand I, the side chain of Asp 93 of EF hand III points 
into the loop, however, the conversion to Ala doesn’t cause as large of a structure perturbation as Asp 
20 to Ala. The packing of Ala side chain into the loop toward the other hydrophobic side chain groups 
causes the loop to bulge slightly compared to apoCaM. This causes Ala 102 and Ala103 to lose their 
α-helical structure, along with helix F to become less helical. The loop region between the two EF 
hands has a slightly different conformation due to helix G being tilted inward. The Asp 129 to Ala 
causes the Ca
2+
-binding loop of EF hand IV to be slightly longer because of this tilt in helix G. 
Overall the EF hand III and IV mutations cause more overall conformational changes compared to the 
N-lobe, as evidenced by the higher r.m.s.d. value for the lobe and the aforementioned differences. 
These structural changes also correlate well with the chemical shift differences observed 
between the structures, which shows the N-lobe of CaM1234 has larger differences in the Ca
2+
-binding 
loops, but less differences in the rest of the N-lobe, whereas the C-lobe shows lower chemical shift 
difference values in the Ca
2+
-binding loop but a larger amount of differences throughout the whole 
lobe. 
6.3.4 NMR structure of CaM34 and the iNOS CaM binding domain peptide complex.  
We then determined the solution structure of CaM34 bound to a peptide of a target protein, iNOS. The 
complex of CaM34 with iNOS was chosen because of multiple factors. First off, iNOS is Ca
2+
-
independent, thus binds to CaM in the absence and presence of Ca
2+
, so a complex will be formed 
even with the Ca
2+
-deplete C-lobe. Also this CaM mutant would retain the ability to bind Ca
2+
 in its N 
 145 
 
lobe, thus this lobe should interact with the iNOS peptide much like holoCaM does, which has 
previously been shown to bind tighter to the iNOS peptide than the C-lobe. And lastly, to determine if 
the EF hand III and IV mutations cause structural changes in the N-lobe as observed from the 
chemical shift differences between holoCaM and Ca
2+
-CaM34 in figure 6.5D.  
 
Figure 6.10: Superposition of 
1
H-
15
N HSQC spectra of CaM34-iNOS (black) and holoCaM-iNOS 
(red). 
1
H-
15
N HSQC spectra overlay shows the amide resonances of residues in the C-lobe of CaM34-iNOS 
are different from those of the holoCaM-iNOS complex. The backbone amide resonances of CaM34-
iNOS are labeled. 
Overall, the 
1
H- 
15
N HSQC spectrum of CaM34 in complex with the peptide of the iNOS 
CaM-binding domain exhibits good resolution and well dispersed signals, indicating a uniform and 
folded protein structure (Figure 6.10). Upon comparison with the 
1
H- 
15
N HSQC spectrum of the 
holoCaM complex chemical shift changes induced by the C-lobe EF hand mutations appear 
predominately for the amides in the C-domain. Specifically the amides of residues that participate in 
 146 
 
coordinating the Ca
2+
 ion in EF hands III and IV, with the greatest differences occurring for the 
amides in the center of the Ca
2+
-binding loop (Figure 6.11). The majority of the amide resonances of 
the N-lobe show little chemical shift differences, suggesting both complexes have a similar structure 
of the N-lobe bound to iNOS, however, a few meaningful differences are observed. 
 
Figure 6.11: Chemical shift differences between CaM34-iNOS and holoCaM-iNOS. 
The contribution of 
1
HN and 
15
N chemical shift changes for each residue was calculated as Δδ = 
√[(Δδ1HN)2 + (Δδ15N/5)2], where Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical 
shifts between the indicated protein. The greatest differences are localized to Ca
2+
 binding loops in 
the C-lobe where each mutation is present. 
The three-dimensional solution structure of CaM34-iNOS complex was determined using 
multidimensional heteronuclear NMR spectroscopy. The NMR assignment of the CaM34-iNOS 
complex followed the procedure described in sections 1.3.1 and 2.3.2 with the backbone resonance 
assignment based primarily on 3D triple resonance techniques, using the previously assigned 
chemical shifts of the holoCaM-iNOS complex as a starting point. This combination of techniques 
resulted in complete backbone assignments for CaM34, with the exception of the two prolines, the first 
two N-terminal amino acids and Ile100 (Appendix I). Subsequently, sidechain resonances for CaM34 
were assigned using HC(C)H-TOCSY, (H)CCH-TOCSY and H(CCO)NH experiments and for the 
iNOS peptide using the 
15
N-
13
C-double-filtered NOESY experiment. NOEs for the structure were 
extracted from 
15
N NOESY-HSQC, 
13
Cali-NOESY and 
15
N-
13
C-double-filtered NOESY experiments. 
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The structure of the complex is based on a large number of experimental constraints and is well-
defined. Residues 1− 12 at the N-terminus of the iNOS peptide (corresponding to residues 503-514 of 
full length iNOS) show a lack of structure because they could not be unambiguously assigned and 
were omitted from the structure calculation. The root-mean-square distance (r.m.s.d.) for ordered 
residues is 1.0 Å for the backbone atoms and 1.4 Å for all non-hydrogen atoms (Table 6.2).  
Table 6.2: Statistics for the structural ensemble of the CaM34-iNOS peptide complex. 
 CaM34-iNOS Complex 
NMR-derived distance and dihedral angle restraints 
 CaM34 iNOS peptide CaM34-iNOS complex 
NOE constraints 1718 213 81 
Dihedral angles from TALOS+ 262 N/A N/A 
Total number of restraints                                              2274  
Structure statistics for the 20 lowest energy structures 
Mean deviation from ideal covalent 
geometry 
 
Bond lengths (Ǻ)  0.010 
Bond angles (deg.) 1.2 
Average pairwise RMSD (Ǻ) for all heavy 
atoms of the 20 lowest energy structures 
All 
Residues 
Ordered 
Residues
a 
C-lobe
b 
N-lobe
c 
Backbone Atoms  1.3 1.0 1.0 0.7 
Heavy Atoms 1.7 1.4 1.6 1.2 
Ramachandran statistics (%)  
Residues in most favored region  84.4 
Residues in additional allowed regions  14.4 
Residues in generously allowed region  0.5 
Residues in disallowed region 0.7 
a 
Ordered residue ranges: 5A-42A, 44A-92A, 100A-147A, 517B-528B 
b 
C-lobe residues: 81A-148A 
c 
N-lobe residues: 4A-74A 
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Figure 6.12: Solution structure of the CaM34-iNOS complex. 
(A) Superposition of the ensemble of the 20 lowest-energy calculated NMR solution structures of  
CaM34 bound to iNOS peptide Backbone atom traces of CaM are colored dark blue, and the iNOS 
peptide colored light blue. (B) Cartoon ribbon view of the average solution structure of the CaM34-
eNOS complex. CaM has the same color scheme as figure 6.1. The peptide is colored lighter blue. 
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The family of 20 lowest energy structures is shown in Figure 6.12A. This ensemble of 
structures shows a more closely overlapped N-lobe of CaM34 compared to a C-lobe that displays more 
fluctuation in the ensemble of structures. This can be further shown by looking at the r.m.s.d. values 
for each individual lobe of CaM34 in complex with the iNOS peptide. The r.m.s.d. for the C-lobe 
residues is 1.0 Å for the backbone atoms and 1.7 Å for all non-hydrogen atoms, whereas it is 0.7 Å 
for the backbone atoms and 1.2 Å for all non-hydrogen atoms of the N-lobe. The CaM34-iNOS 
complex has a Ca
2+
-replete N-lobe and a Ca
2+
-deplete C-lobe bound to the iNOS peptide as shown in 
figure 6.12B. This structure shows CaM is still able to bind to iNOS with both lobes, even when the 
C-lobe of CaM is Ca
2+
-deplete due to the Asp to Ala mutations.  
6.3.4.1 Structure comparison to the holoCaM-iNOS complex. 
When the CaM34-iNOS complex structure is compared to the previously determined solution structure 
of the holoCaM−iNOS complex (PDB entry 2LL6), the N-lobes of CaM and peptide orientation are 
quite similar, however the loop regions of EF hands III and IV of the C-lobe of CaM are structurally 
different (Figure 6.13). When the two structures are aligned with respect to CaM34-iNOS’s backbone 
atoms a r.m.s.d. value of 2.438 Å for the backbone atoms of CaM-iNOS was found. When the two 
structures are aligned with respect to CaM’s N-lobe backbone atoms a r.m.s.d. value of 2.180 Å was 
found, whereas, an r.m.s.d. value of 3.215 with respect to the C-lobe backbone atoms was found. The 
N-lobes of CaM and the iNOS peptide of each structure superimpose quite well on each other, 
whereas the loop regions of EF hands III and IV of the C-lobe of CaM do not. Even though the C-
lobe of CaM34 is Ca
2+
-deplete, the α-helices between the EF hand loops still bind to the iNOS peptide 
in a similar fashion as in the holoCaM-iNOS complex. This is evident from the solution structure and 
also from the NOESY spectra. The inter-residue NOEs observed for the α-helices between the EF 
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hand loops of CaM34’s C-lobe are very similar to those observed for the same residues in the 
holoCaM-iNOS complex. 
 
Figure 6.13: Comparison of the solution structure of the CaM34-iNOS peptide complex with the 
solution structure of wtCaM-iNOS peptide complex. 
The solution structures of the CaM34-iNOS peptide (dark colors) and wtCaM-iNOS (light colors) are 
aligned by superimposition of the backbone atoms of the N-lobes of CaM and the iNOS peptides 
viewed along the bound peptide from its C-terminus (C′) to its N-terminus (N′) and subsequently 
rotated 90° around the vertical axis. The color scheme is the same as Figure 6.1. 
The loop regions of EF hands III and IV are more compact in the holoCaM-iNOS complex 
compared to the CaM34-iNOS complex. The mutation of Asp to Ala in position 1 of the loop removes 
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the oxygen ligand necessary to coordinate a Ca
2+
 ion and causes the loop to adopt a more open 
conformation. This causes the loop region between EF hands III and IV to move closer to the iNOS 
peptide. This also causes the  loop region between EF hands I and II and helix B (labeling of helices 
shown in figure 6.7) to be shifted closer to the iNOS peptide. The loop regions between EF hands I 
and II and between III and IV contain multiple hydrophobic residues that pack close together and 
interact with the hydrophobic residues of the iNOS peptide. In conclusion the mutation of Asp to Ala 
causes the Ca
2+
 binding loop regions in the C-lobe EF hands to adopt a more open conformation, 
which in turn causes local structural changes, as shown in the loop region between EF hands III and 
IV, and long range structural conformation changes, as shown in the loop region between EF hands I 
and II and helix B. This may account for the amide chemical shift changes in the N-domain of Ca
2+
-
saturated CaM34 observed by Xiong et al.(2010) and in the previous section. 
 
Figure 6.14: : Comparison of the C-terminal residues of the solution structure of the CaM34-
iNOS peptide complex with the solution structures of apoCaM. 
The solution structures of the CaM34-iNOS peptide (dark colors) and apoCaM (light colors) are 
aligned by superimposition of the backbone atoms of the C-lobes of CaM. The color scheme is the 
same as that in Figure 6.1. 
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When the CaM34-iNOS complex structure is compared to the previously determined apoCaM 
structure (PDB entry 1CFC, Kuboniwa et al., 1995), there is structural similarity of the loop region of 
EF hand III of the C-lobes of CaM (Figure 6.14). When the two structures are aligned with respect to 
CaM’s EF hand III loop region backbone atoms (residues 93-104) a r.m.s.d. value of 1.135 Å was 
found. When the two structures are aligned with respect to CaM’s C-lobe backbone atoms (residues 
93-140) a r.m.s.d. value of 3.500 Å was found. The structure and r.m.s.d. values suggest the EF hands 
of the C-lobe adopt a similar Ca
2+
 free conformation for the Ca
2+
-binding loop region, however the 
overall conformation of the helix-loop-helix motif is similar to the “open” conformation observed in 
the Ca
2+
-replete form, as shown in the right side of figure 6.14. 
6.3.4.2 15N T2 relaxation data indicates CaM34-iNOS’ C-lobe residues have higher T2 
relaxation times compared to holoCaM-iNOS.  
Further to the structure determination of the CaM34-iNOS complex 
15
N T2 relaxation experiments 
were acquired. Figure 6.15 compares the results determined in this study to results previously 
determined for CaM bound to iNOS (Piazza et al., 2012) it is evident that the CaM34 mutations have 
an effect on the T2 relaxation rate of residues in the C-lobe. The N-lobe residues have almost 
identical T2 relaxation rates, with the exception of a few residues of helix C that have increased rates. 
These residues also had chemical shift differences when the 
1
H-
15
N HSQC spectra were compared. 
Comparison of the T2 rates for the C-lobe residues shows an increase in rates throughout the whole 
lobe, with the greatest increases occurring in the loop regions. This could be due to these loop region 
experiencing a higher degree of flexibility due to the mutations. This data shows that these mutations 
not only prevent CaM from binding Ca
2+
 in its C-lobe and cause structural perturbations but they also 
increase the internal dynamics of the C-lobe.  
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Figure 6.15: 
15
N T2 Relaxation data for the CaM34-iNOS and holoCaM-iNOS complexes. 
Plots as a function of residue number of the measured T2 values for (A) the CaM34-iNOS complex 
and (B) the holoCaM-iNOS complex. Only residues for which the 
15
N-
1
H cross peaks were 
sufficiently well resolved to permit accurate measurement of its intensity are included. 
6.3.4.3 Structural effects on iNOS activation by CaM mutants. 
Previously, Spratt et al. (2007a) performed activity studies on iNOS activity using the three CaM 
mutants. They found that iNOS was active for both CaM34 and CaM12, with rates of 115% and 75%, 
respectively, in the presence of Ca
2+
,whereas CaM1234 produced rate of less than 25%. In the presence 
of EDTA a substantial decrease in iNOS activity was found for wild type CaM and CaM34, whereas 
no substantial decrease in iNOS activity was found for CaM12 or CaM1234. The CaM34-iNOS structure 
shows that the N-lobe is bound to iNOS in the same conformation as holoCaM. The N-lobe of CaM 
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alone has previously been shown to activate the iNOS enzyme in the presence of Ca
2+
, thus its tight 
association with iNOS, along with the association of the Ca
2+
-deplete C-lobe may be enough to fully 
activate iNOS (Spratt et al., 2006, 2007b; Xia et al., 2009). The reduced iNOS activity observed for 
CaM34 in the presence of EDTA could be caused by the rearrangement of EF hands I and II due to the 
removal of Ca
2+
 from the N-lobe. This conformational change may not allow for the necessary 
interactions of the N-lobe of CaM to the FMN domain of iNOS required for efficient electron 
transfer, although CaM may still be bound to the CaM binding domain of the enzyme due to strong 
hydrophobic interactions. The structural explanation for the reduced activity observed for CaM1234 
with iNOS can be speculated on by comparing the structure of apoCaM to CaM1234. Although 
CaM1234 is still able to bind to iNOS, binding may only be to the highly hydrophobic CaM-binding 
domain of iNOS. The structural perturbations induced by the EF hand mutations may affect how 
CaM1234 interacts with the rest of iNOS, specifically CaM’s N-lobe interaction with the FMN domain. 
This may prevent the conformational change required for efficient electron transfer to the heme 
domain or prevent CaM from stabilizing the FMN to heme electron transfer, “output”, state.  
6.4 Conclusion 
In summary, the use of mutations in the EF hands of CaM to disable Ca
2+
-binding also cause slight 
structural perturbations, shown in this study by the use of NMR spectroscopy. The structure 
determination of CaM1234 revealed that the mutation of Asp to Ala causes the EF hand loops to adopt 
perturbed conformations when compared to apoCaM. The structure also displayed a less stable C-
lobe compared to N-lobe as previously observed for apoCaM. To investigate if these mutations also 
perturb the structure of CaM bound to a target peptide the structure of CaM34 bound to the iNOS 
peptide was determined. The mutation of Asp to Ala causes the Ca
2+
 binding loop regions in the C-
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lobe EF hands to adopt a conformation resembling apoCaM, which causes local structural changes, as 
shown in the loop region between EF hands III and IV, and long range structural conformation 
changes, as shown in the loop region between EF hands I and II and helix B. This study provides 
structural evidence of changes that are present in CaM mutants with mutations at Asp in position 1 of 
the EF hand. 
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Chapter 7  
NMR structural studies of daptomycin* 
7.1 Introduction 
7.1.1 Overview of daptomycin. 
Daptomycin is one of the first approved antibiotic of the cyclic lipopeptides family. The 
compound was discovered by Eli Lilly and Company in the 1980s and selected for use in clinical 
trials. Daptomycin is produced as a secondary metabolite by a soil actinomycete, Streptomyces 
roseosporus, as a member of the A21978C lipopeptide family (Figure 7.1). The A21978C lipopeptide 
family consists of 13 amino acids, 10 of which form a cycle, including 3 D-amino acid residues (D-
asparagine, D-alanine, and D-serine) and 3 uncommon amino acids (ornithine, 3-methyl-glutamic 
acid and kynurenine). The lipopeptide ring is closed by an ester bond that is formed between the C-
terminal Kyn13 and the hydroxyl group of Thr4. The difference between the members of this 
lipopeptide family can be found in the length of the fatty acyl moiety that is attached to the N-
terminal Trp1 residue, which ranges from 10-13 carbon atoms. Daptomycin contains a n-decanoyl 
fatty acid chain, which is produced by supplementing decanoic acid to cultures of S. roseosporus 
during fermentation (Huber et al., 1988). It is synthesized by three non-ribosomal peptide synthetases 
(NRPS) in S. roseosporus (Robbel and Marahiel, 2010).  
                                                     
*
 Unless otherwise stated, all of the work reported in this chapter was performed and analyzed by the 
candidate. The bicelles and liposomes for the following work were prepared by Tian Hua Zhang.  
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Figure 7.1: Chemical structure of daptomycin. 
The clinical trials involved a twice daily dose regimen of daptomycin which produced 
adverse effects ultimately leading to the termination of the daptomycin trials (Garrison et al., 1990; 
Rybak et al., 1992). Cubist Pharmaceuticals acquired the rights in 1997 and after successful clinical 
trials involving a once daily dose regiment daptomycin was approved for treatment in 2003 (Oleson et 
al., 2000; Sauermann et al., 2008). It has been shown to have a broad spectrum of activity in vitro 
against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and 
vancomycin-resistant enterococci (Eliopoulos et al., 1986; Rybak et al., 1992; Oleson et al., 2000).  
7.1.2 Studies of daptomycin structure. 
There have been considerably different structures of Ca
2+
-free daptomycin (apo-daptomycin) and 
Ca
2+
-conjugated daptomycin determined by NMR spectroscopy (Ball et al., 2004; Jung et al., 2004; 
Rotondi and Gierasch, 2005; Scott et al., 2007). These structures were determined in aqueous solution 
or with DHPC micelles and based on 
1
H resonances only. Ball et al. (2004) determined the first 
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solution structure of apo-daptomycin in H2O shown in figure 7.2. Their study produced a well-
defined structure of apo-daptomycin that exhibits an extended conformation with turns at Ala8 and 
Gly10/Ser11. The side chain groups of the residues of the 10-member ring are solvent exposed with 
their backbone amide groups pointed inward and the decanoyl chain is flexible, displaying a high 
degree of conformational freedom. They were unable to produce a structure of Ca
2+
-conjugated 
daptomycin due to severely broadened resonances of daptomycin.  
 
Figure 7.2: NMR structure of apo daptomycin in H2O. 
The apo daptomycin structure was determined in buffer consisting of 0.75 mM daptomycin, in 90% 
H2O and 10% D2O at pH 5.0.This structure was modified from PDB entry 1XT7 (Ball et al., 2004). 
Another study by Jung et al. (2004) determined the apo-daptomycin and Ca
2+
-conjugated 
daptomycin structures shown in figure 7.3. They found the structure of Ca
2+
-conjugated daptomycin 
to be much better defined and more constrained than apo-daptomycin. The apo-daptomycin structure 
was different than the structure by Ball, here the backbone formed two bends at Asp7 and Asp9 with 
a highly variable region centered at Gly5. In the Ca
2+
-conjugated structure the binding of Ca
2+
 caused 
the ring structure to be drawn inwards, with the side chain of Asp3 to tuck under. A type IV turn was 
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also formed between Thr 4 and Ala 8. Calcium binding resulted in a reduced total charge of 
daptomycin and an increase in the amphipathicity and the solvent-exposed hydrophobic surface. This 
was due to the redistribution of the charged side chains toward the top of the ring structure and the 
clustering of hydrophobic moieties at the other end.  
 
Figure 7.3: NMR structure of apo-daptomycin and Ca
2+
-bound daptomycin.  
(A) The apo daptomycin structure was determined in buffer consisting of 2 mM daptomycin, 100 mM 
KCl, 0.2 mM EDTA, 1 mM EGTA, and 7 % D2O, pH 6.6.This structure was modified from PDB 
entry 1T5M (Jung et al., 2004). (B) The Ca
2+
-conjugated daptomycin structure was determined in 
buffer consisting of 2 mM daptomycin, 100 mM KCl, 0.2 mM EDTA, 5 mM CaCl2, and 7 % D2O, 
pH 6.7. This structure was modified from PDB entry 1T5N (Jung et al., 2004). 
 Another NMR study determined the structure of daptomycin in the presence of 1,2-
dihexanoyl-sn-glycero-3-phosphocholine (DHPC) micelles (Scott et al., 2007). The calculated 
 160 
 
structures were shown to be quite different from the previously reported structures through 
measurement of backbone Cα RMSDs. In DHPC micelles with Ca2+, daptomycin displays an 
extended ring structure, most similar to the apo structure determined by the Jung study (Figure 7.4). 
Scott et al. suggest that apo-daptomycin undergoes a minor conformational rearrangement when 
interacting with DHPC in the presence of Ca, in contrast to what Jung et al. reported.  
 
Figure 7.4: NMR structure of daptomycin in DHPC micelles with Ca
2+
. 
Overlay of the structure of daptomycin in DHPC micelles (red) with the apo-daptomycin structure of 
Jung et al. (green).The daptomycin structure was determined in DHPC micelles with a buffer 
consisting of 100 mM KCl, 0.2 mM EDTA, 5 mM CaCl2, pH 6.7. The fatty acid chain is shown in 
yellow. This figure was modified from Scott et al. (2007).  
The structural studies described here have been used to try and determine how daptomycin 
interacts with the bacterial membrane, whether or not oligomerization occurs in the presence of Ca
2+
 
and for elucidating the mode of action for daptomycin’s activity. 
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7.1.3 Proposed mode of action by daptomycin. 
The proposed mechanism for the mode of action of daptomycin has not been fully elucidated, but 
most studies agree that daptomycin’s activity is calcium-dependent and involves the cell membrane. 
After the initial cell membrane interaction there are two general schools of thought regarding the 
mode of action: inhibited synthesis of cell wall macromolecules, specifically peptidoglycan and 
lipoteichoic acids (Allen et al., 1987; Canepari et al., 1990); and disruption of the cell membrane 
(Silverman et al., 2003; Ball et al., 2004; Jung et al., 2004; Scott et al., 2007; Zhang et al., 2014b). 
 The first studies performed by Allen et al. (1987) suggested that daptomycin inhibits the 
formation of precursor molecules utilized in the biosynthesis of peptidoglycan. Their hypothesis was 
later revised when they found they could not identify a specific step in cell wall formation that was 
affected by daptomycin, but that daptomycin associates with the energized membrane, disrupting the 
membrane potential (Alborn et al., 1991). They proposed that this disruption of membrane potential 
resulted in the inhibition of the enzymes involved in cell wall synthesis. Other studies by Canepari et 
al. (Canepari et al., 1990; Boaretti and Canepari, 1995) found that daptomycin binds to the cell 
membrane irreversibly, thus preventing it from reaching any of the precursor molecules utilized in the 
biosynthesis of peptidoglycan. They suggested that daptomycin inhibited the synthesis of lipoteichoic 
acid (LTA) synthesis, but these results were not convincing as they could not identify any specific 
proteins involved in the synthesis of LTA. 
 Studies a few years later by Silverman et al. (2003) demonstrated Ca
2+
-dependent, 
daptomycin triggered potassium release and showed its bactericidal activity was correlated with the 
dissipation of the cell membrane potential. They proposed a multistep mechanism of action for 
daptomycin. The first step of their proposed mechanism involves daptomycin’s Ca2+-dependent 
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insertion into the bacterial cytoplasmic membrane, followed by oligomerization to form possible 
pores or ion channels. This oligomerization would disrupt the integrity of the membrane, triggering a 
release of potassium and lead to rapid cell death.   
 Jung et al. (2004) proposed a two-step model for the interaction of daptomycin with bacterial 
membranes based on their NMR structural studies and CD spectroscopy experiments. In the initial 
step Ca
2+
 binds to daptomycin in solution, increasing its amphipathicity and decreasing its charge, 
thus allowing daptomycin to interact with neutral or acidic membranes. Next, Ca
2+
 bridges the gap 
between daptomycin and the acidic phospholipids, causing a second structural transition. This allows 
for a deeper insertion into the membrane bilayer and significant membrane perturbations, including 
lipid flip-flop. In contrast to Silverman, they found that membrane depolarization may not be the 
main cause of death as it occurs subsequently, and propose daptomycin’s mode of action may involve 
multiple targets like other antibacterial cationic peptides. 
 The mode of action proposed by Jung et al. was further revised by Scott et al. (2007). In their 
mechanism daptomycin first forms a loose micelle that would have a large membrane disruptive 
potential, which aids in allowing insertion to the bacterial membrane (as previously proposed by 
Straus and Hancock, 2006). When the Ca
2+
 to daptomycin ratio reaches 1:1, daptomycin oligomerizes 
to form a 14-16mer (Ho et al., 2008). Their solution structure of daptomycin in DHPC micelles was 
very similar to the apo-form and showed only a minor conformation change with the addition of Ca
2+
, 
indicating daptomycin would not undergo a significant structural change before membrane insertion 
as proposed by Jung. The next step in the mechanism involves daptomycin dissociation from the 
micelle and Ca
2+
-mediated insertion into the bacterial membrane. 
31
P NMR studies showed that 
daptomycin was able to perturb acidic membranes by inducing positive curvature strain in a Ca
2+
-
dependent manner (Jung et al., 2008). Next, oligomerization may occur in the membrane followed by 
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cell death due to membrane depolarization or interference with membrane-associated processes such 
as synthesis of cell wall components. 
 The most recent studies by Muraih and Zhang involving daptomycin and 1,2-dimyristoyl- 
sn-glycero-3-phospho-rac-(1’-glycerol) (DMPG) and 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
(DMPC) containing liposomes showed daptomycin binds and forms oligomers with 6-7 subunits in 
the presence of physiological levels of Ca
2+
. However oligomerization of daptomycin does not occur 
with PC only liposomes even though daptomycin can bind to these liposomes at much higher Ca
2+
 
concentrations (Muraih et al., 2011; Muraih and Palmer, 2012). Zhang confirmed that daptomycin 
forms discrete pores on PG containing liposomes that are permeable for cations of limited size and 
suggested a revised mode of action (Zhang et al., 2014b). The first step involves Ca
2+
-mediated 
binding of monomeric daptomycin to PG on the outer leaflet of the bacterial membrane. Then a 
tetramer forms through four bound monomers before being translocated across the membrane to the 
inner leaflet. Finally, an octameric ion pore forms when two tetramers on the opposite leaflets line up 
(Zhang et al., 2014a). Cell death would then occur through several factors, including some of the 
oligomers acting as active pores causing membrane depolarization through the influx of Na
+
.  
All of the suggested modes of action for daptomycin based off of NMR structural studies 
were performed either free in solution or in the presence of DHPC micelles. The structure of 
daptomycin in the presence of a PG containing membrane mimetic, which has been shown to be 
necessary for oligomer formation and activity, has not been previously determined and could be 
different from the previously determined structures of daptomycin. The following work attempted to 
determine the solution structure of daptomycin in the presence of Ca
2+
 and a DMPC/DMPG 
membrane mimetic.  
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7.2 Materials and methods 
7.2.1 Preparing daptomycin samples with SDS micelles. 
15
N-labeled daptomycin was provided by Cubist Pharmaceuticals. SDS micelles were prepared by 
dissolving SDS in 400 μL of H2O to a final concentration of 50 mM. 15N-labeled daptomycin was 
added to this solution and brought up to 450 μL of H2O then 50 μL of D2O was added. The final 
sample consisted of 40 mM SDS and 0.5 mM daptomycin in 500 μL of 90:10 H2O:D2O. 
7.2.2 Preparing daptomycin samples with bicelles. 
7.2.2.1 DMPC/DHPC bicelles. 
The synthetic lipids DMPC and DHPC (both from Avanti Polar Lipids, Alabaster, AL, USA) were 
used to prepare the bicelles (Figure 7.5). DMPC was dissolved in 1 mL of chloroform and evaporated 
under N2 gas in a round bottom flask, then dried under vacuum for 3 hours. The lipid film was 
resuspended in 1.5 mL of H2O and DHPC added to obtain the desired [DMPC]/[DHPC] molar ratios 
(q). For samples with q = 0.5 and total phospholipid concentration of 15% (w/v) the final sample 
consisted of 0.5 mM 
15
N-labeled daptomycin, 189 mM DHPC, 94.5 mM DMPC in 500 μL of 90:10 
H2O:D2O.  
7.2.2.2 DMPC/DMPG/DHPC bicelles. 
The synthetic lipid DMPG was also obtained from Avanti Polar Lipids (Alabaster, AL, USA). DMPC 
and DMPG were dissolved in 1 mL of chloroform and evaporated under N2 gas in a round bottom 
flask, then dried under vacuum for 3 hours. The lipid film was resuspended in 1.0 mL of 5.0 mM 
MOPS pH 6.6 buffer and DHPC added to obtain the desired [DMPC:DMPG]/[DHPC] molar ratios 
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(q). For samples with q = 0.5 and total phospholipid concentration of 15% (w/v) the final sample 
consisted of 0.5 mM 
15
N-labeled daptomycin, 189 mM DHPC, 71.25 mM DMPC, and 71.25 mM 
DMPG in 500 μL of 5.0 mM MOPS pH 6.6, 90:10 H2O:D2O. For samples with q = 0.1 and total 
phospholipid concentration of 2.0% (w/v) the final sample consisted of 0.5 or 1.0 mM 
15
N-labeled 
daptomycin, 40 mM DHPC, 3 mM DMPC and 1 mM DMPG in 500 μL of 5.0 mM MOPS pH 6.6, 
90:10 H2O:D2O. For samples with q = 0.1 and total phospholipid concentration of 1.0% (w/v) the 
final sample consisted of 0.5 mM 
15
N-labeled daptomycin, 20 mM DHPC, 1.5 mM DMPC and 0.5 
mM DMPG in 500 μL of 5.0 mM MOPS pH 6.6, 90:10 H2O:D2O. 
 
Figure 7.5: Molecular structures of DMPC, DMPG and DHPC, and the schematic 
representation of a DMPC/DHPC bicelles. 
7.2.3 Preparing daptomycin samples with liposomes. 
The synthetic lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) and 1,2-
dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG) (both from Avanti Polar Lipids, Alabaster, 
AL, USA) were used to prepare the liposomes (Figure 7.5). POPE and DOPG were dissolved in 1 mL 
of chloroform in equimolar ratios and evaporated under N2 gas in a round bottom flask, then dried 
under vacuum for 3 hours. The lipid film was resuspended in 1.0 mL of 5.0 mM MOPS pH 6.6 
buffer. The lipid suspension was extruded through a 100 nm polycarbonate filter 15 times, using a 
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nitrogen-pressurized extruder to produce the liposomes. The final sample consisted of 0.1 or 0.3 mM 
15
N-labeled daptomycin, 400 μM POPE/DOPG in 500 μL of 5.0 mM MOPS, 0.5 mM CaCl2, pH 6.6, 
90:10 H2O:D2O. 
 
Figure 7.6: Molecular structures of POPE and DOPG. 
7.2.4 Preparing 19F modified daptomycin samples with liposomes. 
JW2-14, a 
19
F-modified derivative of daptomycin was provided by the Taylor lab (University of 
Waterloo). Bicelles were made as described in section 7.2.2.2. Liposomes were made as described in 
section 7.2.3.1 with either 500 μM DMPC/500 μM DMPG or 400 μM DMPC/500 μM DMPG/100 
μM TOCL (lipid tetraoleyl-cardiolipin from Avanti Polar Lipids, Alabaster, AL, USA). The final 
samples consisted of 0.25 mM JW2-14 in 500 μL of 20 mM HEPES, 150 mM NaCl, pH 7.4, 90:10 
H2O:D2O with the following: only buffer; DHPC/DMPC/DMPG bicelles; DMPC/DMPG liposomes; 
or DMPC/DMPG/TOCL liposomes. The samples were examined with no CaCl2 or 0.25 mM CaCl2. 
 167 
 
 
Figure 7.7: Structure of JW2-14, a 
19
F-modified derivative of daptomycin. 
Daptomycin was modified with 4-(Trifluoro-methyl)benzoic acid at the free amino group of Orn6. 
7.2.5 In-cell NMR Sample Preparation. 
A 10 mL overnight starter culture of Bacillus subtilis was grown in LB medium. The culture was 
centrifuged at 2000 x g for 4 min and the supernatant was discarded. The cell pellet was resuspended 
in either: 10 mL of fresh LB with 0.1 mM 
15
N-daptomycin and 1 mM CaCl2; or 10 mL of HBG 
(HEPES buffered glucose, 20 mM HEPES, 2 g/L glucose, pH 7.1) with 0.1 mM 
15
N-daptomycin and 
1 mM CaCl2. The samples were incubated at 200 RPM, 37°C for 45 min then centrifuged at 2000 x g 
for 4 min and the supernatant was decanted into a separate tube for further NMR analysis. The cell 
pellet was resuspended in either 450 μL of fresh LB or HBG, then 50 μL of D2O was added to each 
samples. The samples were transferred into 5 mm NMR sample tubes and 
1
H-
15
N HSQC and 
1
H-
15
N 
Transverse Relaxation-Optimized Spectroscopy (TROSY) spectra were obtained. 
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7.2.6 NMR spectroscopy.  
1
H-
15
N HSQC, 
1
H-
15
N TROSY and 2D HMQC NOESY spectra were recorded at 25
o
C on Bruker 600 
and 700 MHz DRX spectrometers equipped with XYZ-gradients triple-resonance probes (Bruker, 
Billerica, MA, USA). 1D 
1
H-decoupled 
19
F spectra were recorded on Bruker 300 spectrometer 
equipped with Z-gradient probe (Bruker, Billerica, MA, USA). 2D 
1
H-
15
N HMQC-NOESY spectra 
were acquired with either 50 ms or 120 ms mixing times. Spectra were analyzed using the program 
CARA (Keller, 2005).  
7.3 Results and discussion 
The previously determined structures of daptomycin were determined either free in solution or in the 
presence of DHPC micelles, using only 
1
H resonance assignments. The structure of daptomycin in the 
presence of a membrane mimetic that contains PG, which has been shown to be necessary for 
oligomer formation and activity, has not been previously determined and could be different. In this 
study solution state NMR experiments were performed with 
15
N-labelled daptomycin using various 
membrane mimetic conditions to try and elucidate this structure. The use of 
15
N-labeled daptomycin 
will also allow for higher resolution structures to be determined. These experiments were performed 
with the following membrane mimetics: SDS micelles; DHPC/DMPC bicelles with and without Ca
2+
; 
DHPC/DMPC/DMPG bicelles with and without Ca
2+
; POPE/DOPG liposomes; and on cell 
experiments with Bacillus subtilis. 
7.3.1 NMR of Daptomycin with micelles and DHPC/DMPC bicelles. 
In order to have bicelles suitable for high resolution solution NMR studies the ratio of long-chain 
phospholipid (DMPC) relative to short-chain phospholipid (DHPC) must be reduced to obtain a ratio 
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q, [DMPC/DHPC] < 1. Below this threshold of 1, an isotropic solution of bicelles will be obtained 
with an estimated diameter of 80-100 Å necessary for solution state NMR (Vold and Prosser, 1996; 
Vold et al., 1997; Struppe et al., 2000; Whiles et al., 2002; Marcotte and Auger, 2005). For these 
experiments a total phospholipid concentration of 15% (w/v) is ideal although, total phospholipid 
concentrations of 1-10% can be used (Struppe and Vold, 1998; Struppe et al., 2000; Whiles et al., 
2002). Initially 
1
H
15
N-HSQC experiments were performed on samples consisting of 500 μL of 500 
μM 15N labelled daptomycin with SDS micelles and DMPC/DHPC bicelles with a total phospholipid 
concentration of 15% (w/v) and a q ratio, [DMPC/DHPC] = 0.5 in 5 mM MOPS, pH 6.6, 90:10 
H2O:D2O with no CaCl2 or 5 mM CaCl2. 
Well resolved 
1
H
15
N-HSQC spectra were obtained for daptomycin with SDS and 
DHPC/DMPC bicelles in the absence of CaCl2 (Figures 7.8A, D and 7.9). Upon comparing the 
spectra of daptomycin with bicelles to daptomycin with SDS micelles (Figure 7.9) one can see that a 
couple smaller cross peaks have become visible in the center of the spectrum and that most of the 
other peaks have experienced a downfield proton shift.  
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Figure 7.8: 
1
H-
15
N HSQC spectra of 
15
N-labeled Daptomycin with micelles and bieclles under 
various conditions. 
1
H-
15
N HSQC spectra of 0.5 mM 
15
N-labeled daptomycin with 189 mM DMPC/ 94.5 mM DHPC 
bicelles in 90:10 H2O:D2O with (A) no CaCl2, (B) 5 mM CaCl2, and (C) 5 mM CaCl2 and 10 mM 
EDTA. Total phospholipid w/v = 15% and [DMPC]/[DHPC] = 0.5 was used for all bicelles samples. 
(D) 
1
H-
15
N HSQC spectrum of 0.5 mM 
15
N-labeled daptomycin with SDS micelles in 90:10 
H2O:D2O.  
When CaCl2 is added to the bicelles sample a few of the strong peaks previously observed 
have either become weaker or vanished and new smaller cross peaks have arisen (Figure 7.8B and 
7.10). This would indicate a change in conformation for daptomycin, which has previously been 
observed with daptomycin when Ca
2+
 is added in aqueous solution but not observed with the addition 
of Ca
2+
 in the presence of DHPC micelles (Jung et al., 2004; Scott et al., 2007). This observation 
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supports the need to perform further NMR experiments with better membrane mimetics to obtain a 
higher resolution structure of daptomycin. 
 
Figure 7.9: Overlay of 
1
H-
15
N HSQC spectra of Daptomycin with SDS micelles and 
DMPC/DHPC bicelles. 
1
H-
15
N HSQC spectra of 0.5 mM daptomycin with [DMPC]/[DHPC] = 0.5, total phospholipid w/v = 
15% bicelles in 90:10 H2O:D2O shown in red and 0.5 mM daptomycin with SDS micelles in 90:10 
H2O:D2O shown in purple.  
The change in spectrum was reversible with the addition of EDTA. When the 
1
H
15
N-HSQC 
spectra of daptomycin in bicelles with 0.5 mM CaCl2 and with 0.5 mM CaCl2 and 10 mM EDTA 
were overlaid the cross peaks completely overlap. This suggests that the change in spectrum observed 
when CaCl2 was added is caused by a conformation change of the residues of daptomycin that 
interact with the Ca
2+
 ion.  
 172 
 
 
 
Figure 7.10: Overlay of 1H-15N HSQC spectra of Daptomycin with DMPC/DHPC bicelles 
under various conditions. 
1
H-
15
N HSQC spectra of 0.5 mM daptomycin with [DMPC]/[DHPC] = 0.5, total phospholipid w/v = 
15% bicelles in 90:10 H2O:D2O shown in red, with 5 mM CaCl2
 
shown in green and with 5 mM 
CaCl2 and 10 mM EDTA shown in blue. 
7.3.2 31P NMR of DMPG/DMPC/DHPC bicelles. 
These initial experiments prove that NMR studies of daptomycin with bicelles are feasible. 
The following experiments were performed with bicelles that contain DMPG, which is necessary for 
daptomycin activity. These bicelles were prepared with DMPC, DMPG and DHPC lipids and had a 
DMPC to DMPG ratio of 3 to 1 and a DMPG to daptomycin ratio of 1 to 1. The samples were 
required to have a lower total phospholipid concentration due to only being able to increase the 
concentration of daptomycin to a maximum of about 1 mM because it was previously shown that a 
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higher concentration of daptomycin produced broader line widths (Ball et al., 2004) and there is a 
limited amount of 
15
N-labeled daptomycin. To ensure bicelles with a lower total phospholipid 
concentration would be suitable to use for further daptomycin NMR studies 
31
P NMR experiments 
were performed. 
 
Figure 7.11: 
31
P NMR spectra of DMPC/DHPC bicelles with q = 0.5 value and varying total 
phospholipid concentrations.  
Bicelles consisted of a total phospholipid w/v of: 1.5 % (19 mM DHPC, 7.125 mM DMPC, 2.375 
mM DMPG, q=0.5, [DMPC]:[DMPG] 3:1 ); 4 % (50.67 mM DHPC, 19 mM DMPC, 6.33 mM 
DMPG q=0.5, [DMPC]:[DMPG] 3:1); 7.5 % (95 mM DHPC, 33.62 mM DMPC, 11.87 mM DMPG 
q=0.5, [DMPC]:[DMPG] 3:1); and 15 % (190 mM DHPC, 71.25 mM DMPC, 23.75 mM DMPG 
q=0.5, [DMPC]:[DMPG] 3:1). 
31
P spectra were acquired for samples of bicelles with q ratio of 0.5 and varying total 
phospholipid concentrations (w/v) of 15%, 7.5%, 4% and 1.5%. The spectra show three peaks 
corresponding to the phosphate from DMPG, DHPC and DMPC. The low intensity downfield peak 
corresponds to DMPG, which is also present in the lowest concentration in each sample. The largest 
peak corresponds to DHPC, which is present in the highest concentration in each sample and the peak 
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upfield of this corresponds to DMPC. These peaks are characteristic for 
31
P spectra of these lipids in 
bicelles (Whiles et al., 2002; Triba et al., 2006; Wu et al., 2010). The spectra show little change in the 
31
P
 
chemical shift observed for DMPG, DHPC and DMPC when the total phospholipid concentration 
is lowered to concentrations as low as 1.5%, which has been seen by other studies (Struppe and Vold, 
1998; Struppe et al., 2000; Whiles et al., 2002). Thus reducing the total phospholipid concentration of 
the bicelles in future experiments should not be an issue. 
7.3.3 NMR of Daptomycin with DMPG/DMPC/DHPC bicelles. 
NMR experiments were performed on samples of daptomycin with DMPG/DMPC/DHPC 
bicelles. As mentioned above the experiments were done with a 1:1 ratio of PG to daptomycin thus a 
lower concentration of DMPG has to be used. To maintain a high enough total phospholipid 
concentration required for high resolution NMR studies a higher amount of DHPC was used which 
resulted in a lower q value for the sample. The samples contained either 0.5 or 1.0 mM 
15
N-labeled 
daptomycin with bicelles that have a [DMPC:DMPG/DHPC] q ratio of 0.1 and total phospholipid 
concentration of 1.0% and 2.0% (w/v). 
1
H
15
N-HSQC experiments were performed on these samples 
with no CaCl2 present, 0.25 mM CaCl2 (1:2 ratio CaCl2:Dap) and 0.5 mM CaCl2 (1:1 ratio 
CaCl2:Dap).  
A well resolved 
1
H
15
N-HSQC spectrum was obtained in the absence of CaCl2 (Figure 7.12A). 
When this sample is compared to the Ca
2+
-free DMPC/DHPC daptomycin sample previously 
determined, the two spectra overlay extremely well, however, there is a new weak cross peak that is 
observed at the bottom left of the spectrum (Figure 7.14).  
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Figure 7.12: 
1
H-
15
N HSQC spectra of daptomycin with DMPC/DMPG/DHPC bicelles under 
various conditions. 
1
H-
15
N HSQC spectra of 0.5 mM daptomycin in 20 mM DHPC, 1.5 mM DMPC, 0.5 mM DMPG 
bicelles with (A) no CaCl2; (B) 0.25 mM CaCl2; (C) and 0.5 mM CaCl2. (D) 
1
H-
15
N HSQC spectrum 
of 1 mM daptomycin with 40 mM DHPC, 3 mM DMPC, 1 mM DMPG bicelles in 90:10 H2O:D2O 
and 0.5 mM CaCl2. Total phospholipid w/v = 1.0% for A-C and 2.0% for D and 
[DMPC/DMPG]/[DHPC] q value of 0.1 was used for all bicelles samples.
 
When CaCl2 is added in a 1:2 ratio of CaCl2:Dap a few of the strong peaks previously 
observed have either become weaker or vanished and new smaller cross peaks have arisen, as was 
observed with the DMPC/DHPC bicelles, and the peak from the bottom left of the spectrum has 
increased in intensity (Figure 7.12B and 7.13). In this experiment the signal to noise has become 
worse and a precipitate had formed in the sample. When this spectrum is compared to that obtained 
for daptomycin with DMPC/DHPC bicelles (Figure 7.14) there are more cross peaks visible in the 
PGPC bicelles, however, all the cross peaks visible in the PC bicelles sample overlay very well with 
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those of the PGPC bicelles. This indicates that daptomycin adopts the same predominate structure in 
both PGPC bicelles and PC bicelles, and suggests that there are other less predominate conformations 
present in both samples, possibly those of daptomycin alone, Ca
2+
-conjugated daptomycin and in the 
PGPC bicelles a Ca
2+
-conjugated daptomycin interacting with the PGPC bicelles. 
 
Figure 7.13: Overlay of 
1
H-
15
N HSQC spectra of daptomycin with DMPC/DMPG/DHPC 
bicelles under various conditions. 
1
H-
15
N HSQC spectrum of 0.5 mM daptomycin with [DMPC/DMPG]/[DHPC] = 0.1, total 
phospholipid w/v = 1.0 % bicelles in 90:10 H2O:D2O shown in red, with 0.25 mM CaCl2
 
shown in 
green and with 0.5 mM CaCl2 shown in blue. 
When CaCl2 was added in a 1:1 ratio CaCl2:Dap a precipitate formed before the 
1
H
15
N-HSQC 
experiment was performed, and a spectrum was obtained that was similar to the 1:2 ratio CaCl2:Dap 
one (Figures 7.12C and 7.13). The formation of a precipitate makes it difficult to obtain useful NMR 
data to facilitate a structure calculation and has been observed in other studies (Jung et al., 2004; Scott 
et al., 2007). 
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Figure 7.14: Overlay of 
1
H-
15
N HSQC spectra of daptomycin with DMPC/DMPG/DHPC 
bicelles and DMPC/DHPC bicelles under various conditions. 
(A) 1
H-
15
N HSQC spectrum of 0.5 mM daptomycin with [DMPC/DMPG]/[DHPC] = 0.1, total 
phospholipid w/v = 1.0 % bicelles in 90:10 H2O:D2O shown in red and 0.5 mM daptomycin with 
[DMPC]/[DHPC] = 0.5, total phospholipid w/v = 15% bicelles in 90:10 H2O:D2O shown in black. (B)
 
1
H-
15
N HSQC spectrum of 0.5 mM daptomycin with [DMPC/DMPG]/[DHPC] = 0.1, total 
phospholipid w/v = 1.0 % bicelles in 90:10 H2O:D2O, 0.5 mM CaCl2
 
shown in blue and 0.5 mM 
daptomycin with [DMPC]/[DHPC] = 0.5, total phospholipid w/v = 15% bicelles in 90:10 H2O:D2O 5 
mM CaCl2 shown in purple. 
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In order to obtain NMR data for a structure calculation longer NMR experiments, such as 2D 
and 3D NOESY and TOCSY, must be acquired. To obtain these various spectra in a reasonable 
amount of time a more concentrated sample of 
15
N-labeled daptomycin must be used. An 
1
H-
15
N 
HSQC spectrum of 1 mM daptomycin with 40 mM DHPC, 3 mM DMPC, 1 mM DMPG bicelles in 
90:10 H2O:D2O and 0.5 mM CaCl2, total phospholipid w/v = 2.0% and [DMPC/DMPG]/[DHPC] q 
value of 0.1 was acquired. Upon comparison of the spectrum obtained (Figure 7.12D) with the 
previous daptomycin DMPC/DMPG/DHPC spectrum (Figure 7.12B) it can be seen that they are very 
similar. This sample was chosen to acquire the future experiments.  
2D HMQC NOESY spectra were obtained for samples of 1 mM daptomycin with 40 mM 
DHPC, 3 mM DMPC, 1 mM DMPG bicelles in 90:10 H2O:D2O and 0.5 mM CaCl2. Two NOESY 
experiments were performed: one with 50 ms mixing time; and one with 120 ms mixing time. The 
spectra acquired did not produce any useful information as no NOE correlations were observable. 
Also at the completion of both experiments both samples has sizable precipitates present.  
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Figure 7.15: 2D 
1
H-
15
N HMQC-NOESY spectra of daptomycin with DMPC/DMPG/DHPC 
bicelles. 
1
H-
15
N HMQC-NOESY spectrum of 1 mM daptomycin with 40 mM DHPC, 3 mM DMPC, 1 mM 
DMPG bicelles in 90:10 H2O:D2O and 0.5 mM CaCl2 with (A) 50 ms mixing time and (B)
 
120 ms 
mixing time. Total phospholipid w/v = 2.0% and [DMPC/DMPG]/[DHPC] q value of 0.1 was used 
for all bicelles samples. 
7.3.4 NMR of daptomycin with liposomes. 
1
H
15
N-HSQC experiments were performed on samples consisting of 500 μL of either 100 or 300 μM 
15
N labelled daptomycin and 0.5 mM CaCl2 with 400 μM POPE/DOPG liposomes, however, a signal 
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could not be obtained. The spectra obtained also had poor signal to noise and a large white precipitate 
was formed by the end of the experiment. The lack of signal is probably due to the large size of the 
liposomes, which would have a reorientation time that is too long on the NMR timescale (Marcotte 
and Auger, 2005; Robinson et al., 2012).  
7.3.5 NMR of 19F-labeled daptomycin in bicelles and liposomes. 
A 
19
F-labeled daptomycin sample was provided by the Taylor lab (University of Waterloo) which 
allowed for the acquisition of 
19
F NMR spectra. 
19
F NMR spectra were acquired for the modified 
daptomycin, JW2-14 sample (Figure 7.7) in buffer, DHPC/DMPC bicelles, DMPC/DMPG liposomes 
and DMPC/DMPG/TOCL liposomes, each with and without Ca
2+
. TOCL was used in this study 
because it was found that daptomycin resistant bacteria contain a mutation that enhances cardiolipin 
synthase activity and its presence could be responsible for preventing membrane translocation of 
daptomycin oligomers (Palmer et al., 2011; Davlieva et al., 2013; Zhang et al., 2014a)   
 For every sample in the absence of CaCl2 two 
19
F signals were observed at 62.8 and 75.7 ppm 
(Figure 7.14A, C, E and G). Since JW2-14 only contains one F3 moiety on the modified ornithine 
residue, these two peaks could be indicative of two distinct conformations of daptomycin. The spectra 
obtained of JW2-14 with CaCl2 in buffer only and with PGPC bicelles in buffer were very similar to 
those obtained in the absence of CaCl2 (Figure 7.16A- D). However, the spectra obtained of JW2-14 
with CaCl2 in PCPG liposomes and PCPGCL liposomes only had the peak at 75.7 ppm observable 
(Figure 7.14F and H).  
  Taking this information together one can see that the addition of Ca
2+
 to samples of JW2-14 
in liposomes shifts the equilibrium towards one conformation.  
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Figure 7.16: 
19
F spectra of JW2-14 with PC/PG bicelles and liposomes and PC/PG/CL 
liposomes under various conditions. 
All spectra acquired contained 0.25 mM JW2-14 (
19
F-daptomycin) in 20 mM HEPES, 100 mM NaCl, 
pH 7.4 buffer with 90:10 H2O:D2O with: (A)
 
buffer only; (B) buffer with 0.25 mM CaCl2; (C) ) 40 
mM DHPC/3 mM DMPC/1 mM DMPG bicelles; (D) 40 mM DHPC/3 mM DMPC/1 mM DMPG 
bicelles with 0.25 mM CaCl2; (E) 500 μM DMPC and 500 μM DMPG liposomes; (F) 500 μM DMPC 
and 500 μM DMPG liposomes with 0.25 mM CaCl2; (G) 400 μM DMPC/500 μM DMPG/100 μM 
TOCL liposomes; and (H) 400 μM DMPC/500 μM DMPG/100 μM TOCL liposomes with 0.25 mM 
CaCl2.  Total phospholipid w/v = 2.0% and [DMPC/DMPG]/[DHPC] q value of 0.1 was used for C 
and D. 
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7.3.6 On-cell NMR. 
On cell NMR experiments (Reckel et al., 2007; Robinson et al., 2012) with 
15
N-labelled daptomycin 
and Bacillus subtilis cells were tried also. Bacillus subtilis cells were chosen to perform these 
experiments because it had been previously shown that daptomycin readily forms oligomers on these 
cells and has high activity (Zhang et al., 2013). 
1
H
15
N-HSQC and 
1
H
15
N-TROSY experiments were 
performed on fresh cells with 
15
N-labelled daptomycin bound that were prepared as described above 
(7.2.5); however, a signal could not be obtained for either experiment, thus no structural information 
could be obtained. This could be due to the size of the cell which would be too large for NMR, having 
a very long rotational correlation time because of slow tumbling, or because daptomycin binds in 
many different conformations.  
1
H
15
N-HSQC and 
1
H
15
N-TROSY experiments were performed on the supernatant from the 
daptomycin incubation to determine if the lack of signal obtained above was due to the daptomycin 
not associating with the bacterial cells. A weak signal was obtained with the 
15
N-TROSY experiment 
(Figure 7.17). Since this signal was so weak it was concluded that most of the daptomycin must be 
bound to the Bacillus subtilis cells, however, because of the size and differences in population of 
daptomycin per cell no on cell signal could be obtained.  
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Figure 7.17: 
1
H-
15
N TROSY spectrum of the supernatant of daptomycin incubated with Bacillus 
subtilis. 
7.4 Conclusion 
It is clear from these studies that at this time high resolution solution state NMR studies cannot 
provide enough information for a full structure determination due to sample aggregation and 
experimental size limitation. However, the aggregation of daptomycin with PCPG bicelles and 
liposomes in the presence of Ca
2+
 would not be a problem for solid-state NMR experiments. 
Preliminary experiments performed at the University of Guelph have produced some promising 
results and could be an avenue further explored to elucidate a structure. To complete those studies it 
would be advantageous to obtain a doubly isotopically 
13
C,
15
N-labeled daptomycin sample. A high 
resolution structure of the oligomerization of daptomycin in the presence of Ca
2+
 and PG containing 
membrane mimetic would be very valuable to better understand the mode of action of daptomycin.  
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Chapter 8 
Summary and future work  
 
8.1 Summary 
In chapter 2, the interactions of CaM with the peptides based on the eNOS CaM binding 
domain or the eNOS CAM binding domain phosphorylated at Thr495 were investigated at various 
free Ca
2+
 concentrations. We determined through the use of NMR spectroscopy, fluorescence and 
ITC that this interaction was very similar at saturating Ca
2+
 concentrations. However, at the lower 
Ca
2+
 concentration of 225nM, near physiological Ca
2+
 levels, no significant binding of CaM to 
eNOSpThr495 is observed by either method, whereas CaM is binding to nonphosphoryated eNOS. 
The calcium affinity of the CaM-eNOS peptide complex is reduced due to the Thr495 
phosphorylation, and this leads to weaker binding at low physiological calcium concentrations. Our 
results indicate there is a diminished propensity for the formation of an α-helix by the peptide in 
combination with electrostatic repulsion that may account for the diminished CaM-dependent 
activation of the eNOS enzyme under low physiological calcium concentrations. 
In chapter 3, we present the complete backbone NMR resonance assignments of C-lobe Ca
2+
-
replete and deplete CaM12, N-lobe Ca
2+
-replete and deplete CaM34, CaM1234 in the absence of Ca
2+
, 
and N-lobe Ca
2+
-replete CaM34 with the iNOS peptide. These assignments are necessary to solve the 
solution structures of these Ca
2+
-deficient CaM mutants and compare them to known structures of 
apoCaM or to perform any other NMR studies on these mutants. Furthermore, this method will allow 
for the quick structural characterization of other CaM or CaM mutants interacting with various NOS 
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peptides and provides the basis for a detailed study of CaM-NOS interaction dynamics using 
15
N 
relaxation methods. 
In Chapter 4, the first study to present NMR structural and dynamics data of the CaM-NOS 
complexes at free Ca
2+
 concentrations that are in the resting and elevated intracellular Ca
2+
 
concentration range was shown. These results demonstrate the importance of performing experiments 
on CaM-NOS interactions at Ca
2+
 concentrations that correspond to Ca
2+
 levels relevant to the 
regulation of NOS by CaM in vivo. We show that when experiments are performed at Ca
2+
 
concentrations that are typically used in the literature, i.e. saturating Ca
2+
 concentrations, the CaM-
NOS systems are less dynamic than at Ca
2+
 concentrations corresponding to basal and elevated 
cellular levels. The studies of the CaM-NOS complexes that were carried out at saturated Ca
2+
 
concentrations miss differences in dynamics that are only detectable at physiological Ca
2+
 levels. 
Thus, studies involving CaM interactions with NOS at saturating Ca
2+
 concentrations don’t allow the 
investigator to see the contributions of the dynamics present in the CaM-NOS complexes. This 
illustrates the importance of analyzing these complexes at Ca
2+
 concentrations that are within the 
physiological range in order to fully understand how NOS is regulated by CaM interactions in vivo. 
In chapter 5, the solution structure of the complex of the eNOS peptide with CaM at 225 nM 
Ca
2+
 concentration was determined, and along with the previous amide exchange and internal 
mobility results, show that the residues of CaM interacting with eNOS’ 1-5-8-14 anchoring residues 
have a strong interaction at the 225 nM free Ca
2+
 concentration, which keeps the complex intact, 
while the rest of the residues of the CaM protein are able to fluctuate or “breathe”. Comparing the two 
lobes of CaM, the residues of the C-lobe display a more rigid structure, indicating a stronger 
interaction with the eNOS peptide to hold the complex together, while the N-lobe is more dynamic 
and loosely associated to the eNOS peptide. This is the first study to determine an NMR structure of 
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the CaM-eNOS complex at a free Ca
2+
 concentration that is a physiologically relevant elevated 
intracellular Ca
2+
 concentration. This structure provides further evidence that the C-lobe of CaM 
binds first to the N-terminus of eNOS’ CaM-binding domain and possibly part of the heme domain, 
while loosely associating to the C-terminus of eNOS’ CaM-binding domain when the intracellular 
Ca
2+
 concentration is elevated to 225 nM. And possibly as the intracellular Ca
2+
 concentration 
increases the N-lobe then binds Ca
2+
 and becomes tightly bound to the C-terminus of eNOS’ CaM-
binding domain, allowing for the possibility of a bridge to form between CaM and the FMN domain, 
which would induce a shift to the FMN-heme electron transfer conformation to allow efficient 
electron transfer in the NOS enzymes. 
 In chapter 6, the use of mutations of Asp in position 1 in the EF hands of CaM to disable 
Ca
2+
-binding was shown to cause slight structural perturbations through the use of NMR 
spectroscopy. The structure determination of CaM1234 revealed that the mutation of Asp to Ala causes 
the EF hand loops to adopt perturbed conformations when compared to apoCaM. The structure also 
displayed a less stable C-lobe compared to N-lobe as previously observed for apoCaM. To investigate 
if these mutations also perturb the structure of CaM bound to a target peptide the structure of CaM34 
bound to the iNOS peptide was determined. The mutation of Asp to Ala causes the Ca
2+
 binding loop 
regions in the C-lobe EF hands to adopt a conformation resembling apoCaM, which causes local 
structural changes, affecting the loop region between EF hands III and IV, and long range structural 
conformation changes, affecting the loop region between EF hands I and II and helix B. This study 
provides structural evidence of changes that are present in CaM mutants with mutations at Asp in 
position 1 of the EF hand. 
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8.2 Future work 
8.2.1 Binding kinetics of CaM interacting with the eNOS CaM binding domain at 225 
nM free Ca2+. 
SPR experiments involving CaM and the eNOS peptide have been undertaken in the lab to compare 
the binding kinetics at saturating Ca
2+
 and 225 nM free Ca
2+
 concentrations. This work will further 
complement the solution structure of CaM with eNOS at 225 nM Ca
2+
 to characterize this interaction 
and determine if there are any differences in binding kinetics upon the increase in Ca
2+
 
concentrations. 
8.2.2 Higher resolution solution structure of CaM1234 and solution structure of CaM12 
bound to the eNOS CaM binding domain peptide. 
To further investigate the possible structural perturbations induced by the 4 EF hand mutations in 
CaM1234 a higher resolution structure could be obtained. This would not require much more work to 
accomplish and could be facilitated by the addition of 
13
Cali and 
13
Caromatic NOESY experiments to 
acquire  more structure constraints. In chapter 5 a structure of CaM bound to the eNOS CaM binding 
domain peptide was determined at 225 nM free Ca
2+
. This structure determined that CaM binds to the 
eNOS peptide with a Ca
2+
-replete C-lobe and Ca
2+
-deplete N-lobe, through interactions 
predominately in CaM’s C-lobe. However, some contacts were observed between the Ca2+-deplete N-
lobe and the peptide. The CaM12-eNOS complex structure should be similar to this structure, 
however, differences may be found due to the N-lobe EF hand mutations. This could provide 
evidence of whether or not CaM12 is a suitable substitute for Ca
2+
-free N-lobe CaM studies. 
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8.2.3 NMR structural studies of CaM interacting with nNOS at low free Ca2+ 
concentrations. 
The structural and dynamic interaction of CaM with eNOS was performed in this thesis, a similar 
investigation of CaM with nNOS could be done to see if nNOS has the same characteristics at low 
Ca
2+
 concentrations. 
8.2.4 NMR structural studies of CaM interacting with holo nNOS. 
Currently there is no NMR structural data of CaM interacting with the holo-NOS isoforms. 
Preliminary work in the lab has determined that a large enough quantity of holo-nNOS can be 
produced to facilitate NMR experiments. However, since the complex of CaM with nNOS is 
extremely large, conventional 
1
H-
15
N HSQC experiments have not been able to produce useful 
spectra. Preliminary 
15
N TROSY experiments have shown that structural data is possible with this 
method, but will require a purer NOS enzyme and possibly higher NMR field strength. This would 
allow us to determine which residues of CaM interact with regions of the holoNOS enzymes other 
than the CaM-binding domains though chemical shift changes between the CaM-NOS peptides and 
CaM-holoNOS spectra. This could lay the ground work for NMR experiments using methionine 
labeled NOS, which could probe for structural changes in NOS in the absence and presence of CaM 
and Ca
2+
.
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Appendix A 
NMR pulse program information 
15N-HSQC:  
# 1 "/opt/xwinnmr/exp/stan/nmr/lists/pp/hsqcetf3gpsi"  
;hsqcetf3gpsi  
;avance-version (02/07/15)  
;HSQC  
;2D H-1/X correlation via double inept transfer  
; using sensitivity improvement  
;phase sensitive using Echo/Antiecho-TPPI gradient 
selection  
;with decoupling during acquisition  
;using trim pulses in inept transfer  
;using f3 - channel  
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. Rance, J. 
Magn.  
; Reson. 93, 151-170 (1991)  
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. Chem. Soc. 114,  
; 10663-5 (1992)  
;J. Schleucher, M. Schwendinger, M. Sattler, P. Schmidt, O. 
Schedletzky,  
; S.J. Glaser, O.W. Sorensen & C. Griesinger, J. Biomol. 
NMR 4,  
; 301-306 (1994)  
 
HNCA:  
# 1 "/opt/xwinnmr/exp/stan/nmr/lists/pp/hncagp3d"  
;hncagp3d  
;avance-version (02/05/31)  
;HNCA  
;3D sequence with  
; inverse correlation for triple resonance using multiple  
; inept transfer steps  
; F1(H) -> F3(N) -> F2(Ca,t1) -> F3(N,t2) -> F1(H,t3)  
;on/off resonance Ca and C=O pulses using shaped pulse  
;phase sensitive (t1)  
;phase sensitive using Echo/Antiecho gradient selection (t2)  
;using constant time in t2  
;(use parameterset HNCAGP3D)  
;S. Grzesiek & A. Bax, J. Magn. Reson. 96, 432 - 440 
(1992)  
;(J. Schleucher, M. Sattler & C. Griesinger, Angew. Chem. 
Int. Ed. 32,  
; 1489-1491 (1993))  
;(L.E. Kay, G.Y. Xu & T. Yamazaki, J. Magn. Reson. A109, 
129-133 (1994))  
prosol relations=<triple>  
 
HNcoCA:  
# 1 "/opt/xwinnmr/exp/stan/nmr/lists/pp/hncocagp3d"  
;hncocagp3d  
;avance-version (03/08/05)  
;HN(CO)CA  
;3D sequence with  
; inverse correlation for triple resonance using multiple  
; inept transfer steps  
; F1(H) -> F3(N) -> F2(C=O) -> F2(Ca,t1)  
; -> F2(C=O) -> F3(N,t2) -> F1(H,t3)  
;on/off resonance Ca and C=O pulses using shaped pulse  
;phase sensitive (t1)  
;phase sensitive using Echo/Antiecho gradient selection (t2)  
;using constant time in t2  
;(use parameterset HNCOCAGP3D)  
;S. Grzesiek & A. Bax, J. Magn. Reson. 96, 432 - 440 
(1992)  
;(L.E. Kay, G.Y. Xu & T. Yamazaki, J. Magn. Reson. A109, 
129-133 (1994))  
prosol relations=<triple> 
 
CBCAcoNH:  
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/cbcaconhgpwg3d"  
;cbcaconhgpwg3d  
;avance-version (02/05/31)  
;CBCACONH  
;3D sequence with  
; inverse correlation for triple resonance using inept transfer 
steps  
; F1(H) -> F2(Caliph.,t1 -> Ca) -> F2(C=O) -> F3(N,t2) -> 
F1(H,t3)  
;on/off resonance Ca and C=O pulses using shaped pulse  
;phase sensitive (t1)  
;phase sensitive (t2)  
;using constant time in t1  
;using constant time in t2  
;water suppression using watergate sequence  
;(use parameterset CBCACONHGPWG3D)  
;S. Grzesiek & A. Bax, J. Biomol. NMR 3, 185-204 (1993)  
;(D.R. Muhandiram & L.E. Kay, J. Magn. Reson. B 103, 
203-216 (1994))  
prosol relations=<triple> 
 
13C-NOESY HSQC:  
#1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcetgp3d"  
;noesyhsqcetgp3d  
;avance-version (02/07/15)  
;NOESY-HSQC  
;3D sequence with  
; homonuclear correlation via dipolar coupling  
; dipolar coupling may be due to noe or chemical exchange.  
; H-1/X correlation via double inept transfer  
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; using sensitivity improvement  
;phase sensitive (t1)  
;phase sensitive using Echo/Antiecho-TPPI gradient 
selection (t2)  
;using trim pulses in inept transfer  
;with decoupling during acquisition  
;using shaped pulses for inversion on f2 - channel  
;(use parameterset NOESYHSQCETGP3D)  
;A.L. Davis, J. Keeler, E.D. Laue & D. Moskau, J. Magn. 
Reson. 98,  
; 207-216 (1992)  
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. Rance, J. 
Magn.  
; Reson. 93, 151-170 (1991)  
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. Chem. Soc. 114,  
; 10663-5 (1992)  
;J. Schleucher et al., Angew. Chem. 114(10), 1518 (1993) 
 
15N-NOESY HSQC:  
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesyhsqcfpf3gpsi3d"  
;noesyhsqcfpf3gpsi3d  
;avance-version (03/06/18)  
;NOESY-HSQC  
;3D sequence with  
; homonuclear correlation via dipolar coupling  
; dipolar coupling may be due to noe or chemical exchange  
; H-1/X correlation via double inept transfer  
; using sensitivity improvement  
;phase sensitive (t1)  
;phase sensitive using Echo/Antiecho-TPPI gradient 
selection (t2)  
;with decoupling during acquisition  
;using flip-back pulse  
;using f3 - channel  
;(use parameterset NOESYHSQCFPF3GPSI3D)  
;O. Zhang, L.E. Kay, J.P. Olivier & J.D. Forman-Kay,  
; J. Biomol. NMR 4, 845 - 858 (1994)  
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. Rance, J. 
Magn.  
; Reson. 93, 151-170 (1991)  
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. Chem. Soc. 114,  
; 10663-5 (1992)  
;J. Schleucher, M. Schwendinger, M. Sattler, P. Schmidt, O. 
Schedletzky,  
; S.J. Glaser, O.W. Sorensen & C. Griesinger, J. Biomol. 
NMR 4, 
; 301-306 (1994)  
prosol relations=<triple> 
 
15N-double-filtered NOESY: 
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/noesygpphwgxf" 
;noesygpphwgxf 
;avance-version (02/02/07) 
;2D homonuclear correlation via dipolar coupling 
;dipolar coupling may be due to noe or chemical exchange 
;phase sensitive 
;selecting C-12 or N-14 bound protons in F1 and F2 
;water suppression using watergate sequence 
; 
;M. Ikura & A. Bax, J. Am. Chem. Soc. 114, 2433-2440 
(1992) 
;M. Piotto, V. Saudek & V. Sklenar, J. Biomol. NMR 2, 661 
- 666 (1992) 
;V. Sklenar, M. Piotto, R. Leppik $ V. Saudek, J. Magn. 
Reson., 
;   Series A 102, 241 -245 (1993) 
 
HC(C)H-TOCSY:  
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hcchdigp3d"  
;hcchdigp3d  
;avance-version (03/01/17)  
;HCCH-TOCSY  
;3D sequence with  
; inverse correlation using multiple inept transfer and  
; C-C DIPSI3 spinlock  
; F1(H,t1) -> F2(C,t2) -> F2(C') -> F1(H',t3)  
;off resonance C=O pulse using shaped pulse  
;phase sensitive (t1)  
;phase sensitive (t2)  
;spinlock during z-filter  
;(use parameterset HCCHDIGP3D)  
;(L.E. Kay, G.Y. Xu, A.U. Singer, D.R. Muhandiram & J. 
D. Forman-Kay  
; J. Magn. Reson. B 101, 333 - 337 (1993))  
prosol relations=<triple> 
 
(H)CCH-TOCSY:  
# 1 "C:/Bruker/XWIN-
NMR/exp/stan/nmr/lists/pp/hcchdigp3d2" 
;hcchdigp3d2 
;avance-version (02/07/16) 
;HCCH-TOCSY 
;3D sequence with 
;   inverse correlation using multiple inept transfer and 
;      C-C DIPSI3 spinlock 
;      F1(H) -> F2(C,t1) -> F2(C',t2) -> F1(H',t3) 
;off resonance C=O pulse using shaped pulse 
;phase sensitive (t1) 
;phase sensitive (t2) 
;spinlock during z-filter 
;(use parameterset HCCHDIGP3D2) 
;(L.E. Kay, G.Y. Xu, A.U. Singer, D.R. Muhandiram & J. 
D. Forman-Kay 
;   J. Magn. Reson. B 101, 333 - 337 (1993)) 
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Appendix B 
CaM-eNOSpThr495 Peptide Assigned Chemical Shifts 
_Residue_seq_code 
_Residue_label 
_Atom_name 
_Atom_type 
_Chem_shift_value 
   2ASP   CA  C    51.96 
   2ASP    H  H    8.506 
   2ASP   HA  H    4.585 
   2ASP    N  N  120.378 
   3GLN   CA  C   52.735 
   3GLN   CB  C   31.074 
   3GLN   CG  C   35.178 
   3GLN    H  H    8.208 
   3GLN   HA  H    4.212 
   3GLN  HB2  H    2.209 
   3GLN  HB3  H    2.209 
   3GLN    N  N  119.707 
   4LEU   CA  C   51.658 
   4LEU   CB  C   39.624 
   4LEU   CG  C   23.322 
   4LEU  CD1  C   20.016 
   4LEU    H  H    8.181 
   4LEU   HA  H     4.14 
   4LEU  HB2  H    1.725 
   4LEU  HB3  H    1.725 
   4LEU   HG  H    0.625 
   4LEU  HD1  H    0.537 
   4LEU  HD2  H    0.537 
   4LEU    N  N  123.069 
   5THR   CA  C   57.687 
   5THR   CB  C    68.58 
   5THR  CG2  C    18.99 
   5THR    H  H    8.607 
   5THR   HA  H    4.322 
   5THR   HB  H    4.601 
   5THR  HG2  H    1.169 
   5THR    N  N  112.909 
   6GLU   CA  C   57.247 
   6GLU   CB  C   29.136 
   6GLU   CG  C   33.696 
   6GLU    H  H    8.877 
   6GLU   HA  H    3.825 
   6GLU  HB2  H     1.88 
   6GLU  HB3  H     1.88 
   6GLU  HG2  H    2.219 
   6GLU  HG3  H    2.219 
   6GLU    N  N  120.224 
   7GLU   CA  C   57.198 
   7GLU   CB  C   26.274 
   7GLU   CG  C   33.696 
   7GLU    H  H    8.524 
   7GLU   HA  H    3.917 
   7GLU  HB2  H    1.908 
   7GLU  HB3  H    1.908 
   7GLU  HG2  H    2.201 
   7GLU  HG3  H    2.201 
   7GLU    N  N   119.35 
   8GLN   CA  C   55.976 
   8GLN   CB  C     26.4 
   8GLN   CG  C   33.582 
   8GLN    H  H    7.603 
   8GLN   HA  H    3.903 
   8GLN  HB2  H    1.908 
   8GLN  HB3  H    1.908 
   8GLN  HG2  H    2.201 
   8GLN  HG3  H    2.201 
   8GLN    N  N  119.917 
   9ILE   CA  C   63.796 
   9ILE   CB  C   35.178 
   9ILE  CG1  C    27.54 
   9ILE  CG2  C   14.772 
   9ILE  CD1  C    10.44 
   9ILE    H  H     8.26 
   9ILE   HA  H    3.639 
   9ILE   HB  H    1.801 
   9ILE HG12  H    0.943 
   9ILE HG13  H    0.943 
   9ILE  HD1  H    0.708 
   9ILE    N  N  119.503 
  10ALA   CA  C   52.702 
  10ALA   CB  C   15.114 
  10ALA    H  H     7.84 
  10ALA   HA  H    3.961 
  10ALA   HB  H    1.365 
  10ALA    N  N  121.044 
  11GLU   CA  C   56.563 
  11GLU   CB  C     26.4 
  11GLU   CG  C   33.468 
  11GLU    H  H    7.635 
  11GLU   HA  H    3.908 
  11GLU  HB2  H    1.899 
  11GLU  HB3  H    1.899 
  11GLU  HG2  H    2.213 
  11GLU  HG3  H    2.213 
  11GLU    N  N  119.113 
  12PHE   CA  C   56.954 
  12PHE   CB  C   35.064 
  12PHE    H  H    8.441 
  12PHE   HA  H    4.786 
  12PHE  HB2  H    3.311 
  12PHE    N  N  119.574 
  13LYS   CA  C   57.296 
  13LYS   CB  C   29.592 
  13LYS   CG  C    25.83 
  13LYS   CD  C   33.696 
  13LYS    H  H    9.103 
  13LYS   HA  H    3.903 
  13LYS  HB2  H    1.727 
  13LYS  HB3  H    1.727 
  13LYS  HG2  H    1.919 
  13LYS  HG3  H    1.919 
  13LYS    N  N  123.454 
  14GLU   CA  C   56.465 
  14GLU   CB  C   26.502 
  14GLU   CG  C   33.584 
  14GLU    H  H    7.667 
  14GLU   HA  H    3.911 
  14GLU  HB2  H    1.908 
  14GLU  HB3  H    1.908 
  14GLU  HG2  H    2.186 
  14GLU  HG3  H    2.186 
  14GLU    N  N  119.525 
  15ALA   CA  C   52.751 
  15ALA   CB  C   15.228 
  15ALA    H  H    7.816 
  15ALA   HA  H    3.961 
  15ALA   HB  H    1.366 
  15ALA    N  N  121.983 
  16PHE   CA  C   59.544 
  16PHE   CB  C   36.774 
  16PHE    H  H    8.764 
  16PHE   HA  H    3.095 
  16PHE  HB2  H    2.771 
  16PHE  HB3  H    2.771 
  16PHE  HD1  H    6.477 
  16PHE  HD2  H    6.477 
  16PHE  HE1  H    6.903 
  16PHE  HE2  H    6.903 
  16PHE   HZ  H    7.035 
  16PHE    N  N  118.874 
  17SER   CA  C   58.567 
  17SER   CB  C     60.6 
  17SER    H  H    7.825 
  17SER   HA  H    3.979 
  17SER  HB2  H    3.883 
  17SER  HB3  H    3.883 
  17SER    N  N  111.578 
  18LEU   CA  C   54.608 
  18LEU   CB  C   39.638 
  18LEU   CG  C   26.388 
  18LEU  CD1  C   21.819 
  18LEU    H  H     7.24 
  18LEU   HA  H    3.947 
  18LEU  HB2  H    1.931 
  18LEU  HB3  H    1.931 
  18LEU   HG  H    1.679 
  18LEU  HD1  H    0.683 
  18LEU  HD2  H    1.103 
  18LEU    N  N  121.167 
  19PHE   CA  C   57.247 
  19PHE   CB  C    33.81 
  19PHE    H  H     7.09 
  19PHE   HA  H    3.911 
  19PHE  HB2  H    2.218 
  19PHE  HB3  H    2.218 
  19PHE  HD1  H    6.977 
  19PHE  HD2  H    6.977 
  19PHE    N  N  114.405 
  20ASP   CA  C   49.476 
  20ASP   CB  C   36.782 
  20ASP    H  H    7.662 
  20ASP   HA  H    4.476 
  20ASP  HB2  H    2.509 
  20ASP  HB3  H    2.509 
  20ASP    N  N  115.823 
  21LYS   CA  C   56.025 
  21LYS   CB  C     29.7 
  21LYS   CG  C   21.476 
  21LYS   CD  C   25.702 
  21LYS    H  H    7.539 
  21LYS   HA  H    3.786 
  21LYS  HB2  H    1.688 
  21LYS  HB3  H    1.688 
  21LYS  HG2  H    1.369 
  21LYS  HG3  H    1.283 
  21LYS  HD2  H     1.56 
  21LYS  HD3  H     1.56 
  21LYS  HE2  H    2.881 
  21LYS  HE3  H    2.881 
  21LYS    N  N  124.906 
  22ASP   CA  C   49.965 
  22ASP   CB  C   36.774 
  22ASP    H  H    7.965 
  22ASP   HA  H    4.431 
  22ASP  HB2  H    2.495 
  22ASP  HB3  H    2.943 
  22ASP    N  N   113.55 
  23GLY   CA  C   44.442 
  23GLY    H  H    7.606 
  23GLY  HA2  H    3.712 
  23GLY  HA3  H    3.712 
  23GLY    N  N  109.354 
  24ASP   CA  C    51.04 
  24ASP   CB  C   37.686 
  24ASP    H  H    8.266 
  24ASP   HA  H    4.355 
  24ASP  HB2  H    2.905 
  24ASP  HB3  H    2.905 
  24ASP    N  N  120.643 
  25GLY   CA  C   42.683 
  25GLY    H  H   10.545 
  25GLY  HA2  H    3.551 
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  25GLY  HA3  H    3.551 
  25GLY    N  N  113.205 
  26THR   CA  C   56.954 
  26THR   CB  C   69.948 
  26THR  CG2  C    18.99 
  26THR    H  H     8.02 
  26THR   HA  H     5.17 
  26THR   HB  H    3.688 
  26THR  HG2  H    0.876 
  26THR    N  N  112.852 
  27ILE   CA  C   57.931 
  27ILE   CB  C    37.23 
  27ILE  CG1  C    24.12 
  27ILE  CG2  C   15.342 
  27ILE  CD1  C   12.948 
  27ILE    H  H    9.689 
  27ILE   HA  H    3.827 
  27ILE   HB  H    1.883 
  27ILE HG12  H    0.707 
  27ILE HG13  H    0.707 
  27ILE  HD1  H    0.558 
  27ILE    N  N  127.005 
  28THR   CA  C   56.612 
  28THR   CB  C   69.606 
  28THR  CG2  C    19.56 
  28THR    H  H    8.275 
  28THR   HA  H    4.642 
  28THR   HB  H    4.654 
  28THR  HG2  H    1.175 
  28THR    N  N  116.439 
  29THR   CA  C   63.845 
  29THR   CB  C   65.616 
  29THR  CG2  C   20.472 
  29THR    H  H    9.054 
  29THR   HA  H    3.635 
  29THR   HB  H    4.049 
  29THR  HG2  H    1.115 
  29THR    N  N  113.287 
  30LYS   CA  C   56.465 
  30LYS   CB  C     29.7 
  30LYS   CG  C   21.705 
  30LYS   CD  C   25.931 
  30LYS    H  H    7.578 
  30LYS   HA  H    3.903 
  30LYS  HB2  H    1.702 
  30LYS  HB3  H    1.702 
  30LYS  HG2  H     1.35 
  30LYS  HG3  H     1.35 
  30LYS  HD2  H    1.922 
  30LYS  HD3  H    1.922 
  30LYS    N  N   121.23 
  31GLU   CA  C   57.149 
  31GLU   CB  C   26.058 
  31GLU   CG  C   33.696 
  31GLU    H  H    7.712 
  31GLU   HA  H    3.863 
  31GLU  HB2  H     1.92 
  31GLU  HB3  H     1.92 
  31GLU  HG2  H    2.175 
  31GLU  HG3  H    2.175 
  31GLU    N  N  122.002 
  32LEU   CA  C   55.529 
  32LEU   CB  C   39.981 
  32LEU   CG  C   23.418 
  32LEU  CD1  C   21.133 
  32LEU    H  H    8.509 
  32LEU   HA  H    3.925 
  32LEU  HB2  H    1.937 
  32LEU  HB3  H    1.937 
  32LEU   HG  H    1.643 
  32LEU  HD1  H    0.659 
  32LEU  HD2  H    1.101 
  32LEU    N  N   119.13 
  33GLY   CA  C   45.664 
  33GLY    H  H    8.388 
  33GLY  HA2  H    3.844 
  33GLY  HA3  H    3.433 
  33GLY    N  N  103.747 
  34THR   CA  C   64.285 
  34THR   CB  C   66.186 
  34THR  CG2  C   18.648 
  34THR    H  H    7.935 
  34THR   HA  H    3.795 
  34THR   HB  H    4.167 
  34THR  HG2  H    1.124 
  34THR    N  N  117.487 
  35VAL    H  H    7.089 
  35VAL    N  N  120.287 
  36MET   CA  C   57.101 
  36MET   CB  C   29.929 
  36MET    H  H    8.318 
  36MET   HA  H    3.911 
  36MET  HB2  H    1.715 
  36MET  HB3  H    1.715 
  36MET  HG2  H    1.883 
  36MET  HG3  H    1.883 
  36MET    N  N  117.816 
  37ARG   CA  C   56.172 
  37ARG   CB  C   27.084 
  37ARG   CG  C   25.488 
  37ARG   CD  C   40.878 
  37ARG    H  H    8.233 
  37ARG   HA  H    4.698 
  37ARG  HB2  H    1.776 
  37ARG  HB3  H    1.776 
  37ARG  HG2  H    1.846 
  37ARG  HG3  H    1.846 
  37ARG    N  N  117.706 
  38SER   CA  C   59.251 
  38SER   CB  C   67.782 
  38SER    H  H    7.874 
  38SER   HA  H    4.187 
  38SER  HB2  H    4.072 
  38SER  HB3  H    4.072 
  38SER    N  N  118.974 
  39LEU   CA  C   51.333 
  39LEU   CB  C   39.638 
  39LEU   CG  C    23.19 
  39LEU  CD1  C   20.791 
  39LEU    H  H    7.248 
  39LEU   HA  H    4.139 
  39LEU  HB2  H    1.746 
  39LEU  HB3  H    1.746 
  39LEU   HG  H    1.658 
  39LEU  HD1  H    0.517 
  39LEU  HD2  H    0.529 
  39LEU    N  N  118.835 
  40GLY   CA  C   42.878 
  40GLY    H  H    7.471 
  40GLY  HA2  H    4.093 
  40GLY  HA3  H    4.093 
  40GLY    N  N   104.99 
  41GLN   CA  C   51.187 
  41GLN   CB  C   30.618 
  41GLN   CG  C   37.116 
  41GLN    H  H     7.86 
  41GLN   HA  H     4.37 
  41GLN  HB2  H    2.507 
  41GLN  HB3  H    2.507 
  41GLN  HG2  H    2.935 
  41GLN  HG3  H    2.935 
  41GLN    N  N  118.032 
  42ASN   CA  C   48.694 
  42ASN   CB  C   36.554 
  42ASN    H  H    8.561 
  42ASN   HA  H    5.094 
  42ASN  HB2  H    2.348 
  42ASN  HB3  H    2.348 
  42ASN    N  N  115.671 
  43PRO   HA  H    4.711 
  43PRO  HD2  H    3.448 
  44THR   CA  C   57.638 
  44THR   CB  C   68.466 
  44THR  CG2  C    18.99 
  44THR    H  H    8.882 
  44THR   HA  H    4.321 
  44THR   HB  H    4.595 
  44THR  HG2  H    1.162 
  44THR    N  N  113.509 
  45GLU   CA  C   57.101 
  45GLU   CB  C   26.274 
  45GLU   CG  C   33.696 
  45GLU    H  H    8.662 
  45GLU   HA  H     3.88 
  45GLU  HB2  H    1.893 
  45GLU  HB3  H    1.893 
  45GLU  HG2  H    2.175 
  45GLU  HG3  H    2.175 
  45GLU    N  N  120.506 
  46ALA   CA  C   52.311 
  46ALA   CB  C    15.08 
  46ALA    H  H    8.139 
  46ALA   HA  H    3.925 
  46ALA   HB  H     1.26 
  46ALA    N  N  120.586 
  47GLU   CA  C    56.27 
  47GLU   CB  C   26.286 
  47GLU   CG  C   33.468 
  47GLU    H  H    7.597 
  47GLU   HA  H    3.876 
  47GLU  HB2  H    1.908 
  47GLU  HB3  H    1.908 
  47GLU  HG2  H    2.189 
  47GLU  HG3  H    2.189 
  47GLU    N  N  118.171 
  48LEU   CA  C   55.048 
  48LEU   CB  C   39.981 
  48LEU   CG  C   23.532 
  48LEU  CD1  C   20.562 
  48LEU    H  H    7.848 
  48LEU   HA  H    3.927 
  48LEU  HB2  H    1.937 
  48LEU  HB3  H    1.937 
  48LEU   HG  H    1.629 
  48LEU  HD1  H    0.763 
  48LEU  HD2  H    1.086 
  48LEU    N  N  120.228 
  49GLN   CA  C   55.732 
  49GLN   CB  C   27.882 
  49GLN   CG  C   33.354 
  49GLN    H  H    8.037 
  49GLN   HA  H    3.901 
  49GLN  HB2  H    1.978 
  49GLN  HB3  H    1.978 
  49GLN  HG2  H    2.219 
  49GLN  HG3  H    2.219 
  49GLN    N  N   117.91 
  50ASP   CA  C   54.706 
  50ASP   CB  C   37.572 
  50ASP    H  H     8.01 
  50ASP   HA  H    4.157 
  50ASP  HB2  H    2.517 
  50ASP  HB3  H    2.517 
  50ASP    N  N  119.284 
  51MET   CA  C   56.563 
  51MET   CB  C   29.478 
  51MET    H  H    7.614 
  51MET   HA  H    3.923 
  51MET  HB2  H    1.728 
  51MET  HB3  H    1.728 
  51MET    N  N  119.245 
  52ILE   CA  C    61.89 
  52ILE   CB  C   34.494 
  52ILE  CG1  C   26.058 
  52ILE  CG2  C   13.518 
  52ILE  CD1  C    9.984 
  52ILE    H  H    7.514 
  52ILE   HA  H    3.328 
  52ILE   HB  H    1.786 
  52ILE HG12  H    0.905 
  52ILE HG13  H    0.905 
  52ILE  HG2  H    0.557 
  52ILE  HD1  H    0.554 
  52ILE    N  N  117.584 
  53ASN   CA  C   53.093 
  53ASN   CB  C   35.292 
  53ASN    H  H    8.418 
  53ASN   HA  H    4.222 
  53ASN  HB2  H    2.832 
  53ASN  HB3  H    2.832 
  53ASN    N  N  117.126 
  54GLU   CA  C   56.123 
  54GLU   CB  C     26.4 
  54GLU   CG  C   33.582 
  54GLU    H  H    7.466 
  54GLU   HA  H    3.903 
  54GLU  HB2  H    1.908 
  54GLU  HB3  H    1.908 
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  54GLU  HG2  H    2.216 
  54GLU  HG3  H    2.216 
  54GLU    N  N   116.38 
  55VAL   CA  C   58.176 
  55VAL   CB  C   30.162 
  55VAL  CG1  C    18.99 
  55VAL  CG2  C   16.824 
  55VAL    H  H    7.044 
  55VAL   HA  H    4.314 
  55VAL   HB  H    2.216 
  55VAL  HG1  H    1.159 
  55VAL  HG2  H    0.778 
  55VAL    N  N  108.622 
  56ASP   CA  C   50.991 
  56ASP   CB  C   36.896 
  56ASP    H  H    7.561 
  56ASP   HA  H     4.39 
  56ASP  HB2  H    2.943 
  56ASP  HB3  H    2.503 
  56ASP    N  N   121.43 
  57ALA   CA  C    51.48 
  57ALA   CB  C   16.793 
  57ALA    H  H    8.357 
  57ALA   HA  H    4.053 
  57ALA   HB  H    1.369 
  57ALA    N  N   131.84 
  58ASP   CA  C   49.916 
  58ASP   CB  C   36.774 
  58ASP    H  H    7.985 
  58ASP   HA  H     4.49 
  58ASP  HB2  H    2.921 
  58ASP  HB3  H    2.517 
  58ASP    N  N  113.565 
  59GLY   CA  C   44.491 
  59GLY    H  H    7.424 
  59GLY  HA2  H    3.727 
  59GLY  HA3  H    3.727 
  59GLY    N  N  108.187 
  60ASN   CA  C   49.769 
  60ASN   CB  C   36.554 
  60ASN    H  H    7.919 
  60ASN   HA  H    4.446 
  60ASN  HB2  H    2.517 
  60ASN  HB3  H    2.517 
  60ASN    N  N  118.065 
  61GLY   CA  C   42.878 
  61GLY    H  H   10.485 
  61GLY  HA2  H     4.02 
  61GLY  HA3  H     4.02 
  61GLY    N  N  113.247 
  62THR   CA  C   56.661 
  62THR    H  H    7.511 
  62THR   HA  H     4.58 
  62THR   HB  H    3.788 
  62THR  HG2  H    0.948 
  62THR    N  N  108.699 
  63ILE   CA  C   57.101 
  63ILE   CB  C   37.344 
  63ILE  CG1  C   24.462 
  63ILE  CG2  C   15.684 
  63ILE  CD1  C   10.554 
  63ILE    H  H    8.741 
  63ILE   HA  H    5.054 
  63ILE   HB  H    1.893 
  63ILE HG12  H    0.631 
  63ILE HG13  H    0.631 
  63ILE  HG2  H    1.071 
  63ILE  HD1  H    0.705 
  63ILE    N  N  122.834 
  64ASP   CA  C   49.378 
  64ASP   CB  C   36.782 
  64ASP    H  H    8.702 
  64ASP   HA  H    5.238 
  64ASP  HB2  H    2.626 
  64ASP  HB3  H    2.945 
  64ASP    N  N  127.818 
  65PHE   CA  C   60.717 
  65PHE   CB  C   33.126 
  65PHE    H  H    8.847 
  65PHE   HA  H    3.861 
  65PHE  HB2  H    2.216 
  65PHE  HB3  H    2.216 
  65PHE  HD1  H     6.59 
  65PHE  HD2  H     6.59 
  65PHE   HZ  H    7.035 
  65PHE    N  N  118.653 
  67GLU   CA  C   56.337 
  67GLU   CB  C   26.045 
  67GLU   CG  C    33.47 
  67GLU    H  H     7.94 
  67GLU   HA  H    3.903 
  67GLU  HB2  H    1.908 
  67GLU  HB3  H    1.908 
  67GLU  HG2  H    2.216 
  67GLU  HG3  H    2.216 
  67GLU    N  N  117.631 
  68PHE   CA  C   58.727 
  68PHE   CB  C   37.572 
  68PHE    H  H    8.757 
  68PHE   HA  H     3.84 
  68PHE  HB2  H    3.081 
  68PHE  HB3  H    3.081 
  68PHE  HD1  H    6.844 
  68PHE  HD2  H    6.844 
  68PHE  HE1  H    6.502 
  68PHE  HE2  H    6.502 
  68PHE   HZ  H    7.001 
  68PHE    N  N  123.289 
  69LEU   CA  C   55.158 
  69LEU   CB  C   38.256 
  69LEU   CG  C   22.752 
  69LEU  CD1  C    21.27 
  69LEU  CD2  C   22.752 
  69LEU    H  H    8.403 
  69LEU   HA  H    3.245 
  69LEU  HB2  H    1.361 
  69LEU  HB3  H    1.361 
  69LEU   HG  H    0.881 
  69LEU  HD1  H    0.514 
  69LEU    N  N  118.867 
  70THR   CA  C   63.843 
  70THR   CB  C   65.502 
  70THR  CG2  C   19.192 
  70THR    H  H     7.54 
  70THR   HA  H    3.624 
  70THR   HB  H    4.168 
  70THR  HG2  H    1.068 
  70THR    N  N  116.302 
  71MET   CA  C   56.303 
  71MET   CB  C   29.706 
  71MET    H  H    7.723 
  71MET   HA  H    3.903 
  71MET  HB2  H    1.707 
  71MET  HB3  H    1.707 
  71MET  HG2  H    2.197 
  71MET  HG3  H    2.197 
  71MET    N  N   121.71 
  72MET   CA  C   53.307 
  72MET   CB  C   28.787 
  72MET   CG  C   28.787 
  72MET   CE  C   15.194 
  72MET    H  H    7.982 
  72MET   HA  H    3.773 
  72MET  HB2  H    1.291 
  72MET  HB3  H    1.291 
  72MET  HG2  H    1.732 
  72MET  HG3  H    1.732 
  72MET    N  N  116.535 
  73ALA   CA  C   52.095 
  73ALA   CB  C   15.342 
  73ALA    H  H    8.074 
  73ALA   HA  H     3.88 
  73ALA   HB  H    1.252 
  73ALA    N  N  121.584 
  74ARG   CA  C   55.731 
  74ARG   CB  C   27.987 
  74ARG    H  H    7.358 
  74ARG   HA  H    3.903 
  74ARG  HB2  H    1.805 
  74ARG  HB3  H    1.805 
  74ARG  HG2  H    2.201 
  74ARG  HG3  H    2.201 
  74ARG  HD2  H    3.067 
  74ARG  HD3  H    3.067 
  74ARG    N  N  115.784 
  75LYS   CA  C   53.947 
  75LYS   CB  C     26.4 
  75LYS   CG  C   22.068 
  75LYS   CD  C    30.96 
  75LYS   CE  C   39.738 
  75LYS    H  H     7.64 
  75LYS   HA  H    3.949 
  75LYS  HB2  H     2.23 
  75LYS  HB3  H     2.23 
  75LYS  HG2  H    1.335 
  75LYS  HG3  H    1.335 
  75LYS  HD2  H    1.658 
  75LYS  HD3  H    1.658 
  75LYS  HE2  H    2.832 
  75LYS  HE3  H    2.832 
  75LYS    N  N  117.245 
  76MET   CA  C   53.947 
  76MET   CB  C   29.478 
  76MET   CG  C   29.815 
  76MET    H  H    7.794 
  76MET   HA  H    4.242 
  76MET  HB2  H    2.027 
  76MET  HB3  H    2.027 
  76MET  HG2  H    2.591 
  76MET  HG3  H    2.591 
  76MET    N  N  117.971 
  77LYS   CA  C   54.283 
  77LYS   CB  C   29.478 
  77LYS   CG  C     26.4 
  77LYS    H  H    7.622 
  77LYS   HA  H    4.152 
  77LYS  HB2  H    2.538 
  77LYS  HB3  H    2.538 
  77LYS  HG2  H    2.025 
  77LYS  HG3  H    2.025 
  77LYS  HD2  H    1.693 
  77LYS  HD3  H    1.693 
  77LYS    N  N  119.902 
  78ASP   CA  C   52.061 
  78ASP    H  H    7.991 
  78ASP   HA  H    4.243 
  78ASP  HB2  H    1.864 
  78ASP  HB3  H    1.864 
  78ASP    N  N  119.146 
  79THR   CA  C    59.03 
  79THR   CB  C   67.668 
  79THR  CG2  C   18.534 
  79THR    H  H    7.587 
  79THR   HA  H     4.17 
  79THR   HB  H    4.096 
  79THR  HG2  H     1.08 
  79THR    N  N   112.75 
  80ASP   CA  C    50.85 
  80ASP   CB  C   37.353 
  80ASP    H  H    8.354 
  80ASP   HA  H    4.371 
  80ASP  HB2  H    2.512 
  80ASP  HB3  H    2.512 
  80ASP    N  N  122.888 
  81SER   CA  C   57.717 
  81SER   CB  C   60.884 
  81SER    H  H    8.232 
  81SER   HA  H    4.115 
  81SER  HB2  H    3.796 
  81SER  HB3  H    3.796 
  81SER    N  N  117.571 
  82GLU   CA  C   56.707 
  82GLU   CB  C   29.592 
  82GLU   CG  C   33.468 
  82GLU    H  H    8.364 
  82GLU   HA  H    3.883 
  82GLU  HB2  H    1.965 
  82GLU  HG2  H    2.175 
  82GLU    N  N   121.86 
  83GLU   CA  C   56.606 
  83GLU   CB  C   29.364 
  83GLU   CG  C   33.582 
  83GLU    H  H    8.032 
  83GLU   HA  H    3.883 
  83GLU  HB2  H    1.956 
  83GLU  HB3  H    1.956 
  83GLU  HG2  H    2.219 
  83GLU  HG3  H    2.219 
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  83GLU    N  N  119.398 
  84GLU   CA  C   56.606 
  84GLU   CB  C   25.817 
  84GLU   CG  C    33.47 
  84GLU    H  H    8.153 
  84GLU   HA  H    3.871 
  84GLU  HB2  H    1.917 
  84GLU  HB3  H    1.917 
  84GLU  HG2  H    2.226 
  84GLU  HG3  H    2.226 
  84GLU    N  N  118.279 
  85ILE   CA  C   63.439 
  85ILE   CB  C   34.608 
  85ILE  CG1  C   27.654 
  85ILE  CG2  C   15.912 
  85ILE  CD1  C   10.212 
  85ILE    H  H    7.927 
  85ILE   HA  H    3.612 
  85ILE   HB  H    1.778 
  85ILE HG12  H    0.919 
  85ILE HG13  H    0.919 
  85ILE  HG2  H    1.261 
  85ILE  HD1  H    0.707 
  85ILE    N  N   120.97 
  86ARG   CA  C   57.515 
  86ARG   CB  C   26.856 
  86ARG   CG  C    24.69 
  86ARG   CD  C   40.536 
  86ARG    H  H    8.233 
  86ARG   HA  H    4.008 
  86ARG  HB2  H    1.899 
  86ARG  HB3  H    1.899 
  86ARG  HG2  H    1.496 
  86ARG  HG3  H    1.496 
  86ARG  HD2  H     2.81 
  86ARG  HD3  H     2.81 
  86ARG    N  N  121.766 
  87GLU   CA  C   56.606 
  87GLU   CB  C   25.817 
  87GLU   CG  C   33.698 
  87GLU    H  H    8.156 
  87GLU   HA  H    3.902 
  87GLU  HB2  H     1.89 
  87GLU  HB3  H     1.89 
  87GLU  HG2  H    2.175 
  87GLU  HG3  H    2.175 
  87GLU    N  N  118.369 
  88ALA   CA  C   52.263 
  88ALA   CB  C    15.08 
  88ALA    H  H    7.877 
  88ALA   HA  H    3.949 
  88ALA   HB  H    1.368 
  88ALA    N  N  120.337 
  89PHE   CA  C   59.703 
  89PHE   CB  C   36.774 
  89PHE    H  H    8.459 
  89PHE   HA  H    3.115 
  89PHE  HB2  H    2.731 
  89PHE  HB3  H    2.731 
  89PHE  HD1  H    6.478 
  89PHE  HD2  H    6.478 
  89PHE  HE1  H    7.054 
  89PHE  HE2  H    7.054 
  89PHE    N  N  118.191 
  90ARG   CA  C   56.168 
  90ARG   CB  C   27.654 
  90ARG   CG  C   25.716 
  90ARG   CD  C   40.764 
  90ARG    H  H    7.764 
  90ARG   HA  H    3.905 
  90ARG  HB2  H    1.803 
  90ARG  HB3  H    1.803 
  90ARG  HG2  H    2.135 
  90ARG  HG3  H    2.135 
  90ARG  HD2  H    3.073 
  90ARG  HD3  H    3.073 
  90ARG    N  N  115.953 
  91VAL   CA  C   63.357 
  91VAL   CB  C   28.444 
  91VAL  CG1  C   18.164 
  91VAL  CG2  C   19.877 
  91VAL    H  H    7.229 
  91VAL   HA  H    3.285 
  91VAL   HB  H    1.901 
  91VAL  HG1  H    0.388 
  91VAL  HG2  H    0.856 
  91VAL    N  N  118.202 
  92PHE   CA  C   58.029 
  92PHE   CB  C   38.838 
  92PHE    H  H    6.699 
  92PHE   HA  H    3.945 
  92PHE  HB2  H    2.561 
  92PHE  HB3  H    2.561 
  92PHE  HD1  H    6.373 
  92PHE  HD2  H    6.373 
  92PHE    N  N  112.447 
  93ASP   CA  C   49.525 
  93ASP   CB  C   35.183 
  93ASP    H  H    7.881 
  93ASP   HA  H    4.476 
  93ASP  HB2  H    2.517 
  93ASP  HB3  H    2.517 
  93ASP    N  N  116.461 
  94LYS   CA  C   55.976 
  94LYS   CB  C   31.414 
  94LYS   CG  C   25.246 
  94LYS   CD  C   27.644 
  94LYS   CE  C   40.764 
  94LYS    H  H    7.596 
  94LYS   HA  H    3.668 
  94LYS  HB2  H    2.198 
  94LYS  HB3  H    2.198 
  94LYS  HG2  H    1.517 
  94LYS  HG3  H    1.283 
  94LYS  HD2  H    1.794 
  94LYS  HD3  H    1.794 
  94LYS    N  N  125.494 
  95ASP   CA  C   50.307 
  95ASP   CB  C   36.774 
  95ASP    H  H    8.097 
  95ASP   HA  H    4.415 
  95ASP  HB2  H    2.924 
  95ASP  HB3  H    2.498 
  95ASP    N  N  114.015 
  96GLY   CA  C   44.344 
  96GLY    H  H    7.677 
  96GLY  HA2  H    3.711 
  96GLY  HA3  H    3.711 
  96GLY    N  N  109.147 
  97ASN   CA  C   49.916 
  97ASN   CB  C   35.183 
  97ASN    H  H    8.252 
  97ASN   HA  H      4.5 
  97ASN  HB2  H    3.271 
  97ASN  HB3  H    3.271 
  97ASN    N  N  119.575 
  98GLY   CA  C   42.292 
  98GLY    H  H   10.462 
  98GLY  HA2  H    3.986 
  98GLY  HA3  H    3.986 
  98GLY    N  N  112.465 
  99TYR   CA  C   53.582 
  99TYR   CB  C   39.981 
  99TYR    H  H    7.557 
  99TYR   HA  H    4.882 
  99TYR  HB2  H    2.412 
  99TYR  HB3  H    2.412 
  99TYR  HD1  H    6.736 
  99TYR  HD2  H    6.736 
  99TYR    N  N  116.256 
 100ILE   CA  C   58.616 
 100ILE   CB  C   36.432 
 100ILE  CG1  C   24.234 
 100ILE  CG2  C   14.316 
 100ILE  CD1  C   13.632 
 100ILE    H  H    9.972 
 100ILE   HA  H    4.457 
 100ILE   HB  H    1.731 
 100ILE  HG2  H    0.751 
 100ILE  HD1  H    0.771 
 100ILE    N  N  126.957 
 101SER   CA  C   52.897 
 101SER   CB  C   64.134 
 101SER    H  H    8.844 
 101SER   HA  H    4.711 
 101SER  HB2  H    3.818 
 101SER  HB3  H    3.818 
 101SER    N  N  123.739 
 102ALA   CA  C   53.093 
 102ALA   CB  C   15.114 
 102ALA    H  H    9.178 
 102ALA   HA  H    3.711 
 102ALA   HB  H    1.325 
 102ALA    N  N  123.028 
 103ALA   CA  C   52.409 
 103ALA   CB  C   15.456 
 103ALA    H  H    8.132 
 103ALA   HA  H    3.861 
 103ALA   HB  H    1.262 
 103ALA    N  N  118.443 
 104GLU   CA  C   56.563 
 104GLU   CB  C     26.4 
 104GLU   CG  C   33.582 
 104GLU    H  H    7.786 
 104GLU   HA  H    3.839 
 104GLU  HB2  H    1.917 
 104GLU  HB3  H    1.917 
 104GLU  HG2  H     2.26 
 104GLU  HG3  H     2.26 
 104GLU    N  N  120.139 
 105LEU   CA  C   55.732 
 105LEU   CB  C   40.209 
 105LEU   CG  C   23.532 
 105LEU  CD1  C  20.791 
 105LEU    H  H     8.24 
 105LEU   HA  H    3.902 
 105LEU  HB2  H    1.623 
 105LEU  HB3  H    1.623 
 105LEU   HG  H    1.645 
 105LEU  HD1  H    0.643 
 105LEU  HD2  H    1.036 
 105LEU    N  N  121.545 
 106ARG   CA  C   57.345 
 106ARG   CB  C    30.39 
 106ARG   CG  C   25.944 
 106ARG   CD  C   39.054 
 106ARG    H  H    8.761 
 106ARG   HA  H    3.839 
 106ARG  HB2  H     1.73 
 106ARG  HB3  H     1.73 
 106ARG  HG2  H   1.922 
 106ARG  HG3  H   1.922 
 106ARG  HD2  H   1.069 
 106ARG    N  N  118.625 
 107HIS   CA  C   56.807 
 107HIS   CB  C   27.198 
 107HIS    H  H    7.946 
 107HIS   HA  H    3.902 
 107HIS  HB2  H    1.794 
 107HIS  HB3  H    1.794 
 107HIS    N  N  119.052 
 108VAL   CA  C   64.285 
 108VAL   CB  C   28.908 
 108VAL  CG1  C   8.078 
 108VAL  CG2  C     20.7 
 108VAL    H  H    7.736 
 108VAL   HA  H    3.442 
 108VAL   HB  H    2.027 
 108VAL  HG1  H   0.466 
 108VAL  HG2  H   0.861 
 108VAL    N  N   119.16 
 109MET   CA  C   54.686 
 109MET   CB  C   29.706 
 109MET    H  H    8.074 
 109MET   HA  H    4.139 
 109MET  HB2  H   1.709 
 109MET  HB3  H   1.709 
 109MET  HG2  H   2.038 
 109MET  HG3  H   2.038 
 109MET    N  N  15.333 
 110THR   CA  C   63.845 
 110THR   CB  C   66.072 
 110THR  CG2  C  18.876 
 110THR    H  H    8.515 
 110THR   HA  H    3.935 
 110THR   HB  H    4.168 
 110THR  HG2  H     1.08 
 110THR    N  N  116.714 
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 111ASN   CA  C   53.093 
 111ASN   CB  C   35.292 
 111ASN    H  H     7.89 
 111ASN   HA  H    4.242 
 111ASN  HB2  H    2.689 
 111ASN  HB3  H    2.859 
 111ASN    N  N  123.784 
 112LEU   CA  C   52.653 
 112LEU   CB  C   39.738 
 112LEU   CG  C   23.094 
 112LEU  CD1  C   0.244 
 112LEU    H  H    7.621 
 112LEU   HA  H    4.115 
 112LEU  HB2  H     1.75 
 112LEU  HB3  H     1.75 
 112LEU   HG  H    1.643 
 112LEU  HD1  H    0.621 
 112LEU  HD2  H    0.621 
 112LEU    N  N  118.227 
 113GLY   CA  C   42.536 
 113GLY    H  H    7.701 
 113GLY  HA2  H   4.094 
 113GLY  HA3  H   4.094 
 113GLY    N  N  106.787 
 114GLU   CA  C   52.067 
 114GLU   CB  C   26.616 
 114GLU   CG  C   31.071 
 114GLU    H  H    7.864 
 114GLU   HA  H    4.242 
 114GLU  HB2  H    1.518 
 114GLU  HB3  H    1.518 
 114GLU  HG2  H   1.803 
 114GLU  HG3  H   1.803 
 114GLU    N  N  120.288 
 115LYS   CA  C   52.848 
 115LYS   CB  C   30.957 
 115LYS   CG  C   26.502 
 115LYS   CD  C   21.933 
 115LYS    H  H    8.491 
 115LYS   HA  H    4.223 
 115LYS  HB2  H    1.773 
 115LYS  HB3  H    1.773 
 115LYS  HG2  H    1.198 
 115LYS  HG3  H    1.198 
 115LYS  HD2  H    1.496 
 115LYS  HD3  H    1.496 
 115LYS    N  N  124.987 
 116LEU   CA  C   51.089 
 116LEU   CB  C   42.588 
 116LEU   CG  C   24.804 
 116LEU  CD1  C  21.384 
 116LEU  CD2  C  16.482 
 116LEU    H  H    7.978 
 116LEU   HA  H    4.712 
 116LEU  HB2  H    1.473 
 116LEU  HB3  H    1.473 
 116LEU   HG  H    1.433 
 116LEU  HD1  H    0.663 
 116LEU    N  N  124.912 
 117THR   CA  C   57.834 
 117THR   CB  C    68.58 
 117THR  CG2  C    18.99 
 117THR    H  H    9.093 
 117THR   HA  H    4.302 
 117THR   HB  H    4.647 
 117THR  HG2  H    1.153 
 117THR    N  N   114.22 
 118ASP   CA  C   55.243 
 118ASP   CB  C   37.002 
 118ASP    H  H    8.764 
 118ASP   HA  H    4.058 
 118ASP  HB2  H    2.488 
 118ASP  HB3  H    2.488 
 118ASP    N  N  120.925 
 119GLU   CA  C   57.149 
 119GLU   CB  C   25.931 
 119GLU   CG  C   33.812 
 119GLU    H  H    8.509 
 119GLU   HA  H    3.927 
 119GLU  HB2  H    1.887 
 119GLU  HB3  H    1.887 
 119GLU  HG2  H   2.203 
 119GLU  HG3  H   2.203 
 119GLU    N  N  119.395 
 120GLU   CA  C   56.319 
 120GLU   CB  C    25.83 
 120GLU   CG  C   33.696 
 120GLU    H  H    7.585 
 120GLU   HA  H    3.896 
 120GLU  HB2  H    1.901 
 120GLU  HB3  H    1.901 
 120GLU  HG2  H   2.209 
 120GLU  HG3  H   2.209 
 120GLU    N  N  119.909 
 121VAL   CA  C    64.09 
 121VAL   CB  C    28.68 
 121VAL  CG1  C     20.7 
 121VAL  CG2  C  18.078 
 121VAL    H  H    7.849 
 121VAL   HA  H    3.442 
 121VAL   HB  H    2.048 
 121VAL  HG1  H   0.772 
 121VAL  HG2  H   0.199 
 121VAL    N  N  122.092 
 122ASP   CA  C   54.901 
 122ASP   CB  C   37.572 
 122ASP    H  H    7.912 
 122ASP   HA  H    4.157 
 122ASP  HB2  H    2.503 
 122ASP  HB3  H    2.623 
 122ASP    N  N  120.167 
 123GLU   CA  C   56.612 
 123GLU   CB  C   26.172 
 123GLU   CG  C   33.468 
 123GLU    H  H    7.839 
 123GLU   HA  H    3.896 
 123GLU  HB2  H    1.901 
 123GLU  HB3  H    1.901 
 123GLU  HG2  H   2.209 
 123GLU  HG3  H   2.209 
 123GLU    N  N  119.087 
 124MET   CA  C   56.905 
 124MET   CB  C    29.25 
 124MET    H  H    7.433 
 124MET   HA  H    3.867 
 124MET  HB2  H   1.755 
 124MET  HB3  H   1.755 
 124MET  HG2  H   2.195 
 124MET  HG3  H   2.195 
 124MET    N  N  118.897 
 125ILE   CA  C   60.131 
 125ILE   CB  C    33.24 
 125ILE  CG1  C   13.595 
 125ILE  CG2  C   24.789 
 125ILE  CD1  C    6.906 
 125ILE    H  H    7.658 
 125ILE   HA  H     3.38 
 125ILE   HB  H    2.086 
 125ILE HG12  H    0.554 
 125ILE HG13  H    0.554 
 125ILE  HG2  H    1.241 
 125ILE  HD1  H    0.434 
 125ILE    N  N  118.001 
 126ARG   CA  C   56.673 
 126ARG   CB  C   29.478 
 126ARG   CG  C   26.058 
 126ARG   CD  C   40.992 
 126ARG    H  H    7.974 
 126ARG   HA  H    3.883 
 126ARG  HB2  H   1.725 
 126ARG  HB3  H   1.725 
 126ARG    N  N   117.72 
 127GLU   CA  C   56.319 
 127GLU   CB  C   26.286 
 127GLU   CG  C   33.696 
 127GLU    H  H    7.635 
 127GLU   HA  H    3.967 
 127GLU  HB2  H    1.916 
 127GLU  HB3  H    1.916 
 127GLU  HG2  H   2.253 
 127GLU  HG3  H   2.253 
 127GLU    N  N   117.05 
 128ALA   CA  C   48.205 
 128ALA   CB  C   20.105 
 128ALA    H  H    7.155 
 128ALA   HA  H      4.5 
 128ALA   HB  H    1.329 
 128ALA    N  N  116.966 
 129ASP   CA  C   51.822 
 129ASP   CB  C   37.686 
 129ASP    H  H    7.806 
 129ASP   HA  H    4.351 
 129ASP  HB2  H    2.517 
 129ASP  HB3  H    2.517 
 129ASP    N  N  118.033 
 130ILE   CA  C   60.522 
 130ILE   CB  C    36.09 
 130ILE  CG1  C   25.032 
 130ILE  CG2  C    14.43 
 130ILE  CD1  C    9.756 
 130ILE    H  H    8.115 
 130ILE   HA  H    3.797 
 130ILE   HB  H    1.837 
 130ILE HG12  H    1.549 
 130ILE HG13  H    1.549 
 130ILE  HG2  H    0.772 
 130ILE  HD1  H    0.708 
 130ILE    N  N  127.927 
 131ASP   CA  C   51.187 
 131ASP   CB  C   37.468 
 131ASP    H  H    8.202 
 131ASP   HA  H    4.343 
 131ASP  HB2  H      2.9 
 131ASP  HB3  H      2.9 
 131ASP    N  N  116.634 
 132GLY   CA  C   44.638 
 132GLY    H  H    7.535 
 132GLY  HA2  H   3.706 
 132GLY  HA3  H   3.706 
 132GLY    N  N  108.586 
 133ASP   CA  C   50.942 
 133ASP   CB  C   37.458 
 133ASP    H  H    8.215 
 133ASP   HA  H    4.351 
 133ASP  HB2  H    2.327 
 133ASP  HB3  H    2.899 
 133ASP    N  N  120.377 
 134GLY   CA  C   43.122 
 134GLY    H  H    9.971 
 134GLY  HA2  H   3.295 
 134GLY  HA3  H   3.295 
 134GLY    N  N  112.226 
 135GLN   CA  C   50.454 
 135GLN   CB  C   30.614 
 135GLN   CG  C   30.614 
 135GLN    H  H    7.835 
 135GLN   HA  H    4.131 
 135GLN  HB2  H    1.617 
 135GLN  HB3  H    1.617 
 135GLN  HG2  H   1.711 
 135GLN  HG3  H   1.711 
 135GLN    N  N  115.229 
 136VAL   CA  C   58.713 
 136VAL   CB  C   31.416 
 136VAL  CG1  C  20.358 
 136VAL  CG2  C  19.104 
 136VAL    H  H    8.958 
 136VAL   HA  H    5.096 
 136VAL   HB  H    2.195 
 136VAL  HG1  H   0.948 
 136VAL  HG2  H   1.153 
 136VAL    N  N  125.238 
 137ASN   CA  C   48.352 
 137ASN   CB  C    35.64 
 137ASN    H  H    9.435 
 137ASN   HA  H    5.226 
 137ASN  HB2  H    2.964 
 137ASN  HB3  H    2.964 
 137ASN    N  N  129.058 
 138TYR   CA  C   59.669 
 138TYR   CB  C   37.572 
 138TYR    H  H    8.146 
 138TYR   HA  H    3.192 
 138TYR  HB2  H    1.916 
 138TYR  HB3  H    1.916 
 138TYR  HD1  H    6.865 
 138TYR  HD2  H    6.865 
 138TYR    N  N  118.627 
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 139GLU   CA  C    57.54 
 139GLU   CB  C   26.274 
 139GLU   CG  C   33.812 
 139GLU    H  H    7.974 
 139GLU   HA  H    3.511 
 139GLU  HB2  H     1.96 
 139GLU  HB3  H     1.96 
 139GLU  HG2  H     2.18 
 139GLU  HG3  H     2.18 
 139GLU    N  N  118.701 
 140GLU   CA  C   56.025 
 140GLU   CB  C   26.274 
 140GLU   CG  C    33.24 
 140GLU    H  H    8.676 
 140GLU   HA  H    3.911 
 140GLU  HB2  H    1.901 
 140GLU  HB3  H    1.901 
 140GLU  HG2  H   2.197 
 140GLU  HG3  H   2.197 
 140GLU    N  N  119.774 
 141PHE   CA  C   59.447 
 141PHE   CB  C   37.686 
 141PHE    H  H    8.507 
 141PHE   HA  H    3.647 
 141PHE  HB2  H    3.178 
 141PHE  HB3  H    3.178 
 141PHE  HD1  H     6.63 
 141PHE  HD2  H     6.63 
 141PHE  HE1  H     6.99 
 141PHE  HE2  H     6.99 
 141PHE   HZ  H     6.39 
 141PHE    N  N  124.074 
 142VAL   CA  C   64.432 
 142VAL   CB  C   28.908 
 142VAL  CG1  C  18.762 
 142VAL  CG2  C  20.586 
 142VAL    H  H    8.639 
 142VAL   HA  H    2.958 
 142VAL   HB  H    1.622 
 142VAL  HG1  H   0.576 
 142VAL  HG2  H   0.291 
 142VAL    N  N  119.203 
 143GLN   CA  C   56.514 
 143GLN   CB  C   25.246 
 143GLN   CG  C   31.414 
 143GLN    H  H    7.818 
 143GLN   HA  H    3.671 
 143GLN  HB2  H    1.912 
 143GLN  HB3  H    1.912 
 143GLN  HG2  H   2.219 
 143GLN  HG3  H   2.219 
 143GLN    N  N  120.173 
 144MET   CA  C   55.683 
 144MET   CB  C    28.11 
 144MET    H  H    7.403 
 144MET   HA  H    3.882 
 144MET  HB2  H   1.781 
 144MET  HB3  H   1.781 
 144MET  HG2  H   1.781 
 144MET  HG3  H   1.781 
 144MET   HE  H     3.09 
 144MET    N  N  118.573 
 145MET   CA  C    53.63 
 145MET   CB  C   29.592 
 145MET    H  H    7.534 
 145MET   HA  H     3.94 
 145MET  HB2  H   1.725 
 145MET  HB3  H   1.725 
 145MET  HG2  H   1.672 
 145MET  HG3  H   1.672 
 145MET    N  N  114.053 
 146THR   CA  C   59.251 
 146THR   CB  C   67.896 
 146THR  CG2  C  18.534 
 146THR    H  H    7.554 
 146THR   HA  H    4.175 
 146THR   HB  H    4.087 
 146THR  HG2  H    0.977 
 146THR    N  N  109.275 
 147ALA   CA  C   50.307 
 147ALA   CB  C   16.336 
 147ALA    H  H    7.406 
 147ALA   HA  H    4.117 
 147ALA   HB  H    1.256 
 147ALA    N  N  126.913 
 148LYS   CA  C   54.803 
 148LYS   CB  C   30.843 
 148LYS   CG  C   21.933 
 148LYS   CD  C   26.388 
 148LYS   CE  C   39.852 
 148LYS    H  H    7.834 
 148LYS   HA  H    3.955 
 148LYS  HB2  H    1.652 
 148LYS  HB3  H    1.652 
 148LYS  HG2  H     1.22 
 148LYS  HG3  H     1.22 
 148LYS  HD2  H    1.916 
 148LYS  HD3  H    1.916 
 148LYS    N  N  126.268 
eNOSpThr495 
 153THR    H  H    8.298 
 153THR   HA  H    4.078 
 153THR   HB  H    3.963 
 153THR  HG2  H     0.91 
 154PHE    H  H    8.432 
 154PHE   HA  H    4.526 
 154PHE  HB2  H    4.241 
 154PHE  HB3  H    4.241 
 155LYS    H  H    8.314 
 155LYS   HA  H    3.989 
 155LYS  HB2  H    1.993 
 155LYS  HB3  H    1.993 
 155LYS  HG2  H    0.904 
 155LYS  HG3  H    0.904 
 155LYS  HD2  H    1.402 
 155LYS  HD3  H    1.402 
 156GLU    H  H    7.797 
 156GLU   HA  H    4.447 
 156GLU  HB2  H    1.402 
 156GLU  HB3  H    1.402 
 156GLU  HG2  H   1.509 
 156GLU  HG3  H   1.509 
 157VAL    H  H    7.387 
 157VAL   HA  H    3.945 
 157VAL   HB  H    1.833 
 157VAL  HG1  H   0.613 
 157VAL  HG2  H   0.733 
 158ALA    H  H    7.191 
 158ALA   HA  H    4.167 
 158ALA   HB  H    1.521 
 159ASN    H  H    7.709 
 159ASN   HA  H    4.087 
 159ASN  HB2  H    2.885 
 159ASN  HB3  H    2.885 
 160ALA    H  H    6.782 
 160ALA   HB  H    1.114 
 161VAL    H  H    6.561 
 161VAL   HA  H    4.393 
 161VAL   HB  H    1.313 
 161VAL  HG1  H   0.476 
 161VAL  HG2  H   0.476 
 162LYS    H  H    7.348 
 162LYS   HA  H    4.393 
 162LYS  HB2  H    2.205 
 162LYS  HB3  H    2.205 
 162LYS  HG2  H     1.03 
 162LYS  HG3  H     1.03 
 163ILE    H  H    9.267 
 163ILE   HA  H    4.279 
 163ILE   HB  H    2.197 
 163ILE HG12  H    1.318 
 163ILE HG13  H    1.318 
 163ILE  HD1  H    1.023 
 164SER    H  H    8.802 
 164SER   HA  H    4.418 
 164SER  HB2  H     2.89 
 164SER  HB3  H     2.89 
 165ALA    H  H    7.784 
 165ALA   HA  H    4.136 
 165ALA   HB  H    1.504 
 166SER    H  H    8.539 
 166SER   HA  H     4.31 
 166SER  HB2  H    3.497 
 166SER  HB3  H    3.497 
 167LEU    H  H    8.648 
 167LEU   HA  H    3.857 
 167LEU  HB2  H    2.253 
 167LEU  HB3  H    2.253 
 167LEU   HG  H    1.758 
 167LEU  HD1  H    1.226 
 167LEU  HD2  H    0.899 
 168MET    H  H    8.451 
 168MET  HB2  H   1.793 
 168MET  HB3  H   1.793 
 168MET  HG2  H   1.993 
 168MET  HG3  H   1.993 
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Appendix C 
CaM Y99E-eNOS Peptide Assigned Chemical Shift 
_Residue_seq_code 
_Residue_label 
_Atom_name 
_Atom_type 
_Chem_shift_value 
 2ASP H H  8.493 
 2ASP N N 120.229 
 3GLN H H  8.207 
 3GLN N N 119.571 
 4LEU H H  8.177 
 4LEU N N  122.97 
 5THR H H  8.611 
 5THR N N 112.923 
 6GLU H H  8.875 
 6GLU N N 120.083 
 7GLU H H  8.532 
 7GLU N N 119.246 
 8GLN H H  7.586 
 8GLN N N  119.77 
 9ILE H H  8.271 
 9ILE N N 119.252 
 10ALA H H  7.84 
 10ALA N N 120.938 
 11GLU H H  7.637 
 11GLU N N  118.88 
 12PHE H H  8.449 
 12PHE N N 119.525 
 13LYS H H  9.106 
 13LYS N N 123.495 
 14GLU H H  7.653 
 14GLU N N 119.053 
 15ALA H H  7.789 
 15ALA N N 121.934 
 16PHE H H  8.766 
 16PHE N N 118.861 
 17SER H H  7.826 
 17SER N N 111.507 
 18LEU H H  7.237 
 18LEU N N 121.142 
 19PHE H H  7.071 
 19PHE N N 114.305 
 20ASP H H  7.664 
 20ASP N N 115.786 
 21LYS H H  7.55 
 21LYS N N 124.882 
 22ASP H H  7.962 
 22ASP N N 113.582 
 23GLY H H  7.599 
 23GLY N N 109.251 
 24ASP H H  8.254 
 24ASP N N 120.421 
 25GLY H H  10.56 
 25GLY N N  113.19 
 26THR H H  8.021 
 26THR N N 112.893 
 27ILE H H  9.682 
 27ILE N N 127.001 
 28THR H H  8.264 
 28THR N N 116.659 
 29THR H H  9.056 
 29THR N N 113.245 
 30LYS H H  7.575 
 30LYS N N 121.098 
 31GLU H H  7.71 
 31GLU N N 122.001 
 33GLY H H  8.383 
 33GLY N N  103.65 
 34THR H H  7.928 
 34THR N N 117.566 
 35VAL H H  7.091 
 35VAL N N 120.234 
 36MET H H  8.323 
 36MET N N 117.714 
 37ARG H H  8.23 
 37ARG N N 117.626 
 38SER H H  7.879 
 38SER N N  118.88 
 39LEU H H  7.258 
 39LEU N N 118.681 
 40GLY H H  7.46 
 40GLY N N 104.808 
 41GLN H H  7.869 
 41GLN N N 117.938 
 42ASN H H  8.557 
 42ASN N N 115.663 
 44THR H H  8.894 
 44THR N N 113.567 
 45GLU H H  8.654 
 45GLU N N 120.295 
 46ALA H H  8.137 
 46ALA N N 120.487 
 47GLU H H  7.591 
 47GLU N N 118.007 
 48LEU H H  7.853 
 48LEU N N 120.152 
 49GLN H H  8.028 
 49GLN N N 117.871 
 50ASP H H  8.011 
 50ASP N N 119.212 
 51MET H H  7.616 
 51MET N N 119.106 
 52ILE H H  7.511 
 52ILE N N 117.539 
 53ASN H H  8.415 
 53ASN N N 117.128 
 54GLU H H  7.465 
 54GLU N N 116.411 
 55VAL H H  7.039 
 55VAL N N 108.519 
 56ASP H H  7.557 
 56ASP N N 121.284 
 57ALA H H  8.359 
 57ALA N N 131.832 
 58ASP H H  7.988 
 58ASP N N 113.582 
 59GLY H H  7.424 
 59GLY N N 108.085 
 60ASN H H  7.918 
 60ASN N N 117.926 
 61GLY H H  10.485 
 61GLY N N  113.23 
 62THR H H  7.507 
 62THR N N 108.615 
 63ILE H H  8.73 
 63ILE N N 122.672 
 64ASP H H  8.706 
 64ASP N N 127.837 
 65PHE H H  8.845 
 65PHE N N 118.569 
 67GLU H H  7.952 
 67GLU N N 117.588 
 68PHE H H  8.765 
 68PHE N N 123.283 
 69LEU H H  8.405 
 69LEU N N 118.741 
 70THR H H  7.542 
 70THR N N 116.411 
 71MET H H  7.72 
 71MET N N 121.576 
 72MET H H  7.977 
 72MET N N 116.517 
 73ALA H H  8.061 
 73ALA N N 121.465 
 74ARG H H  7.354 
 74ARG N N 115.794 
 75LYS H H  7.636 
 75LYS N N 117.245 
 76MET H H  7.792 
 76MET N N 117.911 
 77LYS H H  7.627 
 77LYS N N 119.836 
 78ASP H H  8.009 
 78ASP N N 119.273 
 79THR H H  7.597 
 79THR N N 112.709 
 80ASP H H  8.341 
 80ASP N N 122.718 
 81SER H H  8.233 
 81SER N N 117.456 
 82GLU H H  8.375 
 82GLU N N 121.788 
 83GLU H H  8.044 
 83GLU N N 119.225 
 84GLU H H  8.159 
 84GLU N N 118.203 
 85ILE H H  7.937 
 85ILE N N 120.792 
 86ARG H H  8.231 
 86ARG N N 121.538 
 87GLU H H  8.161 
 87GLU N N 118.379 
 88ALA H H  7.882 
 88ALA N N 120.239 
 89PHE H H  8.449 
 89PHE N N 118.117 
 90ARG H H  7.775 
 90ARG N N 116.079 
 91VAL H H  7.23 
 91VAL N N 118.183 
 92PHE H H  6.688 
 92PHE N N 113.127 
 93ASP H H  7.819 
 93ASP N N 116.503 
 94LYS H H  7.602 
 94LYS N N 125.373 
 95ASP H H  8.07 
 95ASP N N 114.036 
 96GLY H H  7.613 
 96GLY N N 108.687 
 97ASN H H  8.172 
 97ASN N N 119.358 
 98GLY H H  10.54 
 98GLY N N 113.216 
 100ILE H H  9.928 
 100ILE N N 127.731 
 101SER H H  8.782 
 101SER N N 123.256 
 102ALA H H  9.162 
 102ALA N N 122.818 
 103ALA H H  8.117 
 103ALA N N 118.189 
 104GLU H H  7.787 
 104GLU N N 120.128 
 105LEU H H  8.231 
 105LEU N N 121.366 
 106ARG H H  8.787 
 106ARG N N 118.502 
 107HIS H H  7.957 
 107HIS N N 118.774 
 108VAL H H  7.685 
 108VAL N N 119.066 
 109MET H H  8.11 
 109MET N N 115.413 
 110THR H H  8.529 
 110THR N N 116.879 
 111ASN H H  7.87 
 111ASN N N 123.846 
 112LEU H H  7.667 
 112LEU N N 118.323 
 113GLY H H  7.699 
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 113GLY N N  106.76 
 114GLU H H  7.864 
 114GLU N N 119.971 
 115LYS H H  8.49 
 115LYS N N 124.969 
 116LEU H H  7.985 
 116LEU N N 124.895 
 117THR H H  9.119 
 117THR N N 114.373 
 118ASP H H  8.763 
 118ASP N N 120.773 
 119GLU H H  8.514 
 119GLU N N 119.166 
 120GLU H H  7.568 
 120GLU N N 119.969 
 121VAL H H  7.858 
 121VAL N N 122.014 
 122ASP H H  7.879 
 122ASP N N 120.064 
 123GLU H H  7.809 
 123GLU N N 119.053 
 124MET H H  7.427 
 124MET N N 118.974 
 125ILE H H  7.707 
 125ILE N N 118.137 
 126ARG H H  7.962 
 126ARG N N 117.749 
 127GLU H H  7.593 
 127GLU N N 117.582 
 128ALA H H  7.167 
 128ALA N N  116.6 
 130ILE H H  8.162 
 130ILE N N 128.314 
 131ASP H H  8.3 
 131ASP N N 118.314 
 132GLY H H  7.555 
 132GLY N N 108.507 
 133ASP H H  8.072 
 133ASP N N 120.492 
 134GLY H H  9.977 
 134GLY N N  112.41 
 135GLN H H  7.715 
 135GLN N N 115.893 
 136VAL H H  8.887 
 136VAL N N  124.77 
 137ASN H H  9.267 
 137ASN N N 128.023 
 138TYR H H  8.12 
 138TYR N N 118.376 
 139GLU H H  8.002 
 139GLU N N 118.503 
 141PHE H H  8.654 
 141PHE N N 124.119 
 142VAL H H  8.677 
 142VAL N N  119.14 
 143GLN H H  7.793 
 143GLN N N  120.24 
 144MET H H  7.391 
 144MET N N 118.549 
 145MET H H  7.544 
 145MET N N 114.271 
 146THR H H  7.591 
 146THR N N 109.129 
 147ALA H H  7.371 
 147ALA N N 126.868 
 148LYS H H  7.855 
 148LYS N N 126.436 
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Appendix D 
CaM Y99E N111D-iNOS Peptide Assigned Chemical Shift
_Residue_seq_code 
_Residue_label 
_Atom_name 
_Atom_type 
_Chem_shift_value 
 2ASP H H 8.596 
 2ASP HA H 4.685 
 2ASP N N 120.326 
 3GLN H H 8.279 
 3GLN HA H 4.345 
 3GLN N N 119.614 
 4LEU H H 7.598 
 4LEU HA H 4.666 
 4LEU N N 120.715 
 5THR H H 8.647 
 5THR HA H 4.403 
 5THR HB H 4.607 
 5THR HG2 H 1.282 
 5THR N N 112.651 
 6GLU H H 8.97 
 6GLU HA H 3.897 
 6GLU HB2 H 1.993 
 6GLU HB3 H 1.993 
 6GLU HG2 H 2.316 
 6GLU HG3 H 2.316 
 6GLU N N 120.228 
 7GLU H H 8.628 
 7GLU HA H 4.046 
 7GLU HB2 H 1.964 
 7GLU HB3 H 1.964 
 7GLU HG2 H 2.316 
 7GLU HG3 H 2.316 
 7GLU N N 119.446 
 8GLN H H 7.587 
 8GLN HA H 3.961 
 8GLN HB2 H 1.901 
 8GLN HB3 H 1.901 
 8GLN HG2 H 2.286 
 8GLN HG3 H 2.286 
 8GLN N N 119.987 
 9ILE H H 8.495 
 9ILE HA H 3.791 
 9ILE HB H 1.889 
 9ILE HG2 H 1.024 
 9ILE HD1 H 0.783 
 9ILE N N 120.186 
 10ALA H H 8.052 
 10ALA HA H 4.046 
 10ALA HB H 1.465 
 10ALA N N 121.495 
 11GLU H H 7.784 
 11GLU HA H 4.017 
 11GLU HB2 H 1.985 
 11GLU HB3 H 1.985 
 11GLU HG2 H 2.514 
 11GLU HG3 H 2.514 
 11GLU N N 118.214 
 12PHE H H 8.299 
 12PHE HA H 4.562 
 12PHE HB2 H 3.46 
 12PHE HB3 H 3.46 
 12PHE N N 117.041 
 13LYS H H 9.023 
 13LYS HA H 3.642 
 13LYS HB2 H 1.759 
 13LYS HB3 H 1.759 
 13LYS HG2 H 1.524 
 13LYS HG3 H 1.524 
 13LYS N N 122.853 
 14GLU H H 7.906 
 14GLU HA H 4.041 
 14GLU HB2 H 2.155 
 14GLU HB3 H 2.155 
 14GLU HG2 H 2.346 
 14GLU HG3 H 2.346 
 14GLU N N 120.28 
 15ALA H H 8.206 
 15ALA HA H 3.959 
 15ALA HB H 1.759 
 15ALA N N 123.678 
 16PHE H H 8.544 
 16PHE HA H 3.301 
 16PHE HB2 H 2.653 
 16PHE HB3 H 2.287 
 16PHE N N 118.838 
 17SER H H 7.965 
 17SER HA H 4.024 
 17SER HB2 H 4.024 
 17SER HB3 H 4.024 
 17SER N N 114.532 
 18LEU H H 7.289 
 18LEU HA H 3.897 
 18LEU HB2 H 1.649 
 18LEU HB3 H 1.649 
 18LEU HG H 1.24 
 18LEU HD1 H 0.687 
 18LEU HD2 H 0.687 
 18LEU N N 120.169 
 19PHE H H 7.093 
 19PHE HA H 4.125 
 19PHE HB2 H 2.683 
 19PHE HB3 H 2.683 
 19PHE N N 112.443 
 20ASP H H 7.547 
 20ASP HA H 4.498 
 20ASP HB2 H 2.274 
 20ASP HB3 H 2.274 
 20ASP N N 117.116 
 21LYS H H 7.617 
 21LYS HA H 3.944 
 21LYS HB2 H 1.803 
 21LYS HB3 H 1.803 
 21LYS HG2 H 1.45 
 21LYS HG3 H 1.45 
 21LYS N N 124.017 
 22ASP H H 7.93 
 22ASP HA H 4.536 
 22ASP HB2 H 2.585 
 22ASP HB3 H 3.023 
 22ASP N N 113.68 
 23GLY H H 7.598 
 23GLY HA2 H 3.833 
 23GLY HA3 H 3.833 
 23GLY N N 108.614 
 24ASP H H 8.417 
 24ASP HA H 4.472 
 24ASP HB2 H 2.995 
 24ASP HB3 H 2.995 
 24ASP N N 120.703 
 25GLY H H 10.444 
 25GLY HA2 H 3.666 
 25GLY HA3 H 4.302 
 25GLY N N 112.393 
 26THR H H 8.12 
 26THR HA H 5.452 
 26THR HG2 H 0.98 
 26THR N N 111.768 
 27ILE H H 9.846 
 27ILE HA H 4.792 
 27ILE HB H 1.7 
 27ILE N N 126.142 
 28THR H H 8.412 
 28THR HA H 4.813 
 28THR HB H 4.693 
 28THR HG2 H 1.23 
 28THR N N 116.292 
 29THR H H 9.163 
 29THR HA H 3.736 
 29THR HB H 4.155 
 29THR HG2 H 1.239 
 29THR N N 112.316 
 30LYS H H 7.575 
 30LYS HA H 4.089 
 30LYS HB2 H 1.805 
 30LYS HB3 H 1.805 
 30LYS HG2 H 1.324 
 30LYS HG3 H 1.324 
 30LYS N N 120.699 
 31GLU H H 7.653 
 31GLU HA H 4.046 
 31GLU HB2 H 1.788 
 31GLU HB3 H 1.788 
 31GLU HG2 H 2.345 
 31GLU HG3 H 2.345 
 31GLU N N 121.23 
 32LEU H H 8.793 
 32LEU HA H 4.238 
 32LEU HB2 H 1.964 
 32LEU HB3 H 1.964 
 32LEU HG H 1.436 
 32LEU N N 120.113 
 33GLY H H 8.797 
 33GLY HA2 H 4.004 
 33GLY HA3 H 3.514 
 33GLY N N 105.542 
 34THR H H 7.861 
 34THR HA H 3.897 
 34THR HB H 4.257 
 34THR HG2 H 1.252 
 34THR N N 117.079 
 35VAL H H 7.338 
 35VAL HA H 3.557 
 35VAL HB H 1.973 
 35VAL HG1 H 0.711 
 35VAL HG2 H 0.423 
 35VAL N N 121.328 
 36MET H H 8.572 
 36MET HA H 3.974 
 36MET HB2 H 1.685 
 36MET HB3 H 1.685 
 36MET HG2 H 2.067 
 36MET HG3 H 2.067 
 36MET N N 117.074 
 37ARG H H 8.369 
 37ARG HA H 4.792 
 37ARG HB2 H 1.847 
 37ARG HB3 H 1.847 
 37ARG HG2 H 2.008 
 37ARG HG3 H 2.008 
 37ARG N N 118.19 
 38SER H H 7.923 
 38SER HA H 4.209 
 38SER HB2 H 4.089 
 38SER HB3 H 4.089 
 38SER N N 117.968 
 39LEU H H 7.414 
 39LEU HA H 4.196 
 39LEU HB2 H 1.745 
 39LEU HB3 H 1.745 
 39LEU HG H 1.673 
 39LEU HD1 H 0.627 
 39LEU HD2 H 0.627 
 39LEU N N 117.716 
 40GLY H H 7.706 
 40GLY HA2 H 3.727 
 40GLY HA3 H 3.727 
 40GLY N N 106.394 
 41GLN H H 7.887 
 41GLN HA H 4.389 
 41GLN HB2 H 1.589 
 41GLN HB3 H 1.589 
 41GLN HG2 H 2.118 
 41GLN HG3 H 2.118 
 41GLN N N 118.053 
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 42ASN H H 8.64 
 42ASN HA H 5.133 
 42ASN HB2 H 2.419 
 42ASN HB3 H 2.741 
 42ASN N N 115.831 
 44THR H H 8.77 
 44THR HA H 4.36 
 44THR HB H 4.726 
 44THR HG2 H 1.282 
 44THR N N 112.903 
 45GLU H H 8.769 
 45GLU HA H 3.961 
 45GLU HB2 H 2.008 
 45GLU HB3 H 2.008 
 45GLU HG2 H 2.301 
 45GLU HG3 H 2.301 
 45GLU N N 120.256 
 46ALA H H 8.231 
 46ALA HA H 4.089 
 46ALA HB H 1.336 
 46ALA N N 120.661 
 47GLU H H 7.648 
 47GLU HA H 3.969 
 47GLU HB2 H 1.889 
 47GLU HB3 H 1.889 
 47GLU HG2 H 2.31 
 47GLU HG3 H 2.31 
 47GLU N N 118.577 
 48LEU H H 8.347 
 48LEU HA H 4.196 
 48LEU HB2 H 1.613 
 48LEU HB3 H 1.613 
 48LEU HG H 1.673 
 48LEU HD1 H 1.18 
 48LEU HD2 H 0.819 
 48LEU N N 120.102 
 49GLN H H 7.993 
 49GLN HA H 3.983 
 49GLN N N 118.06 
 50ASP H H 7.87 
 50ASP HA H 4.209 
 50ASP HB2 H 2.695 
 50ASP HB3 H 2.695 
 50ASP N N 119.027 
 51MET H H 7.906 
 51MET HA H 4.046 
 51MET HB2 H 1.769 
 51MET HB3 H 1.769 
 51MET HG2 H 1.432 
 51MET HG3 H 1.432 
 51MET N N 120.127 
 52ILE H H 7.809 
 52ILE HA H 3.488 
 52ILE HB H 2.009 
 52ILE HG12H 0.771 
 52ILE HG13H 0.771 
 52ILE HG2 H 1.228 
 52ILE HD1 H 0.675 
 52ILE N N 116.828 
 53ASN H H 8.303 
 53ASN HA H 4.6 
 53ASN HB2 H 2.903 
 53ASN HB3 H 2.903 
 53ASN N N 117.324 
 54GLU H H 7.495 
 54GLU HA H 4.005 
 54GLU HB2 H 2.058 
 54GLU HB3 H 2.058 
 54GLU HG2 H 2.322 
 54GLU HG3 H 2.322 
 54GLU N N 116.85 
 55VAL H H 7.266 
 55VAL HA H 4.089 
 55VAL HB H 2.021 
 55VAL HG1 H 1.024 
 55VAL HG2 H 1.024 
 55VAL N N 114.505 
 56ASP H H 8.017 
 56ASP HA H 4.472 
 56ASP HB2 H 2.683 
 56ASP HB3 H 2.683 
 56ASP N N 119.568 
 57ALA H H 8.225 
 57ALA HA H 4.209 
 57ALA HB H 1.465 
 57ALA N N 131.372 
 58ASP H H 8.239 
 58ASP HA H 4.564 
 58ASP HB2 H 2.976 
 58ASP HB3 H 2.976 
 58ASP N N 114.238 
 59GLY H H 7.615 
 59GLY HA2 H 3.833 
 59GLY HA3 H 3.833 
 59GLY N N 108.616 
 60ASN H H 8.193 
 60ASN HA H 4.579 
 60ASN HB2 H 2.622 
 60ASN HB3 H 3.26 
 60ASN N N 118.664 
 61GLY H H 10.347 
 61GLY HA2 H 4.259 
 61GLY HA3 H 4.259 
 61GLY N N 112.638 
 62THR H H 7.591 
 62THR HA H 4.771 
 62THR HB H 4.693 
 62THR HG2 H 1.099 
 62THR N N 108.14 
 63ILE H H 8.552 
 63ILE HA H 4.913 
 63ILE HB H 1.979 
 63ILE HG2 H 1.128 
 63ILE HD1 H 0.746 
 63ILE N N 122.617 
 64ASP H H 9.118 
 64ASP HA H 5.426 
 64ASP HB2 H 2.874 
 64ASP HB3 H 2.874 
 64ASP N N 128.589 
 65PHE H H 8.866 
 65PHE HA H 3.666 
 65PHE HB2 H 1.803 
 65PHE HB3 H 1.803 
 65PHE N N 118.902 
 67GLU H H 7.602 
 67GLU HA H 4.259 
 67GLU HB2 H 2.033 
 67GLU HB3 H 2.033 
 67GLU HG2 H 2.37 
 67GLU HG3 H 2.37 
 67GLU N N 118.591 
 68PHE H H 8.157 
 68PHE HA H 3.768 
 68PHE HB2 H 3.372 
 68PHE HB3 H 3.372 
 68PHE N N 123.063 
 69LEU H H 8.746 
 69LEU HA H 3.131 
 69LEU N N 119.516 
 70THR H H 7.992 
 70THR HA H 3.642 
 70THR HB H 4.024 
 70THR HG2 H 1.13 
 70THR N N 113.666 
 71MET H H 7.23 
 71MET HA H 4.046 
 71MET HB2 H 1.901 
 71MET HB3 H 1.901 
 71MET HG2 H 2.118 
 71MET HG3 H 2.118 
 71MET N N 119.457 
 72MET H H 7.834 
 72MET HA H 3.969 
 72MET HB2 H 1.877 
 72MET HB3 H 1.877 
 72MET HG2 H 2.154 
 72MET HG3 H 2.154 
 72MET N N 116.203 
 73ALA H H 8.421 
 73ALA HA H 3.919 
 73ALA HB H 1.24 
 73ALA N N 119.949 
 74ARG H H 7.37 
 74ARG HA H 4.032 
 74ARG HB2 H 1.865 
 74ARG HB3 H 1.865 
 74ARG HG2 H 1.649 
 74ARG HG3 H 1.649 
 74ARG N N 116.307 
 75LYS H H 7.863 
 75LYS HA H 4.329 
 75LYS N N 120.043 
 76MET H H 8.075 
 76MET HA H 4.302 
 76MET HB2 H 2.1 
 76MET HB3 H 2.1 
 76MET HG2 H 2.788 
 76MET HG3 H 2.788 
 76MET N N 116.94 
 77LYS H H 7.37 
 77LYS HA H 4.355 
 77LYS HB2 H 1.469 
 77LYS HB3 H 1.469 
 77LYS HG2 H 1.24 
 77LYS HG3 H 1.24 
 77LYS N N 116.565 
 78ASP H H 8.258 
 78ASP HA H 4.605 
 78ASP HB2 H 1.656 
 78ASP HB3 H 1.656 
 78ASP N N 123.077 
 79THR H H 8.448 
 79THR HA H 4.174 
 79THR HB H 4.663 
 79THR HG2 H 1.274 
 79THR N N 114.285 
 80ASP H H 8.341 
 80ASP HA H 4.762 
 80ASP HB2 H 2.731 
 80ASP HB3 H 2.731 
 80ASP N N 120.76 
 81SER H H 7.899 
 81SER HA H 4.321 
 81SER HB2 H 4.024 
 81SER HB3 H 4.024 
 81SER N N 115.676 
 82GLU H H 8.306 
 82GLU HA H 4.047 
 82GLU HB2 H 2.052 
 82GLU HB3 H 2.052 
 82GLU HG2 H 2.272 
 82GLU HG3 H 2.272 
 82GLU N N 122.016 
 83GLU H H 8.02 
 83GLU HA H 3.919 
 83GLU N N 118.018 
 84GLU H H 8.222 
 84GLU HA H 4.161 
 84GLU HB2 H 1.396 
 84GLU HB3 H 1.396 
 84GLU HG2 H 1.865 
 84GLU HG3 H 1.865 
 84GLU N N 118.594 
 85ILE H H 7.858 
 85ILE HA H 3.849 
 85ILE HB H 1.853 
 85ILE HG12H 1.661 
 85ILE HG13H 1.661 
 85ILE HD1 H 0.723 
 85ILE N N 119.119 
 86ARG H H 8.295 
 86ARG HA H 4.053 
 86ARG HB2 H 1.781 
 86ARG HB3 H 1.781 
 86ARG HG2 H 1.396 
 86ARG HG3 H 1.396 
 86ARG N N 120.605 
 87GLU H H 7.899 
 87GLU HA H 3.909 
 87GLU HB2 H 2.125 
 87GLU HB3 H 2.125 
 87GLU HG2 H 2.301 
 87GLU HG3 H 2.301 
 87GLU N N 119.503 
 88ALA H H 8.356 
 88ALA HA H 4.165 
 88ALA HB H 1.729 
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 88ALA N N 122.323 
 89PHE H H 8.542 
 89PHE HA H 3.27 
 89PHE HB2 H 2.668 
 89PHE HB3 H 2.301 
 89PHE N N 119.005 
 90ARG H H 7.91 
 90ARG HA H 3.74 
 90ARG HB2 H 1.889 
 90ARG HB3 H 1.889 
 90ARG HG2 H 1.685 
 90ARG HG3 H 1.685 
 90ARG N N 117.149 
 91VAL H H 7.33 
 91VAL HA H 3.356 
 91VAL HB H 2.154 
 91VAL HG1 H 0.868 
 91VAL HG2 H 0.423 
 91VAL N N 118.456 
 92PHE H H 6.748 
 92PHE HA H 3.957 
 92PHE HB2 H 2.634 
 92PHE HB3 H 2.634 
 92PHE N N 112.806 
 93ASP H H 7.945 
 93ASP HA H 4.558 
 93ASP HB2 H 2.115 
 93ASP HB3 H 2.616 
 93ASP N N 116.493 
 94LYS H H 7.769 
 94LYS HA H 3.856 
 94LYS HB2 H 1.744 
 94LYS HB3 H 1.744 
 94LYS HG2 H 1.348 
 94LYS HG3 H 1.348 
 94LYS N N 124.188 
 95ASP H H 8.133 
 95ASP HA H 4.508 
 95ASP HB2 H 3.007 
 95ASP HB3 H 3.007 
 95ASP N N 113.847 
 96GLY H H 7.645 
 96GLY HA2 H 4.252 
 96GLY HA3 H 4.252 
 96GLY N N 108.775 
 97ASN H H 8.278 
 97ASN HA H 4.664 
 97ASN N N 119.457 
 98GLY H H 10.587 
 98GLY HA2 H 3.636 
 98GLY HA3 H 4.259 
 98GLY N N 112.949 
 99GLU H H 7.447 
 99GLU HA H 4.942 
 99GLU HG3 H 2.118 
 99GLU HB2 H 1.586 
 99GLU N N 116.565 
 100ILE H H 9.856 
 100ILE HA H 4.558 
 100ILE HB H 1.773 
 100ILE HG2 H 0.79 
 100ILE N N 127.273 
 101SER H H 8.944 
 101SER HA H 4.813 
 101SER HB2 H 3.915 
 101SER HB3 H 3.915 
 101SER N N 123.267 
 102ALA H H 9.278 
 102ALA HA H 3.897 
 102ALA HB H 1.436 
 102ALA N N 122.805 
 103ALA H H 8.093 
 103ALA HA H 3.885 
 103ALA HB H 1.18 
 103ALA N N 117.991 
 104GLU H H 7.901 
 104GLU HA H 3.94 
 104GLU HB2 H 1.781 
 104GLU HB3 H 1.781 
 104GLU HG2 H 2.118 
 104GLU HG3 H 2.118 
 104GLU N N 119.736 
 105LEU H H 8.377 
 105LEU HA H 4.173 
 105LEU HB2 H 1.925 
 105LEU HB3 H 1.925 
 105LEU HG H 1.408 
 105LEU HD1 H 0.952 
 105LEU N N 120.746 
 106ARG H H 8.914 
 106ARG HA H 3.724 
 106ARG HB2 H 1.935 
 106ARG HB3 H 1.935 
 106ARG HG2 H 1.45 
 106ARG N N 118.469 
 107HIS H H 8.094 
 107HIS HA H 4.305 
 107HIS HB2 H 3.404 
 107HIS HB3 H 3.404 
 107HIS N N 118.94 
 108VAL H H 7.776 
 108VAL HA H 3.38 
 108VAL HB H 1.481 
 108VAL HG1 H 0.615 
 108VAL HG2 H 0.615 
 108VAL N N 117.624 
 109MET H H 8.078 
 109MET HA H 4.196 
 109MET HB2 H 2.006 
 109MET HB3 H 2.006 
 109MET HG2 H 2.491 
 109MET HG3 H 2.491 
 109MET N N 115.355 
 110THR H H 8.646 
 110THR HA H 3.988 
 110THR HB H 4.297 
 110THR HG2 H 1.172 
 110THR N N 116.934 
 111ASP H H 8.371 
 111ASP HA H 4.399 
 111ASP HB2 H 2.918 
 111ASP HB3 H 2.918 
 111ASP N N 126.414 
 112LEU H H 7.74 
 112LEU HA H 4.173 
 112LEU HB2 H 1.877 
 112LEU HB3 H 1.877 
 112LEU HG H 1.637 
 112LEU HD1 H 0.699 
 112LEU HD2 H 0.699 
 112LEU N N 118.812 
 113GLY H H 7.951 
 113GLY HA2 H 4.217 
 113GLY HA3 H 4.217 
 113GLY N N 107.595 
 114GLU H H 7.997 
 114GLU HA H 3.776 
 114GLU HB2 H 1.913 
 114GLU HB3 H 1.913 
 114GLU HG2 H 2.07 
 114GLU HG3 H 2.07 
 114GLU N N 120.265 
 115LYS H H 8.464 
 115LYS HA H 4.366 
 115LYS HB2 H 1.641 
 115LYS HB3 H 1.641 
 115LYS HG2 H 1.26 
 115LYS HG3 H 1.26 
 115LYS N N 123.622 
 116LEU H H 8.092 
 116LEU HA H 4.751 
 116LEU HB2 H 1.48 
 116LEU HB3 H 1.48 
 116LEU HG H 1.553 
 116LEU HD1 H 0.776 
 116LEU HD2 H 0.776 
 116LEU N N 124.962 
 117THR H H 8.965 
 117THR HA H 4.435 
 117THR HB H 4.726 
 117THR HG2 H 1.25 
 117THR N N 113.14 
 118ASP H H 8.83 
 118ASP HA H 4.179 
 118ASP HB2 H 2.595 
 118ASP HB3 H 2.595 
 118ASP N N 120.745 
 119GLU H H 8.604 
 119GLU HA H 4.068 
 119GLU HB2 H 1.964 
 119GLU HB3 H 1.964 
 119GLU HG2 H 2.316 
 119GLU HG3 H 2.316 
 119GLU N N 118.999 
 121VAL H H 7.961 
 121VAL HA H 3.62 
 121VAL HB H 2.178 
 121VAL HG1 H 0.964 
 121VAL HG2 H 0.964 
 121VAL N N 120.225 
 122ASP H H 7.985 
 122ASP HA H 4.341 
 122ASP HB2 H 2.695 
 122ASP HB3 H 2.695 
 122ASP N N 119.975 
 123GLU H H 8.049 
 123GLU HA H 3.945 
 123GLU HB2 H 2.021 
 123GLU HB3 H 2.021 
 123GLU HG2 H 2.274 
 123GLU HG3 H 2.274 
 123GLU N N 119.554 
 124MET H H 7.725 
 124MET HA H 3.849 
 124MET HB2 H 1.901 
 124MET HB3 H 1.901 
 124MET HG2 H 2.43 
 124MET HG3 H 2.43 
 124MET N N 119.025 
 125ILE H H 7.776 
 125ILE HA H 3.407 
 125ILE HB H 2.058 
 125ILE HG12H 0.639 
 125ILE HG13H 0.639 
 125ILE HG2 H 1.18 
 125ILE HD1 H 0.603 
 125ILE N N 117.431 
 126ARG H H 8.049 
 126ARG HA H 3.704 
 126ARG HB2 H 2.045 
 126ARG HB3 H 2.045 
 126ARG N N 118.591 
 127GLU H H 7.412 
 127GLU HA H 3.915 
 127GLU HB2 H 1.865 
 127GLU HB3 H 1.865 
 127GLU HG2 H 2.142 
 127GLU HG3 H 2.142 
 127GLU N N 116.166 
 128ALA H H 7.168 
 128ALA HA H 4.558 
 128ALA HB H 1.336 
 128ALA N N 116.836 
 129ASP H H 7.661 
 129ASP HA H 4.387 
 129ASP HB2 H 2.31 
 129ASP HB3 H 2.647 
 129ASP N N 117.725 
 130ILE H H 8.314 
 130ILE HA H 3.871 
 130ILE HB H 1.935 
 130ILE HG12H 0.82 
 130ILE HG13H 0.82 
 130ILE HG2 H 1.612 
 130ILE N N 128.275 
 131ASP H H 8.331 
 131ASP HA H 4.458 
 131ASP HB2 H 2.595 
 131ASP HB3 H 2.595 
 131ASP N N 116.646 
 132GLY H H 7.587 
 132GLY HA2 H 3.842 
 132GLY HA3 H 3.842 
 132GLY N N 108.275 
 133ASP H H 8.331 
 133ASP HA H 4.426 
 133ASP HB2 H 2.454 
 133ASP HB3 H 2.454 
 202 
 
 133ASP N N 120.427 
 134GLY H H 10.15 
 134GLY HA2 H 3.343 
 134GLY HA3 H 4.005 
 134GLY N N 112.494 
 135GLN H H 7.822 
 135GLN HA H 4.918 
 135GLN HB2 H 1.773 
 135GLN HB3 H 1.773 
 135GLN HG2 H 1.891 
 135GLN HG3 H 1.891 
 135GLN N N 116.033 
 136VAL H H 8.888 
 136VAL HA H 5.015 
 136VAL HB H 2.096 
 136VAL HG1 H 1.113 
 136VAL HG2 H 0.776 
 136VAL N N 124.308 
 137ASN H H 9.381 
 137ASN HA H 5.324 
 137ASN HB2 H 3.284 
 137ASN HB3 H 3.284 
 137ASN N N 127.502 
 138TYR H H 8.082 
 138TYR HA H 4.414 
 138TYR N N 120.057 
 139GLU H H 8.029 
 139GLU HA H 3.812 
 139GLU HB2 H 2.081 
 139GLU HB3 H 2.081 
 139GLU HG2 H 2.331 
 139GLU HG3 H 2.331 
 139GLU N N 118.147 
 140GLU H H 8.739 
 140GLU HA H 3.855 
 140GLU HB2 H 2.081 
 140GLU HB3 H 2.081 
 140GLU HG2 H 2.345 
 140GLU HG3 H 2.345 
 140GLU N N 120.005 
 141PHE H H 8.582 
 141PHE HA H 3.812 
 141PHE HB2 H 3.02 
 141PHE HB3 H 3.358 
 141PHE N N 123.762 
 142VAL H H 8.601 
 142VAL HA H 3.237 
 142VAL HB H 1.759 
 142VAL HG1 H 0.776 
 142VAL HG2 H 0.512 
 142VAL N N 118.506 
 143GLN H H 7.848 
 143GLN HA H 3.812 
 143GLN HB2 H 2.07 
 143GLN HB3 H 2.07 
 143GLN HG2 H 2.322 
 143GLN HG3 H 2.322 
 143GLN N N 119.26 
 144MET H H 7.444 
 144MET HA H 4.053 
 144MET HB2 H 1.565 
 144MET HB3 H 1.565 
 144MET HG2 H 1.565 
 144MET HG3 H 1.565 
 144MET N N 116.781 
 145MET H H 7.569 
 145MET HA H 4.149 
 145MET HB2 H 1.889 
 145MET HB3 H 1.889 
 145MET N N 114.826 
 146THR H H 7.65 
 146THR HA H 4.274 
 146THR HG2 H 1.099 
 146THR N N 108.642 
 147ALA H H 7.689 
 147ALA HA H 4.267 
 147ALA HB H 1.362 
 147ALA N N 126.536 
 148LYS H H 7.884 
 148LYS HA H 4.077 
 148LYS HB2 H 1.685 
 148LYS HB3 H 1.685 
 148LYS HG2 H 1.333 
 148LYS HG3 H 1.333 
 148LYS N N 125.902 
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Appendix E 
CaM1234 Assigned Chemical Shifts 
_Residue_seq_code 
_Residue_label 
_Atom_name 
_Atom_type 
_Chem_shift_value 
 3GLN CA C 52.566 
 3GLN CB C 27.393 
 3GLN H H 8.115 
 3GLN HA H 4.369 
 3GLN HB2 H 1.894 
 3GLN HB3 H 1.894 
 3GLN N N 118.296 
 4LEU CA C 51.624 
 4LEU CB C 40.532 
 4LEU H H 8.231 
 4LEU HA H 4.492 
 4LEU HB2 H 1.665 
 4LEU HB3 H 1.665 
 4LEU HG H 1.279 
 4LEU HD1 H 0.805 
 4LEU HD2 H 0.805  
 4LEU N N 121.564 
 5THR CA C 57.548 
 5THR CB C 68.371 
 5THR H H 8.672 
 5THR HA H 4.439 
 5THR HB H 4.58 
 5THR HG2 H 1.139 
 5THR N N 112.706 
 6GLU CA C 57.414 
 6GLU CB C 26.291 
 6GLU H H 8.952 
 6GLU HA H 3.913 
 6GLU HB2 H 1.999 
 6GLU HB3 H 1.999 
 6GLU N N 120.025 
 7GLU CA C 57.38 
 7GLU CB C 26.055 
 7GLU H H 8.652 
 7GLU HA H 3.93 
 7GLU HB2 H 1.964 
 7GLU HB3 H 1.964 
 7GLU N N 119.114 
 8GLN CA C 55.899 
 8GLN CB C 26.213 
 8GLN H H 7.657 
 8GLN HA H 3.86 
 8GLN HB2 H 2.139 
 8GLN HB3 H 2.139 
 8GLN N N 120.294 
 9ILE CA C 64.012 
 9ILE CB C 35.181 
 9ILE H H 8.18 
 9ILE HA H 3.386 
 9ILE HB H 1.736 
 9ILE HG12 H 0.928 
 9ILE HG13 H 0.928 
 9ILE HG2 H 0.787 
 9ILE HD1 H 0.682 
 9ILE N N 118.311 
 10ALA CA C 52.634 
 10ALA CB C 15.041 
 10ALA H H 7.85 
 10ALA HA H 4.141 
 10ALA HB H 1.455 
 10ALA N N 120.211 
 11GLU CA C 56.64 
 11GLU CB C 26.449 
 11GLU H H 7.714 
 11GLU HA H 4.141 
 11GLU HB2 H 2.016 
 11GLU HB3 H 2.016 
 11GLU N N 119.943 
 12PHE CA C 55.663 
 12PHE CB C 34.08 
 12PHE H H 8.736 
 12PHE HA H 4.738 
 12PHE HB2 H 3.491 
 12PHE HB3 H 3.491 
 12PHE N N 119.942 
 13LYS CA C 57.144 
 13LYS CB C 29.281 
 13LYS H H 9.187 
 13LYS HA H 3.737 
 13LYS HB2 H 1.964 
 13LYS HB3 H 1.964 
 13LYS HG2 H 1.718 
 13LYS HG3 H 1.718 
 13LYS N N 121.35 
 14GLU CA C 56.774 
 14GLU CB C 26.37 
 14GLU H H 7.986 
 14GLU HA H 4.018 
 14GLU HB2 H 2.21 
 14GLU HB3 H 2.21 
 14GLU N N 120.528 
 15ALA CA C 52.364 
 15ALA CB C 16.379 
 15ALA H H 7.582 
 15ALA HA H 4.088 
 15ALA HB H 1.613 
 15ALA N N 120.583 
 16PHE CA C 59.4 
 16PHE CB C 37.935 
 16PHE H H 8.581 
 16PHE HA H 3.702 
 16PHE HB2 H 2.982 
 16PHE HB3 H 2.982 
 16PHE N N 117.456 
 17SER CA C 58.895 
 17SER CB C 60.309 
 17SER H H 8.345 
 17SER HA H 4.018 
 17SER N N 111.656 
 18LEU CA C 54.418 
 18LEU CB C 38.879 
 18LEU H H 7.261 
 18LEU HA H 3.913 
 18LEU HB2 H 1.7 
 18LEU HB3 H 1.7 
 18LEU HG H 1.49 
 18LEU HD1 H 0.752 
 18LEU HD2 H 0.752 
 18LEU N N 120.546 
 19PHE CA C 55.764 
 19PHE CB C 38.171 
 19PHE H H 7.056 
 19PHE HA H 4.123 
 19PHE HB2 H 2.912 
 19PHE HB3 H 2.912 
 19PHE N N 113.968 
 21LYS CA C 54.485 
 21LYS CB C 29.91 
 21LYS H H 8.363 
 21LYS HA H 4.053 
 21LYS HB2 H 1.753 
 21LYS HB3 H 1.753 
 21LYS N N 121.213 
 22ASP CA C 52.701 
 22ASP CB C 38.221 
 22ASP H H 8.494 
 22ASP HA H 4.633 
 22ASP HB2 H 2.561 
 22ASP HB3 H 2.561 
 22ASP N N 122.069 
 23GLY CA C 43.517 
 23GLY H H 8.351 
 23GLY HA2 H 3.895 
 23GLY HA3 H 3.895 
 23GLY N N 109.345 
 24ASP CA C 51.624 
 24ASP CB C 38.596 
 24ASP H H 7.985 
 24ASP HA H 4.685 
 24ASP HB2 H 2.701 
 24ASP HB3 H 2.701 
 24ASP N N 119.784 
 25GLY CA C 43.57 
 25GLY H H 8.322 
 25GLY HA2 H 3.983 
 25GLY HA3 H 3.983 
 25GLY N N 106.551 
 26THR CA C 57.043 
 26THR CB C 70.033 
 26THR H H 7.523 
 26THR HA H 5.23 
 26THR HB H 4.018 
 26THR HG2 H 0.963 
 26THR N N 107.782 
 27ILE CA C 56.808 
 27ILE CB C 37.847 
 27ILE H H 8.432 
 27ILE HA H 4.72 
 27ILE HB H 1.753 
 27ILE HG12 H 1.103 
 27ILE HG13 H 1.103 
 27ILE HG2 H 0.805 
 27ILE HD1 H 0.577 
 27ILE N N 111.325 
 28THR CA C 57.785 
 28THR CB C 68.629 
 28THR H H 8.538 
 28THR HA H 4.896 
 28THR HB H 3.948 
 28THR HG2 H 1.121 
 28THR N N 110.566 
 29THR CA C 62.77 
 29THR CB C 64.887 
 29THR H H 8.215 
 29THR HA H 3.72 
 29THR HB H 4.72 
 29THR HG2 H 1.209 
 29THR N N 110.671 
 30LYS CA C 55.697 
 30LYS CB C 29.36 
 30LYS H H 7.571 
 30LYS HA H 4.123 
 30LYS HB2 H 1.841 
 30LYS HB3 H 1.841 
 30LYS HG2 H 1.542 
 30LYS HG3 H 1.542 
 30LYS N N 119.083 
 31GLU CA C 54.115 
 31GLU CB C 27.235 
 31GLU H H 7.478 
 31GLU HA H 4.018 
 31GLU HB2 H 1.911 
 31GLU HB3 H 1.911 
 31GLU HG2 H 2.157 
 31GLU HG3 H 2.157 
 31GLU N N 118.126 
 32LEU CA C 55.865 
 32LEU CB C 39.033 
 32LEU H H 7.37 
 32LEU HA H 3.807 
 32LEU HB2 H 1.771 
 32LEU HB3 H 1.771 
 32LEU HG H 1.244 
 32LEU HD1 H 0.735 
 32LEU N N 120.459 
 33GLY CA C 45.32 
 33GLY H H 8.523 
 33GLY HA2 H 3.737 
 33GLY HA3 H 3.351 
 33GLY N N 104.903 
 34THR CA C 63.608 
 34THR CB C 65.526 
 34THR H H 7.385 
 34THR HA H 3.737 
 34THR HB H 4.001 
 34THR HG2 H 1.068 
 34THR N N 118.195 
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 35VAL CA C 63.709 
 35VAL CB C 28.415 
 35VAL H H 7.93 
 35VAL HA H 3.175 
 35VAL HB H 1.876 
 35VAL HG1 H 0.7 
 35VAL HG2 H 0.471 
 35VAL N N 122.39 
 36MET CA C 57.515 
 36MET CB C 29.045 
 36MET H H 8.353 
 36MET HA H 3.913 
 36MET HB2 H 1.929 
 36MET HB3 H 1.929 
 36MET HG2 H 2.052 
 36MET HG3 H 2.052 
 36MET N N 118.092 
 37ARG CA C 56.505 
 37ARG CB C 27.078 
 37ARG H H 8.422 
 37ARG HA H 4.633 
 37ARG HB2 H 1.823 
 37ARG HB3 H 1.823 
 37ARG HG2 H 1.595 
 37ARG HG3 H 1.595 
 37ARG N N 119.169 
 38SER CA C 59.03 
 38SER CB C 60.208 
 38SER H H 8.001 
 38SER HA H 4.176 
 38SER N N 118.814 
 39LEU CA C 51.826 
 39LEU CB C 39.97 
 39LEU H H 7.261 
 39LEU HA H 4.65 
 39LEU HB2 H 1.858 
 39LEU HB3 H 1.858 
 39LEU HG H 1.7 
 39LEU HD1 H 0.928 
 39LEU N N 120.675 
 40GLY CA C 42.969 
 40GLY H H 7.859 
 40GLY HA2 H 4.334 
 40GLY HA3 H 3.755 
 40GLY N N 106.965 
 41GLN CA C 51.355 
 41GLN CB C 27.235 
 41GLN H H 7.673 
 41GLN HA H 4.334 
 41GLN HB2 H 1.718 
 41GLN HB3 H 1.718 
 41GLN HG2 H 1.981 
 41GLN HG3 H 1.981 
 41GLN N N 117.583 
 42ASN CA C 48.325 
 42ASN H H 8.605 
 42ASN HA H 5.107 
 42ASN HB2 H 2.631 
 42ASN HB3 H 2.631 
 42ASN N N 116.352 
 44THR CA C 57.851 
 44THR CB C 68.145 
 44THR H H 8.68 
 44THR HA H 4.29 
 44THR HB H 4.613 
 44THR HG2 H 1.181 
 44THR N N 112.844 
 45GLU CA C 57.212 
 45GLU CB C 26.134 
 45GLU H H 8.777 
 45GLU HA H 3.817 
 45GLU HB2 H 1.977 
 45GLU HB3 H 1.977 
 45GLU HG2 H 2.2 
 45GLU HG3 H 2.2 
 45GLU N N 120.218 
 46ALA CA C 52.23 
 46ALA CB C 15.356 
 46ALA H H 8.245 
 46ALA HA H 4.016 
 46ALA HB H 1.38 
 46ALA N N 120.747 
 47GLU CA C 56.168 
 47GLU CB C 27.078 
 47GLU H H 7.669 
 47GLU HA H 3.991 
 47GLU HB2 H 1.877 
 47GLU HB3 H 1.877 
 47GLU HG2 H 2.176 
 47GLU HG3 H 2.176 
 47GLU N N 118.663 
 48LEU CA C 55.394 
 48LEU CB C 38.958 
 48LEU H H 8.175 
 48LEU HA H 3.966 
 48LEU HB2 H 1.504 
 48LEU HB3 H 1.504 
 48LEU HG H 1.628 
 48LEU HD1 H 0.708 
 48LEU HD2 H 0.708 
 48LEU N N 119.754 
 49GLN CA C 55.899 
 49GLN CB C 25.269 
 49GLN H H 7.979 
 49GLN HA H 3.867 
 49GLN HB2 H 1.943 
 49GLN HB3 H 1.943 
 49GLN HG2 H 2.18 
 49GLN HG3 H 2.18 
 49GLN N N 117.263 
 50ASP CA C 54.721 
 50ASP CB C 37.62 
 50ASP H H 7.829 
 50ASP HA H 4.086 
 50ASP HB2 H 2.652 
 50ASP HB3 H 2.652 
 50ASP N N 118.83 
 51MET CA C 57.01 
 51MET CB C 31.09 
 51MET H H 7.829 
 51MET HA H 4.002 
 51MET HB2 H 2.146 
 51MET HB3 H 2.146 
 51MET HG2 H 1.91 
 51MET HG3 H 1.91 
 51MET N N 118.63 
 52ILE CA C 62.463 
 52ILE CB C 35.181 
 52ILE H H 8.132 
 52ILE HB H 1.859 
 52ILE HG2 H 0.813 
 52ILE HD1 H 0.728 
 52ILE N N 118.575 
 53ASN CA C 52.6 
 53ASN CB C 35.26 
 53ASN H H 8.23 
 53ASN HA H 4.356 
 53ASN HB2 H 2.821 
 53ASN HB3 H 2.821 
 53ASN N N 117.456 
 54GLU CA C 55.63 
 54GLU CB C 27.235 
 54GLU H H 7.656 
 54GLU HA H 4.103 
 54GLU HB2 H 2.011 
 54GLU HB3 H 2.011 
 54GLU HG2 H 2.163 
 54GLU HG3 H 2.163 
 54GLU N N 117.344 
 55VAL CA C 59.905 
 55VAL CB C 29.989 
 55VAL H H 7.46 
 55VAL HA H 4.187 
 55VAL HB H 2.095 
 55VAL HG1 H 0.88 
 55VAL HG2 H 0.745 
 55VAL N N 113.904 
 57ALA CA C 51.22 
 57ALA CB C 16.143 
 57ALA H H 8.152 
 57ALA HA H 4.187 
 57ALA HB H 1.353 
 57ALA N N 123.284 
 58ASP CA C 51.258 
 58ASP CB C 38.097 
 58ASP H H 8.239 
 58ASP HA H 4.677 
 58ASP HB2 H 2.652 
 58ASP HB3 H 2.652 
 58ASP N N 116.241 
 59GLY CA C 43.151 
 59GLY H H 7.986 
 59GLY HA2 H 3.901 
 59GLY HA3 H 3.901 
 59GLY N N 107.441 
 60ASN CA C 50.345 
 60ASN CB C 35.974 
 60ASN H H 8.341 
 60ASN HA H 4.677 
 60ASN HB2 H 2.821 
 60ASN HB3 H 2.821 
 60ASN N N 118.036 
 61GLY CA C 43.099 
 61GLY H H 8.451 
 61GLY HA2 H 4.002 
 61GLY HA3 H 4.002 
 61GLY N N 107.713 
 62THR CA C 57.414 
 62THR CB C 69.599 
 62THR H H 7.696 
 62THR HA H 5.115 
 62THR HB H 4.069 
 62THR HG2 H 0.998 
 62THR N N 111.076 
 63ILE CA C 57.515 
 63ILE CB C 38.722 
 63ILE H H 8.978 
 63ILE HA H 4.575 
 63ILE HB H 1.791 
 63ILE HG2 H 1.1 
 63ILE HD1 H 0.897 
 63ILE N N 120.045 
 64ASP CA C 48.998 
 64ASP CB C 39.102 
 64ASP H H 8.42 
 64ASP HA H 5.183 
 64ASP HB2 H 2.551 
 64ASP HB3 H 2.551 
 64ASP N N 124.941 
 65PHE CA C 60.107 
 65PHE H H 8.92 
 65PHE HA H 3.715 
 65PHE HB2 H 1.876 
 65PHE HB3 H 1.876 
 65PHE N N 118.092 
 67GLU CA C 56.438 
 67GLU CB C 26.527 
 67GLU H H 8.027 
 67GLU HA H 3.868 
 67GLU HB2 H 1.859 
 67GLU HB3 H 1.859 
 67GLU HG2 H 2.276 
 67GLU HG3 H 2.276 
 67GLU N N 117.856 
 68PHE CA C 58.525 
 68PHE CB C 36.676 
 68PHE H H 8.464 
 68PHE HA H 3.976 
 68PHE HB2 H 2.999 
 68PHE HB3 H 2.999 
 68PHE N N 122.207 
 69LEU CA C 54.99 
 69LEU CB C 38.171 
 69LEU H H 8.404 
 69LEU HA H 3.216 
 69LEU HB2 H 1.299 
 69LEU HB3 H 1.299 
 69LEU HD1 H 0.647 
 69LEU HD2 H 0.828 
 69LEU N N 118.368 
 70THR CA C 63.911 
 70THR CB C 65.526 
 70THR H H 7.646 
 70THR HA H 3.741 
 70THR HB H 3.994 
 70THR HG2 H 1.063 
 70THR N N 115.827 
 71MET CA C 56.741 
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 71MET CB C 29.596 
 71MET H H 7.795 
 71MET HA H 3.994 
 71MET HB2 H 1.787 
 71MET HB3 H 1.787 
 71MET HG2 H 2.058 
 71MET HG3 H 2.058 
 71MET N N 120.865 
 72MET CA C 53.172 
 72MET CB C 28.551 
 72MET H H 7.968 
 72MET HA H 4.049 
 72MET HB2 H 1.787 
 72MET HB3 H 1.787 
 72MET HG2 H 2.312 
 72MET HG3 H 2.312 
 72MET N N 117.111 
 73ALA CA C 52.061 
 73ALA CB C 15.12 
 73ALA H H 8.24 
 73ALA HA H 4.049 
 73ALA HB H 1.281 
 73ALA N N 121.186 
 74ARG CA C 55.798 
 74ARG CB C 27.235 
 74ARG H H 7.408 
 74ARG HA H 3.886 
 74ARG HB2 H 1.751 
 74ARG HB3 H 1.751 
 74ARG HG2 H 1.896 
 74ARG HG3 H 1.896 
 74ARG N N 116.472 
 75LYS CA C 53.947 
 75LYS CB C 28.966 
 75LYS H H 7.617 
 75LYS HA H 4.139 
 75LYS HB2 H 1.715 
 75LYS HB3 H 1.715 
 75LYS N N 118.285 
 76MET CA C 53.677 
 76MET CB C 29.91 
 76MET H H 7.878 
 76MET HA H 4.157 
 76MET HB2 H 1.95 
 76MET HB3 H 1.95 
 76MET N N 117.498 
 77LYS CA C 54.216 
 77LYS CB C 29.989 
 77LYS H H 7.642 
 77LYS HA H 4.248 
 77LYS HB2 H 1.896 
 77LYS HB3 H 1.896 
 77LYS N N 120.321 
 78ASP CA C 52.061 
 78ASP CB C 38.171 
 78ASP H H 8.219 
 78ASP HA H 4.646 
 78ASP HB2 H 2.692 
 78ASP HB3 H 2.692 
 78ASP N N 121.295 
 79THR CA C 59.77 
 79THR CB C 66.965 
 79THR H H 8.039 
 79THR HA H 4.193 
 79THR HB H 4.338 
 79THR HG2 H 1.154 
 79THR N N 114.252 
 80ASP CA C 52.061 
 80ASP CB C 38.327 
 80ASP H H 8.359 
 80ASP HA H 4.664 
 80ASP HB2 H 2.619 
 80ASP HB3 H 2.619 
 80ASP N N 122.925 
 81SER CA C 56.842 
 81SER CB C 60.907 
 81SER H H 8.329 
 81SER HA H 4.302 
 81SER HB2 H 3.741 
 81SER HB3 H 3.741 
 81SER N N 116.628 
 82GLU CA C 55.529 
 82GLU CB C 26.921 
 82GLU H H 8.353 
 82GLU HA H 4.049 
 82GLU HB2 H 1.841 
 82GLU HB3 H 1.841 
 82GLU HG2 H 2.131 
 82GLU HG3 H 2.131 
 82GLU N N 121.876 
 83GLU CA C 55.773 
 83GLU CB C 26.527 
 83GLU H H 8.129 
 83GLU HA H 3.994 
 83GLU HB2 H 1.805 
 83GLU HB3 H 1.805 
 83GLU HG2 H 2.058 
 83GLU HG3 H 2.058 
 83GLU N N 119.886 
 84GLU CA C 55.865 
 84GLU CB C 26.921 
 84GLU H H 7.9 
 84GLU HA H 3.976 
 84GLU HB2 H 1.859 
 84GLU HB3 H 1.859 
 84GLU N N 118.973 
 85ILE CA C 60.881 
 85ILE CB C 36.125 
 85ILE H H 7.97 
 85ILE HA H 3.759 
 85ILE HB H 1.914 
 85ILE HG2 H 0.919 
 85ILE HD1 H 0.702 
 85ILE N N 120.87 
 86ARG CA C 56.37 
 86ARG CB C 29.832 
 86ARG H H 8.179 
 86ARG HA H 4.03 
 86ARG N N 121.318 
 87GLU CA C 55.36 
 87GLU CB C 26.685 
 87GLU H H 8.265 
 87GLU HA H 3.94 
 87GLU HB2 H 1.823 
 87GLU HB3 H 1.823 
 87GLU HG2 H 2.058 
 87GLU HG3 H 2.058 
 87GLU N N 119.274 
 88ALA CA C 51.523 
 88ALA CB C 15.592 
 88ALA H H 7.857 
 88ALA HA H 4.012 
 88ALA HB H 1.552 
 88ALA N N 122.158 
 89PHE CA C 57.097 
 89PHE H H 7.882 
 89PHE HA H 2.981 
 89PHE HB2 H 2.782 
 89PHE HB3 H 2.782 
 89PHE N N 115.965 
 91VAL CA C 62.548 
 91VAL H H 7.924 
 91VAL HA H 3.506 
 91VAL HB H 1.841 
 91VAL HG1 H 0.846 
 91VAL HG2 H 0.846 
 91VAL N N 119.084 
 92PHE CA C 55.836 
 92PHE CB C 36.833 
 92PHE H H 6.854 
 92PHE HA H 4.266 
 92PHE HB2 H 2.728 
 92PHE HB3 H 2.728 
 92PHE N N 112.485 
 94LYS CA C 54.855 
 94LYS CB C 29.832 
 94LYS H H 7.811 
 94LYS N N 125.896 
 95ASP CA C 51.826 
 95ASP CB C 38.159 
 95ASP H H 8.266 
 95ASP HA H 4.664 
 95ASP HB2 H 2.71 
 95ASP HB3 H 2.71 
 95ASP N N 118.967 
 96GLY CA C 43.047 
 96GLY H H 8.113 
 96GLY HA2 H 3.868 
 96GLY HA3 H 3.868 
 96GLY N N 107.633 
 97ASN CA C 50.547 
 97ASN CB C 36.099 
 97ASN H H 8.235 
 97ASN HA H 4.627 
 97ASN HB2 H 2.782 
 97ASN HB3 H 2.782 
 97ASN N N 117.733 
 98GLY CA C 42.681 
 98GLY H H 8.312 
 98GLY HA2 H 3.886 
 98GLY HA3 H 3.886 
 98GLY N N 107.446 
 99TYR CA C 56.909 
 99TYR H H 7.855 
 99TYR HA H 4.03 
 99TYR N N 118.748 
 101SER CA C 54.923 
 101SER CB C 62.166 
 101SER H H 8.529 
 101SER HA H 3.976 
 101SER HB2 H 3.669 
 101SER HB3 H 3.669 
 101SER N N 119.086 
 102ALA CA C 52.465 
 102ALA CB C 15.435 
 102ALA H H 8.68 
 102ALA HA H 3.94 
 102ALA HB H 1.299 
 102ALA N N 124.831 
 103ALA CA C 51.927 
 103ALA CB C 15.513 
 103ALA H H 8.222 
 103ALA HA H 3.994 
 103ALA HB H 1.281 
 103ALA N N 119.005 
 104GLU CA C 55.495 
 104GLU CB C 26.763 
 104GLU H H 7.735 
 104GLU HA H 4.012 
 104GLU N N 118.601 
 105LEU CA C 54.923 
 105LEU CB C 38.879 
 105LEU H H 8.088 
 105LEU HA H 4.012 
 105LEU HB2 H 1.769 
 105LEU HB3 H 1.769 
 105LEU HG H 1.299 
 105LEU HD1 H 0.629 
 105LEU HD2 H 0.629 
 105LEU N N 120.659 
 106ARG CA C 56.539 
 106ARG CB C 27.157 
 106ARG H H 8.025 
 106ARG HA H 3.922 
 106ARG HB2 H 1.751 
 106ARG HB3 H 1.751 
 106ARG N N 117.594 
 107HIS CA C 55.596 
 107HIS CB C 26.527 
 107HIS H H 7.68 
 107HIS HA H 4.229 
 107HIS HB2 H 1.95 
 107HIS HB3 H 1.95 
 107HIS N N 117.689 
 108VAL CA C 62.497 
 108VAL CB C 29.202 
 108VAL H H 7.929 
 108VAL HA H 3.994 
 108VAL HB H 2.058 
 108VAL HG1 H 0.792 
 108VAL N N 118.922 
 109MET CA C 54.485 
 109MET CB C 29.674 
 109MET H H 8.142 
 109MET HA H 4.664 
 109MET HB2 H 1.751 
 109MET HB3 H 1.751 
 109MET HG2 H 2.131 
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 109MET HG3 H 2.131 
 109MET N N 117.291 
 110THR CA C 61.521 
 110THR CB C 66.503 
 110THR H H 7.914 
 110THR HA H 4.103 
 110THR HB H 4.229 
 110THR N N 112.374 
 111ASN CA C 51.691 
 111ASN CB C 36.047 
 111ASN H H 7.906 
 111ASN HA H 4.682 
 111ASN HB2 H 2.746 
 111ASN HB3 H 2.746 
 111ASN N N 119.669 
 112LEU CA C 52.768 
 112LEU CB C 39.72 
 112LEU H H 7.764 
 112LEU HA H 4.139 
 112LEU HB2 H 1.66 
 112LEU HB3 H 1.66 
 112LEU HD1 H 0.683 
 112LEU N N 119.868 
 113GLY CA C 43.204 
 113GLY H H 8.168 
 113GLY HA2 H 3.849 
 113GLY HA3 H 3.849 
 113GLY N N 107.803 
 114GLU CA C 53.711 
 114GLU CB C 27.157 
 114GLU H H 8.018 
 114GLU HA H 4.175 
 114GLU HB2 H 1.751 
 114GLU HB3 H 1.751 
 114GLU HG2 H 1.968 
 114GLU HG3 H 1.968 
 114GLU N N 119.894 
 115LYS CA C 53.812 
 115LYS CB C 29.674 
 115LYS H H 8.238 
 115LYS HA H 4.193 
 115LYS HB2 H 1.805 
 115LYS HB3 H 1.805 
 115LYS N N 120.422 
 116LEU CA C 51.523 
 116LEU CB C 41.318 
 116LEU H H 7.843 
 116LEU HA H 4.627 
 116LEU HB2 H 1.516 
 116LEU HB3 H 1.516 
 116LEU HD1 H 0.647 
 116LEU HD2 H 0.647 
 116LEU N N 122.019 
 117THR CA C 58.154 
 117THR CB C 68.224 
 117THR H H 8.805 
 117THR HA H 4.447 
 117THR HB H 4.646 
 117THR HG2 H 1.19 
 117THR N N 113.495 
 118ASP CA C 54.653 
 118ASP CB C 37.305 
 118ASP H H 8.706 
 118ASP HA H 4.193 
 118ASP HB2 H 2.475 
 118ASP HB3 H 2.475 
 118ASP N N 120.936 
 119GLU CA C 56.741 
 119GLU CB C 26.449 
 119GLU H H 8.494 
 119GLU HA H 4.067 
 119GLU HB2 H 1.805 
 119GLU HB3 H 1.805 
 119GLU N N 118.257 
 120GLU CA C 56 
 120GLU CB C 27.471 
 120GLU H H 7.781 
 120GLU HA H 4.121 
 120GLU HB2 H 1.841 
 120GLU HB3 H 1.841 
 120GLU N N 120.294 
 121VAL CA C 63.675 
 121VAL CB C 27.235 
 121VAL H H 8.122 
 121VAL HA H 3.831 
 121VAL HB H 2.04 
 121VAL HG1 H 0.883 
 121VAL N N 120.729 
 122ASP CA C 54.524 
 122ASP CB C 42.771 
 122ASP H H 8.248 
 122ASP HA H 4.211 
 122ASP HB2 H 2.619 
 122ASP HB3 H 2.619 
 122ASP N N 119.726 
 123GLU CA C 56.62 
 123GLU CB C 26.58 
 123GLU H H 8.222 
 123GLU HA H 4.049 
 123GLU HB2 H 1.878 
 123GLU HB3 H 1.878 
 123GLU N N 119.915 
 124MET CA C 56.13 
 124MET CB C 30.461 
 124MET H H 7.878 
 124MET HA H 3.886 
 124MET HB2 H 2.131 
 124MET HB3 H 2.131 
 124MET N N 119.08 
 125ILE CA C 61.958 
 125ILE CB C 34.842 
 125ILE H H 8.169 
 125ILE HA H 3.795 
 125ILE HB H 1.733 
 125ILE HG2 H 0.828 
 125ILE HD1 H 0.774 
 125ILE N N 119.157 
 126ARG CA C 56.202 
 126ARG CB C 27.629 
 126ARG H H 7.904 
 126ARG HA H 4.067 
 126ARG HB2 H 2.022 
 126ARG HB3 H 2.022 
 126ARG N N 119.956 
 127GLU CA C 54.99 
 127GLU CB C 26.763 
 127GLU H H 8.024 
 127GLU HA H 4.012 
 127GLU HB2 H 1.932 
 127GLU HB3 H 1.932 
 127GLU N N 118.102 
 128ALA CA C 50.176 
 128ALA CB C 16.379 
 128ALA H H 7.689 
 128ALA HA H 4.175 
 128ALA HB H 1.353 
 128ALA N N 121.388 
 130ILE CA C 58.693 
 130ILE CB C 35.968 
 130ILE H H 7.774 
 130ILE HA H 4.211 
 130ILE HB H 1.823 
 130ILE HG12 H 1.208 
 130ILE HG13 H 1.208 
 130ILE HD1 H 0.81 
 130ILE N N 118.856 
 131ASP CA C 51.388 
 131ASP CB C 37.384 
 131ASP H H 8.345 
 131ASP HA H 4.646 
 131ASP HB2 H 2.674 
 131ASP HB3 H 2.674 
 131ASP N N 123.284 
 132GLY CA C 43.309 
 132GLY H H 8.229 
 132GLY HA2 H 3.813 
 132GLY HA3 H 3.813 
 132GLY N N 108.046 
 133ASP CA C 51.422 
 133ASP CB C 38.346 
 133ASP H H 8.19 
 133ASP HA H 4.682 
 133ASP HB2 H 2.493 
 133ASP HB3 H 2.493 
 133ASP N N 119.587 
 134GLY CA C 42.89 
 134GLY H H 8.213 
 134GLY HA2 H 3.831 
 134GLY HA3 H 3.831 
 134GLY N N 108.03 
 135GLN CA C 52.499 
 135GLN H H 8.109 
 135GLN HA H 4.646 
 135GLN HB2 H 1.769 
 135GLN HB3 H 1.769 
 135GLN N N 118.777 
 136VAL CA C 58.532 
 136VAL CB C 31.326 
 136VAL H H 8.476 
 136VAL HA H 4.609 
 136VAL HB H 1.878 
 136VAL HG1 H 1.027 
 136VAL HG2 H 1.027 
 136VAL N N 122.094 
 137ASN CA C 49.537 
 137ASN CB C 35.889 
 137ASN H H 8.607 
 137ASN HA H 4.627 
 137ASN HB2 H 2.583 
 137ASN HB3 H 2.583 
 137ASN N N 123.726 
 138TYR CA C 58.154 
 138TYR CB C 35.26 
 138TYR H H 8.275 
 138TYR HA H 4.121 
 138TYR N N 123.091 
 139GLU CA C 56.606 
 139GLU CB C 26.501 
 139GLU H H 8.201 
 139GLU HA H 3.976 
 139GLU HB2 H 1.787 
 139GLU HB3 H 1.787 
 139GLU HG2 H 2.004 
 139GLU HG3 H 2.004 
 139GLU N N 119.717 
 140GLU CA C 55.899 
 140GLU CB C 26.921 
 140GLU H H 7.876 
 140GLU HA H 4.03 
 140GLU HB2 H 1.914 
 140GLU HB3 H 1.914 
 140GLU N N 117.372 
 141PHE CA C 57.919 
 141PHE CB C 36.519 
 141PHE H H 7.973 
 141PHE HA H 3.904 
 141PHE N N 120.644 
 142VAL CA C 63.237 
 142VAL CB C 29.26 
 142VAL H H 8.13 
 142VAL HA H 3.958 
 142VAL HB H 1.733 
 142VAL HG1 H 0.756 
 142VAL HG2 H 0.756 
 142VAL N N 118.798 
 143GLN CA C 55.431 
 143GLN CB C 29.91 
 143GLN H H 7.759 
 143GLN HA H 4.067 
 143GLN HB2 H 1.914 
 143GLN HB3 H 1.914 
 143GLN N N 119.619 
 144MET CA C 53.543 
 144MET CB C 28.966 
 144MET H H 7.784 
 144MET HA H 4.139 
 144MET HB2 H 2.022 
 144MET HB3 H 2.022 
 144MET N N 116.729 
 145MET CA C 53.677 
 145MET CB C 29.674 
 145MET H H 7.87 
 145MET HA H 4.229 
 145MET HB2 H 1.896 
 145MET HB3 H 1.896 
 145MET N N 117.399 
 146THR CA C 59.703 
 146THR CB C 67.041 
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 146THR H H 7.652 
 146THR HA H 4.248 
 146THR HB H 4.067 
 146THR HG2 H 1.154 
 146THR N N 111.38 
 147ALA CA C 49.974 
 147ALA CB C 16.221 
 147ALA H H 7.711 
 147ALA HA H 4.229 
 147ALA HB H 1.281 
 147ALA N N 125.991 
 148LYS CA C 54.889 
 148LYS H H 7.662 
 148LYS HA H 4.139 
 148LYS N N 125.356 
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Appendix F 
CaM12 Assigned Chemical Shifts 
      
ApoCaM12  
_Residue_seq_code 
_Residue_label 
_Atom_name 
_Atom_type 
_Chem_shift_value 
 3GLN H H 8.115 
 3GLN N N 118.296 
 4LEU H H 8.231 
 4LEU N N 121.564 
 5THR H H 8.672 
 5THR N N 112.706 
 6GLU H H 8.944 
 6GLU N N 119.983 
 7GLU H H 8.642 
 7GLU N N 119.1 
 8GLN H H 7.657 
 8GLN N N 120.294 
 9ILE H H 8.183 
 9ILE N N 118.438 
 10ALA H H 7.85 
 10ALA N N 120.211 
 11GLU H H 7.714 
 11GLU N N 119.943 
 12PHE H H 8.748 
 12PHE N N 119.942 
 13LYS H H 9.191 
 13LYS N N 121.35 
 14GLU H H 7.986 
 14GLU N N 120.528 
 15ALA H H 7.576 
 15ALA N N 120.583 
 16PHE H H 8.586 
 16PHE N N 117.484 
 17SER H H 8.345 
 17SER N N 111.656 
 18LEU H H 7.261 
 18LEU N N 120.546 
 19PHE H H 7.056 
 19PHE N N 113.968 
 20ALA H H 7.452 
 20ALA N N 123.081 
 21LYS H H 8.362 
 21LYS N N 121.199 
 22ASP H H 8.494 
 22ASP N N 122.069 
 23GLY H H 8.347 
 23GLY N N 109.317 
 24ASP H H 7.985 
 24ASP N N 119.784 
 25GLY H H 8.32 
 25GLY N N 106.537 
 26THR H H 7.523 
 26THR N N 107.782 
 27ILE H H 8.429 
 27ILE N N 111.198 
 28THR H H 8.529 
 28THR N N 110.566 
 29THR H H 8.215 
 29THR N N 110.671 
 30LYS H H 7.564 
 30LYS N N 119.055 
 31GLU H H 7.469 
 31GLU N N 118.084 
 32LEU H H 7.362 
 32LEU N N 120.544 
 33GLY H H 8.531 
 33GLY N N 104.903 
 34THR H H 7.384 
 34THR N N 118.195 
 35VAL H H 7.93 
 35VAL N N 122.39 
 36MET H H 8.349 
 36MET N N 118.134 
 37ARG H H 8.422 
 37ARG N N 119.169 
 38SER H H 7.998 
 38SER N N 118.814 
 39LEU H H 7.261 
 39LEU N N 120.675 
 40GLY H H 7.859 
 40GLY N N 106.965 
 41GLN H H 7.673 
 41GLN N N 117.583 
 42ASN H H 8.605 
 42ASN N N 116.352 
 44THR H H 8.688 
 44THR N N 112.844 
 45GLU H H 8.774 
 45GLU N N 120.218 
 46ALA H H 8.245 
 46ALA N N 120.747 
 47GLU H H 7.669 
 47GLU N N 118.663 
 48LEU H H 8.175 
 48LEU N N 119.754 
 49GLN H H 7.979 
 49GLN N N 117.263 
 50ASP H H 7.837 
 50ASP N N 118.802 
 51MET H H 7.844 
 51MET N N 118.602 
 52ILE H H 8.132 
 52ILE N N 118.575 
 53ASN H H 8.23 
 53ASN N N 117.456 
 54GLU H H 7.656 
 54GLU N N 117.344 
 55VAL H H 7.458 
 55VAL N N 113.749 
 56ALA H H 8.189 
 56ALA N N 124.057 
 57ALA H H 8.132 
 57ALA N N 123.228 
 58ASP H H 8.223 
 58ASP N N 116.185 
 59GLY H H 7.976 
 59GLY N N 107.385 
 60ASN H H 8.338 
 60ASN N N 118.064 
 61GLY H H 8.451 
 61GLY N N 107.713 
 62THR H H 7.696 
 62THR N N 111.076 
 63ILE H H 8.967 
 63ILE N N 120.087 
 64ASP H H 8.42 
 64ASP N N 124.941 
 65PHE H H 8.928 
 65PHE N N 118.092 
 67GLU H H 8.02 
 67GLU N N 117.588 
 68PHE H H 8.464 
 68PHE N N 122.207 
 69LEU H H 8.394 
 69LEU N N 118.283 
 70THR H H 7.638 
 70THR N N 115.827 
 71MET H H 7.795 
 71MET N N 120.865 
 72MET H H 7.968 
 72MET N N 117.111 
 73ALA H H 8.211 
 73ALA N N 120.833 
 74ARG H H 7.394 
 74ARG N N 116.554 
 75LYS H H 7.622 
 75LYS N N 118.287 
 76MET H H 7.879 
 76MET N N 117.661 
 77LYS H H 7.667 
 77LYS N N 120.522 
 78ASP H H 8.248 
 78ASP N N 121.734 
 79THR H H 8.072 
 79THR N N 114.662 
 80ASP H H 8.381 
 80ASP N N 122.933 
 81SER H H 8.385 
 81SER N N 117.005 
 82GLU H H 8.362 
 82GLU N N 121.619 
 83GLU H H 8.11 
 83GLU N N 118.269 
 84GLU H H 7.94 
 84GLU N N 118.933 
 85ILE H H 7.857 
 85ILE N N 120.059 
 86ARG H H 8.29 
 86ARG N N 119.229 
 87GLU H H 8.32 
 87GLU N N 116.761 
 88ALA H H 7.442 
 88ALA N N 121.161 
 89PHE H H 7.42 
 89PHE N N 113.977 
 90ARG H H 8.147 
 90ARG N N 117.775 
 91VAL H H 7.09 
 91VAL N N 116.807 
 93ASP H H 7.763 
 93ASP N N 121.119 
 94LYS H H 8.336 
 94LYS N N 124.233 
 95ASP H H 8.53 
 95ASP N N 116.231 
 96GLY H H 7.995 
 96GLY N N 109.905 
 97ASN H H 8.936 
 97ASN N N 118.477 
 98GLY H H 8.368 
 98GLY N N 109.301 
 99TYR H H 7.701 
 99TYR N N 118.033 
 100ILE H H 8.541 
 100ILE N N 113.244 
 101SER H H 8.83 
 101SER N N 117.204 
 102ALA H H 8.742 
 102ALA N N 124.615 
 103ALA H H 8.194 
 103ALA N N 118.833 
 104GLU H H 7.661 
 104GLU N N 120.033 
 105LEU H H 8.131 
 105LEU N N 120.563 
 106ARG H H 7.971 
 106ARG N N 117.033 
 107HIS H H 7.657 
 107HIS N N 118.426 
 108VAL H H 8.048 
 108VAL N N 119.488 
 109MET H H 8.271 
 109MET N N 119.06 
 110THR H H 7.858 
 110THR N N 110.972 
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 111ASN H H 7.592 
 111ASN N N 119.492 
 112LEU H H 7.666 
 112LEU N N 119.633 
 113GLY H H 8.091 
 113GLY N N 107.833 
 114GLU H H 8.101 
 114GLU N N 120.033 
 115LYS H H 8.181 
 115LYS N N 119.933 
 116LEU H H 7.695 
 116LEU N N 120.891 
 117THR H H 8.875 
 117THR N N 113.319 
 118ASP H H 8.74 
 118ASP N N 120.733 
 119GLU H H 8.493 
 119GLU N N 117.747 
 120GLU H H 7.728 
 120GLU N N 120.331 
 121VAL H H 8.142 
 121VAL N N 120.628 
 122ASP H H 8.294 
 122ASP N N 119.034 
 123GLU H H 7.791 
 123GLU N N 119.033 
 124MET H H 7.83 
 124MET N N 118.533 
 125ILE H H 8.254 
 125ILE N N 118.204 
 126ARG H H 7.867 
 126ARG N N 119.433 
 127GLU H H 7.765 
 127GLU N N 116.802 
 128ALA H H 7.534 
 128ALA N N 121.372 
 129ASP H H 8.281 
 129ASP N N 119.433 
 130ILE H H 7.761 
 130ILE N N 120.833 
 131ASP H H 8.53 
 131ASP N N 123.821 
 132GLY H H 8.281 
 132GLY N N 107.761 
 133ASP H H 8.211 
 133ASP N N 119.133 
 134GLY H H 8.465 
 134GLY N N 109.277 
 135GLN H H 8.228 
 135GLN N N 119.247 
 136VAL H H 9.341 
 136VAL N N 119.233 
 137ASN H H 8.701 
 137ASN N N 124.877 
 138TYR H H 7.441 
 138TYR N N 122.233 
 139GLU H H 8.092 
 139GLU N N 125.599 
 140GLU H H 7.781 
 140GLU N N 116.806 
 141PHE H H 7.488 
 141PHE N N 118.833 
 142VAL H H 8.061 
 142VAL N N 119.833 
 143GLN H H 7.783 
 143GLN N N 117.13 
 144MET H H 7.688 
 144MET N N 117.833 
 145MET H H 7.902 
 145MET N N 115.932 
 146THR H H 7.632 
 146THR N N 110.272 
 147ALA H H 7.54 
 147ALA N N 125.404 
 148LYS H H 7.629 
 148LYS N N 125.305 
Ca
2+
-saturated 
CaM12 
_Residue_seq_code 
_Residue_label 
_Atom_name 
_Atom_type 
_Chem_shift_value 
 3 GLN H H 8.106 
 3 GLN N N 118.176 
 4 LEU H H 8.231 
 4 LEU N N 121.564 
 5 THR H H 8.672 
 5 THR N N 112.706 
 6 GLU H H 8.944 
 6 GLU N N 119.983 
 7 GLU H H 8.627 
 7 GLU N N 119.055 
 8 GLN H H 7.657 
 8 GLN N N 120.207 
 9 ILE H H 8.185 
 9 ILE N N 118.169 
 10 ALA H H 7.854 
 10 ALA N N 120.166 
 11 GLU H H 7.715 
 11 GLU N N 120.042 
 12 PHE H H 8.748 
 12 PHE N N 119.942 
 13 LYS H H 9.167 
 13 LYS N N 121.29 
 14 GLU H H 7.985 
 14 GLU N N 120.633 
 15 ALA H H 7.582 
 15 ALA N N 120.643 
 16 PHE H H 8.593 
 16 PHE N N 117.439 
 17 SER H H 8.358 
 17 SER N N 111.805 
 18 LEU H H 7.261 
 18 LEU N N 120.546 
 19 PHE H H 7.062 
 19 PHE N N 114.117 
 20 ALA H H 7.536 
 20 ALA N N 123.26 
 21 LYS H H 8.403 
 21 LYS N N 120.975 
 22 ASP H H 8.481 
 22 ASP N N 122.174 
 23 GLY H H 8.259 
 23 GLY N N 109.143 
 24 ASP H H 7.992 
 24 ASP N N 119.59 
 25 GLY H H 8.284 
 25 GLY N N 106.363 
 26 THR H H 7.525 
 26 THR N N 108.155 
 27 ILE H H 8.501 
 27 ILE N N 111.882 
 28 THR H H 8.548 
 28 THR N N 110.541 
 29 THR H H 8.297 
 29 THR N N 109.975 
 30 LYS H H 7.593 
 30 LYS N N 119.266 
 31 GLU H H 7.462 
 31 GLU N N 117.972 
 32 LEU H H 7.36 
 32 LEU N N 120.668 
 33 GLY H H 8.646 
 33 GLY N N 105.027 
 34 THR H H 7.391 
 34 THR N N 117.996 
 35 VAL H H 7.843 
 35 VAL N N 122.734 
 36 MET H H 8.321 
 36 MET N N 118.239 
 37 ARG H H 8.432 
 37 ARG N N 119.019 
 38 SER H H 8.008 
 38 SER N N 118.829 
 39 LEU H H 7.261 
 39 LEU N N 120.675 
 40 GLY H H 7.862 
 40 GLY N N 106.965 
 41 GLN H H 7.673 
 41 GLN N N 117.782 
 42 ASN H H 8.57 
 42 ASN N N 116.561 
 44 THR H H 8.688 
 44 THR N N 112.844 
 45 GLU H H 8.774 
 45 GLU N N 120.218 
 46 ALA H H 8.259 
 46 ALA N N 120.732 
 47 GLU H H 7.677 
 47 GLU N N 118.663 
 48 LEU H H 8.159 
 48 LEU N N 120.726 
 49 GLN H H 7.971 
 49 GLN N N 117.547 
 50 ASP H H 7.837 
 50 ASP N N 118.802 
 51 MET H H 7.844 
 51 MET N N 118.602 
 52 ILE H H 8.136 
 52 ILE N N 118.575 
 53 ASN H H 8.269 
 53 ASN N N 117.426 
 54 GLU H H 7.659 
 54 GLU N N 117.618 
 55 VAL H H 7.409 
 55 VAL N N 113.127 
 56 ALA H H 8.189 
 56 ALA N N 123.385 
 57 ALA H H 8.132 
 57 ALA N N 123.228 
 58 ASP H H 8.236 
 58 ASP N N 116.26 
 59 GLY H H 7.719 
 59 GLY N N 111.559 
 60 ASN H H 8.303 
 60 ASN N N 118.094 
 61 GLY H H 8.094 
 61 GLY N N 108.027 
 62 THR H H 7.674 
 62 THR N N 110.952 
 63 ILE H H 9.103 
 63 ILE N N 123.58 
 64 ASP H H 8.716 
 64 ASP N N 125.893 
 65 PHE H H 8.992 
 65 PHE N N 118.301 
 67 GLU H H 7.992 
 67 GLU N N 117.962 
 68 PHE H H 8.463 
 68 PHE N N 122.072 
 69 LEU H H 8.398 
 69 LEU N N 118.283 
 70 THR H H 7.65 
 70 THR N N 115.317 
 71 MET H H 7.722 
 71 MET N N 120.84 
 72 MET H H 7.958 
 72 MET N N 117.305 
 73 ALA H H 8.174 
 73 ALA N N 121.237 
 74 ARG H H 7.394 
 74 ARG N N 116.455 
 75 LYS H H 7.624 
 75 LYS N N 118.287 
 76 MET H H 7.783 
 76 MET N N 118.565 
 77 LYS H H 7.838 
 77 LYS N N 119.907 
 78 ASP H H 8.224 
 78 ASP N N 121.912 
 79 THR H H 8.057 
 79 THR N N 114.645 
 80 ASP H H 8.268 
 80 ASP N N 123.651 
 81 SER H H 8.409 
 81 SER N N 117.061 
 82 GLU H H 8.415 
 82 GLU N N 122.075 
 83 GLU H H 8.252 
 83 GLU N N 119.834 
 84 GLU H H 8.025 
 84 GLU N N 118.582 
 85 ILE H H 7.956 
 85 ILE N N 121.955 
 86 ARG H H 8.343 
 86 ARG N N 121.407 
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 87 GLU H H 8.002 
 87 GLU N N 118.379 
 88 ALA H H 7.929 
 88 ALA N N 122.314 
 89 PHE H H 8.49 
 89 PHE N N 118.562 
 90 ARG H H 7.619 
 90 ARG N N 115.235 
 91 VAL H H 7.477 
 91 VAL N N 118.088 
 92 PHE H H 7.515 
 92 PHE N N 116.283 
 93 ASP H H 7.798 
 93 ASP N N 116.769 
 94 LYS H H 7.648 
 94 LYS N N 125.517 
 95 ASP H H 8.106 
 95 ASP N N 113.638 
 96 GLY H H 7.718 
 96 GLY N N 108.939 
 97 ASN H H 8.239 
 97 ASN N N 119.2 
 98 GLY H H 10.581 
 98 GLY N N 112.653 
 99 TYR H H 7.537 
 99 TYR N N 115.477 
 100 ILE H H 10.065 
 100 ILE N N 126.889 
 101 SER H H 8.885 
 101 SER N N 123.445 
 102 ALA H H 9.129 
 102 ALA N N 122.583 
 103 ALA H H 8.241 
 103 ALA N N 118.164 
 104 GLU H H 7.803 
 104 GLU N N 119.285 
 105 LEU H H 8.541 
 105 LEU N N 120.928 
 106 ARG H H 8.491 
 106 ARG N N 117.278 
 107 HIS H H 7.887 
 107 HIS N N 118.019 
 108 VAL H H 7.827 
 108 VAL N N 118.879 
 109 MET H H 8.17 
 109 MET N N 116.245 
 110 THR H H 8.085 
 110 THR N N 114.782 
 111 ASN H H 7.879 
 111 ASN N N 121.72 
 112 LEU H H 7.803 
 112 LEU N N 118.518 
 113 GLY H H 7.81 
 113 GLY N N 106.619 
 114 GLU H H 7.833 
 114 GLU N N 120.2 
 115 LYS H H 8.513 
 115 LYS N N 123.469 
 116 LEU H H 8.035 
 116 LEU N N 124.335 
 117 THR H H 9.142 
 117 THR N N 114.239 
 118 ASP H H 8.833 
 118 ASP N N 120.684 
 119 GLU H H 8.611 
 119 GLU N N 118.808 
 120 GLU H H 7.698 
 120 GLU N N 120.205 
 121 VAL H H 8.029 
 121 VAL N N 120.898 
 122 ASP H H 7.98 
 122 ASP N N 119.31 
 123 GLU H H 7.905 
 123 GLU N N 119.104 
 124 MET H H 7.792 
 124 MET N N 118.941 
 125 ILE H H 7.912 
 125 ILE N N 117.575 
 126 ARG H H 8.152 
 126 ARG N N 118.295 
 127 GLU H H 7.903 
 127 GLU N N 115.314 
 128 ALA H H 7.287 
 128 ALA N N 118.595 
 129 ASP H H 7.801 
 129 ASP N N 117.265 
 130 ILE H H 8.292 
 130 ILE N N 127.457 
 131 ASP H H 8.215 
 131 ASP N N 116.244 
 132 GLY H H 7.5 
 132 GLY N N 108.23 
 133 ASP H H 8.253 
 133 ASP N N 120.304 
 134 GLY H H 10.302 
 134 GLY N N 112.578 
 135 GLN H H 7.887 
 135 GLN N N 115.135 
 136 VAL H H 9.065 
 136 VAL N N 125.049 
 137 ASN H H 9.435 
 137 ASN N N 128.638 
 138 TYR H H 8.409 
 138 TYR N N 118.077 
 139 GLU H H 8.059 
 139 GLU N N 118.243 
 140 GLU H H 8.698 
 140 GLU N N 119.482 
 141 PHE H H 8.912 
 141 PHE N N 124.507 
 142 VAL H H 8.461 
 142 VAL N N 118.879 
 143 GLN H H 7.284 
 143 GLN N N 117.74 
 144 MET H H 7.923 
 144 MET N N 119.454 
 145 MET H H 7.776 
 145 MET N N 114.416 
 146 THR H H 7.516 
 146 THR N N 111.421 
 147 ALA H H 7.709 
 147 ALA N N 126.353 
 148 LYS H H 7.674 
 148 LYS N N 125.345 
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Appendix G 
CaM34 Assigned Chemical Shift
Apo CaM34 
_Residue_seq_code 
_Residue_label 
_Atom_name 
_Atom_type 
_Chem_shift_value 
 3 GLN H H 8.109 
 3 GLN N N 118.27 
 4 LEU H H 8.221 
 4 LEU N N 121.532 
 5 THR H H 8.691 
 5 THR N N 112.733 
 6 GLU H H 8.941 
 6 GLU N N 119.971 
 7 GLU H H 8.641 
 7 GLU N N 119.033 
 8 GLN H H 7.648 
 8 GLN N N 120.185 
 9 ILE H H 8.147 
 9 ILE N N 118.192 
 10 ALA H H 7.838 
 10 ALA N N 120.153 
 11 GLU H H 7.72 
 11 GLU N N 119.933 
 12 PHE H H 8.737 
 12 PHE N N 120.133 
 13 LYS H H 9.137 
 13 LYS N N 121.202 
 14 GLU H H 7.98 
 14 GLU N N 120.226 
 15 ALA H H 7.574 
 15 ALA N N 120.572 
 16 PHE H H 8.441 
 16 PHE N N 117.574 
 17 SER H H 8.339 
 17 SER N N 110.792 
 18 LEU H H 7.278 
 18 LEU N N 120.947 
 19 PHE H H 7.308 
 19 PHE N N 114.477 
 20 ASP H H 7.228 
 20 ASP N N 122.233 
 21 LYS H H 8.001 
 21 LYS N N 123.433 
 22 ASP H H 8.653 
 22 ASP N N 116.965 
 23 GLY H H 7.939 
 23 GLY N N 110.063 
 24 ASP H H 8.696 
 24 ASP N N 120.533 
 25 GLY H H 10.101 
 25 GLY N N 111.703 
 26 THR H H 7.511 
 26 THR N N 109.533 
 27 ILE H H 8.195 
 27 ILE N N 110.193 
 28 THR H H 8.258 
 28 THR N N 110.521 
 29 THR H H 8.224 
 29 THR N N 112.262 
 30 LYS H H 7.561 
 30 LYS N N 118.659 
 31 GLU H H 7.44 
 31 GLU N N 117.284 
 32 LEU H H 7.27 
 32 LEU N N 120.701 
 33 GLY H H 8.723 
 33 GLY N N 105.223 
 34 THR H H 7.436 
 34 THR N N 118.155 
 35 VAL H H 7.891 
 35 VAL N N 122.496 
 36 MET H H 8.386 
 36 MET N N 118.307 
 37 ARG H H 8.438 
 37 ARG N N 119.204 
 38 SER H H 8.04 
 38 SER N N 118.782 
 39 LEU H H 7.263 
 39 LEU N N 120.896 
 40 GLY H H 7.841 
 40 GLY N N 106.903 
 41 GLN H H 7.691 
 41 GLN N N 117.431 
 42 ASN H H 8.592 
 42 ASN N N 116.392 
 44 THR H H 8.711 
 44 THR N N 113.033 
 45 GLU H H 8.781 
 45 GLU N N 120.233 
 46 ALA H H 8.251 
 46 ALA N N 120.833 
 47 GLU H H 7.668 
 47 GLU N N 118.672 
 48 LEU H H 8.254 
 48 LEU N N 119.899 
 49 GLN H H 7.984 
 49 GLN N N 117.333 
 50 ASP H H 7.773 
 50 ASP N N 118.711 
 51 MET H H 7.891 
 51 MET N N 118.933 
 52 ILE H H 8.254 
 52 ILE N N 118.95 
 53 ASN H H 8.197 
 53 ASN N N 117.177 
 54 GLU H H 7.507 
 54 GLU N N 117.133 
 55 VAL H H 7.552 
 55 VAL N N 112.677 
 56 ASP H H 8.373 
 56 ASP N N 121.733 
 57 ALA H H 8.078 
 57 ALA N N 124.767 
 58 ASP H H 8.355 
 58 ASP N N 114.648 
 59 GLY H H 7.832 
 59 GLY N N 108.723 
 60 ASN H H 9.182 
 60 ASN N N 119.562 
 61 GLY H H 9.888 
 61 GLY N N 109.859 
 62 THR H H 7.497 
 62 THR N N 110.65 
 63 ILE H H 8.832 
 63 ILE N N 118.662 
 64 ASP H H 8.354 
 64 ASP N N 124.049 
 65 PHE H H 8.577 
 65 PHE N N 118.448 
 67 GLU H H 8.021 
 67 GLU N N 117.392 
 68 PHE H H 8.401 
 68 PHE N N 122.199 
 69 LEU H H 8.393 
 69 LEU N N 118.488 
 70 THR H H 7.651 
 70 THR N N 115.233 
 71 MET H H 7.668 
 71 MET N N 121.155 
 72 MET H H 7.948 
 72 MET N N 117.24 
 73 ALA H H 8.179 
 73 ALA N N 120.928 
 74 ARG H H 7.394 
 74 ARG N N 116.495 
 75 LYS H H 7.641 
 75 LYS N N 118.033 
 76 MET H H 7.871 
 76 MET N N 117.633 
 77 LYS H H 7.652 
 77 LYS N N 120.409 
 78 ASP H H 8.228 
 78 ASP N N 121.767 
 79 THR H H 8.039 
 79 THR N N 114.252 
 80 ASP H H 8.352 
 80 ASP N N 122.925 
 81 SER H H 8.32 
 81 SER N N 116.613 
 82 GLU H H 8.353 
 82 GLU N N 121.876 
 83 GLU H H 8.125 
 83 GLU N N 119.864 
 84 GLU H H 7.9 
 84 GLU N N 118.973 
 85 ILE H H 7.977 
 85 ILE N N 120.899 
 86 ARG H H 8.179 
 86 ARG N N 121.318 
 87 GLU H H 8.265 
 87 GLU N N 119.274 
 88 ALA H H 7.866 
 88 ALA N N 122.173 
 89 PHE H H 7.883 
 89 PHE N N 116.002 
 93 ALA H H 7.973 
 93 ALA N N 122.815 
 94 LYS H H 8.068 
 94 LYS N N 120.302 
 95 ASP H H 8.266 
 95 ASP N N 118.968 
 96 GLY H H 8.113 
 96 GLY N N 107.633 
 97 ASN H H 8.232 
 97 ASN N N 117.894 
 98 GLY H H 8.304 
 98 GLY N N 107.446 
 99 TYR H H 7.843 
 99 TYR N N 118.763 
 101 SER H H 8.508 
 101 SER N N 119.086 
 102 ALA H H 8.676 
 102 ALA N N 124.846 
 103 ALA H H 8.225 
 103 ALA N N 118.99 
 104 GLU H H 7.739 
 104 GLU N N 118.542 
 105 LEU H H 8.078 
 105 LEU N N 120.754 
 106 ARG H H 8.023 
 106 ARG N N 117.594 
 107 HIS H H 7.695 
 107 HIS N N 117.689 
 108 VAL H H 7.932 
 108 VAL N N 118.951 
 109 MET H H 8.14 
 109 MET N N 117.489 
 110 THR H H 7.914 
 110 THR N N 112.447 
 111 ASN H H 7.906 
 111 ASN N N 119.669 
 112 LEU H H 7.773 
 112 LEU N N 119.89 
 113 GLY H H 8.168 
 113 GLY N N 107.803 
 114 GLU H H 8.014 
 114 GLU N N 119.894 
 115 LYS H H 8.238 
 115 LYS N N 120.422 
 116 LEU H H 7.854 
 116 LEU N N 122.019 
 117 THR H H 8.774 
 117 THR N N 113.451 
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 118 ASP H H 8.697 
 118 ASP N N 120.838 
 119 GLU H H 8.488 
 119 GLU N N 118.257 
 120 GLU H H 7.781 
 120 GLU N N 120.199 
 121 VAL H H 8.119 
 121 VAL N N 120.736 
 122 ASP H H 8.255 
 122 ASP N N 119.741 
 123 GLU H H 8.212 
 123 GLU N N 119.934 
 124 MET H H 7.853 
 124 MET N N 119.225 
 125 ILE H H 8.171 
 125 ILE N N 119.223 
 126 ARG H H 7.905 
 126 ARG N N 120.066 
 127 GLU H H 8.028 
 127 GLU N N 117.882 
 128 ALA H H 7.695 
 128 ALA N N 121.373 
 129 ALA H H 7.999 
 129 ALA N N 121.227 
 130 ILE H H 7.774 
 130 ILE N N 118.856 
 131 ASP H H 8.335 
 131 ASP N N 123.284 
 132 GLY H H 8.229 
 132 GLY N N 108.046 
 133 ASP H H 8.183 
 133 ASP N N 119.543 
 134 GLY H H 8.213 
 134 GLY N N 108.03 
 135 GLN H H 8.106 
 135 GLN N N 118.74 
 137 ASN H H 8.587 
 137 ASN N N 123.656 
 138 TYR H H 8.278 
 138 TYR N N 123.192 
 139 GLU H H 8.194 
 139 GLU N N 119.739 
 141 PHE H H 7.973 
 141 PHE N N 120.644 
 142 VAL H H 8.12 
 142 VAL N N 118.761 
 143 GLN H H 7.763 
 143 GLN N N 119.641 
 144 MET H H 7.788 
 144 MET N N 116.758 
 145 MET H H 7.87 
 145 MET N N 117.399 
 146 THR H H 7.649 
 146 THR N N 111.439 
 147 ALA H H 7.718 
 147 ALA N N 126.027 
 148 LYS H H 7.662 
 148 LYS N N 125.356 
Ca
2+
-saturated 
CaM34 
_Residue_seq_code 
_Residue_label 
_Atom_name 
_Atom_type 
_Chem_shift_value 
 1ALA H H 8.38 
 1ALA N N 123.171 
 2ASP H H 7.998 
 2ASP N N 117.408 
 3GLN H H 7.829 
 3GLN N N 118.016 
 5THR H H 8.634 
 5THR N N 112.609 
 6GLU H H 8.972 
 6GLU N N 120.15 
 7GLU H H 8.669 
 7GLU N N 119.2 
 8GLN H H 7.675 
 8GLN N N 119.767 
 9ILE H H 8.347 
 9ILE N N 119.371 
 10ALA H H 7.939 
 10ALA N N 120.709 
 11GLU H H 7.716 
 11GLU N N 119.268 
 12PHE H H 8.507 
 12PHE N N 119.555 
 13LYS H H 9.112 
 13LYS N N 123.203 
 14GLU H H 7.69 
 14GLU N N 119.954 
 15ALA H H 7.904 
 15ALA N N 122.354 
 16PHE H H 8.736 
 16PHE N N 118.654 
 17SER H H 7.892 
 17SER N N 112.667 
 18LEU H H 7.319 
 18LEU N N 120.064 
 19PHE H H 7.186 
 19PHE N N 114.443 
 20ASP H H 7.752 
 20ASP N N 117.819 
 21LYS H H 7.522 
 21LYS N N 124.068 
 22ASP H H 7.943 
 22ASP N N 113.338 
 23GLY H H 7.626 
 23GLY N N 108.959 
 24ASP H H 8.338 
 24ASP N N 120.323 
 25GLY H H 10.546 
 25GLY N N 112.826 
 26THR H H 8.084 
 26THR N N 112.231 
 27ILE H H 9.788 
 27ILE N N 126.653 
 28THR H H 8.362 
 28THR N N 116.324 
 29THR H H 9.097 
 29THR N N 112.41 
 30LYS H H 7.395 
 30LYS N N 120.326 
 31GLU H H 7.593 
 31GLU N N 120.72 
 32LEU H H 8.656 
 32LEU N N 120.383 
 33GLY H H 8.647 
 33GLY N N 105.992 
 34THR H H 7.77 
 34THR N N 118.049 
 35VAL H H 7.51 
 35VAL N N 121.826 
 36MET H H 8.418 
 36MET N N 119.254 
 37ARG H H 8.476 
 37ARG N N 119.136 
 38SER H H 7.887 
 38SER N N 118.704 
 39LEU H H 7.289 
 39LEU N N 119.966 
 40GLY H H 7.799 
 40GLY N N 106.59 
 41GLN H H 7.749 
 41GLN N N 118.152 
 42ASN H H 8.655 
 42ASN N N 115.97 
 44THR H H 8.656 
 44THR N N 112.731 
 45GLU H H 8.746 
 45GLU N N 120.395 
 46ALA H H 8.214 
 46ALA N N 120.693 
 47GLU H H 7.633 
 47GLU N N 118.445 
 48LEU H H 8.093 
 48LEU N N 120.526 
 49GLN H H 8.183 
 49GLN N N 118.049 
 50ASP H H 8.001 
 50ASP N N 119.95 
 51MET H H 7.807 
 51MET N N 118.732 
 52ILE H H 7.661 
 52ILE N N 117.69 
 53ASN H H 8.544 
 53ASN N N 117.436 
 54GLU H H 7.46 
 54GLU N N 116.047 
 55VAL H H 7.142 
 55VAL N N 109.529 
 56ASP H H 7.544 
 56ASP N N 121.765 
 57ALA H H 8.267 
 57ALA N N 131.278 
 58ASP H H 8.124 
 58ASP N N 113.547 
 59GLY H H 7.518 
 59GLY N N 108.146 
 60ASN H H 8.051 
 60ASN N N 118.31 
 61GLY H H 10.509 
 61GLY N N 112.999 
 62THR H H 7.594 
 62THR N N 108.394 
 63ILE H H 8.732 
 63ILE N N 123.051 
 64ASP H H 8.833 
 64ASP N N 128.003 
 65PHE H H 8.879 
 65PHE N N 118.422 
 68PHE H H 8.682 
 68PHE N N 123.255 
 69LEU H H 8.249 
 69LEU N N 119.108 
 70THR H H 7.401 
 70THR N N 116.545 
 71MET H H 7.601 
 71MET N N 121.166 
 73ALA H H 8.038 
 73ALA N N 122.383 
 74ARG H H 7.468 
 74ARG N N 116.585 
 75LYS H H 7.614 
 75LYS N N 118.371 
 76MET H H 7.931 
 76MET N N 114.667 
 77LYS H H 7.669 
 77LYS N N 120.132 
 78ASP H H 8.229 
 78ASP N N 121.253 
 79THR H H 7.988 
 79THR N N 113.486 
 80ASP H H 8.295 
 80ASP N N 122.305 
 81SER H H 8.336 
 81SER N N 116.217 
 82GLU H H 8.328 
 82GLU N N 121.891 
 83GLU H H 8.125 
 83GLU N N 119.864 
 84GLU H H 7.901 
 84GLU N N 118.873 
 85ILE H H 7.949 
 85ILE N N 121.398 
 87GLU H H 8.287 
 87GLU N N 119.285 
 88ALA H H 7.897 
 88ALA N N 122.007 
 89PHE H H 7.9 
 89PHE N N 116.274 
 94LYS H H 8.068 
 94LYS N N 120.302 
 95ASP H H 8.253 
 95ASP N N 119.39 
 96GLY H H 8.143 
 96GLY N N 107.709 
 97ASN H H 8.232 
 97ASN N N 117.894 
 98GLY H H 8.259 
 98GLY N N 107.748 
 99TYR H H 7.848 
 99TYR N N 118.619 
 101SER H H 8.508 
 101SER N N 119.086 
 102ALA H H 8.706 
 102ALA N N 125.209 
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 103ALA H H 8.201 
 103ALA N N 118.096 
 104GLU H H 7.757 
 104GLU N N 118.609 
 105LEU H H 8.078 
 105LEU N N 120.754 
 106ARG H H 8.019 
 106ARG N N 117.472 
 107HIS H H 7.679 
 107HIS N N 117.567 
 108VAL H H 7.958 
 108VAL N N 118.951 
 109MET H H 8.14 
 109MET N N 117.489 
 110THR H H 7.927 
 110THR N N 112.825 
 111ASN H H 7.906 
 111ASN N N 119.669 
 112LEU H H 7.737 
 112LEU N N 119.89 
 113GLY H H 8.176 
 113GLY N N 107.894 
 114GLU H H 8.019 
 114GLU N N 119.572 
 115LYS H H 8.216 
 115LYS N N 120.422 
 116LEU H H 7.876 
 116LEU N N 121.897 
 117THR H H 8.722 
 117THR N N 112.559 
 118ASP H H 8.699 
 118ASP N N 120.382 
 119GLU H H 8.419 
 119GLU N N 117.571 
 120GLU H H 7.75 
 120GLU N N 120.199 
 121VAL H H 8.099 
 121VAL N N 121.002 
 122ASP H H 8.296 
 122ASP N N 119.741 
 123GLU H H 8.196 
 123GLU N N 119.994 
 124MET H H 7.853 
 124MET N N 119.225 
 125ILE H H 8.171 
 125ILE N N 119.223 
 126ARG H H 7.885 
 126ARG N N 120.199 
 127GLU H H 8.05 
 127GLU N N 117.926 
 128ALA H H 7.628 
 128ALA N N 120.98 
 129ALA H H 8.01 
 129ALA N N 121.756 
 130ILE H H 7.788 
 130ILE N N 118.823 
 131ASP H H 8.25 
 131ASP N N 122.876 
 132GLY H H 8.304 
 132GLY N N 108.65 
 133ASP H H 8.169 
 133ASP N N 119.581 
 134GLY H H 8.19 
 134GLY N N 108.876 
 135GLN H H 8.055 
 135GLN N N 118.74 
 137ASN H H 8.507 
 137ASN N N 123.293 
 138TYR H H 8.228 
 138TYR N N 122.875 
 139GLU H H 8.177 
 139GLU N N 119.799 
 141PHE H H 7.957 
 141PHE N N 120.866 
 142VAL H H 8.065 
 142VAL N N 119.038 
 143GLN H H 7.735 
 143GLN N N 119.597 
 144MET H H 7.712 
 144MET N N 117.192 
 145MET H H 7.593 
 145MET N N 114.946 
 146THR H H 7.734 
 146THR N N 112.376 
 147ALA H H 7.809 
 147ALA N N 125.72 
 148LYS H H 7.749 
 148LYS N N 125.508 
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Appendix H 
CaM-eNOS peptide at 225 nM free Ca2+ Assigned Chemical Shifts 
_Residue_seq_code 
_Residue_label 
_Atom_name 
_Atom_type 
_Chem_shift_value 
   3 GLN  CA  C    53.5 
   3 GLN  CB  C  29.475 
   3 GLN  CG  C  33.653 
   3 GLN   H  H   8.134 
   3 GLN  HA  H   4.688 
   3 GLN HB2  H   1.877 
   3 GLN HB3  H   1.877 
   3 GLN   N  N  118.12 
   4 LEU  CA  C   51.65 
   4 LEU  CB  C  40.715 
   4 LEU  CG  C  24.216 
   4 LEU CD1  C  20.665 
   4 LEU CD2  C  22.383 
   4 LEU   H  H   8.202 
   4 LEU  HA  H    4.46 
   4 LEU HB2  H   1.554 
   4 LEU HB3  H   1.554 
   4 LEU  HG  H   1.488 
   4 LEU HD1  H   0.678 
   4 LEU HD2  H   0.654 
   4 LEU   N  N 121.407 
   5 THR  CA  C  59.433 
   5 THR  CB  C  67.475 
   5 THR CG2  C  18.753 
   5 THR   H  H   8.691 
   5 THR  HA  H   4.265 
   5 THR  HB  H   4.091 
   5 THR HG2  H   1.056 
   5 THR   N  N 112.733 
   6 GLU  CA  C  56.756 
   6 GLU  CB  C  26.508 
   6 GLU  CG  C  33.653 
   6 GLU   H  H   8.953 
   6 GLU  HA  H   3.854 
   6 GLU HB2  H   1.884 
   6 GLU HB3  H   1.884 
   6 GLU HG2  H     2.2 
   6 GLU HG3  H     2.2 
   6 GLU   N  N 119.971 
   7 GLU  CA  C  56.756 
   7 GLU  CB  C  26.279 
   7 GLU  CG  C  33.726 
   7 GLU   H  H   8.653 
   7 GLU  HA  H   3.898 
   7 GLU HB2  H   1.899 
   7 GLU HB3  H   1.899 
   7 GLU HG2  H   2.222 
   7 GLU HG3  H   2.222 
   7 GLU   N  N 119.133 
   8 GLN  CA  C  57.099 
   8 GLN  CB  C  26.737 
   8 GLN  CG  C  33.612 
   8 GLN   H  H   7.645 
   8 GLN  HA  H   3.957 
   8 GLN HB2  H   1.972 
   8 GLN HB3  H   1.972 
   8 GLN HG2  H   2.237 
   8 GLN HG3  H   2.237 
   8 GLN   N  N 120.207 
   9 ILE  CA  C  62.714 
   9 ILE  CB  C  35.216 
   9 ILE CG1  C  27.654 
   9 ILE CG2  C  14.936 
   9 ILE CD1  C  10.811 
   9 ILE   H  H   8.153 
   9 ILE  HA  H   3.354 
   9 ILE  HB  H   1.708 
   9 ILE HG12 H   0.678 
   9 ILE HG13 H   0.678 
   9 ILE HG2  H   0.767 
   9 ILE HD1  H   0.634 
   9 ILE   N  N 118.171 
  10 ALA  CA  C  52.746 
  10 ALA  CB  C  15.165 
  10 ALA   H  H   7.835 
  10 ALA  HA  H   3.966 
  10 ALA  HB  H    1.34 
  10 ALA   N  N 120.124 
  11 GLU  CA  C   56.56 
  11 GLU  CB  C  27.425 
  11 GLU  CG  C  33.841 
  11 GLU   H  H   7.706 
  11 GLU  HA  H   3.904 
  11 GLU HB2  H   1.802 
  11 GLU HB3  H   1.802 
  11 GLU HG2  H   2.213 
  11 GLU HG3  H   2.213 
  11 GLU   N  N 119.983 
  12 PHE  CA  C  55.839 
  12 PHE  CB  C  33.955 
  12 PHE   H  H   8.728 
  12 PHE  HA  H   4.726 
  12 PHE HB2  H   3.336 
  12 PHE HB3  H   3.336 
  12 PHE   N  N 119.907 
  13 LYS  CA  C   57.29 
  13 LYS  CB  C  30.174 
  13 LYS  CG  C  26.279 
  13 LYS  CD  C  33.612 
  13 LYS   H  H   9.161 
  13 LYS  HA  H   3.904 
  13 LYS HB2  H   1.681 
  13 LYS HB3  H   1.681 
  13 LYS HG2  H   1.886 
  13 LYS HG3  H   1.886 
  13 LYS HD2  H   2.213 
  13 LYS HD3  H   2.213 
  13 LYS   N  N 121.208 
  14 GLU  CA  C   56.46 
  14 GLU  CB  C  26.623 
  14 GLU  CG  C  33.497 
  14 GLU   H  H    7.98 
  14 GLU  HA  H   3.953 
  14 GLU HB2  H   1.947 
  14 GLU HB3  H   1.947 
  14 GLU HG2  H   2.225 
  14 GLU HG3  H   2.225 
  14 GLU   N  N 120.226 
  15 ALA  CA  C   52.75 
  15 ALA  CB  C  16.425 
  15 ALA   H  H   7.563 
  15 ALA  HA  H    4.17 
  15 ALA  HB  H   1.536 
  15 ALA   N  N 120.572 
  16 PHE  CA  C   59.54 
  16 PHE  CB  C   36.82 
  16 PHE   H  H   8.453 
  16 PHE  HA  H   3.904 
  16 PHE HB2  H   2.732 
  16 PHE HB3  H   2.732 
  16 PHE   N  N 117.784 
  17 SER  CA  C   58.56 
  17 SER  CB  C  60.651 
  17 SER   H  H   8.351 
  17 SER  HA  H   4.086 
  17 SER HB2  H   3.892 
  17 SER HB3  H   3.892 
  17 SER   N  N 110.774 
  18 LEU  CA  C  55.839 
  18 LEU  CB  C  39.111 
  18 LEU  CG  C  26.279 
  18 LEU CD1  C  20.435 
  18 LEU CD2  C  23.758 
  18 LEU   H  H   7.278 
  18 LEU  HA  H   3.614 
  18 LEU HB2  H   1.729 
  18 LEU HB3  H   1.729 
  18 LEU HD1  H   0.859 
  18 LEU HD2  H   0.737 
  18 LEU   N  N 120.947 
  19 PHE  CA  C   56.87 
  19 PHE  CB  C  33.841 
  19 PHE   H  H   7.304 
  19 PHE  HA  H   3.904 
  19 PHE HB2  H   2.225 
  19 PHE HB3  H   2.225 
  19 PHE   N  N 114.458 
  20 ASP  CA  C  50.454 
  20 ASP  CB  C  37.622 
  20 ASP   H  H   7.233 
  20 ASP  HA  H   4.874 
  20 ASP HB2  H   2.237 
  20 ASP HB3  H   2.237 
  20 ASP   N  N 122.233 
  21 LYS  CA  C  56.025 
  21 LYS  CB  C  29.601 
  21 LYS  CG  C  21.467 
  21 LYS  CD  C   25.82 
  21 LYS  CE  C  39.226 
  21 LYS   H  H   8.007 
  21 LYS  HA  H   3.771 
  21 LYS HB2  H   1.669 
  21 LYS HB3  H   1.669 
  21 LYS HG2  H   1.306 
  21 LYS HG3  H   1.306 
  21 LYS HD2  H   1.536 
  21 LYS HD3  H   1.536 
  21 LYS HE2  H   2.853 
  21 LYS HE3  H   2.853 
  21 LYS   N  N 123.433 
  22 ASP  CA  C  50.683 
  22 ASP  CB  C  37.049 
  22 ASP   H  H   8.641 
  22 ASP  HA  H     4.4 
  22 ASP HB2  H   2.913 
  22 ASP HB3  H   2.527 
  22 ASP   N  N  116.89 
  23 GLY  CA  C  43.745 
  23 GLY   H  H   7.938 
  23 GLY HA2  H    3.76 
  23 GLY HA3  H    3.76 
  23 GLY   N  N 110.068 
  24 ASP  CA  C   51.04 
  24 ASP  CB  C  37.438 
  24 ASP   H  H   8.723 
  24 ASP  HA  H   4.367 
  24 ASP HB2  H   2.927 
  24 ASP HB3  H   2.542 
  24 ASP   N  N 120.219 
  25 GLY  CA  C   42.68 
  25 GLY   H  H  10.132 
  25 GLY HA2  H   3.752 
  25 GLY HA3  H   3.963 
  25 GLY   N  N 111.889 
  26 THR  CA  C   56.95 
  26 THR  CB  C  70.234 
  26 THR CG2  C  18.832 
  26 THR   H  H   7.507 
  26 THR  HA  H   5.386 
  26 THR  HB  H   3.893 
  26 THR HG2  H   0.925 
  26 THR   N  N 109.844 
  27 ILE  CA  C   58.36 
  27 ILE  CB  C  35.559 
  27 ILE CG1  C   27.31 
  27 ILE CG2  C  14.592 
  27 ILE CD1  C  10.468 
  27 ILE   H  H   8.191 
  27 ILE  HA  H   3.891 
  27 ILE  HB  H   1.701 
  27 ILE HG12 H   1.538 
  27 ILE HG13 H   1.538 
  27 ILE HG2  H   0.786 
  27 ILE HD1  H   0.655 
  27 ILE   N  N 110.289 
  28 THR  CA  C  57.787 
  28 THR  CB  C  68.099 
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  28 THR CG2  C  18.831 
  28 THR   H  H   8.265 
  28 THR  HA  H   4.895 
  28 THR  HB  H   4.593 
  28 THR HG2  H   1.161 
  28 THR   N  N 110.507 
  29 THR  CA  C   63.84 
  29 THR  CB  C  65.807 
  29 THR CG2  C  18.831 
  29 THR   H  H   8.225 
  29 THR  HA  H   3.941 
  29 THR  HB  H   4.146 
  29 THR HG2  H   1.065 
  29 THR   N  N 112.331 
  30 LYS  CA  C  55.839 
  30 LYS  CB  C  29.372 
  30 LYS  CG  C   21.81 
  30 LYS  CD  C  25.935 
  30 LYS   H  H   7.559 
  30 LYS  HA  H   3.965 
  30 LYS HB2  H   1.669 
  30 LYS HB3  H   1.669 
  30 LYS HG2  H   1.306 
  30 LYS HG3  H   1.306 
  30 LYS HD2  H   1.983 
  30 LYS HD3  H   1.983 
  30 LYS   N  N 118.985 
  31 GLU  CA  C   57.14 
  31 GLU  CB  C  26.393 
  31 GLU  CG  C  33.841 
  31 GLU   H  H   7.431 
  31 GLU  HA  H   3.965 
  31 GLU HB2  H   1.898 
  31 GLU HB3  H   1.898 
  31 GLU HG2  H   2.201 
  31 GLU HG3  H   2.201 
  31 GLU   N  N 117.233 
  32 LEU  CA  C   55.52 
  32 LEU  CB  C  39.226 
  32 LEU  CG  C  24.331 
  32 LEU CD1  C  21.581 
  32 LEU CD2  C  20.321 
  32 LEU   H  H    7.27 
  32 LEU  HA  H    3.88 
  32 LEU HB2  H   1.584 
  32 LEU HB3  H   1.584 
  32 LEU  HG  H   1.476 
  32 LEU HD1  H   0.654 
  32 LEU HD2  H   0.859 
  32 LEU   N  N 120.701 
  33 GLY  CA  C  45.642 
  33 GLY   H  H   8.737 
  33 GLY HA2  H   3.699 
  33 GLY HA3  H   3.348 
  33 GLY   N  N 105.217 
  34 THR  CA  C  63.859 
  34 THR  CB  C  65.807 
  34 THR CG2  C  18.717 
  34 THR   H  H   7.446 
  34 THR  HA  H   3.916 
  34 THR  HB  H   4.157 
  34 THR HG2  H   1.077 
  34 THR   N  N 118.196 
  35 VAL  CA  C  64.088 
  35 VAL  CB  C  28.799 
  35 VAL CG1  C   20.55 
  35 VAL CG2  C  18.029 
  35 VAL   H  H   7.889 
  35 VAL  HA  H   3.373 
  35 VAL  HB  H   2.056 
  35 VAL HG1  H   0.811 
  35 VAL HG2  H   0.448 
  35 VAL   N  N 122.546 
  36 MET  CA  C   56.87 
  36 MET  CB  C  26.279 
  36 MET  CG  C  33.841 
  36 MET   H  H   8.386 
  36 MET  HA  H    3.88 
  36 MET HB2  H   1.778 
  36 MET HB3  H   1.778 
  36 MET HG2  H   2.225 
  36 MET HG3  H   2.225 
  36 MET   N  N 118.307 
  37 ARG  CA  C   56.17 
  37 ARG  CB  C   27.31 
  37 ARG  CG  C  25.018 
  37 ARG  CD  C  40.715 
  37 ARG   H  H   8.451 
  37 ARG  HA  H   3.904 
  37 ARG HB2  H   1.776 
  37 ARG HB3  H   1.776 
  37 ARG HG2  H   1.814 
  37 ARG HG3  H   1.814 
  37 ARG HD2  H   3.046 
  37 ARG HD3  H   3.046 
  37 ARG   N  N 119.233 
  38 SER  CA  C   59.25 
  38 SER  CB  C  67.411 
  38 SER   H  H    8.04 
  38 SER  HA  H   4.176 
  38 SER HB2  H   4.098 
  38 SER HB3  H   4.098 
  38 SER   N  N  118.72 
  39 LEU  CA  C   51.33 
  39 LEU  CB  C  40.257 
  39 LEU  CG  C  23.987 
  39 LEU CD1  C  20.894 
  39 LEU   H  H   7.263 
  39 LEU  HA  H    4.46 
  39 LEU HB2  H   1.741 
  39 LEU HB3  H   1.741 
  39 LEU  HG  H   1.524 
  39 LEU HD1  H   0.992 
  39 LEU   N  N 120.896 
  40 GLY  CA  C   42.88 
  40 GLY   H  H   7.841 
  40 GLY HA2  H   4.122 
  40 GLY HA3  H   3.687 
  40 GLY   N  N 106.917 
  41 GLN  CA  C  52.631 
  41 GLN  CB  C  30.747 
  41 GLN  CG  C   35.33 
  41 GLN   H  H   7.687 
  41 GLN  HA  H   4.243 
  41 GLN HB2  H   2.176 
  41 GLN HB3  H   2.176 
  41 GLN HG2  H   2.696 
  41 GLN HG3  H   2.696 
  41 GLN   N  N 117.171 
  42 ASN  CA  C   48.64 
  42 ASN  CB  C  36.591 
  42 ASN   H  H   8.601 
  42 ASN  HA  H   5.016 
  42 ASN HB2  H   2.611 
  42 ASN HB3  H    2.37 
  42 ASN   N  N 116.423 
  44 THR  CA  C   57.64 
  44 THR  CB  C  68.328 
  44 THR CG2  C  18.831 
  44 THR   H  H   8.711 
  44 THR  HA  H   4.279 
  44 THR  HB  H   4.638 
  44 THR HG2  H   1.186 
  44 THR   N  N 113.033 
  45 GLU  CA  C  56.756 
  45 GLU  CB  C  26.393 
  45 GLU  CG  C  33.726 
  45 GLU   H  H   8.781 
  45 GLU  HA  H   3.892 
  45 GLU HB2  H   1.886 
  45 GLU HB3  H   1.886 
  45 GLU HG2  H   2.225 
  45 GLU HG3  H   2.225 
  45 GLU   N  N 120.233 
  46 ALA  CA  C   52.31 
  46 ALA  CB  C  15.394 
  46 ALA   H  H   8.251 
  46 ALA  HA  H   3.868 
  46 ALA  HB  H   1.255 
  46 ALA   N  N 120.833 
  47 GLU  CA  C  56.641 
  47 GLU  CB  C  26.623 
  47 GLU  CG  C  33.841 
  47 GLU   H  H   7.668 
  47 GLU  HA  H   3.965 
  47 GLU HB2  H   1.923 
  47 GLU HB3  H   1.923 
  47 GLU HG2  H   2.225 
  47 GLU HG3  H   2.225 
  47 GLU   N  N 118.672 
  48 LEU  CA  C   55.61 
  48 LEU  CB  C   39.34 
  48 LEU  CG  C  24.216 
  48 LEU CD1  C  21.696 
  48 LEU CD2  C  20.665 
  48 LEU   H  H   8.244 
  48 LEU  HA  H   3.892 
  48 LEU HB2  H   1.633 
  48 LEU HB3  H   1.633 
  48 LEU  HG  H     1.5 
  48 LEU HD1  H   0.678 
  48 LEU HD2  H   0.896 
  48 LEU   N  N 119.645 
  49 GLN  CA  C  56.756 
  49 GLN  CB  C  26.508 
  49 GLN  CG  C  33.841 
  49 GLN   H  H    7.98 
  49 GLN  HA  H   3.892 
  49 GLN HB2  H   1.911 
  49 GLN HB3  H   1.911 
  49 GLN HG2  H   2.225 
  49 GLN HG3  H   2.225 
  49 GLN   N  N 117.446 
  50 ASP  CA  C    54.7 
  50 ASP  CB  C  37.622 
  50 ASP   H  H   7.761 
  50 ASP  HA  H   4.267 
  50 ASP HB2  H   2.611 
  50 ASP HB3  H   2.611 
  50 ASP   N  N 118.733 
  51 MET  CA  C   56.56 
  51 MET  CB  C  29.601 
  51 MET   H  H     7.9 
  51 MET  HA  H   3.892 
  51 MET HB2  H   1.681 
  51 MET HB3  H   1.681 
  51 MET   N  N 118.996 
  52 ILE  CA  C  62.484 
  52 ILE  CB  C   35.33 
  52 ILE CG1  C  27.539 
  52 ILE CG2  C  14.478 
  52 ILE CD1  C  10.582 
  52 ILE   H  H   8.261 
  52 ILE  HA  H   3.348 
  52 ILE  HB  H   1.705 
  52 ILE HG12 H   0.763 
  52 ILE HG13 H   0.666 
  52 ILE HG2  H   0.763 
  52 ILE HD1  H   0.642 
  52 ILE   N  N 118.833 
  53 ASN  CA  C   53.09 
  53 ASN  CB  C   35.33 
  53 ASN   H  H   8.186 
  53 ASN  HA  H   4.243 
  53 ASN HB2  H   2.684 
  53 ASN HB3  H   2.684 
  53 ASN   N  N 117.296 
  54 GLU  CA  C  56.412 
  54 GLU  CB  C  26.508 
  54 GLU  CG  C  33.612 
  54 GLU   H  H   7.501 
  54 GLU  HA  H   3.965 
  54 GLU HB2  H   1.983 
  54 GLU HB3  H   1.983 
  54 GLU HG2  H   2.213 
  54 GLU HG3  H   2.213 
  54 GLU   N  N 117.133 
  55 VAL  CA  C  59.505 
  55 VAL  CB  C  30.174 
  55 VAL CG1  C  18.717 
  55 VAL   H  H   7.575 
  55 VAL  HA  H   4.194 
  55 VAL  HB  H   2.128 
  55 VAL HG1  H   0.811 
  55 VAL HG2  H   0.811 
  55 VAL   N  N 112.928 
  56 ASP  CA  C   50.99 
  56 ASP  CB  C   36.82 
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  56 ASP   H  H   8.401 
  56 ASP  HA  H   4.388 
  56 ASP HB2  H   2.938 
  56 ASP HB3  H   2.527 
  56 ASP   N  N 121.771 
  57 ALA  CA  C  52.402 
  57 ALA  CB  C   15.28 
  57 ALA   H  H   8.097 
  57 ALA  HA  H   4.001 
  57 ALA  HB  H   1.343 
  57 ALA   N  N 124.771 
  58 ASP  CA  C  50.798 
  58 ASP  CB  C  36.934 
  58 ASP   H  H   8.376 
  58 ASP  HA  H     4.4 
  58 ASP HB2  H   2.926 
  58 ASP HB3  H   2.515 
  58 ASP   N  N 114.518 
  59 GLY  CA  C   44.49 
  59 GLY   H  H   7.827 
  59 GLY HA2  H   3.759 
  59 GLY HA3  H   3.759 
  59 GLY   N  N 108.798 
  60 ASN  CA  C  51.943 
  60 ASN  CB  C  38.424 
  60 ASN   H  H   9.253 
  60 ASN  HA  H   4.688 
  60 ASN HB2  H   2.623 
  60 ASN HB3  H   2.623 
  60 ASN   N  N 119.696 
  61 GLY  CA  C   42.87 
  61 GLY   H  H  10.004 
  61 GLY HA2  H    4.11 
  61 GLY HA3  H   3.687 
  61 GLY   N  N 110.108 
  62 THR  CA  C  59.162 
  62 THR  CB  C  67.526 
  62 THR CG2  C  18.602 
  62 THR   H  H   7.481 
  62 THR  HA  H   4.629 
  62 THR  HB  H   4.098 
  62 THR HG2  H   1.065 
  62 THR   N  N 110.533 
  63 ILE  CA  C  60.537 
  63 ILE  CB  C  36.018 
  63 ILE CG1  C  24.904 
  63 ILE CG2  C  14.478 
  63 ILE CD1  C    9.78 
  63 ILE   H  H    8.82 
  63 ILE  HA  H   3.783 
  63 ILE  HB  H   1.838 
  63 ILE HG12 H   1.548 
  63 ILE HG13 H   1.548 
  63 ILE HG2  H   0.763 
  63 ILE HD1  H   0.726 
  63 ILE   N  N 118.533 
  64 ASP  CA  C  51.027 
  64 ASP  CB  C  37.278 
  64 ASP   H  H    8.38 
  64 ASP  HA  H   4.327 
  64 ASP HB2  H   2.515 
  64 ASP HB3  H   2.515 
  64 ASP   N  N 122.928 
  65 PHE  CA  C   56.87 
  65 PHE  CB  C  33.497 
  65 PHE   H  H   8.559 
  65 PHE  HA  H    3.88 
  65 PHE HB2  H     2.2 
  65 PHE HB3  H     2.2 
  65 PHE   N  N 118.559 
  67 GLU  CA  C   56.87 
  67 GLU  CB  C  26.623 
  67 GLU  CG  C  33.955 
  67 GLU   H  H   7.995 
  67 GLU  HA  H   3.904 
  67 GLU HB2  H   1.902 
  67 GLU HB3  H   1.902 
  67 GLU HG2  H   2.213 
  67 GLU HG3  H   2.213 
  67 GLU   N  N 117.546 
  68 PHE  CA  C  59.047 
  68 PHE  CB  C  36.934 
  68 PHE   H  H   8.377 
  68 PHE  HA  H   3.904 
  68 PHE HB2  H    2.95 
  68 PHE HB3  H    2.95 
  68 PHE   N  N 122.032 
  69 LEU  CA  C  55.158 
  69 LEU  CB  C  38.195 
  69 LEU  CG  C  22.727 
  69 LEU CD1  C  21.238 
  69 LEU CD2  C  22.727 
  69 LEU   H  H   8.393 
  69 LEU  HA  H   3.179 
  69 LEU HB2  H    1.27 
  69 LEU HB3  H   1.065 
  69 LEU  HG  H   0.775 
  69 LEU HD1  H   0.569 
  69 LEU   N  N 118.488 
  70 THR  CA  C   63.63 
  70 THR  CB  C  65.578 
  70 THR CG2  C  18.946 
  70 THR   H  H   7.658 
  70 THR  HA  H   3.638 
  70 THR  HB  H   4.122 
  70 THR HG2  H   1.065 
  70 THR   N  N 115.208 
  71 MET  CA  C  56.303 
  71 MET  CB  C  29.831 
  71 MET  CG  C  29.487 
  71 MET   H  H   7.653 
  71 MET  HA  H   3.892 
  71 MET HB2  H   1.693 
  71 MET HB3  H   1.693 
  71 MET HG2  H   2.249 
  71 MET HG3  H   2.249 
  71 MET   N  N 121.221 
  72 MET  CA  C  53.777 
  72 MET  CB  C  29.029 
  72 MET  CG  C  28.799 
  72 MET   H  H   7.956 
  72 MET  HA  H   3.892 
  72 MET HB2  H   1.753 
  72 MET HB3  H   1.753 
  72 MET HG2  H   2.056 
  72 MET HG3  H   2.056 
  72 MET   N  N 117.459 
  73 ALA  CA  C  52.402 
  73 ALA  CB  C   15.28 
  73 ALA   H  H    8.23 
  73 ALA  HA  H   3.868 
  73 ALA  HB  H   1.258 
  73 ALA   N  N 120.856 
  74 ARG  CA  C  56.297 
  74 ARG  CB  C  27.997 
  74 ARG  CG  C  25.591 
  74 ARG  CD  C   40.83 
  74 ARG   H  H   7.409 
  74 ARG  HA  H   3.892 
  74 ARG HB2  H   1.766 
  74 ARG HB3  H   1.766 
  74 ARG HG2  H   1.729 
  74 ARG HG3  H   1.729 
  74 ARG HD2  H   3.034 
  74 ARG HD3  H   3.034 
  74 ARG   N  N  116.53 
  75 LYS  CA  C  55.495 
  75 LYS  CB  C  26.279 
  75 LYS  CG  C   22.04 
  75 LYS  CD  C  30.289 
  75 LYS  CE  C  39.455 
  75 LYS   H  H   7.657 
  75 LYS  HA  H   3.965 
  75 LYS HB2  H   1.524 
  75 LYS HB3  H   1.524 
  75 LYS HG2  H   1.306 
  75 LYS HG3  H   1.306 
  75 LYS HD2  H   1.669 
  75 LYS HD3  H   1.669 
  75 LYS   N  N 118.008 
  76 MET  CA  C  53.947 
  76 MET  CB  C  29.487 
  76 MET  CG  C   30.06 
  76 MET   H  H   7.883 
  76 MET  HA  H   4.146 
  76 MET HB2  H   2.043 
  76 MET HB3  H   2.043 
  76 MET HG2  H   2.478 
  76 MET HG3  H   2.478 
  76 MET   N  N 117.646 
  77 LYS  CA  C  56.526 
  77 LYS  CB  C  27.425 
  77 LYS  CG  C  26.279 
  77 LYS  CD  C  33.497 
  77 LYS  CE  C   40.83 
  77 LYS   H  H   7.658 
  77 LYS  HA  H   3.941 
  77 LYS HB2  H    1.79 
  77 LYS HB3  H    1.79 
  77 LYS HG2  H   1.923 
  77 LYS HG3  H   1.923 
  77 LYS HD2  H   2.201 
  77 LYS HD3  H   2.201 
  77 LYS   N  N 120.334 
  78 ASP  CA  C  52.516 
  78 ASP  CB  C  40.028 
  78 ASP   H  H   8.212 
  78 ASP  HA  H   4.194 
  78 ASP HB2  H   1.741 
  78 ASP HB3  H   1.741 
  78 ASP   N  N 121.733 
  79 THR  CA  C  59.391 
  79 THR  CB  C  67.067 
  79 THR CG2  C  18.717 
  79 THR   H  H   8.048 
  79 THR  HA  H    4.17 
  79 THR  HB  H   4.146 
  79 THR HG2  H   1.053 
  79 THR   N  N 114.651 
  80 ASP  CA  C   50.85 
  80 ASP  CB  C  36.705 
  80 ASP   H  H   8.432 
  80 ASP  HA  H   4.363 
  80 ASP HB2  H   2.515 
  80 ASP HB3  H   2.515 
  80 ASP   N  N 122.484 
  81 SER  CA  C   56.87 
  81 SER  CB  C  60.884 
  81 SER   H  H   8.403 
  81 SER  HA  H   4.267 
  81 SER HB2  H   3.904 
  81 SER HB3  H   3.904 
  81 SER   N  N 117.135 
  82 GLU  CA  C  56.707 
  82 GLU  CB  C  29.831 
  82 GLU  CG  C  33.468 
  82 GLU   H  H   8.443 
  82 GLU  HA  H   3.883 
  82 GLU HB2  H    1.85 
  82 GLU HG2  H   2.213 
  82 GLU   N  N 121.723 
  83 GLU  CA  C  56.606 
  83 GLU  CB  C  29.364 
  83 GLU  CG  C  33.582 
  83 GLU   H  H   8.118 
  83 GLU  HA  H   3.883 
  83 GLU HB2  H   1.669 
  83 GLU HB3  H   1.669 
  83 GLU HG2  H   2.219 
  83 GLU HG3  H   2.219 
  83 GLU   N  N 119.259 
  84 GLU  CA  C  56.606 
  84 GLU  CB  C  25.817 
  84 GLU  CG  C   33.47 
  84 GLU   H  H   8.212 
  84 GLU  HA  H   3.871 
  84 GLU HB2  H   1.983 
  84 GLU HB3  H   1.983 
  84 GLU HG2  H   2.226 
  84 GLU HG3  H   2.226 
  84 GLU   N  N  118.06 
  85 ILE  CA  C  62.484 
  85 ILE  CB  C  35.445 
  85 ILE CG1  C  26.898 
  85 ILE CG2  C  16.092 
  85 ILE CD1  C  10.212 
  85 ILE   H  H   7.964 
  85 ILE  HA  H   3.678 
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  85 ILE  HB  H   1.705 
  85 ILE HG12 H   0.654 
  85 ILE HG13 H   0.654 
  85 ILE HG2  H   0.992 
  85 ILE HD1  H   0.642 
  85 ILE   N  N 120.736 
  86 ARG  CA  C  56.985 
  86 ARG  CB  C  26.856 
  86 ARG  CG  C   24.69 
  86 ARG  CD  C  40.536 
  86 ARG   H  H   8.351 
  86 ARG  HA  H   3.989 
  86 ARG HB2  H   1.935 
  86 ARG HB3  H   1.935 
  86 ARG HG2  H   1.512 
  86 ARG HG3  H   1.512 
  86 ARG HD2  H   2.841 
  86 ARG HD3  H   2.841 
  86 ARG   N  N 121.452 
  87 GLU  CA  C  56.606 
  87 GLU  CB  C  25.817 
  87 GLU  CG  C  33.698 
  87 GLU   H  H   8.238 
  87 GLU  HA  H   3.861 
  87 GLU HB2  H    1.89 
  87 GLU HB3  H    1.89 
  87 GLU HG2  H   2.213 
  87 GLU HG3  H   2.213 
  87 GLU   N  N 118.288 
  88 ALA  CA  C  52.263 
  88 ALA  CB  C   15.08 
  88 ALA   H  H    7.96 
  88 ALA  HA  H   4.013 
  88 ALA  HB  H   1.657 
  88 ALA   N  N 120.408 
  89 PHE  CA  C  59.703 
  89 PHE  CB  C  36.774 
  89 PHE   H  H   8.498 
  89 PHE  HA  H   3.058 
  89 PHE HB2  H   2.732 
  89 PHE HB3  H   2.732 
  89 PHE HD1  H   6.478 
  89 PHE HD2  H   6.478 
  89 PHE HE1  H   7.054 
  89 PHE HE2  H   7.054 
  89 PHE   N  N 118.123 
  90 ARG  CA  C  56.168 
  90 ARG  CB  C  27.654 
  90 ARG  CG  C  25.716 
  90 ARG  CD  C  40.764 
  90 ARG   H  H    7.86 
  90 ARG  HA  H   3.892 
  90 ARG HB2  H    1.79 
  90 ARG HB3  H    1.79 
  90 ARG HG2  H   1.995 
  90 ARG HG3  H   1.995 
  90 ARG HD2  H   3.046 
  90 ARG HD3  H   3.046 
  90 ARG   N  N 116.002 
  91 VAL  CA  C  63.357 
  91 VAL  CB  C  28.444 
  91 VAL CG1  C  18.164 
  91 VAL CG2  C  19.877 
  91 VAL   H  H     7.3 
  91 VAL  HA  H   3.243 
  91 VAL  HB  H   1.901 
  91 VAL HG1  H   0.376 
  91 VAL HG2  H   0.835 
  91 VAL   N  N 118.008 
  92 PHE  CA  C  57.558 
  92 PHE  CB  C  38.838 
  92 PHE   H  H   6.805 
  92 PHE  HA  H   3.967 
  92 PHE HB2  H   2.478 
  92 PHE HB3  H   2.478 
  92 PHE HD1  H   6.373 
  92 PHE HD2  H   6.373 
  92 PHE   N  N 113.024 
  93 ASP  CA  C  49.525 
  93 ASP  CB  C  35.788 
  93 ASP   H  H   8.018 
  93 ASP  HA  H   4.496 
  93 ASP HB2  H   2.517 
  93 ASP HB3  H   2.517 
  93 ASP   N  N 116.393 
  94 LYS  CA  C  56.183 
  94 LYS  CB  C  29.945 
  94 LYS  CG  C  25.246 
  94 LYS  CD  C  27.644 
  94 LYS  CE  C  40.944 
  94 LYS   H  H   7.721 
  94 LYS  HA  H   3.892 
  94 LYS HB2  H   1.667 
  94 LYS HB3  H   1.667 
  94 LYS HG2  H   1.524 
  94 LYS HG3  H   1.524 
  94 LYS HD2  H    1.79 
  94 LYS HD3  H    1.79 
  94 LYS HE2  H   3.034 
  94 LYS HE3  H   3.034 
  94 LYS   N  N 125.158 
  95 ASP  CA  C  50.683 
  95 ASP  CB  C  36.774 
  95 ASP   H  H   8.156 
  95 ASP  HA  H   4.415 
  95 ASP HB2  H   2.924 
  95 ASP HB3  H   2.498 
  95 ASP   N  N 113.893 
  96 GLY  CA  C  44.344 
  96 GLY   H  H   7.717 
  96 GLY HA2  H   3.711 
  96 GLY HA3  H   3.711 
  96 GLY   N  N 108.799 
  97 ASN  CA  C  49.916 
  97 ASN  CB  C  35.183 
  97 ASN   H  H   8.312 
  97 ASN  HA  H     4.5 
  97 ASN HB2  H   2.527 
  97 ASN HB3  H   2.527 
  97 ASN   N  N 119.381 
  98 GLY  CA  C  42.434 
  98 GLY   H  H  10.555 
  98 GLY HA2  H   3.339 
  98 GLY HA3  H   3.972 
  98 GLY   N  N  112.33 
  99 TYR  CA  C  53.582 
  99 TYR  CB  C  39.981 
  99 TYR   H  H    7.65 
  99 TYR  HA  H   4.871 
  99 TYR HB2  H   2.474 
  99 TYR HB3  H   2.474 
  99 TYR HD1  H   6.736 
  99 TYR HD2  H   6.736 
  99 TYR   N  N 116.075 
 100 ILE  CA  C  58.616 
 100 ILE  CB  C  35.903 
 100 ILE CG1  C  24.234 
 100 ILE CG2  C  14.443 
 100 ILE CD1  C  10.582 
 100 ILE   H  H  10.037 
 100 ILE  HA  H   4.493 
 100 ILE  HB  H   1.705 
 100 ILE HG12 H   1.245 
 100 ILE HG13 H   1.245 
 100 ILE HG2  H   0.774 
 100 ILE HD1  H   0.669 
 100 ILE   N  N 126.834 
 101 SER  CA  C  52.897 
 101 SER  CB  C  64.134 
 101 SER   H  H   8.904 
 101 SER  HA  H   4.738 
 101 SER HB2  H   3.818 
 101 SER HB3  H   3.818 
 101 SER   N  N 123.486 
 102 ALA  CA  C  53.093 
 102 ALA  CB  C  15.114 
 102 ALA   H  H   9.246 
 102 ALA  HA  H   3.747 
 102 ALA  HB  H   1.331 
 102 ALA   N  N 122.796 
 103 ALA  CA  C  52.409 
 103 ALA  CB  C  15.456 
 103 ALA   H  H   8.214 
 103 ALA  HA  H   3.861 
 103 ALA  HB  H   1.262 
 103 ALA   N  N 118.362 
 104 GLU  CA  C  56.563 
 104 GLU  CB  C    26.4 
 104 GLU  CG  C  33.582 
 104 GLU   H  H   7.864 
 104 GLU  HA  H   3.904 
 104 GLU HB2  H   1.917 
 104 GLU HB3  H   1.917 
 104 GLU HG2  H   2.225 
 104 GLU HG3  H   2.225 
 104 GLU   N  N 120.187 
 105 LEU  CA  C  55.732 
 105 LEU  CB  C   39.34 
 105 LEU  CG  C  24.102 
 105 LEU CD1  C  21.696 
 105 LEU CD2  C  20.321 
 105 LEU   H  H   8.341 
 105 LEU  HA  H   3.892 
 105 LEU HB2  H   1.743 
 105 LEU HB3  H   1.743 
 105 LEU  HG  H   1.488 
 105 LEU HD1  H   0.666 
 105 LEU HD2  H   0.896 
 105 LEU   N  N  121.05 
 106 ARG  CA  C  55.724 
 106 ARG  CB  C  29.945 
 106 ARG  CG  C  25.944 
 106 ARG  CD  C  39.054 
 106 ARG   H  H   8.852 
 106 ARG  HA  H   3.904 
 106 ARG HB2  H   1.686 
 106 ARG HB3  H   1.686 
 106 ARG HG2  H   1.524 
 106 ARG HG3  H   1.524 
 106 ARG HD2  H   2.636 
 106 ARG HD3  H   2.853 
 106 ARG   N  N 118.494 
 107 HIS  CA  C  56.807 
 107 HIS  CB  C  27.198 
 107 HIS   H  H   8.045 
 107 HIS  HA  H   3.876 
 107 HIS HB2  H   1.778 
 107 HIS HB3  H   1.778 
 107 HIS   N  N 118.921 
 108 VAL  CA  C  64.285 
 108 VAL  CB  C  28.908 
 108 VAL CG1  C  18.078 
 108 VAL CG2  C    20.7 
 108 VAL   H  H   7.766 
 108 VAL  HA  H   3.385 
 108 VAL  HB  H   2.068 
 108 VAL HG1  H   0.436 
 108 VAL HG2  H   0.835 
 108 VAL   N  N 118.991 
 109 MET  CA  C  54.461 
 109 MET  CB  C  29.706 
 109 MET  CG  C  29.706 
 109 MET   H  H   8.333 
 109 MET  HA  H   4.139 
 109 MET HB2  H   1.681 
 109 MET HB3  H   1.681 
 109 MET HG2  H   2.038 
 109 MET HG3  H   2.038 
 109 MET   N  N 115.789 
 110 THR  CA  C  63.845 
 110 THR  CB  C  66.072 
 110 THR CG2  C  18.876 
 110 THR   H  H   8.603 
 110 THR  HA  H   3.935 
 110 THR  HB  H   4.168 
 110 THR HG2  H    1.08 
 110 THR   N  N   116.7 
 111 ASN  CA  C  53.093 
 111 ASN  CB  C  35.292 
 111 ASN   H  H   7.991 
 111 ASN  HA  H   4.242 
 111 ASN HB2  H   2.689 
 111 ASN HB3  H   2.815 
 111 ASN   N  N 123.354 
 112 LEU  CA  C  52.653 
 112 LEU  CB  C  39.738 
 112 LEU  CG  C  23.094 
 112 LEU CD1  C  20.244 
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 112 LEU   H  H   7.754 
 112 LEU  HA  H   4.182 
 112 LEU HB2  H    1.75 
 112 LEU HB3  H    1.75 
 112 LEU  HG  H   1.669 
 112 LEU HD1  H   0.666 
 112 LEU HD2  H   0.666 
 112 LEU   N  N 118.291 
 113 GLY  CA  C  42.536 
 113 GLY   H  H   7.778 
 113 GLY HA2  H   4.124 
 113 GLY HA3  H   4.124 
 113 GLY   N  N 106.894 
 114 GLU  CA  C  52.067 
 114 GLU  CB  C  26.616 
 114 GLU  CG  C  30.174 
 114 GLU   H  H   7.957 
 114 GLU  HA  H   4.267 
 114 GLU HB2  H   1.518 
 114 GLU HB3  H   1.518 
 114 GLU HG2  H   2.188 
 114 GLU HG3  H   2.188 
 114 GLU   N  N 119.776 
 115 LYS  CA  C  52.848 
 115 LYS  CB  C  30.518 
 115 LYS  CG  C  26.502 
 115 LYS  CD  C  21.933 
 115 LYS   H  H   8.591 
 115 LYS  HA  H   4.255 
 115 LYS HB2  H   1.548 
 115 LYS HB3  H   1.548 
 115 LYS HG2  H   1.512 
 115 LYS HD2  H   1.246 
 115 LYS HD3  H   1.246 
 115 LYS   N  N 124.429 
 116 LEU  CA  C  51.089 
 116 LEU  CB  C  42.588 
 116 LEU  CG  C  24.804 
 116 LEU CD1  C  21.384 
 116 LEU   H  H   8.066 
 116 LEU  HA  H    4.69 
 116 LEU HB2  H   1.343 
 116 LEU HB3  H   1.343 
 116 LEU  HG  H   1.512 
 116 LEU HD1  H   0.663 
 116 LEU   N  N 124.724 
 117 THR  CA  C  57.834 
 117 THR  CB  C   68.58 
 117 THR CG2  C   18.99 
 117 THR   H  H   9.165 
 117 THR  HA  H   4.302 
 117 THR  HB  H   4.647 
 117 THR HG2  H   1.153 
 117 THR   N  N 113.912 
 118 ASP  CA  C  55.243 
 118 ASP  CB  C  37.002 
 118 ASP   H  H    8.86 
 118 ASP  HA  H   4.061 
 118 ASP HB2  H   2.604 
 118 ASP HB3  H   2.412 
 118 ASP   N  N 120.787 
 119 GLU  CA  C  57.149 
 119 GLU  CB  C  25.931 
 119 GLU  CG  C  33.812 
 119 GLU   H  H   8.618 
 119 GLU  HA  H   3.892 
 119 GLU HB2  H   1.886 
 119 GLU HB3  H   1.886 
 119 GLU HG2  H   2.203 
 119 GLU HG3  H   2.203 
 119 GLU   N  N 119.091 
 120 GLU  CA  C  56.319 
 120 GLU  CB  C   25.83 
 120 GLU  CG  C  33.696 
 120 GLU   H  H   7.659 
 120 GLU  HA  H    3.88 
 120 GLU HB2  H   1.898 
 120 GLU HB3  H   1.898 
 120 GLU HG2  H   2.213 
 120 GLU HG3  H   2.213 
 120 GLU   N  N 120.037 
 121 VAL  CA  C   64.09 
 121 VAL  CB  C   28.68 
 121 VAL CG1  C    20.7 
 121 VAL CG2  C  18.078 
 121 VAL   H  H   7.887 
 121 VAL  HA  H   3.385 
 121 VAL  HB  H   2.068 
 121 VAL HG1  H   0.823 
 121 VAL HG2  H   0.448 
 121 VAL   N  N 122.512 
 122 ASP  CA  C  54.901 
 122 ASP  CB  C  37.572 
 122 ASP   H  H   7.973 
 122 ASP  HA  H   4.157 
 122 ASP HB2  H   2.623 
 122 ASP HB3  H   2.623 
 122 ASP   N  N 119.993 
 123 GLU  CA  C  56.612 
 123 GLU  CB  C  26.172 
 123 GLU  CG  C  33.468 
 123 GLU   H  H   7.903 
 123 GLU  HA  H    3.88 
 123 GLU HB2  H   1.978 
 123 GLU HB3  H   1.978 
 123 GLU HG2  H   2.213 
 123 GLU HG3  H   2.213 
 123 GLU   N  N 119.521 
 124 MET  CA  C  56.905 
 124 MET  CB  C   29.25 
 124 MET   H  H   7.496 
 124 MET  HA  H   3.892 
 124 MET HB2  H   1.657 
 124 MET HB3  H   1.657 
 124 MET HG2  H   2.109 
 124 MET HG3  H   2.109 
 124 MET   N  N 118.961 
 125 ILE  CA  C  60.131 
 125 ILE  CB  C   33.24 
 125 ILE CG1  C  13.595 
 125 ILE CG2  C  24.789 
 125 ILE CD1  C   6.906 
 125 ILE   H  H   7.762 
 125 ILE  HA  H   3.409 
 125 ILE  HB  H   2.086 
 125 ILE HG12 H   0.593 
 125 ILE HG13 H   0.593 
 125 ILE HG2  H   1.233 
 125 ILE HD1  H   0.461 
 125 ILE   N  N 117.801 
 126 ARG  CA  C  56.673 
 126 ARG  CB  C  29.478 
 126 ARG  CG  C  26.058 
 126 ARG  CD  C  40.992 
 126 ARG   H  H   8.055 
 126 ARG  HA  H   3.883 
 126 ARG HB2  H   1.681 
 126 ARG HB3  H   1.681 
 126 ARG HG2  H   1.983 
 126 ARG HG3  H   1.983 
 126 ARG   N  N 117.729 
 127 GLU  CA  C  56.319 
 127 GLU  CB  C  26.286 
 127 GLU  CG  C  33.696 
 127 GLU   H  H     7.7 
 127 GLU  HA  H   3.861 
 127 GLU HB2  H   1.935 
 127 GLU HB3  H   1.935 
 127 GLU HG2  H   2.225 
 127 GLU HG3  H   2.225 
 127 GLU   N  N 117.539 
 128 ALA  CA  C  48.205 
 128 ALA  CB  C  19.633 
 128 ALA   H  H   7.223 
 128 ALA  HA  H     4.5 
 128 ALA  HB  H   1.282 
 128 ALA   N  N 116.677 
 129 ASP  CA  C  51.485 
 129 ASP  CB  C  38.195 
 129 ASP   H  H   7.895 
 129 ASP  HA  H    4.46 
 129 ASP HB2  H   2.517 
 129 ASP HB3  H   2.517 
 129 ASP   N  N  118.03 
 130 ILE  CA  C  60.522 
 130 ILE  CB  C   36.09 
 130 ILE CG1  C  25.032 
 130 ILE CG2  C   14.43 
 130 ILE CD1  C   9.756 
 130 ILE   H  H   8.148 
 130 ILE  HA  H   3.797 
 130 ILE  HB  H   1.837 
 130 ILE HG12 H   1.548 
 130 ILE HG13 H   1.548 
 130 ILE HG2  H   0.751 
 130 ILE HD1  H   0.708 
 130 ILE   N  N 127.693 
 131 ASP  CA  C  51.187 
 131 ASP  CB  C  37.468 
 131 ASP   H  H   8.288 
 131 ASP  HA  H   4.376 
 131 ASP HB2  H   2.517 
 131 ASP HB3  H     2.9 
 131 ASP   N  N 116.409 
 132 GLY  CA  C  44.638 
 132 GLY   H  H    7.63 
 132 GLY HA2  H    3.69 
 132 GLY HA3  H    3.69 
 132 GLY   N  N 108.363 
 133 ASP  CA  C  50.942 
 133 ASP  CB  C  37.458 
 133 ASP   H  H   8.298 
 133 ASP  HA  H   4.329 
 133 ASP HB2  H   2.938 
 133 ASP HB3  H   2.938 
 133 ASP   N  N 120.183 
 134 GLY  CA  C  43.122 
 134 GLY   H  H  10.079 
 134 GLY HA2  H   3.941 
 134 GLY HA3  H   3.288 
 134 GLY   N  N 112.149 
 135 GLN  CA  C  50.454 
 135 GLN  CB  C  30.614 
 135 GLN  CG  C  30.614 
 135 GLN   H  H   7.922 
 135 GLN  HA  H   4.844 
 135 GLN HB2  H   1.617 
 135 GLN HB3  H   1.617 
 135 GLN HG2  H   1.862 
 135 GLN HG3  H   1.862 
 135 GLN   N  N 115.069 
 136 VAL  CA  C  58.713 
 136 VAL  CB  C  31.416 
 136 VAL CG1  C  20.358 
 136 VAL CG2  C  19.104 
 136 VAL   H  H   9.046 
 136 VAL  HA  H   5.096 
 136 VAL  HB  H   2.168 
 136 VAL HG1  H    0.92 
 136 VAL HG2  H   1.137 
 136 VAL   N  N 125.107 
 137 ASN  CA  C  48.352 
 137 ASN  CB  C   35.64 
 137 ASN   H  H   9.458 
 137 ASN  HA  H   5.226 
 137 ASN HB2  H   2.964 
 137 ASN HB3  H   2.964 
 137 ASN   N  N 128.858 
 138 TYR  CA  C  59.669 
 138 TYR  CB  C  37.572 
 138 TYR   H  H   8.235 
 138 TYR  HA  H   3.603 
 138 TYR HB2  H   2.901 
 138 TYR HB3  H   2.901 
 138 TYR HD1  H   6.865 
 138 TYR HD2  H   6.865 
 138 TYR   N  N 118.481 
 139 GLU  CA  C   57.54 
 139 GLU  CB  C  26.274 
 139 GLU  CG  C  33.812 
 139 GLU   H  H   8.067 
 139 GLU  HA  H   3.868 
 139 GLU HB2  H    1.89 
 139 GLU HB3  H    1.89 
 139 GLU HG2  H   2.219 
 139 GLU HG3  H   2.219 
 139 GLU   N  N 118.474 
 140 GLU  CA  C  56.025 
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 140 GLU  CB  C  26.274 
 140 GLU  CG  C   33.24 
 140 GLU   H  H   8.742 
 140 GLU  HA  H    3.88 
 140 GLU HB2  H   1.846 
 140 GLU HB3  H   1.846 
 140 GLU HG2  H   2.197 
 140 GLU HG3  H   2.197 
 140 GLU   N  N 119.279 
 141 PHE  CA  C  59.447 
 141 PHE  CB  C  37.686 
 141 PHE   H  H   8.593 
 141 PHE  HA  H   3.602 
 141 PHE HB2  H   2.945 
 141 PHE HB3  H   2.945 
 141 PHE HD1  H    6.63 
 141 PHE HD2  H    6.63 
 141 PHE HE1  H    6.99 
 141 PHE HE2  H    6.99 
 141 PHE  HZ  H    6.39 
 141 PHE   N  N 124.141 
 142 VAL  CA  C  64.432 
 142 VAL  CB  C  28.908 
 142 VAL CG1  C  18.762 
 142 VAL CG2  C  20.586 
 142 VAL   H  H   8.776 
 142 VAL  HA  H   2.986 
 142 VAL  HB  H   1.633 
 142 VAL HG1  H   0.576 
 142 VAL HG2  H   0.291 
 142 VAL   N  N 118.383 
 143 GLN  CA  C  56.514 
 143 GLN  CB  C  25.246 
 143 GLN  CG  C  31.414 
 143 GLN   H  H   7.787 
 143 GLN  HA  H   3.671 
 143 GLN HB2  H   1.912 
 143 GLN HB3  H   1.912 
 143 GLN HG2  H   2.219 
 143 GLN HG3  H   2.219 
 143 GLN   N  N 119.891 
 144 MET  CA  C  55.683 
 144 MET  CB  C   28.11 
 144 MET   H  H    7.45 
 144 MET  HA  H   3.892 
 144 MET HB2  H   1.781 
 144 MET HB3  H   1.781 
 144 MET HG2  H   1.781 
 144 MET HG3  H   1.781 
 144 MET   N  N 118.429 
 145 MET  CA  C   53.63 
 145 MET  CB  C  29.592 
 145 MET   H  H   7.724 
 145 MET  HA  H   3.905 
 145 MET HB2  H   1.672 
 145 MET HB3  H   1.672 
 145 MET HG2  H   1.672 
 145 MET HG3  H   1.672 
 145 MET   N  N 114.145 
 146 THR  CA  C  59.251 
 146 THR  CB  C  67.896 
 146 THR CG2  C  18.534 
 146 THR   H  H     7.7 
 146 THR  HA  H    4.17 
 146 THR  HB  H   4.103 
 146 THR HG2  H   1.053 
 146 THR   N  N 108.482 
 147 ALA  CA  C  50.307 
 147 ALA  CB  C  16.336 
 147 ALA   H  H   7.291 
 147 ALA  HA  H   4.095 
 147 ALA  HB  H    1.27 
 147 ALA   N  N 126.469 
 148 LYS  CA  C  54.803 
 148 LYS  CB  C  30.843 
 148 LYS  CG  C  21.933 
 148 LYS  CD  C  26.388 
 148 LYS  CE  C  39.852 
 148 LYS   H  H   7.993 
 148 LYS  HA  H    3.92 
 148 LYS HB2  H   1.678 
 148 LYS HB3  H   1.678 
 148 LYS HG2  H   1.281 
 148 LYS HG3  H   1.281 
 148 LYS   N  N 126.503 
eNOSpThr495 peptide 
 153 THR   H  H   7.803 
 153 THR  HA  H   4.031 
 153 THR  HB  H   4.002 
 153 THR HG2  H   1.225 
 154 PHE   H  H    8.13 
 154 PHE  HA  H   4.178 
 154 PHE HB2  H   4.005 
 154 PHE HB3  H   4.005 
 155 LYS   H  H    7.86 
 155 LYS  HA  H   3.999 
 155 LYS HB2  H   2.262 
 155 LYS HB3  H   2.262 
 155 LYS HG2  H   0.824 
 155 LYS HG3  H   0.824 
 155 LYS HD2  H   1.569 
 155 LYS HD3  H   1.569 
 156 GLU   H  H   7.616 
 156 GLU  HA  H   4.152 
 156 GLU HB2  H   1.549 
 156 GLU HB3  H   1.549 
 156 GLU HG2  H   1.844 
 156 GLU HG3  H   1.844 
 157 VAL   H  H   7.338 
 157 VAL  HA  H   4.407 
 157 VAL  HB  H   1.342 
 157 VAL HG1  H   0.861 
 157 VAL HG2  H   1.065 
 158 ALA   H  H   7.164 
 159 ASN   H  H   7.482 
 160 ALA   H  H   6.872 
 161 VAL   H  H   6.569 
 161 VAL  HB  H   1.331 
 161 VAL HG1  H   0.872 
 161 VAL HG2  H   0.872 
 162 LYS   H  H   7.256 
 162 LYS HD2  H   1.383 
 162 LYS HD3  H   1.383 
 163 ILE   H  H    9.23 
 163 ILE  HA  H   4.178 
 163 ILE  HB  H   2.316 
 163 ILE HG12 H   1.336 
 163 ILE HG13 H   1.336 
 163 ILE HD1  H   1.074 
 164 SER   H  H     8.2 
 164 SER  HA  H   4.165 
 164 SER HB2  H   2.266 
 164 SER HB3  H   2.266 
 165 ALA   H  H   7.769 
 165 ALA  HA  H   4.172 
 165 ALA  HB  H   1.533 
 166 SER   H  H   8.067 
 166 SER  HA  H   4.158 
 166 SER HB2  H   2.306 
 166 SER HB3  H   2.306 
 167 LEU   H  H   7.949 
 167 LEU  HA  H   4.008 
 167 LEU HB2  H   2.276 
 167 LEU HB3  H   2.276 
 167 LEU  HG  H   1.558 
 167 LEU HD1  H   0.935 
 167 LEU HD2  H   0.853 
 168 MET   H  H   7.823 
 168 MET  HA  H   4.015 
 168 MET HB2  H   1.678 
 168 MET HB3  H   1.678 
 168 MET HG2  H   1.532 
 168 MET HG3  H   1.532 
 169 GLY   H  H   7.508 
 170 THR   H  H    6.83 
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Appendix I 
CaM34-iNOS Peptide Assigned Chemical Shifts 
_Residue_seq_code 
_Residue_label 
_Atom_name 
_Atom_type 
_Chem_shift_value 
 2 ASP CA C 51.929 
 2 ASP CB C 38.505 
 2 ASP H H 8.499 
 2 ASP HA H 4.576 
 2 ASP HB2 H 2.507 
 2 ASP HB3 H 2.507 
 2 ASP N N 120.33 
 3 GLN CA C 52.768 
 3 GLN CB C 26.518 
 3 GLN CG C 30.85 
 3 GLN H H 8.16 
 3 GLN HA H 4.198 
 3 GLN HB2 H 1.889 
 3 GLN HB3 H 1.778 
 3 GLN HG2 H 2.165 
 3 GLN HG3 H 2.165 
 3 GLN N N 119.72 
 4 LEU CA C 51.584 
 4 LEU CB C 40.83 
 4 LEU CG C 23.77 
 4 LEU CD1 C 20.686 
 4 LEU H H 7.5 
 4 LEU HA H 4.448 
 4 LEU HB2 H 1.528 
 4 LEU HB3 H 1.353 
 4 LEU HG H 1.436 
 4 LEU HD1 H 0.733 
 4 LEU HD2 H 0.68 
 4 LEU N N 120.693 
 5 THR CA C 57.873 
 5 THR CB C 68.444 
 5 THR CG2 C 18.858 
 5 THR H H 8.559 
 5 THR HA H 4.277 
 5 THR HB H 4.618 
 5 THR HG2 H 1.161 
 5 THR N N 112.728 
 6 GLU CA C 57.481 
 6 GLU CB C 26.512 
 6 GLU CG C 33.586 
 6 GLU H H 8.854 
 6 GLU HA H 3.847 
 6 GLU HB2 H 1.876 
 6 GLU HB3 H 1.876 
 6 GLU HG2 H 2.165 
 6 GLU HG3 H 2.165 
 6 GLU N N 120.254 
 7 GLU CA C 57.176 
 7 GLU CB C 26.054 
 7 GLU CG C 33.593 
 7 GLU H H 8.512 
 7 GLU HA H 3.883 
 7 GLU HB2 H 1.878 
 7 GLU HB3 H 1.878 
 7 GLU HG2 H 2.166 
 7 GLU HG3 H 2.166 
 7 GLU N N 119.498 
 8 GLN CA C 56.411 
 8 GLN CB C 26.625 
 8 GLN CG C 33.358 
 8 GLN H H 7.54 
 8 GLN HA H 3.87 
 8 GLN HB2 H 1.778 
 8 GLN HB3 H 1.887 
 8 GLN HG2 H 2.165 
 8 GLN HG3 H 2.165 
 8 GLN N N 120.119 
 9 ILE CA C 64.046 
 9 ILE CB C 34.954 
 9 ILE CG1 C 27.539 
 9 ILE CG2 C 14.518 
 9 ILE CD1 C 10.291 
 9 ILE H H 8.383 
 9 ILE HA H 3.634 
 9 ILE HB H 1.804 
 9 ILE HG1 H 0.883 
 9 ILE HG1 H 0.883 
 9 ILE HG2 H 0.936 
 9 ILE HD1 H 0.662 
 9 ILE N N 120.115 
 10 ALA CA C 52.657 
 10 ALA CB C 14.975 
 10 ALA H H 7.935 
 10 ALA HA H 3.929 
 10 ALA HB H 1.345 
 10 ALA N N 121.405 
 11 GLU CA C 56.673 
 11 GLU CB C 26.968 
 11 GLU CG C 33.472 
 11 GLU H H 7.671 
 11 GLU HA H 3.89 
 11 GLU HB2 H 1.778 
 11 GLU HB3 H 1.883 
 11 GLU HG2 H 2.165 
 11 GLU HG3 H 2.165 
 11 GLU N N 118.499 
 12 PHE CA C 59.501 
 12 PHE CB C 35.644 
 12 PHE H H 8.227 
 12 PHE HA H 3.152 
 12 PHE HB2 H 2.173 
 12 PHE HB3 H 2.173 
 12 PHE N N 117.342 
 13 LYS CA C 57.154 
 13 LYS CB C 26.169 
 13 LYS CG C 24.455 
 13 LYS CD C 29.824 
 13 LYS CE C 39.419 
 13 LYS H H 8.917 
 13 LYS HA H 3.923 
 13 LYS HB2 H 1.883 
 13 LYS HB3 H 1.883 
 13 LYS HG2 H 1.527 
 13 LYS HG3 H 1.527 
 13 LYS HD2 H 1.761 
 13 LYS HD3 H 1.761 
 13 LYS HE2 H 2.517 
 13 LYS HE3 H 2.517 
 13 LYS N N 122.871 
 14 GLU CA C 56.471 
 14 GLU CB C 26.662 
 14 GLU CG C 33.479 
 14 GLU H H 7.78 
 14 GLU HA H 3.858 
 14 GLU HB2 H 1.778 
 14 GLU HB3 H 1.883 
 14 GLU HG2 H 2.175 
 14 GLU HG3 H 2.175 
 14 GLU N N 120.129 
 15 ALA CA C 52.869 
 15 ALA CB C 15.232 
 15 ALA H H 8.102 
 15 ALA HA H 3.867 
 15 ALA HB H 1.653 
 15 ALA N N 123.561 
 16 PHE CA C 58.983 
 16 PHE CB C 36.739 
 16 PHE H H 8.425 
 16 PHE HA H 3.132 
 16 PHE HB2 H 2.135 
 16 PHE HB3 H 2.135 
 16 PHE N N 118.907 
 17 SER CA C 58.999 
 17 SER CB C 60.436 
 17 SER H H 7.89 
 17 SER HA H 3.877 
 17 SER HB2 H 3.923 
 17 SER HB3 H 3.923 
 17 SER N N 114.729 
 18 LEU CA C 54.62 
 18 LEU CB C 38.374 
 18 LEU CG C 23.668 
 18 LEU CD1 C 20.686 
 18 LEU CD2 C 22.414 
 18 LEU H H 7.18 
 18 LEU HA H 3.785 
 18 LEU HB2 H 1.6 
 18 LEU HB3 H 1.6 
 18 LEU HG H 1.528 
 18 LEU HD1 H 0.472 
 18 LEU HD2 H 0.611 
 18 LEU N N 120.066 
 19 PHE CA C 56.37 
 19 PHE CB C 39.172 
 19 PHE H H 6.993 
 19 PHE HA H 3.949 
 19 PHE HB2 H 2.801 
 19 PHE HB3 H 2.801 
 19 PHE N N 112.537 
 20 ASP CA C 49.638 
 20 ASP CB C 37.106 
 20 ASP H H 7.436 
 20 ASP HA H 4.447 
 20 ASP HB2 H 2.489 
 20 ASP HB3 H 2.489 
 20 ASP N N 117.217 
 21 LYS CA C 55.529 
 21 LYS CB C 29.596 
 21 LYS CG C 21.714 
 21 LYS CD C 26.176 
 21 LYS CE C 39.19 
 21 LYS H H 7.505 
 21 LYS HA H 3.811 
 21 LYS HB2 H 1.699 
 21 LYS HB3 H 1.699 
 21 LYS HG2 H 1.331 
 21 LYS HG3 H 1.233 
 21 LYS HD2 H 1.491 
 21 LYS HD3 H 1.491 
 21 LYS HE2 H 2.816 
 21 LYS HE3 H 2.816 
 21 LYS N N 124.296 
 22 ASP CA C 50.061 
 22 ASP CB C 36.897 
 22 ASP H H 7.825 
 22 ASP HA H 4.421 
 22 ASP HB2 H 2.485 
 22 ASP HB3 H 2.88 
 22 ASP N N 113.736 
 23 GLY CA C 44.487 
 23 GLY H H 7.504 
 23 GLY HA2 H 3.713 
 23 GLY HA3 H 3.713 
 23 GLY N N 109.075 
 24 ASP C C 174.572 
 24 ASP CA C 50.917 
 24 ASP CB C 37.683 
 24 ASP H H 8.304 
 24 ASP HA H 4.309 
 24 ASP HB2 H 2.863 
 24 ASP HB3 H 2.863 
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 24 ASP N N 120.749 
 25 GLY CA C 42.602 
 25 GLY H H 10.341 
 25 GLY HA2 H 3.529 
 25 GLY HA3 H 3.529 
 25 GLY N N 112.474 
 26 THR CA C 56.878 
 26 THR CB C 70.031 
 26 THR CG2 C 18.972 
 26 THR H H 8.01 
 26 THR HA H 5.299 
 26 THR HB H 3.666 
 26 THR HG2 H 0.866 
 26 THR N N 111.838 
 27 ILE CA C 58.255 
 27 ILE CB C 37.133 
 27 ILE CG1 C 14.89 
 27 ILE CG2 C 24.348 
 27 ILE CD1 C 11.352 
 27 ILE H H 9.735 
 27 ILE HA H 4.65 
 27 ILE HB H 1.594 
 27 ILE HG1 H 0.787 
 27 ILE HG1 H 0.787 
 27 ILE HG2 H 0.977 
 27 ILE HD1 H 0.026 
 27 ILE N N 126.257 
 28 THR CA C 56.878 
 28 THR CB C 70.009 
 28 THR CG2 C 19.543 
 28 THR H H 8.315 
 28 THR HA H 4.651 
 28 THR HB H 3.838 
 28 THR HG2 H 0.952 
 28 THR N N 116.303 
 29 THR CA C 63.742 
 29 THR CB C 65.16 
 29 THR CG2 C 20.586 
 29 THR H H 9.049 
 29 THR HA H 3.621 
 29 THR HB H 4.054 
 29 THR HG2 H 1.121 
 29 THR N N 112.277 
 30 LYS CA C 56.539 
 30 LYS CB C 29.906 
 30 LYS CG C 22.171 
 30 LYS CD C 26.397 
 30 LYS CE C 39.304 
 30 LYS H H 7.447 
 30 LYS HA H 3.949 
 30 LYS HB2 H 1.692 
 30 LYS HB3 H 1.692 
 30 LYS HG2 H 1.256 
 30 LYS HG3 H 1.331 
 30 LYS HD3 H 1.502 
 30 LYS HE2 H 2.827 
 30 LYS N N 120.776 
 31 GLU CA C 56.677 
 31 GLU CB C 27.082 
 31 GLU CG C 33.593 
 31 GLU H H 7.521 
 31 GLU HA H 3.906 
 31 GLU HB2 H 1.897 
 31 GLU HB3 H 1.897 
 31 GLU HG2 H 2.164 
 31 GLU HG3 H 2.164 
 31 GLU N N 121.064 
 32 LEU CA C 55.394 
 32 LEU CB C 39.852 
 32 LEU CG C 23.892 
 32 LEU CD1 C 20.814 
 32 LEU H H 8.687 
 32 LEU HA H 4.057 
 32 LEU HB2 H 1.705 
 32 LEU HB3 H 1.705 
 32 LEU HG H 1.53 
 32 LEU HD1 H 0.702 
 32 LEU HD2 H 0.702 
 32 LEU N N 120.376 
 33 GLY CA C 45.733 
 33 GLY H H 8.697 
 33 GLY HA2 H 3.851 
 33 GLY HA3 H 3.378 
 33 GLY N N 105.863 
 34 THR CA C 64.259 
 34 THR CB C 66.033 
 34 THR CG2 C 18.515 
 34 THR H H 7.747 
 34 THR HA H 3.779 
 34 THR HB H 4.162 
 34 THR HG2 H 1.105 
 34 THR N N 117.298 
 35 VAL CA C 64.214 
 35 VAL CB C 28.715 
 35 VAL CG1 C 17.74 
 35 VAL CG2 C 20.115 
 35 VAL H H 7.243 
 35 VAL HA H 3.405 
 35 VAL HB H 1.889 
 35 VAL HG1 H 0.295 
 35 VAL HG2 H 0.721 
 35 VAL N N 121.563 
 36 MET CA C 56.269 
 36 MET CB C 26.27 
 36 MET CG C 33.472 
 36 MET H H 8.458 
 36 MET HA H 3.901 
 36 MET HB2 H 1.891 
 36 MET HB3 H 1.891 
 36 MET HG2 H 2.16 
 36 MET HG3 H 2.16 
 36 MET N N 117.4 
 37 ARG CA C 56.337 
 37 ARG CB C 27.317 
 37 ARG CG C 24.922 
 37 ARG CD C 40.904 
 37 ARG H H 8.323 
 37 ARG HA H 3.89 
 37 ARG HB2 H 1.759 
 37 ARG HB3 H 1.759 
 37 ARG HG2 H 1.515 
 37 ARG HG3 H 1.515 
 37 ARG HD2 H 3.017 
 37 ARG HD3 H 3.017 
 37 ARG N N 118.303 
 38 SER CA C 59.635 
 38 SER CB C 60.376 
 38 SER H H 7.753 
 38 SER HA H 3.936 
 38 SER HB2 H 3.929 
 38 SER HB3 H 3.929 
 38 SER N N 119.141 
 39 LEU CA C 51.438 
 39 LEU CB C 38.391 
 39 LEU CG C 24.067 
 39 LEU CD1 C 23.359 
 39 LEU CD2 C 20.527 
 39 LEU H H 7.248 
 39 LEU HA H 4.112 
 39 LEU HB2 H 1.575 
 39 LEU HB3 H 1.575 
 39 LEU HG H 1.528 
 39 LEU HD1 H 0.57 
 39 LEU HD2 H 0.445 
 39 LEU N N 117.995 
 40 GLY CA C 42.872 
 40 GLY H H 7.626 
 40 GLY HA2 H 4.071 
 40 GLY HA3 H 4.071 
 40 GLY N N 106.739 
 41 GLN CA C 50.853 
 41 GLN CB C 27.759 
 41 GLN CG C 30.395 
 41 GLN H H 7.755 
 41 GLN HA H 4.269 
 41 GLN HB2 H 1.742 
 41 GLN HB3 H 1.742 
 41 GLN HG2 H 1.989 
 41 GLN HG3 H 1.989 
 41 GLN N N 118.046 
 42 ASN CA C 48.562 
 42 ASN CB C 36.318 
 42 ASN H H 8.54 
 42 ASN HA H 5.013 
 42 ASN HB2 H 2.606 
 42 ASN HB3 H 2.329 
 42 ASN N N 115.94 
 44 THR CA C 57.851 
 44 THR CB C 68.317 
 44 THR CG2 C 18.858 
 44 THR H H 8.663 
 44 THR HA H 4.277 
 44 THR HB H 4.625 
 44 THR HG2 H 1.154 
 44 THR N N 112.937 
 45 GLU CA C 57.245 
 45 GLU CB C 26.276 
 45 GLU CG C 33.582 
 45 GLU H H 8.651 
 45 GLU HA H 3.896 
 45 GLU HB2 H 1.876 
 45 GLU HB3 H 1.876 
 45 GLU HG2 H 2.165 
 45 GLU HG3 H 2.165 
 45 GLU N N 120.439 
 46 ALA CA C 52.316 
 46 ALA CB C 15.089 
 46 ALA H H 8.109 
 46 ALA HA H 3.923 
 46 ALA HB H 1.22 
 46 ALA N N 120.66 
 47 GLU CA C 56.508 
 47 GLU CB C 26.632 
 47 GLU CG C 33.586 
 47 GLU H H 7.532 
 47 GLU HA H 3.877 
 47 GLU HB2 H 1.878 
 47 GLU HB3 H 1.772 
 47 GLU HG2 H 2.165 
 47 GLU HG3 H 2.165 
 47 GLU N N 118.571 
 48 LEU CA C 55.327 
 48 LEU CB C 39.568 
 48 LEU CG C 29.596 
 48 LEU CD1 C 23.656 
 48 LEU CD2 C 21.16 
 48 LEU H H 8.232 
 48 LEU HA H 4.059 
 48 LEU HB2 H 1.699 
 48 LEU HB3 H 1.699 
 48 LEU HG H 1.679 
 48 LEU HD1 H 0.702 
 48 LEU HD2 H 0.78 
 48 LEU N N 120.085 
 49 GLN CA C 55.927 
 49 GLN CB C 27.145 
 49 GLN CG C 33.479 
 49 GLN H H 7.938 
 49 GLN HA H 3.913 
 49 GLN HB2 H 1.889 
 49 GLN HB3 H 1.889 
 49 GLN HG2 H 2.166 
 49 GLN HG3 H 2.166 
 49 GLN N N 118.111 
 50 ASP CA C 54.953 
 50 ASP CB C 37.278 
 50 ASP CG C 33.593 
 50 ASP H H 7.923 
 50 ASP HA H 4.021 
 50 ASP HB2 H 2.48 
 50 ASP N N 119.876 
 51 MET CA C 56.976 
 51 MET CB C 30.374 
 51 MET CG C 29.831 
 51 MET H H 7.913 
 51 MET HA H 3.847 
 51 MET HB2 H 2.394 
 51 MET HB3 H 2.65 
 51 MET HG2 H 1.743 
 51 MET HG3 H 1.743 
 51 MET N N 119.513 
 52 ILE CA C 61.675 
 52 ILE CB C 33.822 
 52 ILE CG1 C 13.604 
 52 ILE CG2 C 26.054 
 52 ILE CD1 C 8.921 
 52 ILE H H 7.681 
 52 ILE HA H 3.348 
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 52 ILE HB H 1.868 
 52 ILE HG1 H 0.568 
 52 ILE HG1 H 0.515 
 52 ILE HG2 H 1.482 
 52 ILE HD1 H 0.547 
 52 ILE N N 116.864 
 53 ASN CA C 52.97 
 53 ASN CB C 35.078 
 53 ASN H H 8.202 
 53 ASN HA H 4.263 
 53 ASN HB2 H 2.826 
 53 ASN HB3 H 2.73 
 53 ASN N N 117.493 
 54 GLU CA C 55.798 
 54 GLU CB C 26.857 
 54 GLU CG C 33.244 
 54 GLU H H 7.362 
 54 GLU HA H 3.87 
 54 GLU HB2 H 1.889 
 54 GLU HB3 H 1.889 
 54 GLU HG2 H 2.171 
 54 GLU HG3 H 2.171 
 54 GLU N N 116.857 
 55 VAL CA C 58.727 
 55 VAL CB C 30.738 
 55 VAL CG1 C 20.343 
 55 VAL CG2 C 19.519 
 55 VAL H H 7.147 
 55 VAL HA H 3.987 
 55 VAL HB H 1.91 
 55 VAL HG1 H 0.93 
 55 VAL HG2 H 0.891 
 55 VAL N N 114.264 
 56 ASP CA C 51.356 
 56 ASP CB C 38.364 
 56 ASP H H 7.86 
 56 ASP HA H 4.435 
 56 ASP HB2 H 2.506 
 56 ASP HB3 H 2.368 
 56 ASP N N 119.756 
 57 ALA CA C 51.183 
 57 ALA CB C 16.942 
 57 ALA H H 8.115 
 57 ALA HA H 4.08 
 57 ALA HB H 1.345 
 57 ALA N N 131.417 
 58 ASP CA C 50.008 
 58 ASP CB C 36.897 
 58 ASP H H 8.12 
 58 ASP HA H 4.434 
 58 ASP HB2 H 2.873 
 58 ASP HB3 H 2.485 
 58 ASP N N 114.151 
 59 GLY CA C 44.487 
 59 GLY H H 7.484 
 59 GLY HA2 H 3.717 
 59 GLY HA3 H 3.717 
 59 GLY N N 108.768 
 60 ASN C C 174.17 
 60 ASN CA C 49.974 
 60 ASN CB C 34.713 
 60 ASN H H 8.081 
 60 ASN HA H 4.428 
 60 ASN HB2 H 2.492 
 60 ASN HB3 H 2.492 
 60 ASN N N 118.77 
 61 GLY CA C 42.905 
 61 GLY H H 10.243 
 61 GLY HA2 H 3.327 
 61 GLY HA3 H 4.067 
 61 GLY N N 112.712 
 62 THR CA C 56.774 
 62 THR CB C 69.688 
 62 THR CG2 C 19.543 
 62 THR H H 7.477 
 62 THR HA H 4.649 
 62 THR HB H 3.827 
 62 THR HG2 H 0.947 
 62 THR N N 108.06 
 63 ILE CA C 57.75 
 63 ILE CB C 37.363 
 63 ILE CG1 C 24.341 
 63 ILE CG2 C 15.431 
 63 ILE CD1 C 11.319 
 63 ILE H H 8.43 
 63 ILE HA H 4.796 
 63 ILE HB H 1.855 
 63 ILE HG2 H 1.096 
 63 ILE HD1 H 0.787 
 63 ILE N N 122.617 
 64 ASP CA C 49.402 
 64 ASP CB C 39.761 
 64 ASP H H 8.996 
 64 ASP HA H 5.333 
 64 ASP HB2 H 2.814 
 64 ASP HB3 H 2.814 
 64 ASP N N 128.615 
 65 PHE CA C 60.213 
 65 PHE CB C 32.902 
 65 PHE H H 8.756 
 65 PHE HA H 3.542 
 65 PHE HB2 H 1.673 
 65 PHE HB3 H 1.673 
 65 PHE N N 118.892 
 67 GLU CA C 56.605 
 67 GLU CB C 26.397 
 67 GLU CG C 33.25 
 67 GLU H H 7.814 
 67 GLU HA H 3.899 
 67 GLU HB2 H 1.889 
 67 GLU HB3 H 1.761 
 67 GLU HG2 H 2.155 
 67 GLU HG3 H 2.155 
 67 GLU N N 119.708 
 68 PHE CA C 58.255 
 68 PHE CB C 37.591 
 68 PHE H H 8.048 
 68 PHE HA H 3.647 
 68 PHE HB2 H 2.627 
 68 PHE HB3 H 2.627 
 68 PHE N N 123.035 
 69 LEU CA C 54.774 
 69 LEU CB C 38.577 
 69 LEU CG C 23.919 
 69 LEU CD1 C 20.835 
 69 LEU CD2 C 22.549 
 69 LEU H H 8.649 
 69 LEU HA H 3.763 
 69 LEU HB2 H 1.109 
 69 LEU HB3 H 1.109 
 69 LEU HG H 1.529 
 69 LEU HD1 H 0.478 
 69 LEU HD2 H 0.603 
 69 LEU N N 119.481 
 70 THR CA C 63.861 
 70 THR CB C 66.045 
 70 THR CG2 C 18.515 
 70 THR H H 7.894 
 70 THR HA H 3.501 
 70 THR HB H 3.947 
 70 THR HG2 H 0.997 
 70 THR N N 113.842 
 71 MET CA C 56 
 71 MET CB C 29.595 
 71 MET CG C 29.481 
 71 MET H H 7.12 
 71 MET HA H 3.913 
 71 MET HB2 H 1.7 
 71 MET HB3 H 1.7 
 71 MET HG2 H 2.337 
 71 MET HG3 H 2.337 
 71 MET N N 119.518 
 72 MET CA C 54.99 
 72 MET CB C 26.617 
 72 MET CG C 29.595 
 72 MET H H 7.715 
 72 MET HA H 3.86 
 72 MET HB2 H 1.727 
 72 MET HB3 H 1.727 
 72 MET HG2 H 2.395 
 72 MET HG3 H 2.395 
 72 MET HE H 2.11 
 72 MET N N 116.386 
 73 ALA CA C 51.859 
 73 ALA CB C 15.376 
 73 ALA H H 8.318 
 73 ALA HA H 3.832 
 73 ALA HB H 1.128 
 73 ALA N N 119.953 
 74 ARG CA C 55.933 
 74 ARG CB C 29.14 
 74 ARG CG C 26.86 
 74 ARG CD C 40.675 
 74 ARG H H 7.281 
 74 ARG HA H 3.86 
 74 ARG HB2 H 1.664 
 74 ARG HB3 H 1.664 
 74 ARG HG2 H 1.762 
 74 ARG HG3 H 1.762 
 74 ARG HD2 H 3.039 
 74 ARG HD3 H 3.039 
 74 ARG N N 116.354 
 75 LYS CA C 54.788 
 75 LYS CB C 26.404 
 75 LYS CG C 21.714 
 75 LYS CD C 30.852 
 75 LYS CE C 39.419 
 75 LYS H H 7.767 
 75 LYS HA H 3.948 
 75 LYS HB2 H 1.494 
 75 LYS HB3 H 1.494 
 75 LYS HG2 H 1.223 
 75 LYS HG3 H 1.223 
 75 LYS HD2 H 1.626 
 75 LYS HD3 H 1.626 
 75 LYS HE2 H 2.805 
 75 LYS HE3 H 2.805 
 75 LYS N N 120.084 
 76 MET CA C 54.552 
 76 MET CB C 30.052 
 76 MET CG C 26.204 
 76 MET CE C 21.978 
 76 MET H H 7.941 
 76 MET HA H 3.954 
 76 MET HB2 H 1.628 
 76 MET HB3 H 1.628 
 76 MET HG2 H 1.49 
 76 MET HG3 H 1.49 
 76 MET HE H 1.226 
 76 MET N N 116.881 
 77 LYS CA C 53.307 
 77 LYS CB C 27.246 
 77 LYS CG C 21.828 
 77 LYS CD C 30.509 
 77 LYS CE C 39.419 
 77 LYS H H 7.264 
 77 LYS HA H 4.221 
 77 LYS HB2 H 1.495 
 77 LYS HB3 H 1.495 
 77 LYS HG2 H 1.229 
 77 LYS HG3 H 1.346 
 77 LYS HD2 H 1.644 
 77 LYS HD3 H 1.793 
 77 LYS HE2 H 2.805 
 77 LYS HE3 H 2.805 
 77 LYS N N 116.614 
 78 ASP CA C 51.732 
 78 ASP CB C 39.021 
 78 ASP H H 8.14 
 78 ASP HA H 4.426 
 78 ASP HB2 H 2.312 
 78 ASP HB3 H 2.312 
 78 ASP N N 123.089 
 79 THR CA C 61.15 
 79 THR CB C 66.147 
 79 THR CG2 C 18.972 
 79 THR H H 8.316 
 79 THR HA H 4.034 
 79 THR HB H 4.151 
 79 THR HG2 H 1.128 
 79 THR N N 114.423 
 80 ASP CA C 51.759 
 80 ASP CB C 37.81 
 80 ASP H H 8.24 
 80 ASP HA H 4.44 
 80 ASP HB2 H 2.506 
 80 ASP HB3 H 2.506 
 80 ASP N N 120.819 
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 81 SER CA C 57.683 
 81 SER CB C 60.664 
 81 SER H H 7.798 
 81 SER HA H 4.215 
 81 SER HB2 H 3.801 
 81 SER HB3 H 3.932 
 81 SER N N 115.729 
 82 GLU CA C 56.707 
 82 GLU CB C 26.625 
 82 GLU CG C 33.479 
 82 GLU H H 8.186 
 82 GLU HA H 3.896 
 82 GLU HB2 H 1.897 
 82 GLU HB3 H 1.897 
 82 GLU HG2 H 2.164 
 82 GLU HG3 H 2.164 
 82 GLU N N 122.083 
 83 GLU CA C 55.928 
 83 GLU CB C 26.832 
 83 GLU CG C 33.593 
 83 GLU H H 7.937 
 83 GLU HA H 3.873 
 83 GLU HB2 H 1.761 
 83 GLU HB3 H 1.889 
 83 GLU HG2 H 2.166 
 83 GLU HG3 H 2.166 
 83 GLU N N 118.04 
 84 GLU CA C 54.62 
 84 GLU CB C 26.318 
 84 GLU CG C 39.34 
 84 GLU H H 8.08 
 84 GLU HA H 3.917 
 84 GLU HB2 H 1.477 
 84 GLU HB3 H 1.477 
 84 GLU HG2 H 2.804 
 84 GLU HG3 H 2.804 
 84 GLU N N 118.604 
 85 ILE CA C 63.338 
 85 ILE CB C 34.688 
 85 ILE CG1 C 27.45 
 85 ILE CG2 C 14.324 
 85 ILE CD1 C 9.984 
 85 ILE H H 7.863 
 85 ILE HA H 3.619 
 85 ILE HB H 1.786 
 85 ILE HG1 H 0.879 
 85 ILE HG1 H 0.879 
 85 ILE HG2 H 0.938 
 85 ILE HD1 H 0.662 
 85 ILE N N 120.249 
 86 ARG CA C 57.346 
 86 ARG CB C 26.854 
 86 ARG CG C 24.569 
 86 ARG CD C 40.715 
 86 ARG H H 8.177 
 86 ARG HA H 3.925 
 86 ARG HB2 H 1.769 
 86 ARG HB3 H 1.876 
 86 ARG HG2 H 1.513 
 86 ARG HG3 H 1.513 
 86 ARG HD2 H 2.786 
 86 ARG HD3 H 2.786 
 86 ARG N N 120.64 
 87 GLU CA C 56.51 
 87 GLU CB C 26.401 
 87 GLU CG C 33.575 
 87 GLU H H 7.823 
 87 GLU HA H 3.887 
 87 GLU HB2 H 1.896 
 87 GLU HB3 H 1.896 
 87 GLU HG2 H 2.164 
 87 GLU HG3 H 2.164 
 87 GLU N N 119.782 
 88 ALA CA C 52.566 
 88 ALA CB C 14.632 
 88 ALA H H 8.194 
 88 ALA HA H 4.028 
 88 ALA HB H 1.609 
 88 ALA N N 122.318 
 89 PHE CA C 58.983 
 89 PHE CB C 36.37 
 89 PHE H H 8.406 
 89 PHE HA H 3.133 
 89 PHE HB2 H 2.183 
 89 PHE HB3 H 2.607 
 89 PHE N N 118.832 
 90 ARG CA C 55.899 
 90 ARG CB C 27.394 
 90 ARG CG C 24.993 
 90 ARG CD C 40.888 
 90 ARG H H 7.74 
 90 ARG HA H 3.893 
 90 ARG HB2 H 1.749 
 90 ARG HB3 H 1.749 
 90 ARG HG2 H 1.506 
 90 ARG HG3 H 1.506 
 90 ARG HD2 H 3.012 
 90 ARG HD3 H 3.012 
 90 ARG N N 116.969 
 91 VAL CA C 63.333 
 91 VAL CB C 28.456 
 91 VAL CG1 C 18.401 
 91 VAL CG2 C 20.229 
 91 VAL H H 7.282 
 91 VAL HA H 3.288 
 91 VAL HB H 1.848 
 91 VAL HG1 H 0.296 
 91 VAL HG2 H 0.75 
 91 VAL N N 118.958 
 92 PHE CA C 56.606 
 92 PHE CB C 39.419 
 92 PHE H H 6.822 
 92 PHE HA H 3.954 
 92 PHE HB2 H 2.798 
 92 PHE HB3 H 2.798 
 92 PHE N N 113.384 
 93 ALA CA C 48.83 
 93 ALA CB C 16.495 
 93 ALA H H 7.889 
 93 ALA HA H 3.921 
 93 ALA HB H 1.339 
 93 ALA N N 122.222 
 94 LYS CA C 54.809 
 94 LYS CB C 30.71 
 94 LYS CG C 21.791 
 94 LYS CD C 26.251 
 94 LYS CE C 39.63 
 94 LYS H H 7.836 
 94 LYS HA H 3.932 
 94 LYS HB2 H 1.624 
 94 LYS HB3 H 1.624 
 94 LYS HG2 H 1.217 
 94 LYS HG3 H 1.217 
 94 LYS HD2 H 1.486 
 94 LYS HD3 H 1.486 
 94 LYS HE2 H 2.801 
 94 LYS HE3 H 2.801 
 94 LYS N N 120.861 
 95 ASP CA C 52.162 
 95 ASP CB C 37.8 
 95 ASP H H 8.567 
 95 ASP HA H 4.434 
 95 ASP HB2 H 2.512 
 95 ASP HB3 H 2.512 
 95 ASP N N 119.161 
 96 GLY CA C 43.276 
 96 GLY H H 7.955 
 96 GLY HA2 H 3.768 
 96 GLY N N 107.207 
 97 ASN CA C 50.244 
 97 ASN CB C 36.322 
 97 ASN H H 8.109 
 97 ASN HA H 4.501 
 97 ASN HB2 H 2.486 
 97 ASN HB3 H 2.486 
 97 ASN N N 117.565 
 98 GLY CA C 42.636 
 98 GLY H H 8.429 
 98 GLY HA2 H 3.768 
 98 GLY HA3 H 3.768 
 98 GLY N N 107.108 
 99 TYR CA C 52.735 
 99 TYR CB C 37.832 
 99 TYR H H 7.019 
 99 TYR HA H 4.437 
 99 TYR HB2 H 2.502 
 99 TYR HB3 H 2.502 
 99 TYR N N 114.221 
 101 SER CA C 53.879 
 101 SER CB C 64.091 
 101 SER H H 8.945 
 101 SER HA H 4.05 
 101 SER HB2 H 3.623 
 101 SER HB3 H 3.623 
 101 SER N N 123.8 
 102 ALA CA C 53.24 
 102 ALA CB C 14.975 
 102 ALA H H 9.053 
 102 ALA HA H 3.741 
 102 ALA HB H 1.342 
 102 ALA N N 124.809 
 103 ALA CA C 52.597 
 103 ALA CB C 15.203 
 103 ALA H H 8.16 
 103 ALA HA H 3.874 
 103 ALA HB H 1.217 
 103 ALA N N 118.545 
 104 GLU CA C 56.522 
 104 GLU CB C 27.395 
 104 GLU CG C 34.156 
 104 GLU H H 7.61 
 104 GLU HA H 3.906 
 104 GLU HB2 H 1.887 
 104 GLU HB3 H 1.782 
 104 GLU HG2 H 2.144 
 104 GLU N N 118.667 
 105 LEU CA C 55.764 
 105 LEU CB C 39.445 
 105 LEU CG C 23.77 
 105 LEU CD1 C 21.6 
 105 LEU H H 8.069 
 105 LEU HA H 4.116 
 105 LEU HB2 H 1.769 
 105 LEU HB3 H 1.769 
 105 LEU HG H 1.513 
 105 LEU HD1 H 0.643 
 105 LEU HD2 H 1.096 
 105 LEU N N 121.56 
 106 ARG CA C 57.313 
 106 ARG CB C 27.084 
 106 ARG CG C 25.26 
 106 ARG CD C 40.65 
 106 ARG H H 8.742 
 106 ARG HA H 3.939 
 106 ARG HB2 H 1.765 
 106 ARG HB3 H 1.882 
 106 ARG HG2 H 1.48 
 106 ARG HD2 H 2.795 
 106 ARG HD3 H 3.005 
 106 ARG N N 118.436 
 107 HIS CA C 56.471 
 107 HIS CB C 26.74 
 107 HIS H H 7.795 
 107 HIS HA H 4.241 
 107 HIS HB2 H 3.178 
 107 HIS HB3 H 3.178 
 107 HIS N N 118.439 
 108 VAL CA C 64.05 
 108 VAL CB C 29.253 
 108 VAL CG1 C 20.476 
 108 VAL CG2 C 18.766 
 108 VAL H H 7.61 
 108 VAL HA H 3.413 
 108 VAL HB H 1.901 
 108 VAL HG1 H 0.724 
 108 VAL HG2 H 0.296 
 108 VAL N N 118.849 
 109 MET CA C 55.798 
 109 MET CB C 27.394 
 109 MET CG C 31.08 
 109 MET H H 8.054 
 109 MET HA H 3.899 
 109 MET HB2 H 1.761 
 109 MET HB3 H 1.761 
 109 MET HG2 H 2.166 
 109 MET HG3 H 2.166 
 109 MET N N 115.69 
 110 THR CA C 63.728 
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 110 THR CB C 65.93 
 110 THR CG2 C 18.818 
 110 THR H H 8.433 
 110 THR HA H 3.794 
 110 THR HB H 4.156 
 110 THR HG2 H 1.112 
 110 THR N N 115.945 
 111 ASN CA C 52.949 
 111 ASN CB C 34.964 
 111 ASN H H 7.836 
 111 ASN HA H 4.267 
 111 ASN HB2 H 2.827 
 111 ASN HB3 H 2.827 
 111 ASN N N 123.336 
 112 LEU CA C 52.802 
 112 LEU CB C 39.533 
 112 LEU CG C 23.541 
 112 LEU CD1 C 20.248 
 112 LEU H H 7.643 
 112 LEU HA H 4.057 
 112 LEU HB2 H 1.697 
 112 LEU HB3 H 1.46 
 112 LEU HG H 1.572 
 112 LEU HD1 H 0.546 
 112 LEU N N 119.072 
 113 GLY CA C 42.636 
 113 GLY H H 7.698 
 113 GLY HA2 H 3.597 
 113 GLY HA3 H 4.077 
 113 GLY N N 106.862 
 114 GLU CA C 51.859 
 114 GLU CB C 27.539 
 114 GLU CG C 31.651 
 114 GLU H H 7.841 
 114 GLU HA H 4.267 
 114 GLU HB2 H 1.756 
 114 GLU HB3 H 1.756 
 114 GLU HG2 H 1.927 
 114 GLU HG3 H 1.927 
 114 GLU N N 120.273 
 115 LYS CA C 53.105 
 115 LYS CB C 29.481 
 115 LYS CG C 21.714 
 115 LYS CD C 26.283 
 115 LYS CE C 39.304 
 115 LYS H H 8.336 
 115 LYS HA H 4.195 
 115 LYS HB2 H 1.769 
 115 LYS HB3 H 1.769 
 115 LYS HG2 H 1.342 
 115 LYS HG3 H 1.224 
 115 LYS HD2 H 1.491 
 115 LYS HD3 H 1.491 
 115 LYS HE2 H 2.805 
 115 LYS HE3 H 2.805 
 115 LYS N N 123.547 
 116 LEU CA C 51.438 
 116 LEU CB C 42.168 
 116 LEU CG C 23.77 
 116 LEU CD1 C 20.8 
 116 LEU H H 7.937 
 116 LEU HA H 4.445 
 116 LEU HB2 H 1.534 
 116 LEU HB3 H 1.534 
 116 LEU HG H 1.513 
 116 LEU HD1 H 0.632 
 116 LEU HD2 H 0.632 
 116 LEU N N 125.24 
 117 THR CA C 57.851 
 117 THR CB C 68.352 
 117 THR CG2 C 18.876 
 117 THR H H 8.884 
 117 THR HA H 4.28 
 117 THR HB H 4.622 
 117 THR HG2 H 1.164 
 117 THR N N 113.274 
 118 ASP CA C 55.259 
 118 ASP CB C 37.114 
 118 ASP H H 8.694 
 118 ASP HA H 4.037 
 118 ASP HB2 H 2.519 
 118 ASP HB3 H 2.519 
 118 ASP N N 120.555 
 119 GLU CA C 55.091 
 119 GLU CB C 27.202 
 119 GLU CG C 33.358 
 119 GLU H H 8.492 
 119 GLU HA H 3.927 
 119 GLU HB2 H 1.759 
 119 GLU HB3 H 1.876 
 119 GLU HG2 H 2.157 
 119 GLU HG3 H 2.157 
 119 GLU N N 119.03 
 120 GLU CA C 56.438 
 120 GLU CB C 27.197 
 120 GLU CG C 33.358 
 120 GLU H H 7.769 
 120 GLU HA H 3.886 
 120 GLU HB2 H 1.9 
 120 GLU HB3 H 1.761 
 120 GLU HG2 H 2.157 
 120 GLU HG3 H 2.157 
 120 GLU N N 119.017 
 121 VAL CA C 63.944 
 121 VAL CB C 28.567 
 121 VAL CG1 C 20.343 
 121 VAL CG2 C 18.744 
 121 VAL H H 7.927 
 121 VAL HA H 3.498 
 121 VAL HB H 2.032 
 121 VAL HG1 H 0.822 
 121 VAL HG2 H 0.98 
 121 VAL N N 120.488 
 122 ASP CA C 53.776 
 122 ASP CB C 39.172 
 122 ASP H H 7.923 
 122 ASP HA H 3.939 
 122 ASP HB2 H 1.887 
 122 ASP HB3 H 2.801 
 122 ASP N N 120.148 
 123 GLU CA C 56.746 
 123 GLU CB C 26.361 
 123 GLU CG C 33.595 
 123 GLU H H 8.175 
 123 GLU HA H 3.877 
 123 GLU HB2 H 1.896 
 123 GLU HB3 H 1.896 
 123 GLU HG2 H 2.164 
 123 GLU HG3 H 2.164 
 123 GLU N N 122.029 
 124 MET CA C 56.438 
 124 MET CB C 30.973 
 124 MET CG C 31.446 
 124 MET H H 7.841 
 124 MET HA H 3.638 
 124 MET HB2 H 2.164 
 124 MET HB3 H 2.164 
 124 MET HG2 H 2.26 
 124 MET HG3 H 2.26 
 124 MET N N 118.2 
 125 ILE CA C 61.816 
 125 ILE CB C 34.363 
 125 ILE CG1 C 26.401 
 125 ILE CG2 C 14.023 
 125 ILE CD1 C 9.372 
 125 ILE H H 7.699 
 125 ILE HA H 3.36 
 125 ILE HB H 1.867 
 125 ILE HG1 H 1.465 
 125 ILE HG1 H 1.465 
 125 ILE HG2 H 0.633 
 125 ILE HD1 H 0.556 
 125 ILE N N 118.392 
 126 ARG CA C 56.741 
 126 ARG CB C 27.426 
 126 ARG CG C 25.77 
 126 ARG H H 8.006 
 126 ARG HA H 3.854 
 126 ARG HB2 H 2.174 
 126 ARG HB3 H 2.174 
 126 ARG HG2 H 1.877 
 126 ARG HG3 H 1.877 
 126 ARG N N 119.829 
 127 GLU CA C 55.529 
 127 GLU CB C 26.937 
 127 GLU CG C 33.612 
 127 GLU H H 7.792 
 127 GLU HA H 3.937 
 127 GLU HB2 H 1.692 
 127 GLU HB3 H 1.692 
 127 GLU HG2 H 2.174 
 127 GLU HG3 H 2.174 
 127 GLU N N 116.582 
 128 ALA CA C 49.436 
 128 ALA CB C 18.229 
 128 ALA H H 7.119 
 128 ALA HA H 3.917 
 128 ALA HB H 1.336 
 128 ALA N N 119.373 
 129 ALA CA C 49.756 
 129 ALA CB C 16.625 
 129 ALA H H 7.502 
 129 ALA HA H 4.141 
 129 ALA HB H 1.231 
 129 ALA N N 120.476 
 130 ILE CA C 58.238 
 130 ILE CB C 36.019 
 130 ILE CG1 C 24.509 
 130 ILE CG2 C 14.654 
 130 ILE CD1 C 10.239 
 130 ILE H H 8.071 
 130 ILE HA H 3.925 
 130 ILE HB H 1.676 
 130 ILE HG1 H 1.274 
 130 ILE HG1 H 1.274 
 130 ILE HG2 H 0.681 
 130 ILE HD1 H 0.662 
 130 ILE N N 123.246 
 131 ASP CA C 49.974 
 131 ASP CB C 37.622 
 131 ASP H H 8.251 
 131 ASP HA H 4.411 
 131 ASP HB2 H 2.482 
 131 ASP HB3 H 2.482 
 131 ASP N N 122.43 
 132 GLY CA C 43.579 
 132 GLY H H 7.873 
 132 GLY HA2 H 3.774 
 132 GLY HA3 H 3.774 
 132 GLY N N 106.4 
 133 ASP CA C 50.311 
 133 ASP CB C 38.143 
 133 ASP H H 7.603 
 133 ASP HA H 4.438 
 133 ASP HB2 H 2.801 
 133 ASP HB3 H 2.801 
 133 ASP N N 118.443 
 134 GLY CA C 43.141 
 134 GLY H H 8.319 
 134 GLY HA2 H 3.748 
 134 GLY HA3 H 3.748 
 134 GLY N N 107.316 
 135 GLN CA C 50.951 
 135 GLN CB C 27.118 
 135 GLN CG C 30.394 
 135 GLN H H 7.559 
 135 GLN HA H 4.684 
 135 GLN HB2 H 1.679 
 135 GLN HB3 H 1.679 
 135 GLN HG2 H 1.879 
 135 GLN HG3 H 1.879 
 135 GLN N N 116.214 
 136 VAL CA C 58.794 
 136 VAL CB C 29.869 
 136 VAL CG1 C 19.699 
 136 VAL CG2 C 18.201 
 136 VAL H H 9.106 
 136 VAL HA H 4.628 
 136 VAL HB H 2.039 
 136 VAL HG1 H 0.936 
 136 VAL HG2 H 0.696 
 136 VAL N N 125.848 
 137 ASN CA C 48.776 
 137 ASN CB C 36.428 
 137 ASN H H 9.112 
 137 ASN HA H 5.017 
 137 ASN HB2 H 2.597 
 137 ASN HB3 H 2.321 
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 137 ASN N N 127.154 
 138 TYR CA C 59.703 
 138 TYR CB C 36.335 
 138 TYR H H 8.347 
 138 TYR HA H 3.163 
 138 TYR HB2 H 2.183 
 138 TYR HB3 H 2.321 
 138 TYR N N 118.958 
 139 GLU CA C 57.649 
 139 GLU CB C 25.94 
 139 GLU CG C 33.25 
 139 GLU H H 8.11 
 139 GLU HA H 3.838 
 139 GLU HB2 H 1.876 
 139 GLU HB3 H 1.876 
 139 GLU HG2 H 2.177 
 139 GLU HG3 H 2.177 
 139 GLU N N 118.008 
 140 GLU C C 173.466 
 140 GLU CA C 56.101 
 140 GLU CB C 31.534 
 140 GLU H H 8.237 
 140 GLU HA H 3.649 
 140 GLU HB2 H 2.262 
 140 GLU HB3 H 2.262 
 140 GLU N N 119.41 
 141 PHE CA C 59.097 
 141 PHE CB C 37.571 
 141 PHE H H 8.313 
 141 PHE HA H 3.781 
 141 PHE HB2 H 2.834 
 141 PHE HB3 H 2.834 
 141 PHE N N 123.172 
 142 VAL CA C 64.214 
 142 VAL CB C 28.766 
 142 VAL CG1 C 20.305 
 142 VAL CG2 C 18.589 
 142 VAL H H 8.34 
 142 VAL HA H 3.038 
 142 VAL HB H 1.644 
 142 VAL HG1 H 0.349 
 142 VAL HG2 H 0.592 
 142 VAL N N 118.252 
 143 GLN CA C 56.337 
 143 GLN CB C 25.336 
 143 GLN CG C 31.511 
 143 GLN H H 7.634 
 143 GLN HA H 3.636 
 143 GLN HB2 H 1.953 
 143 GLN HB3 H 1.953 
 143 GLN HG2 H 2.157 
 143 GLN HG3 H 2.157 
 143 GLN N N 119.499 
 144 MET CA C 55.764 
 144 MET CB C 30.736 
 144 MET CG C 31.534 
 144 MET H H 7.605 
 144 MET HA H 3.662 
 144 MET HB2 H 2.256 
 144 MET HB3 H 2.256 
 144 MET HG2 H 2.288 
 144 MET HG3 H 2.288 
 144 MET N N 117.28 
 145 MET CA C 53.408 
 145 MET CB C 29.253 
 145 MET CG C 30.052 
 145 MET H H 7.467 
 145 MET HA H 4.004 
 145 MET HB2 H 2.032 
 145 MET HB3 H 2.032 
 145 MET HG2 H 1.907 
 145 MET HG3 H 1.907 
 145 MET N N 114.953 
 146 THR CA C 59.097 
 146 THR CB C 67.755 
 146 THR CG2 C 18.401 
 146 THR H H 7.465 
 146 THR HA H 4.156 
 146 THR HB H 4.096 
 146 THR HG2 H 0.984 
 146 THR N N 107.746 
 147 ALA CA C 50.109 
 147 ALA CB C 16.437 
 147 ALA H H 7.656 
 147 ALA HA H 4.123 
 147 ALA HB H 1.23 
 147 ALA N N 126.366 
 148 LYS CA C 54.753 
 148 LYS CB C 26.283 
 148 LYS CG C 21.828 
 148 LYS CD C 30.852 
 148 LYS CE C 39.419 
 148 LYS H H 7.758 
 148 LYS HA H 3.945 
 148 LYS HB2 H 1.493 
 148 LYS HB3 H 1.493 
 148 LYS HG2 H 1.217 
 148 LYS HG3 H 1.217 
 148 LYS HD2 H 1.624 
 148 LYS HD3 H 1.624 
 148 LYS HE2 H 2.816 
 148 LYS HE3 H 2.816 
 148 LYS N N 125.937 
iNOS peptide 
 515 LEU CA C 55.533 
 515 LEU H H 9.403 
 515 LEU HA H 3.779 
 515 LEU HB2 H 1.759 
 515 LEU HB3 H 1.759 
 515 LEU HG H 1.333 
 515 LEU HD1 H 0.717 
 515 LEU HD2 H 0.717 
 515 LEU N N 128.585 
 516 LYS CA C 56.947 
 516 LYS H H 8.841 
 516 LYS HA H 3.749 
 516 LYS HB2 H 1.744 
 516 LYS HB3 H 1.744 
 516 LYS HG2 H 1.235 
 516 LYS HG3 H 1.235 
 516 LYS N N 115.21 
 517 VAL CA C 63.221 
 517 VAL H H 6.876 
 517 VAL HA H 3.476 
 517 VAL HB H 1.94 
 517 VAL HG1 H 0.81 
 517 VAL HG2 H 0.81 
 517 VAL N N 117.71 
 518 LEU CA C 55.392 
 518 LEU H H 7.67 
 518 LEU HA H 3.854 
 518 LEU HB2 H 1.581 
 518 LEU HB3 H 1.581 
 518 LEU HG H 1.414 
 518 LEU HD1 H 0.806 
 518 LEU N N 120.709 
 519 VAL CA C 64.212 
 519 VAL H H 8.606 
 519 VAL HA H 3.768 
 519 VAL HB H 1.907 
 519 VAL HG1 H 0.717 
 519 VAL HG2 H 0.717 
 519 VAL N N 111.964 
 520 LYS CA C 57.786 
 520 LYS H H 7.112 
 520 LYS HA H 4.014 
 520 LYS HB2 H 2.006 
 520 LYS HB3 H 2.006 
 520 LYS HG2 H 0.717 
 520 LYS HG3 H 0.717 
 520 LYS HD2 H 1.7 
 520 LYS HD3 H 1.7 
 520 LYS N N 119.833 
 521 ALA CA C 53.207 
 521 ALA H H 7.838 
 521 ALA HA H 4.161 
 521 ALA HB H 1.681 
 521 ALA N N 120.555 
 522 VAL CA C 64.502 
 522 VAL H H 8.265 
 522 VAL HA H 3.557 
 522 VAL HB H 2.331 
 522 VAL HG1 H 0.996 
 522 VAL HG2 H 0.996 
 522 VAL N N 116.827 
 523 LEU CA C 56.264 
 523 LEU H H 8.76 
 523 LEU HA H 4.003 
 523 LEU HB2 H 2.036 
 523 LEU HB3 H 2.036 
 523 LEU HG H 1.691 
 523 LEU HD1 H 0.952 
 523 LEU HD2 H 0.952 
 523 LEU N N 121.446 
 524 PHE CA C 58.812 
 524 PHE H H 7.948 
 524 PHE HA H 4.184 
 524 PHE HB2 H 3.428 
 524 PHE HB3 H 3.428 
 524 PHE HD1 H 6.773 
 524 PHE HD2 H 6.773 
 524 PHE N N 118.793 
 525 ALA CA C 52.859 
 525 ALA H H 7.738 
 525 ALA HA H 3.715 
 525 ALA HB H 1.578 
 525 ALA N N 117.951 
 526 CYS CA C 61.415 
 526 CYS H H 8.567 
 526 CYS HA H 4.07 
 526 CYS HB2 H 3.073 
 526 CYS HB3 H 2.933 
 526 CYS N N 115.303 
 527 MET CA C 56.156 
 527 MET H H 8.462 
 527 MET HA H 3.919 
 527 MET HB2 H 2.046 
 527 MET HB3 H 2.046 
 527 MET HG2 H 2.691 
 527 MET HG3 H 2.691 
 527 MET N N 120.601 
 528 LEU CA C 52.975 
 528 LEU H H 7.196 
 528 LEU HA H 3.93 
 528 LEU HB2 H 1.449 
 528 LEU HB3 H 1.449 
 528 LEU HG H 1.102 
 528 LEU HD1 H 0.316 
 528 LEU HD2 H 0.316 
 528 LEU N N 118.166 
 529 MET CA C 54.169 
 529 MET H H 7.27 
 529 MET HA H 4.048 
 529 MET HB2 H 1.963 
 529 MET HB3 H 1.963 
 529 MET HG2 H 2.643 
 529 MET HG3 H 2.643 
 529 MET N N 117.255 
 530 ARG CA C 53.31 
 530 ARG H H 7.981 
 530 ARG HA H 4.048 
 530 ARG HB2 H 1.82 
 530 ARG HB3 H 1.82 
 530 ARG HG2 H 1.696 
 530 ARG HG3 H 1.696 
 530 ARG N N 122.437 
 531 LYS CA C 54.802 
 531 LYS H H 7.923 
 531 LYS HA H 4.184 
 531 LYS HB2 H 1.601 
 531 LYS HB3 H 1.601 
 531 LYS HG2 H 1.276 
 531 LYS HG3 H 1.276 
 531 LYS HE2 H 3.104 
 531 LYS HE3 H 3.104 
 531 LYS N N 128.142 
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Appendix J 
CaM at 1.3 μM free Ca2+ Assigned Chemical Shifts 
    
_Residue_seq_code 
_Residue_label 
_Atom_name 
_Atom_type 
_Chem_shift_value 
3 GLN H H 8.093 
 3 GLN N N 118.305 
 4 LEU H H 8.185 
 4 LEU N N 121.741 
 5 THR H H 8.691 
 5 THR N N 112.733 
 6 GLU H H 8.919 
 6 GLU N N 120.077 
 7 GLU H H 8.634 
 7 GLU N N 119.231 
 8 GLN H H 7.629 
 8 GLN N N 120.437 
 9 ILE H H 8.115 
 9 ILE N N 118.313 
 10 ALA H H 7.835 
 10 ALA N N 120.124 
 11 GLU H H 7.684 
 11 GLU N N 120.059 
 12 PHE H H 8.691 
 12 PHE N N 120.241 
 13 LYS H H 9.138 
 13 LYS N N 121.341 
 14 GLU H H 7.966 
 14 GLU N N 120.352 
 15 ALA H H 7.545 
 15 ALA N N 120.716 
 16 PHE H H 8.428 
 16 PHE N N 117.813 
 17 SER H H 8.328 
 17 SER N N 110.931 
 18 LEU H H 7.261 
 18 LEU N N 121.127 
 19 PHE H H 7.275 
 19 PHE N N 114.595 
 20 ASP H H 7.216 
 20 ASP N N 122.323 
 21 LYS H H 7.972 
 21 LYS N N 123.505 
 22 ASP H H 8.601 
 22 ASP N N 116.797 
 23 GLY H H 7.906 
 23 GLY N N 110.115 
 24 ASP H H 8.669 
 24 ASP N N 120.623 
 25 GLY H H 10.111 
 25 GLY N N 111.985 
 26 THR H H 7.504 
 26 THR N N 110.146 
 27 ILE H H 8.181 
 27 ILE N N 110.653 
 28 THR H H 8.239 
 28 THR N N 110.721 
 29 THR H H 8.201 
 29 THR N N 112.395 
 30 LYS H H 7.532 
 30 LYS N N 118.803 
 31 GLU H H 7.408 
 31 GLU N N 117.413 
 32 LEU H H 7.247 
 32 LEU N N 120.701 
 33 GLY H H 8.705 
 33 GLY N N 105.413 
 34 THR H H 7.415 
 34 THR N N 118.133 
 35 VAL H H 7.854 
 35 VAL N N 122.623 
 36 MET H H 8.359 
 36 MET N N 118.307 
 37 ARG H H 8.416 
 37 ARG N N 119.233 
 38 SER H H 8.01 
 38 SER N N 118.995 
 39 LEU H H 7.238 
 39 LEU N N 120.986 
 40 GLY H H 7.815 
 40 GLY N N 107.023 
 41 GLN H H 7.673 
 41 GLN N N 117.816 
 42 ASN H H 8.574 
 42 ASN N N 116.603 
 44 THR H H 8.711 
 44 THR N N 113.033 
 45 GLU H H 8.756 
 45 GLU N N 120.377 
 46 ALA H H 8.225 
 46 ALA N N 121.013 
 47 GLU H H 7.639 
 47 GLU N N 118.78 
 48 LEU H H 8.251 
 48 LEU N N 119.959 
 49 GLN H H 7.945 
 49 GLN N N 117.495 
 50 ASP H H 7.731 
 50 ASP N N 118.841 
 51 MET H H 7.858 
 51 MET N N 119.059 
 52 ILE H H 8.257 
 52 ILE N N 119.121 
 53 ASN H H 8.146 
 53 ASN N N 117.304 
 54 GLU H H 7.48 
 54 GLU N N 117.349 
 55 VAL H H 7.52 
 55 VAL N N 112.777 
 56 ASP H H 8.357 
 56 ASP N N 121.841 
 57 ALA H H 8.061 
 57 ALA N N 124.805 
 58 ASP H H 8.335 
 58 ASP N N 114.525 
 59 GLY H H 7.787 
 59 GLY N N 108.859 
 60 ASN H H 9.179 
 60 ASN N N 119.705 
 61 GLY H H 9.997 
 61 GLY N N 110.402 
 62 THR H H 7.463 
 62 THR N N 110.641 
 63 ILE H H 8.813 
 63 ILE N N 118.921 
 64 ASP H H 8.567 
 64 ASP N N 124.741 
 65 PHE H H 8.536 
 65 PHE N N 118.667 
 67 GLU H H 7.967 
 67 GLU N N 117.549 
 68 PHE H H 8.354 
 68 PHE N N 122.305 
 69 LEU H H 8.362 
 69 LEU N N 118.56 
 70 THR H H 7.629 
 70 THR N N 115.305 
 71 MET H H 7.611 
 71 MET N N 121.295 
 72 MET H H 7.919 
 72 MET N N 117.359 
 73 ALA H H 8.211 
 73 ALA N N 120.833 
 74 ARG H H 7.379 
 74 ARG N N 116.712 
 75 LYS H H 7.628 
 75 LYS N N 118.177 
 76 MET H H 7.837 
 76 MET N N 117.723 
 77 LYS H H 7.824 
 77 LYS N N 120.302 
 78 ASP H H 8.227 
 78 ASP N N 121.923 
 79 THR H H 8.048 
 79 THR N N 114.681 
 80 ASP H H 8.274 
 80 ASP N N 123.52 
 81 SER H H 8.367 
 81 SER N N 117.212 
 82 GLU H H 8.377 
 82 GLU N N 121.991 
 83 GLU H H 8.272 
 83 GLU N N 119.491 
 84 GLU H H 7.92 
 84 GLU N N 119.05 
 85 ILE H H 7.985 
 85 ILE N N 121.858 
 86 ARG H H 8.302 
 86 ARG N N 121.676 
 87 GLU H H 7.968 
 87 GLU N N 117.928 
 88 ALA H H 7.878 
 88 ALA N N 122.505 
 89 PHE H H 8.477 
 89 PHE N N 118.726 
 90 ARG H H 7.609 
 90 ARG N N 115.621 
 91 VAL H H 7.472 
 91 VAL N N 118.122 
 92 PHE H H 7.47 
 92 PHE N N 116.972 
 93 ASP H H 7.755 
 93 ASP N N 116.948 
 94 LYS H H 7.592 
 94 LYS N N 125.458 
 95 ASP H H 8.088 
 95 ASP N N 113.818 
 96 GLY H H 7.693 
 96 GLY N N 109.055 
 97 ASN H H 8.241 
 97 ASN N N 119.409 
 98 GLY H H 10.558 
 98 GLY N N 112.784 
 99 TYR H H 7.509 
 99 TYR N N 115.626 
 100 ILE H H 10.057 
 100 ILE N N 127.014 
 101 SER H H 8.855 
 101 SER N N 123.577 
 102 ALA H H 9.101 
 102 ALA N N 122.738 
 103 ALA H H 8.159 
 103 ALA N N 118.461 
 104 GLU H H 7.779 
 104 GLU N N 119.434 
 105 LEU H H 8.515 
 105 LEU N N 121.131 
 106 ARG H H 8.475 
 106 ARG N N 117.619 
 107 HIS H H 7.871 
 107 HIS N N 118.677 
 108 VAL H H 7.827 
 108 VAL N N 118.879 
 109 MET H H 8.162 
 109 MET N N 116.356 
 110 THR H H 8.057 
 110 THR N N 114.89 
 111 ASN H H 7.844 
 111 ASN N N 121.797 
 112 LEU H H 7.783 
 112 LEU N N 118.58 
 113 GLY H H 7.791 
 113 GLY N N 106.894 
 114 GLU H H 7.819 
 114 GLU N N 120.538 
 115 LYS H H 8.513 
 115 LYS N N 123.522 
 116 LEU H H 8.059 
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 116 LEU N N 125.094 
 117 THR H H 9.146 
 117 THR N N 114.508 
 118 ASP H H 8.81 
 118 ASP N N 120.809 
 119 GLU H H 8.615 
 119 GLU N N 119.002 
 120 GLU H H 7.685 
 120 GLU N N 120.416 
 121 VAL H H 8.035 
 121 VAL N N 120.932 
 122 ASP H H 7.966 
 122 ASP N N 119.445 
 123 GLU H H 7.886 
 123 GLU N N 119.316 
 124 MET H H 7.768 
 124 MET N N 119.181 
 125 ILE H H 7.852 
 125 ILE N N 118.182 
 126 ARG H H 8.132 
 126 ARG N N 118.295 
 127 GLU H H 7.858 
 127 GLU N N 115.842 
 128 ALA H H 7.239 
 128 ALA N N 118.592 
 129 ASP H H 7.774 
 129 ASP N N 117.274 
 130 ILE H H 8.238 
 130 ILE N N 127.45 
 131 ASP H H 8.205 
 131 ASP N N 116.317 
 132 GLY H H 7.489 
 132 GLY N N 108.454 
 133 ASP H H 8.231 
 133 ASP N N 120.693 
 134 GLY H H 10.297 
 134 GLY N N 112.745 
 135 GLN H H 7.854 
 135 GLN N N 115.315 
 136 VAL H H 9.04 
 136 VAL N N 125.163 
 137 ASN H H 9.389 
 137 ASN N N 128.788 
 138 TYR H H 8.389 
 138 TYR N N 118.049 
 139 GLU H H 8.077 
 139 GLU N N 118.303 
 140 GLU H H 8.68 
 140 GLU N N 119.706 
 141 PHE H H 8.912 
 141 PHE N N 124.776 
 142 VAL H H 8.421 
 142 VAL N N 119.43 
 143 GLN H H 7.219 
 143 GLN N N 117.644 
 144 MET H H 7.886 
 144 MET N N 119.6 
 145 MET H H 7.7 
 145 MET N N 114.371 
 146 THR H H 7.504 
 146 THR N N 110.949 
 147 ALA H H 7.713 
 147 ALA N N 126.535 
 148 LYS H H 7.625 
 148 LYS N N 125.506 
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